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4Abstract
INTRODUCTION: Chronic non-malignant pain poses considerable risk 10 patients and 
the health service but its management is still inadequate. The introduction of prescribing 
lor nurses and pharmacists suggests that non-medical prescribing can improve some 
important aspects of healthcare services
A IM : To provide new insights and theory regarding how nurses and pharmacists prescribe 
for chronic pain, together with how the service is perceived by chronic pain patients and 
to uncover barriers and facilitators encountered when this group is prescribed for.
METHOD: A mixed methods strategy was employed in this study. A grounded theory 
approach was used to collect data from non-medical prescrihers and patients. Non­
medical prescribes were then surveyed to confirm the emerging theory and determine 
barriers and facilitators.
FIND INGS: The theory ‘safety and support within the prescribing environment’ explains 
the relationship that non-medical prescribers have with colleagues, patients and other 
factors in their prescribing environment in their prescribing for chronic pain. Non-medical 
prescribers are motivated by various factors and may adopt an innovative or conservative 
approach in their prescribing. Nurses were more likely to engage in informal mentoring 
relationships, but were limited by their lack of medication knowledge. Pharmacists were 
limited by a lack o f experience with patients, inaccessibility to formal CPD in paid work 
time and the threats introduced by concerns around ‘second checking'. Chronic pain 
patients had strategies to maintain relationships with their prescribers and this relationship 
influenced the likelihood of considering other measures to cope with their pain.
CONCLUSION: Nurses and pharmacists who qualified as prescribers would be more 
likely to prescribe for chronic pain if they perceived certain essential elements in their 
prescribing environment. This theory can facilitate assessment o f non-medical 
prescribers’ support, involvement of patients and the development of resources to 
encourage prescribing.
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C H APTER I 
INTRODUCTION
This thesis is a report of the research carried out during a PhD study undertaken at the 
University of Leeds' School Of Healthcare. Two of the schools research groups, the Symptom 
Management and Long Term Conditions programme and the Medicines Management 
programme, were behind the initiation of this studentship. They focus on issues such as 
availability, access and adequacy of healthcare services for patients in general, including those 
that suffer from chronic non-malignant pain (chronic pain). This thesis could therefore be said 
to be a nexus in their research interests and has the potential not only to improve understanding 
Of how people in chronic pain get treatment, but also to give more insight into the 
implementation of the ‘non medical prescribing' policy in England.
This first chapter starts by providing a brief overview of the way that chronic pain is currently 
managed, as well as giving a contextual background to the development of non-medical 
prescribing in England. Following this, the reader is acquainted with the PhD student that 
played the role of the primary investigator. This early introduction is made in order to facilitate 
the reader’s journey and is in line with the approach underpinning this work (this approach is 
further explained in chapter 3). A brief section then outlines the writing style adopted In this 
work and also introduces the more common terminology used throughout the thesis. Finally, a 
summary of the contents of each chapter of the thesis is then provided. It is intended that this 
‘chapter by chapter'-summary in addition to the maps provided at the beginning of each chapter 
will improve the ease with which the entire thesis is navigated.
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1.1 Background
Chronic pain has been defined as a continuous, unpleasant sensory and emotional 
experience which may be due to actual or potential tissue damage and has occurred lor more 
than 12 weeks or past the time that healing would have been thought to have occurred in pain 
alter trauma or surgery (Merskev and Bogduk. 1994: British Pain Society, 2011). This 
qualifying duration within which the pain is classified as chronic or persistent has also been 
extended to at least six months (Breivik el a'J.. 2006). Chronic pain represents significant 
discomfort to individuals with the condition and also has important implications for the 
healthcare system that provides services for these individuals. In addition to the pain suffered by 
patients, there is evidence that the condition may also affect (heir quality of life, productivity 
and socioeconomic position (Breivik et aJ„ 2006). In the UK, evidence suggests that between 
20% (Smith et aJ., 2001) and 50% ('Elliot et al.. 1999) of the adult population may suffer from 
chronic pain, potentially constituting a major concern for healthcare providers.
Adequate standards o f care regarding treatment and management of chronic pain are not being 
achieved. These relate both to how care in this area is provided and to issues in the way those 
patients with the condition access their care. From the perspective of healthcare providers, 
several reasons exist for the inadequacies in the current management of chronic pain. They 
include: communication related problems, such as disregard for the patients' perspective and 
non concordant practices (Breivik et al.. 2006: Walsh et al.. 2008): access to and availability of 
pain-specific training for clinicians (Stannard and Johnson. 2003): clinician related factors such 
as attitude towards the patient (Sherwood et al.. 2000): concerns about the adequacy of 
analgesic prescribing by clinicians as well as the availability of qualified healthcare 
professionals to carry out this service (Schafheutle el al. 2001): access to related healthcare 
services (Green et al.. 2003): and availability and effectiveness of such services when they are 
needed (Stannard and Johnson. 2003).
From the patient's perspective, chronic pain has been associated with other problems which 
though significant, may not initially seem important or apparent. It has been identified that the 
chronic and intractable nature of their pain renders this group of patients predisposed to 
disturbed social and vocational functioning (McCracken et al.. 2002). For patients with chronic 
pain, there is also usually an additional need to address other behavioural and psychological 
issues that often arise from their condition (Walsh et al.. 2008). As a result of these, it is not 
uncommon for patients with chronic pain to utilise considerably more healthcare services, 
compared to other members of the general population (Von KorfTet al., 1991; Eriksen et al.. 
2003). Other related issues that may influence the way chronic pain is managed include the 
ambiguity expressed by patients regarding satisfaction with the service provided and their 
achievement of pain relief (Chung and Lui. 2003) as well as the propensity for these pat ients to
miss appointments and switch healthcare providers as a result of being dissatisfied with services 
received (McCracken et all., 2002).
(n addition to these issues, studies have revealed that although more than 75% of chronic 
pain sufferers resort to conventional treatment for pain relief, the desired goal is not achieved in 
at least one in three patients (Brcivik et al.. 2006) and perhaps as a result of this, patients may 
seek additional care, even when it may not be advisable (McCracken el al.. 1997). Some other 
measures that patients with chronic pain have been known to resort to for their pain relief 
include massage, home remedies, exercise and Transcutaneous Electrical Nerve Stimulation 
(TEN S) (Ferrell et al.. 1993: Shi et al.. 2007: Nnoahan and Kumbang, 2008). Evidence suggests 
that some of these may not be as effective as conventional medicine (Shi et al.. 2007). However, 
simultaneously accessing services from multiple providers may complicate the efficiency and 
effectiveness of their treatment.
Reforms in the United Kingdom aimed at improving the provision of health care 
(including the management of chronic pain) have resulted in the establishment of various 
schemes. Apart from non-medical prescribing which is the focus of this study, others include 
minor ailment schemes (M AS) and patient group directions (PGDs). It is beyond the purview of 
this work to discuss these and further details are available elsewhere (Btenkinsopp. 2003: 
Department of Health (Dol l). 2009). Non-medical prescribing has undergone several changes 
since its inception. Initially, only some appropriately qualified community nurses could 
prescribe. The main aim of this policy was to improve the speed and access of care to patients 
while ensuring that safety was maintained (D oll. 2002). There were however concerns 
regarding how this was being applied in practice such as the potential for duplication of 
prescriptions due to the significant limitations in terms of the number of drugs that these nurses 
could prescribe (Mula and Ware. 2003). Subsequently, based on a review o f the existing 
legislative framework on prescribing, supply and administration of medicines (DoH. 1999) 
further changes were made to include pharmacists and others, as well as to further develop the 
existing models to allow these healthcare professionals to prescribe.
Although now. some other healthcare professionals also have prescribing rights, nurses 
and pharmacists became the first major groups to achieve non-medical prescribing (DoH. 2008). 
Generally, for nurses and pharmacists, the two major categories of prescriber status are 
supplementary and independent. Nurse and pharmacist independent prescribers are able to 
prescribe medicines for any medical condition within their competence. For nurses this includes 
some controlled drugs (DoH, 2006a) but not for pharmacist independent prescribers currently . 
Supplementary prescribing on the other hand is subject to a partnership with an independent 
prescriber (a medical doctor or a dentist). This involves implementing an agreed patient-specific 
clinical management plan after obtaining the patient's consent and allows prescribing of any 
drug within the practitioner's competence (DoH. 2003).
The foremost objectives cited by the Department of Health (D oll) for putting in place the 
reforms that have led to prescribing rights for nurses, pharmacists and other healthcare 
professionals include the follow mg;
• Improving healthcare services for patients
• Better access to medicines
• Availability of more choice for patients
• Cost efficiency
• Better use of the skills mix of healthcare professionals (DoH. 2008).
The evidence suggests that some of these objectives are being met. For instance, studies 
have found that prescribing by nurses and pharmacists has been associated with increased and 
safer access to medicines, as well as a perception of more effective use of healthcare 
professionals’ expertise (Luker et al.. 1998; George et at., 2006). Other related benefits that 
have also been associated with non-medical prescribing were better job satisfaction for nurses 
and pharmacists and a perception of a more important role in teams they belonged to (Warchal 
et al.. 2006: Bradley and Nolan. 2007: Lockwood and Fealy. 2008). There have however also 
been pitfalls in the implementation of the policy. Some of the barriers that have been identified 
to the development of non-medical prescribing include a lack of adequate infrastructure such as 
prescribing pads and electronic prescribing packages (Baird. 2004; Warchal et al.. 2006) and 
various other hurdles specific to their organisations (George et al., 2007). For others, lack of 
integration into the healthcare team and inadequate support from other members Of the 
healthcare team were pinpointed as hindering the way that they were able to earn out their 
prescribing (Stenner and Courtenay. 2007; 2008). These barriers perhaps give an indication of 
why 50% of pharmacists (George et al., 2007) and 25% of nurses (Bradley et at, 2007) in their 
respective cohorts had not started prescribing more than six months after qualifying.
For some time now, there has been some awareness of the need for healthcare 
professionals to adopt a more patient oriented approach. In the 1970s. a working parly report on 
pharmacy practice in hospitals urged pharmacists to take more responsibility for ensuring that 
together with colleagues, a more effective treatment was made available to patients (DSS. 
1970), Recently, the focus of healthcare deliver) on the patient has become even more 
important. The practice o f concordance in the wav that prescribing is carried out is an 
illustration of this paradigm. It has been suggested that focusing on the patient has the potential 
to achieve: better relationships between patients and prescribers: better understanding of the 
patient as a person and incorporation of the patient’s perspective in terms of beliefs and 
expectations (Brown et al., 1995; Little et al.. 2001). In line with this, clinicians have in recent 
vears been encouraged to change from the paternalistic model of consultation and prescribing 
where patients were expected to 'comply with instructions', to the more concordant approach 
that regards the patient as an equal partner in the decision making process (Weiss and Britten.
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2003). There is empirical evidence that when compared to control, the patient-focused model 
(Cox et al.. 2003) and the adoption of si more concordant approach (Smith et al.. 2008) may lead 
to an improvement in expected outcomes. Focusing on the patient and seeing them as partners 
have thus been suggested to have the capacity to improve the effectiveness of health care 
delivery (Law and Britten. 1995: Little et al.. 2001: Weiss and Britten. 2003). It is therefore 
important that the consideration of patients’ views and experiences form an integral part of any 
research into how non-medical prescribing may affect the way healthcare is provided for 
patients.
1.2 My place in this study - a reflective account
Initially. I was uncertain about including this section in the thesis because as the author of 
this document, it was rather difficult to draw a line between what constitutes a reflective account 
and a personal story. This account has been included to inform the reader of the context in 
which the study was carried out and more importantly, providing such an account is justified by 
the methodology underpinning this work that is the decision to adopt a constructivist approach. 
This is further explained in chapter 3.
The relevance of this account becomes clearer when the methodology underpinning this 
work is explained (in chapter 3), as well as when this approach is applied in the way that the 
qualitative data were collected, analysed and the results reported. From the onset and throughout 
this study, reflection was a regular exercise during the study design, data collection, analysis, 
results collation and writing up as such, this account integrates the possible influences from past 
professional experiences and an overview of other relevant aspects that may have influenced 
decisions taken during the study.
1.2.1 Professional background
My journey to this thesis did not actually start when 1 was admitted for a PhD in 2008. but 
rather in 2007 when I decided to come to the UK to study for a Masters in Global Health and 
Public Policy at the University of Edinburgh. Having previously studied pharmacy in the mostly 
•chalk and talk’ educational approach used at the time in Nigeria. I was very keen to use the 
masters degree to experience the more interactive learning style used here, as well as gain more 
insight into the British health care system.
During my scholarship interview. I recognised this project as one which would not only 
facilitate my learning process as an independent researcher, but would also enable me to gain 
considerable exposure to the highly regarded N lIS  (from a developing country perspective). So 
far this intuition seems to have paid off. An article authored by my supervisors and I regarding
the potential of pharmacy prescribing model in the UK for a developing country healthcare 
system, has been published in West Africa’s most widely read pharmacy journal and has 
generated considerable debate (Adigwe et al.. 2011).
Although my professional training (in pharmacy) has mostly been in the positivist 
paradigm, my masters degree marked the beginning of my exposure to other research 
approaches. In addition to being exposed to other important models of health care and types of 
health care systems than I was previously used to. considerable effort was made to broaden 
students' views and experiences of diverse research approaches. Unlike my British colleagues 
who may have been exposed to these other approaches at a much earlier stage of their 
educational career, this period was probably the foundation of the "broad mindedness’ that I 
depended on early in the PhD to match methodology to the research questions.
1.2.2 Being an international student
A considerable effort is made both by universities in general and supervisory teams to 
ensure that international research students are well supported in their studies here in the UK. For 
instance, most universities and faculties have international offices and international liaison 
officers dedicated to providing assistance specifically tailored for this group. However, there 
were certain experiences, which were encountered as a result of being an international student 
particularly from a developing country, which may have influenced aspects o f my study.
Recently there have been a significant number o f changes in the way that international 
students are monitored (U K BA . 2011) perhaps in a bid to prevent abuse of the immigration 
system. Keeping up with the constantly changing legislation, as well as always ensuring that the 
associated mandatory requirements are met requires considerable time and effort. Furthermore 
these have the potential to affect the psychological and other aspects of the students' welfare 
and in turn may influence the way that their research work is carried out.
For instance, increased vigilance on international students requires a minimum number of 
contacts with university officials, suggesting that they may not have the same level o f flexibility 
in working that may be available to their colleagues (for instance working from home for 
extended periods). Also by the time that this thesis would have been submitted my family and I 
would have applied for and undergone at least three screenings for permission to be in and 
remain in the UK. Current requirements include the completion of a document (43- 53 pages 
long) for each member of the applicant’s family, as well as evidence of minimum amounts of 
money for the applicant as well as for each dependent. It is possible that the uncertainty 
regarding the outcome of the application as well as the duration of the whole process (usually 
more than three months) may influence the aspects o f the study being carried out at that 
particular time.
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The requirements in terms o f ethics and other administrative processes were a major 
challenge in the way 1 managed this study, perhaps due to my naivety of the administrative 
system in UK research. The ethics and governance application processes differ significantly 
from my previous experience in healthcare research. For instance, while ethics and governance 
approvals are given together by a central body in Nigeria (the ministry of health), here they are 
separate and are administered at Trust level, rather than centrally. Although now I feel that I 
have now gained considerable experience in navigating the ethical and governance space, on 
reflection I realise that I may have been quicker in gaining these approvals if I were more adept 
and savvy. It is possible that the considerable amount o f time expended in achieving ethics and 
governance approvals may have impinged on the time taken to carry out this study
Finally, prior to coming to study in the UK, I had never heard of or been aware o f the 
existence of C RB or OH checks. For researchers used to the system, these checks may be taken 
lightly. However certain aspects o f these processes were quite daunting. For instance 
researchers from Sub-Saharan African countries may have to undergo additional tests (such as 
T B  and HIV/AIDS) and the associated psychological effects may introduce more stress to their 
working environment.
Although professionally my training as a pharmacist together with the masters provided 
inside knowledge of the study area, tny status as an international student also suggested that 1 
was an outsider This hybrid status may have enabled a fresh perspective to the way that 
research in this area was approached by the thesis.
1.3 Terminology and writing style
Two main writing styles dominate the way this work is presented. Firstly, a subjective 
temporal narrative has been used to present the results from the grounded theory phase in order 
to capture the reflective stance adopted as part of the approach. Here, there has been an 
alternation between the third and the first person narrative mode, to reflect the participants’ 
views and experiences as well as mv opinions and observations. This was done in line with the 
acknowledgement of the influence of my place (as the researcher) in the data collection and 
analysis. (This approach is further explained in chapter 3 where the constructivist approach 
chosen to underpin this study is explained and justified ). However, in other areas of this work, a 
third person objective style has also been used. This is the case in the sections of this work such 
as the report of the quantitative project and the discussion. The change to this more objective 
stvle. though in line with the convention for reporting such research, also reflects my more 
objective stance in (hose aspects of this work.
As has been indicated in the first paragraph of this chapter, the term ‘chronic pain' has 
been substituted for chronic non-malignant pain. This continues throughout this thesis. As such
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although in the literature chronic pain includes pain of cancer origin, in the context o f this work, 
chronic pain refers onl> to that of non-malignant origin and has only heen used in this wav to 
improve the flow of the thesis,
In this work, to facilitate reading and comprehension and to widen the readership where 
possible. I have limited the use of technical terms. For instance grounded theory terms have 
been substituted for language that may be regarded as more familiar to readers from diverse 
methodological backgrounds. However, in areas where these cannot be avoided, care has been 
taken to describe the terms the first time that they are used. Also in the presentation of the 
results from the qualitative projects, quotes and verbatim terms from the research participants 
have been used often to contextuali/e descriptions and help provide contextual descriptions to 
the theme being reported. I his is in line with the use of Mn vivo’ terms which are terms that 
emerged from the data in the same way that they were collected from the participants. This is 
consistent with the grounded theory approach. In the discussion, where the results from this 
study are situated within existing literature, where possible, these *in vivo' terms are replaced 
with more acceptable definitive terms.
1.4 Structure of the thesis
The thesis is presented in seven chapters. At the beginning of each chapter, a v isual aid in 
the form of a chapter map is presented. The chapter immediately following the map is 
highlighted in blue. Below are the synopses of all the chapters in this work.
Chapter 1: Introduction.
This chapter introduces the reader to the work and gives an indication of the origin of the 
research study. It provides the background for the relevant component topics and also 
introduces the reader to the researcher who carried out the study and authored this work. Finally 
it provides a means of helping to familiarise and signpost the reader to the remaining contents of 
the thesis.
Chapter 2: Literature review.
In this chapter, the scope of the relevant research area is defined. It provides details o f the 
strategy employed in searching and retrieving relevant studies in this research area. Furthermore 
it provides information regarding the inclusion and exclusion of relevant studies and carries out 
a critical review of the selected works. Based on the critical review of the extant literature in this 
area, the research gaps arc identified and the chapter is then concluded with the presentation of 
the formulated research questions.
Chapter 3: Methodology.
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This chapter focuses on the consideration and choice o f methodologies underpinning this work. 
The various relevant arguments for approaches considered are presented here and the 
justification for the chosen methodology is given.
Chapter 4: A grounded theory exploration of nurses’ and pharmacists’ views and 
experiences of prescribing for chronic pain.
This chapter provides an account o f the grounded theory exploration of nurse and pharmacist 
prescribers’ view's and experiences. Here, the methods detail the stepwise processes employed 
in the data collection and analysis, followed by the results achieved in this project. This chapter 
is concluded by a discussion of the findings of this project in relation to the existing literature
Chapter 5: Survey of non-medical prescribers.
Here, the independent survey that was designed and carried out as part of the study is reported. 
Aspects o f the emerging theory as well as other related barriers and facilitators were 
incorporated in the questionnaire designed in this project. The validated and piloted 
questionnaire was disseminated to qualified non-medical prescribers. Other aspects presented in 
this chapter include details of the analysis and the measures taken to ensure quality
Chapter 6: A  grounded theory exploration of patients' views and experiences of 
prescribing by nurses and pharmacists for their chronic pain
This chapter presents the independent exploration of chronic pain patients regarding how they 
perceived non-medical prescribing. An overview of the methods employed in the data collection 
and analysis o f this project is provided here. The results of this project are also given and 
discussed in relation to the existing literature.
Chapter?: Integrated discussion and conclusion.
The discussion in this chapter integrates the distinct projects that made up this study. The 
theoretical model that emerged in this thesis is presented here. Recommendations for 
stakeholders and further research are given. The thesis is then concluded and the strategy for 
disseminating the findings given.
ill

C H APTER 2 
L IT ER A T U R E R EV IEW
2.1 Introduction
In this chapter, the existing literature on the influence of the non-medical prescribing 
policy on provision of healthcare services and its impacl on how patients are treated w ill be 
reviewed.
l-irstly. the detailed manner in which the literature review search was carried out is 
presented in the methods section of this chapter. Here, although a systematic review was not 
part of the study, systematic methods were employed to ensure that as many relevant studies as 
possible were included. In the next Hvo sections, the relevant articles are presented in two main 
sections: views and experiences of non-medical prescribers and patients’ views and experiences 
of non-medical prescribing. In each of the above sections, the results as well as critical 
evaluation of the relevant articles are presented. In the final part of the chapter, the conclusion 
of the literature review is presented, leading into the research questions proposed for this study.
2.2 Method of the literature review
The literature review aimed at exploring existing literature to identify themes important to 
prescribing by nurse and pharmacists, as well as determining how this is currently being carried 
out in the area o f chronic pain. The literature search was carried out systematically using the 
following databases: Embase. Medline. C IN A IIL . International Pharmaceutical Abstracts. 
Pharmline (National electronic Library for Medicines) and Index to Theses. Key words and 
phrases were used to focus the search and to identify relevant articles. In addition to this, 
sensitivity in the search was increased using wildcards and Boolean operators to ensure that all 
relevant articles within each database were captured. Two strategies were employed in the 
literature search. Firstly, multipurpose field searches, where keywords are searched in the most 
likely fields. Secondly, in indexed databases such as Pharmline and Embase subject headings 
were scrutinised in an attempt to identify areas likely to be missed out by the first strategy. 
Primary sources of government policies such as government publications and websites were 
consulted. Scanning of reference lists and citation indexing were carried out on the obtained 
papers. Colleagues were also asked for suggestions and conference abstracts were searched. 
Following the search, titles and abstracts were reviewed and if the relevant inclusion criteria 
were met. the articles were included in the review. The search terms and hits are presented in 
appendix 1
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2.3 Results
The results o f the literature review are presented in two sections: views and experiences 
ol non-medical prescribes in the first, views and experiences of patients and service users in the 
second.
2.3.1 Views and experiences of non-medical prescribes
Preliminary searches revealed a significant amount o f research focused on supplementary 
nurse and pharmacist prescribing. It was decided to exclude them to enable a more focused 
review of those that had included the more recent independent prescribing. Also, those nurses 
and pharmacists who qualify as independent non-medical prescribers also hold the 
supplementary prescribing qualification and so are more likely to have relevant experiences in 
using both modes of proscribing. Furthermore, the initial overview revealed the existence of 
research that involved both nurses and pharmacists together. These two initial groups of 
prescribers are the main focus of the current research so this was also included in the criteria for 
inclusion. I low ever. any study that had focused on chronic pain irrespective of the mode of non­
medical prescribing used or professional background of the prescribers involved was included.
2.3.1.1 Inclusion criteria
Any studies that reported having carried out original research in the following areas were 
included in the review:
• Nurse and pharmacist independent prescribing
• Non-medical prescribing for chronic pain
• Nurse supplementary prescribing for chronic pain
• Pharmacist supplementary prescribing for chronic pain
2.3.1.2 exclusion criteria
The following were excluded from the review:
• Studies on extended formulary nurse independent prescribers
• Letters o f opinion to peer reviewed journals
• Self reported descriptive studies
• Descriptions of single practice settings
• Editorials
• Non-English language studies
2.3.1.3 Studies involving nurse and pharmacists prescribers together
The literature review identified five studies that had explored the views and experiences of both 
nurse and pharmacist independent prescribers which were not specifically related to chronic 
pain. The first was an evaluation of how non-medical prescribing had been implemented in one
NHS hospital I rust. (Shrestha et al.. 20.11). This study adopted a quantitative -methodology in 
surveying their non-medical prescribers as well as some other healthcare professionals whose 
views were considered of interest. Their sampling frame included 6 pharmacist prescribers. 15 
pharmacists who were not prescribers. 20 nurse prescribers and 60 doctors. They achieved 
100% response rate for prescribing pharmacists; 93% for the pharmacists who were not 
prescribers; 35% for nurse prescribers and 20% for doctors. They found that while over three 
quarters of the pharmacist prescribers were concerned about competency regarding diagnostic 
skills, the nurse prescribers in their sample were not. They also found that the pharmacist 
prescribers expressed time constraints as a major barrier to their prescribing. In a similar vein, 
they found that the pharmacist? who prescribed were still expected to fulfil similar duties to 
pharmacists who did nol prescribe, in addition to their prescribing roles, Although most o f their 
sample viewed non-medical prescribing positively in terms of improving patient care, almost 
half of the doctors in their sample had concerns about the professional boundary encroachment 
posed by non-medical prescribing (Shrestha et al., 2011).
While they compared views and experiences o f pharmacist prescribers with those of 
pharmacists who were not prescribers they did not do the same for nurse prescribers. No 
explanation was provided for excluding nurses who were not prescribers from their sample. 
This omission may have influenced the findings of aspects where they compared pharmacists to 
nurses. The research team reported piloting the questionnaire: however, some important 
preliminary work usually undertaken before piloting were either not carried out. or omitted from 
their report. For instance, there was no indication as to whether validity and reliability tests were 
carried out and if so, how they were done. Similarly, they did not provide any information or 
justification as to how the attitudinal and other items that were included in their questionnaire 
were developed. It is unclear w hether they relied on the extant literature, anecdotal evidence or 
other means to develop their questionnaire.
The second study focused on pharmacovigilance among nurse and pharmacist prescribers. In 
this study. Stewart and his colleagues (2011) adopted a quantitative design to survey non­
medical prescribers' perceptions of training contributions and potential for enhancement, with 
respect to pharmacovigilance. In their sampling strategy they recruited nurse prescribers 
through one route (the Association of Nurse Prescribers). but then targeted pharmacist 
prescribers using at least four different routes. Using a web based questionnaire, they surveyed 
912 nurse prescribers and 2-439 pharmacist prescribers. achieving a response rate of 293 (32%) 
and 320 (13%) respectively. In their study, they found that a significant proportion of the non­
medical prescribers surveyed felt that they needed to learn more about pharmacovigilance and 
reporting adverse drug reactions. Twenty-nine point six percent of the respondents said they 
were unsure about their competence in aspects o f pharmacovigilance and 34.2% of the
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population agreed that they needed further training with respect to pharmacovigilance. While 
41.4% of the respondents had never submitted a yellow card, pharmacist prescribes were more 
likely to have reported adverse drug reactions than their colleagues in the nursing profession. 
Although the study participants reported being knowledgeable about the yellow card scheme, 
only 22.8% gave correct answers to questions about the scheme (Stewart et al.. 2011).
In the UK. more nurse prescribers have qualified compared to pharmacist prescribers (Latter et 
al.. 2010). But in this study, the sampling frame for pharmacist prescribers was almost three 
times that o f nurse prescribers. No explanation was provided regarding why so many 
pharmacists were recruited, or Why the response from this group was significantly poorer than 
nurses' response. In the parts o f their study where they report the resulis o f the statistical 
analysis carried out. they have included (p<.00l ) suggesting that this was the level at which a 
result would be deemed statistically significant. They did not however, go on to give more 
details about the type of tests that were applied to determine the statistical significance of the 
results. For instance, while the Chi-Square test is considered more appropriate for categorical 
variables. Fisher's Exact Test is considered more appropriate when at least one of the constituent 
entries is relatively small (Agresti. 1902).
In the third study, Maddox and colleagues (2010) looked at factors influencing prescribing 
decisions of nurses and pharmacists. They conducted 18 in-depth interviews with non-medical 
prescribers whom they had purposivelv sampled. They found that in contrast to doctors, non- 
medical prescribers. when faced with a prescribing opportunity made a decision whether to 
prescribe or to refer their patient to another prescriber. They also found that it was only after this 
first level of decision making, that these non-medical prescribers made their second decision, 
with regards to their patients’ treatment options. In their study, nurses and pharmacists reported 
that the choices they made in their prescribing were influenced by their colleagues, regulator) 
influences, economic considerations, patient factors and the pharmaceutical industry.
Maddox and colleagues (2010) presented their findings in a conference and as such it is 
understandable that thev ma> have been limited by the word count restrictions. There were 
however, several omissions in their submission. Firstly, there was little description of the 
sample that was recruited for the study. They did not indicate how many were nurses and how 
many were pharmacists. A better description, especial I) regarding level of experience, 
professional background and specialty may have provided more context to the results. Secondly, 
they adopted a qualitative approach in their stud) und as such carried out interviews w hich were 
recorded and transcribed. However, they did not provide any quotes from the participants to 
enable readers to relate with the emergence o f their themes. Thirdly, there was no indication as 
to whether any measures were taken to ensure trustworthiness in their study. These are measures
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that ensure that findings from qualitative research are dependable and worthy of confidence 
(Lincoln and Ciuba. 1985; Patton. 2002).
Maddox and colleagues also presented another report on research carried out on non-medical 
prescribes (Maddox el at, 2011). In this second study, they focused on how non-medical 
prescribes approached 'taking responsibility’ for their prescribing. They used the critical 
incident technique to carry out semi-structured interview's with 15 nurses and 5 pharmacist 
prescribes whom they recruited by snowball sampling after contacting (he first responders. 
They found that their study participants had a cautious approach when it came to taking 
responsibility for prescribing. Some of the reasons why this was the case included a perceived 
lack of support and potential criticism especially from the media, in the event that prescribing 
errors were committed. Their sample also felt that their approach may have been due to the 
emphasis placed on legal implications for mistakes made when prescribing. Furthermore, it was 
perceived that risk taking in prescribing fitted more with medical prescribing, than with non­
medical prescribing.
In this second study. Maddox and colleagues provided further details of their study sample, 
compared to their earlier work (Maddox et a L  2010). They reported that interviews were 
carried out with 15 nurses and 5 pharmacists, but other than this, no further information was 
made available about the average numbers of years their participants had been prescribing, or 
the specialist areas that their sample was drawn from. Furthermore, there was no indication as to 
whether sampling stopped due to recruitment difficulties, or because saturation had been 
achieved. As in their earlier w ork, there w as no indication of how quality was addressed during 
the study and no quotes from the participants were included.
The fifth study that was revealed in the literature review search was a review of independent 
prescribing by nurses and pharmacists and was carried out between 2008 and 2009 (Latter et aL. 
2010). In a rigorous and well designed study, they employed a number of methods in their data 
collection and analysis which were carried out in three major phases. In the first phase, they 
used postal and email questionnaires to survey 1146 nurse independent prescribes and 358 
pharmacist independent prescribes. They were able to achieve just over 50% response rate in 
both groups. They also carried out telephone surveys with 52% of randomly sampled non­
medical prescribing leads, from a sampling frame that included half of the prescribing leads 
from the 317 Strategic Health Authority Trusts in England. Additionally, they carried out two 
focus group discussions and one interview with non-medical prescribing leads in higher 
education, as well as designated medical practitioners involved in training non-medical 
prescribes. In addition to the primary data that they collected. Latter and her associates (2010) 
also carried out a secondary analysis on data already collected by other bodies. In this part of
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their stud) they concentrated on aspects of non-medical prescribing related to safety and 
analysed data collected from professional bodies such as the Nursing and Midwifery Council 
(NM C) and the Royal Pharmaceutical Society of Great Britain (RPSG B). NHS organisations as 
well as establishments providing professional indemnity insurance for nurses and pharmacists.
The second phase of their study included two patient surveys designed to capture patients’ 
views, experiences and preferences. The first Ibcused on preferences and was designed as a 
discrete choice experiment but was limited by their inability to calculate a sampling frame for 
the patient respondents. This was as a result of the difficulties that they encountered in 
achieving governance approvals from the many relevant bodies. The second questionnaire was 
designed to survey patients’ views and experiences regarding aspects of their treatment by the 
non-medical prescriber. including access to medicines, the consultation process and their 
clinical outcomes. Here they were able to achieve 27% response rate o f the 1010 questionnaires 
distributed in the primary care sites, but were not able to accurately calculate the response rate 
for the questionnaires distributed by the nurse independent prescribers that worked in various 
practices. In this phase, they also investigated the adequacy of existing educational programmes 
for training nurse and pharmacist prescribers and they concluded this phase by interviewing 
other healthcare practitioners to ascertain their views and experiences o f non-medical 
prescribing.
In the third phase of their study, they aimed at sharing their findings and interpretations with 
relevant stakeholders in non-medical prescribing, as well as prioritising the recommendations to 
be issued from their evaluation. Here they used a multi stakeholder workshop which included 
nurse and pharmacist independent prescribers. patients and members of the public. 
Representatives o f bodies such as the British Medical Association (BM A ) and Royal College of 
General Practitioners (RCGP), nursing and pharmacy regulators, as well as Department of 
Health and NHS management were also included. O f the 60 individuals invited to participate. 
34 attended in person and 9 contributed in writing.
In the report of their evaluation. Latter and her associates submitted wide ranging findings 
relating to various aspects of nurse and pharmacist independent prescribing. They found that 
independent prescribing was the more common mode of prescribing employed and that non­
medical prescribing had been largely driven by individual practice. Their work suggested that 
although non-medical prescribing was currently safe and clinically appropriate, there were some 
concerns aboui cost effectiveness and consistency with national guidelines, furthermore, their 
findings suggested a need for improvement in assessment and diagnostic skills of non-medical 
prescribers.
On the role that management organisations had on the development and monitoring of non- 
medical prescribing, they found that while many Trusts demonstrated evidence of appropriate
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governance and risk management structures for non-medical prescribing, only about half of the 
Trusts In England had a clear strategy for developing non-medical prescribing within their 
establishments. Regarding patients' views and experiences, they found that patients had a high 
acceptability of non-medical prescribing and demonstrated no preferences for any one 
prescribing professional over the others. It was however, important to paliems that they 
developed good relationships with their prescribes, that their views were adequately considered 
and that they achieved an optimum level of understanding regarding their treatment and 
medication, following the conclusion of their evaluation, some of the recommendations 
included consideration lor pharmacists to treat a wider range of conditions as well as the 
expansion of non-medical prescribing for patients with co-morbidities. They also called for 
better inclusion of the public and patients in the planning, support and quality assurance 
framework of prescribes.
2.3* 1.4 Nun-medical prescribing for chronic pain
In this literature review, although they did not explore the v iews of both nuse and pharmacist 
independent prescribes, three research projects were found which had focused on aspects of 
non-medical prescribing related to pain. The literature review yielded three articles which 
seemed to report the findings of one research project. Stenner and Courtney explored the views 
and experiences of nurses who prescribed in various specialties within pain in the UK. In their 
first article, they focused on how non-medical prescribing legislation influenced aspects of 
prescribing by nurses (Stenner and Courtney, 2007); in the second paper, they reported the 
benefits nurses perceived that non-medical prescribing had for patients with pain (Stenner and 
Courtney. 2008a): and in the third, they discussed the importance of inter-professional 
relationships and support in how nurses prescribed for pain (Stenner and Courtney. 2008b). In 
their first article, where the impact of legislation on controlled drug prescribing was discussed, 
they found that nurses were successfully using independent prescribing powers in their 
prescribing for pain. The nurses in their study reported that their practice was unimpeded by 
current legislation. However, the level of access they had to patient history and records limited 
the completeness of the picture they had of their patients' treatment profile. The nuree 
prescribes w ithin this study also raised concerns about the confusion regarding how the current 
legislation was interpreted within their various organisations and the implications for their 
prescribing practice, as well as for their patients that suffered from various types of pain. They 
then went further to question the suitability of supplementary prescribing in the way that they 
were able to provide pain relief for their patients (Stenner and Courtney. 2007).
In the second article, they reported that their sample perceived that non-medical 
prescribing represented efficiency and cost effectiveness in the way treatment was provided. It 
was the view of the nurses in this study that patients could benefit from non-medical prescribing 
in terms of faster access to treatment and improved safety in the way that their pain was
managed. They then went on to associate non-medical prescribing with some personal benefits 
to their practice, such as an increase in job satisfaction and the fact that being prescribers helped 
them gain more knowledge. Finally, it was suggested that nurse prescribing could help improve 
relations and communications whh patients (Stenner and Courtney. 2008a).
fheir third article focused on the influence of inter-professional relationships and support on 
nurse prescribing (Stenner and Courtney, 2008b). In this part of the study, the nurses reported 
that although within their practice there was some evidence on collaboration with doctors, there 
were still some concerns about how much their colleagues understood non-medical prescribing 
and how supported they felt within their prescribing environments. Mere also, the importance of 
clarity in the way their individual Trusts and establishments adopted and administered non­
medical prescribing was also highlighted. Finally, the nurses in this study indicated that access to 
continuing professional development (CPD ) was a crucial aspect o f the type of support that they 
needed in their prescribing practice (Stenner and Courtney, 2008b).
It appeared that all three articles by Stenner and Courtney reported findings from the same 
study. For instance, they all reported collecting data using qualitative interviews, they all 
sampled 26 nurse prescribers who practiced in various aspects of pain and they all reported 
using thematic analysis. However, several inconsistencies were revealed. While two reported 
that the purposive sampling was used to select participants, the third reported that volunteer 
sampling was used to select the same sample (2008b). Sampling is an important aspect of data 
collection, as the method of sampling influences the type of data collected and this in turn 
reflects on the findings of the study. The lack of clarity in the way that these reports were 
presented could potentially confuse stakeholders in this area. The researchers did provide quotes 
from the participants in the results section which enabled a bener understanding to be gained 
when the relevant themes were discussed. There was however, little contextual background 
provided about the participants that provided these quotes, such as an indication of the level of 
experience, specialty or practice setting of the nurse prescribers that made these statements.
Stenner and Courtney reported that their interviews were qualitative and went on to give 
further details of the data collection and analysis that they carried out during their work. 
However, they did not sufficiently address what theoretical approach underpinned their work. 
This omission, though seemingly small, is a significant one, because each different approach 
has important implications for the way researchers who adopt them see (heir place in their field 
work, their analysis and the way they report their results. For instance, constructivists place 
considerable significance on acknow ledging the place of the researcher in their work, as well as 
on the provision of historical and socio cultural context (Merriam et al., 2002). It is also 
expected that a study underpinned by the constructivist approach be reported to adequately 
reflect this influence. Finally, in two of their articles. (Stenner and Courtney . 2007; 2008b) the 
results, discussions and conclusions are in tandem with the aims and objectives o f the study. In
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(he third however, this is not the case. Stenner and Courtney's (2008a) article on the benefits of 
nurse prescribing for patients in pain, suggests two sides to the story of how patients in pain 
receive treatment from nurses who prescribe. Although in their title they make it clear that they 
are reporting nurses' views, the inclusion of patients’ views and experiences would have 
contributed to the completeness of their story.
In a later study. Stenner and her associates (201 la) used a questionnaire to capture a cross 
sectional picture of nurses prescribing for inpatient pain in the UK. They used a web based 
questionnaire to survey 161 nurse prescribers who had been identified as prescribers for 
inpatient pain across 192 inpatient pain service centres. Their survey focused mainly on 
describing existing practices and obtaining nurses* views and experiences on their prescribing 
practice. I hey lound that nurses interested in advancing their roles considered prescribing 
integral to their practice. They also found that among their respondents, over half had qualified 
in just the past three years and about a quarter (22%) reported that there were plans underway 
within their teams to produce more nurse prescribers. Their study also revealed that within this 
specialty (pain), nurse prescribers were more qualified than their peers in other specialties. This 
was evidenced bv the fact that just over half (56.9%) of the sample had achieved a post graduate 
qualification at masters level and above. In the same vein, it was reported that these nurse 
prescribers had significant involvement in the professional development of other healthcare 
professionals. It was shown that nurse prescribers were involved in the training and education of 
their peers, pharmacists and doctors within their teams and that they were involved in 
developing treatment protocols in their establishments.
Other findings of this study included the fact that this group used their independent prescribing 
more frequently, compared to their supplementary prescribing qualification and that some 
legislative control associated with using supplementary prescribing had the potential to hinder 
good practice, within the context o f their prescribing. It was also shown that the more senior 
nurse prescribers (as indicated by their banding) were less likely to spend time educating 
patients. In their study. Stenner and her associates (2011 a) achieved a significant response rate - 
85%. which contributes to the validity of their findings. However, they did not report what type 
of validity and reliability testing if any. they carried out on their questionnaire. This may 
influence the way that their findings are interpreted. Also, having used a 27 item questionnaire, 
applying a test such as the Cronbach's alpha would have given a better picture of the internal 
consistency of the constituent items. Furthermore. Stenner and her associates (201 la ) recruited 
mainly staff o f the NIHS for their study but provided little information about the relevant NHS 
ethics approval that was granted. Obtaining approval from an NHS Research Ethics Committee 
suggests that the study has been presented to and deliberated upon by a multi-disciplinary panel 
to ensure that issues such as confidentiality, anonymity and data protection are sufficiently 
addressed.
In the last study that focused on pain. Bond and her colleagues employed a mixture of methods 
in investigating pharmacy-led management o f chronic pain in Grampian and East Anglia 
regions ol the l)K . Their work reports the qualitative aspect o f the pilot trial which they carried 
out with the participating pharmacist prescribers and doctors (Bond et al.. 2011). Some other 
aspects o f this same study seem to have been reported in another conference presentation 
(Bruhn et al.. 2011). In the qualitative phase of their work, they interviewed six pharmacist 
prescribers and twenty three GPs who participated in the pilot trial. In this work, they reported 
that the pharmacists who participated in the trial described their experience as enjoyable, 
satisfying and interesting but they also indicated that they found the experience challenging. In 
their interviews, they also found that although GPs reported trusting and respecting the 
pharmacist only three quarters (17/23) were supportive o f the introduction of non-medical 
prescribing in their practice. Furthermore, GPs were cynical about the contribution of the 
pharmacist prescriber to practice and questioned the cost effectiveness o f introducing the 
service.
Although this work was presented as a conference abstract (October 2011). Bond and her 
colleagues were still able to include some verbatim quotes from the participants. This 
contributed significantly to providing a rich description of the relevant themes. Bond and her 
colleagues carried out their qualitative interviews with the healthcare professionals that 
participated in the pilot randomised control trial. For the pharmacists, they reported 
interviewing all those who participated, whereas they only interviewed about half of the 
participating GPs. There was no explanation of how the sampling of the qualitative aspect of 
their study was carried out. It was unclear if  saturation was reached, or even considered during 
their data collection of this qualitative part of their work. Some description was given regarding 
how the qualitative data were collected and analysed, but it was unclear what theoretical 
approach underpinned this phase of the work. Also it could be argued that by not including 
nurse prescribers in their study, their findings may be relevant only to pharmacists.
2.3.2 Patients* views and experiences of non-medical prescribing
This part of the literature review focused on studies that had explored the views and 
experiences of patients and service users with regards to non-medical prescribing. Here, 
although some studies were found to explore the views of the public, only studies that had 
considered patients were included in the review. Also, studies that reported the views of 
healthcare professionals regarding the impact of non-medical prescriber on patients were not 
included, as a sufficient amount of work that had actually explored patients were found in the 
preliminary search.
2.3.2.1 Inclusion criteria
Any studies thai reported having carried out original research in the following areas were 
included in die review:
• Patients w ith experience of non-medical prescribing
• Chronic pain patients w ith experience of either nurse or pharmacist prescribing
2.3.2.2 Exclusion criteria
The following were excluded from the review:
• Studies reporting view s of the general public
• Studies on patients with no experience of non-medical prescribing
• Letters of opinion to peer reviewed journals
I  Editorials
• Non-English language studies
2.3.2.3 Patients' and service users’ views of non-medical prescribing
The literature review identified four original research studies where the views and 
experiences of patients regarding non-medical prescribing in general, had been explored. In the 
first. Earle and associates (2011) looked at how nurse prescribing had been provided for mental 
health service users within one National Health Service (NHS) Trust in the UK: They used 
semi-structured interviews to collect their data and an interpretative phenomenological approach 
for the analysis. Although two nurse prescribers had qualified in their Trust, only one had 
started prescribing and all the service users recruited were her patients. The service users 
interviewed reported being more relaxed when they saw their nurse prescriber. They also felt 
that nurse prescribing meant that they had more choice and that their treatment was more 
accessible. Furthermore they felt that the nurse prescriber that they saw provided the relevant 
information for their care and were satisfied with the information given alongside their 
medication. Although generally they revealed that they were more relaxed with the nurse 
prescriber. one patient still felt that the doctors were more knowledgeable and as such would 
prefer to see one.
A ll the service users that participated in the study were patients o f a non-medical 
prescriber who was also involved in the study. It is not clear if the patients were aware that this 
nurse was involved and it could be argued that the mostly positive feedback may have been as a 
result of the service users' awareness of their prescriber’s involvement in the study . It was also 
unclear how those selected were chosen from the sampling frame. The strategies used in 
recruiting and sampling were not properly discussed. Similarly, there was no indication as to 
whether recruitment o f service users stopped because saturation had been achieved, or whether
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saturation of the emerging themes had been considered at all. Finally, apart from reporting that 
these service users saw the mental health nurse prescriber, no further description was provided 
about the study participants. Furthermore, the quotes used to illustrate the relevant themes were 
not Contextual ised by providing any demographic characteristics of the people who made them.
In the second study. Hobson et al (2010) employed a qualitative approach in their 
exploration 61 how patients perceived nurse and pharmacist independent prescribing. In 2006. 
they used semi-structured interviews to collect data from patients in four primary and secondary 
care NHS Trusts and then subjected the data to interpretative phenomenological analysis. They 
provided a good description of their sample and reported that the 18 participants in their study 
were o f an age distribution of between 42 and 81. moslly male and saw their non-medical 
prescribers for hypertension and oncology health needs.
Their findings were that patients compared the service that they got from non-medical 
prescribers to that they had previously received from medical prescribers. Areas in which these 
comparisons had been made included the knowledge base from wiiich these healthcare 
professional prescribed, their professional training and their examination skills. They also found 
that their study participants associated non-medical prescribing with increased convenience and 
better access to treatment. O f the two professions, the patients seemed to have higher regard 
and better acceptance for nurse prescribers than for pharmacist prescribers. It was revealed that 
there was a poor understanding among the sample of the specific professional skill set of the 
pharmacist prescriber. Patients in this study had several important concerns about non-medical 
prescribing. Firstly, the workability of non-medical prescribing in community pharmacies, 
singling out for special mention issues such as: privacy of the consultation: sufficiency of space 
within the premises; and the level of access that the pharmacist prescribers would have to their 
medical history. Patients also had concerns about clinical governance measures for non-medical 
prescribers and whether the measures were cost efficient to the NHS. There were also concerns 
about how pharmacist prescribers would cope with the increased workload of prescribing and 
the adequacy of health information technology systems to support aspects of non-medical 
prescribing.
In this study. Hobson et al (2010) clearly described their recruitment and sampling strategy. 
They also reported that they stopped sampling when themes ceased to emerge and became 
saturated. It is interesting however, that they employed randomisation in their sampling strategy 
and although their justification was that they had a large sampling frame, the employment of a 
purposive sampling frame may have yielded a more rigorous interrogation of the emerging 
themes. A significant limitation of this study was their decision to sample only patients who 
were being seen by pharmacist prescribers. Going on to include the views of these patients on 
nurse prescribing (which these patients may have had no experience of) and comparing these 
views to those given of pharmacist prescribing may have led to bias in the way the results were
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interpreted. Also the research team, though they were clear about their approaches, were less so 
about the measures taken to ensure quality in data collection and analysis. It is not clear if 
measures to ensure trustworthiness were omitted from the report, or were not considered during 
the study. Hobson et al (2010) collected data for their study in 2006 which was the same year 
that independent prescribing was introduced in the UK (Doll. 2006b) suggesting that many 
nurse and pharmacist prescribers may not have fully explored the use of these new independent 
rights within their prescribing practice at that point. As such patients' views would also be 
limited to the level o f prescribing that had been provided to them at that stage. Furthermore, in 
their study, patients were not selected specifically for their particular disease conditions. 
Although they reported that these patients saw the pharmacists for mostly hypertension and 
oncology, their recruitment strategy' suggests that this was because the pharmacist prescribers 
who agreed to participate in the study practiced in these areas.
The literature search revealed two articles which seemed to report the findings of the third 
study of patients' views and experiences of non-medical prescribing (Courtney et al., 2010: 
Stenner et al.. 201 lb ). Forty one patients with diabetes were recruited from six NHS primary 
care sites. Semi structured interviews were used for data collection following which thematic 
analysis was conducted on the data collected. These two articles were used to present various 
aspects o f the study carried out to explore aspects of nurse prescribing from the diabetes 
patient's perspective. In one of the articles (Courtney et al.. 2010). they reported on the general 
views that patients had about non-medical prescribing and in the other they reported the 
perception that the patients had of the consultation and prescribing sessions that they had with 
the nurse prescriber (Stenner et al.. 2011 b).
In the first study (Courtney et al.. 2010) patients reported that a mutual trusting 
relationship had been established with their prescriber. They felt that they had achieved good 
communication with their prescribers. They also said that they had confidence that the 
prescriber was skilful enough to provide an adequate level of care for their condition. They felt 
that their non-medical prescribers were knowledgeable in their specialist areas and were under 
the assumption that these healthcare professionals should be able to access paid CPD. There was 
also an assumption that in the context o f their care, nurse prescribers and doctors communicated 
well. In general, they felt that non-medical prescribing could improve the efficiency and speed 
with which they accessed care.
The second article (Stenner et al.. 201 lb ) concentrated on the findings related to issues 
that were specific to the consultation process. Here, their research participants reported that 
nurse prescribers seemed more approachable and that the pace of the consultation seemed less 
hurried than when they saw their GPs. Some themes that had been addressed in their earlier 
work were also reiterated here. For instance, continuity o f care, the rapport built up with the 
nurse prescriber. the associated trust achieved and the care that they received were seen as
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benefits (Courtney et al.. 2010). Patients however had concerns about the level of information 
nurse prescribers provided regarding side effects (Stenner et al.. 201 lb).
The fact that these two articles seemed to emanate from one study raised some issues. 
There was a significant overlap in the results presented. This may have only become obvious 
due to the fact that they were both included in a review, but the slight variations in the way that 
the results were presented in each article could result in some confusion in the way these 
Findings are interpreted. In both articles, it was reported that only patients with diabetes above 
16 were recruited. The sampling strategy employed by the researchers in their work was 
however, not clearly explained. In one article, they reported using random selection to invite 
participants (Courtney et al.. 2010) but no further information was given. The authors provided 
quotes from the participants and this was helpful in picturing the emergence of the themes from 
the interviews carried out. However, they did not provide more contextual description of the 
patients that provided these quotes. For instance, an indication of the patients' ages, how long 
they had suffered diabetes, or how much experience they had of non-medical prescribing would 
have prov ided a richer and thicker context during their discussion.
The fourth study explored dermatology patients' views of nurse prescribing in terms of 
care, concordance and medicine taking (Courtney et al.. 2011). Forty two patients with acne, 
psoriasis or eczema were recruited through nurses located across four strategic health 
authorities. Qualitative interviews were conducted and these yielded themes that were largely 
supportive of non-medical prescribing. Here, continuity of care was identified by the 
participants as a significant benefit of non-medical prescribing. Patients also gave an indication 
that they carried out some comparison of their nurse prescriber’s knowledge and 
professionalism to that they had experienced when they were cared for by their GP. They 
reported that they felt they were more involved in the decision making process regarding how 
their medication was prescribed. They also expressed satisfaction with the information their 
nurse prescriber provided regarding medicines and side effects. The participants in this study 
however had concerns with nurses initiating treatment and dealing with complications. The 
training of nurses to enable them to prescribe was also another important consideration for the 
patients. They assumed that for these nurses to prescribe for their condition, they must have 
gained the necessary qualifications.
The findings of this study suggest that nurse prescribing could help improve efficiency in 
dermatology by supporting patient involvement and contributing to concordance and adherence 
to medication. Although the authors gave details of the data collection and analysis, they did not 
sufficiently address what theoretical approach underpinned their work. They used constant 
comparison to thematically analyse their data and information about their theoretical approach 
may have improved understanding of how their analy sis was carried out. Furthermore, although
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the authors provided quotes to indicate the emergence of the themes from the interviews, little 
contextual description of the patients who provided these quotes were given.
2.3.2.3 Views and experiences of patients with chronic pain
In this literature review three research projects were found that had focused on aspects of 
non-medical prescribing related to pain. In the first. Mennel, Wood and Spark (2004) explored 
the benefits and limitations associated with using the clinical management plan as an integral 
tool for practising supplementary prescribing in rheumatology'. Although their study used one 
case study to explore patients’ views on supplementary prescribing, ii has been included 
because it focused on rheumatology. In their survey. Hennel. Wood and Spark used a 
questionnaire based survey to collect data from 15 rheumatology patients. In their findings, they 
reported 38% of their respondents were aware that the IJK  laws had changed to now allow non­
medical prescribing. A similar percentage admitted knowing about the training that nurses had 
to go through to become prescribers. One hundred percent of the respondents reported being 
comfortable with nurse prescribing and fell that the advice and information nurses could provide 
with respect to their medication was valuable (Hennel et al.. 2004).
The result from this small survey has to be viewed with some caution, f irstly, the authors 
neither provided any information about their recruitment strategy, nor about how they selected 
their sample. There are many sampling strategies and each has specific risks and benefits 
associated with it. More information about the sampling and recruitment strategy may have had 
implications on how the quality is judged. For instance, if they randomised their sample, this 
may have implications on the external validity o f their findings. Secondly, apart from the fact 
That their patients were attending the rheumatology clinic, no other description was made 
available. Many questionnaires routinely collect demographic data but it is unclear whether this 
was omitted from the results, or not collected at all. In a similar vein, no information was given 
as to how this questionnaire was developed. It is unclear whether the questionnaire was 
validated and/or piloted. Finally, no details o f the analysis were provided. Although the results 
suggest that only descriptive statistics were applied, more information about the type of 
software used (if any) and details of the steps taken in the analysis would have been helpful.
In the second study that focused on aspects o f non-medical prescribing related to pain. Bruhn 
and her associates conducted a pilot trial which investigated pharmacy-led management of 
chronic pain in Grampian and East Anglia regions of the UK (Bruhn et al.. 2011), another 
presentation that emanated from the same work has been discussed in the section reviewing 
non-medical prescribers views and experiences (Bond et al., 2011). Here, the aspect of their 
work that focused on the patients is reviewed. Their work was a pilot for a proposed randomised 
control trial, to compare the effects of pharmacist medication review, with or without
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prescribing, on patient functioning and pain control. They used three general practices in the 
Grampian region and three general practices in Mast Anglia. Patients with chronic pain were 
identified using a computerised search strategy. Patients after selection were sent a base line 
questionnaire. Following the return of their completed questionnaires, they were then 
randomised to either one of the two intervention groups (pharmacist medication review, with or 
without prescribing), or to the control group (treatment as usual by the GP). Patients were then 
followed up three months later using a postal questionnaire and their prescribers (Pharmacists 
and GPs) interviewed to explore their experiences (Bond et al.. 2011).
This preliminary work was done mainly to confirm their recruitment strategy, response rates 
and change in outcomes, in order to provide evidence for a definitive trial. However they 
reported some important findings. Using CPG (Chronic Pain Grade) as their outcome measure, 
they were able to determine that more of the patients randomised to the prescribing group 
achieved better pain relief than those in the review and control groups. The same group of 
patients also reported greater improvement in 6 of the 8 SF -12 subscales (an instrument for 
measuring quality o f life). In a later article (Bond et al.. 2011). they reported on the experiences 
of the patients that were randomised to the prescribing group. Here, the views expressed by the 
patients were mostly positive. Most reported that they believed that they were given adequate 
information and were satisfied with their treatment. Seventy-nine percent reported feeling that 
their consultation was thorough. There were however, a few that had complaints. A small 
proportion of the group that saw the pharmacist preseriber said they would have preferred to 
see their GP (9% ), or that they now felt that too many people were now involved in their 
treatment (11%). A similar percentage (9 % ) felt that the time spent with the pharmacist was not 
enough (Bond et aJ.. 2011).
Although their work has been presented at a conference and may have been subject to word 
count limitations. Bruhn et al have managed to give a concise but clear account of how this pilot 
was carried out. There were however, a few issues that were not addressed by their study . 
Firstly, they reported that prior to the commencement of the study, a two day update in pain 
management was provided for the pharmacists. It is not mentioned if  the GPs who participated 
also had a recent update in the area of chronic pain before they saw their patients. If this was not 
the case, it is possible that because this update was not provided to all participating healthcare 
professionals, the level of care they provided to patients would vary and this would in turn 
influence the results achieved. Secondly, the results of their questionnaire survey of the patients 
suggest that only a proportion responded to some or all of the items addressed. It was not made 
clear how missingness was addressed in this study. Missingness refers to the determination of 
missing or incomplete data and the investigation of the likely implications for the findings of the 
study in which this has occurred (Little and Rubin. 1987). Different types of missingness have
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implications on how results should be interpreted and it is important to determine what type of 
missingness occurred in a survey and what steps were taken to address this issue. Thirdly, 
although the authors described how they developed their questionnaire, there was no 
information provided about how the analysis was carried out. It was not clear if any software 
was used in the analysis, or which statistical tests were applied, if  any.
2.4 Limitations of the literature review
Although a significant effort was made to identify and obtain all the reports of studies 
considered relevant for this work, there were some barriers encountered to achieving this 
objective.
Firstly, the mainstay ol the strategy used to identify studies for the literature review was 
to search relevant databases. It was however revealed during the review that with respect to non­
medical prescribing, some of the articles in the journals that make up these data bases may have 
been published some time after the research was carried out. Non-medical prescribing is a new 
and constantly evolving policy. There is a possibility that some work on the cutting edge of this 
research area that were not yet in the public domain may have been missed by the search 
strategy employed.
Secondly, the search strategy employed in the literature review included scanning 
conference abstracts and asking colleagues for suggestions regarding relevant studies they might 
be aware of. Some of the relevant studies found had so far only been presented as conference 
abstracts. Although efforts were made to contact corresponding authors, some the contact details 
were no longer current, or more comprehensive accounts of their studies had not been 
published. The inability to get a fuller picture o f such studies meant that certain important 
aspects may not have been included in the report due to the word count restrictions and as such, 
not available for review.
2.5 Conclusion
Five of the studies that met the inclusion criteria did not specifically focus on chronic 
pain, but provided some insight on the current debate on non-medical prescribing. O f these, one 
evaluated non-medical prescribing in one UK I rust by surveying healthcare professionals and 
found that the policy had been viewed positively in terms of improving patient care but with 
some concerns regarding competencies and time management (Shrestha et al., 2011 ). Another 
surveyed non-medical prescribers* perception of competence in pharmacovigilance and found 
despite feeling knowledgeable in this area there was need for further training with respect to 
pharmacovigilance and reporting of adverse reactions (Stewart et al., 2011). The others were 
more general in their research focus. Maddox et al (2010:2011) used qualitative methods in both
their studies and found that nurses and pharmacists approached prescribing decision making 
differently to their medical colleagues: They reported that non-medical prescribers first made 
the decision to prescribe or refer, before making decisions regarding patients' treatment. In 
addition they lound that non-medical prescribers may be more cautious in prescribing due to 
potential criticism and legal implications for committing errors (Maddox et al., 2010:2011). 
Latter et al (2010) carried out a comprehensive evaluation of nurse and pharmacist independent 
prescribing in England in three phases using a number o f methods. They found that although 
non-medical prescribing was currently practised in a safe and clinically appropriate way. there 
were some concerns with skills needed for practice and consistency with national guidelines in 
certain areas.
O f the literature that had considered aspects of pain, two studies were from the nurse 
prescribes' perspective. The first qualitatively explored the views of nurse prescribers in 
various specialties within pain. Here they found that nurse prescribing was associated with 
inter-professional collaboration, improved job satisfaction and better patient care, but with 
concerns regarding various organisational factors and the lack of understanding of the policy 
(Stenner and Courtney, 2007: 2008a: 2008b). The second was a survey that focused on 
describing existing practices among nurses who prescribed for in-patient pain and revealed that 
nurse prescribing in this area was on the increase and was seen as an important part of the 
advanced nursing role (Stenner et al.. 201 la). One study was found that considered chronic pain 
from |!h:e pharmacist prescribers' perspective. Bond and associates (2011) interviewed 
pharmacist prescribers alongside GPs and found that while the pharmacists described their 
prescribing experience in the area of chronic pain positively, not all the GPs were supportive of 
non-medical prescribing (Bond et aL. 2011).
From the patients' perspective, four of the studies that met the inclusion criteria did not 
focus on chronic pain but addressed important themes regarding patients’ Views of non-medical 
prescribing. The first presented the findings on qualitatively explored views and experiences of 
patients on nurse prescribing for mental health issues in one Trust (Earle et al.. 2011). Service 
users felt that nurse prescribing represented more choice and were happy with the service but 
one patient preferred to see a doctor who was perceived to be more knowledgeable. The second 
explored aspects of nurse prescribing experienced by diabetes patients from their perspective. 
Patients reported being involved and satisfied with the service but had concerns with the ability 
of the prescriber to deal with complications and provide sufficient information (Courtnev et al., 
2010; Stenner et a L  201 lb). The third reported qualitative exploration of nurse and pharmacist 
prescribing by patients with diverse conditions (Hobson et al., 2010). Although patients 
associated non-medical prescribing with improved convenience and better access to treatment 
there were concerns about clinical governance measures and cost efficiency of the policy. The 
fourth stud> reported findings from a qualitative exploration of dermatology patients regarding
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their experience of nurse prescribing (Courtney et al.. 2011). Patients reported feeling more 
involved in the prescribing and were satisfied with the information nurses provided. They 
however raised concents about nurses initiating treatment and dealing with complications.
O f the literature that had considered patients’ and service users" perspectives, two had 
focused on aspects of chronic pain. Bruhn el al (2011) included patients' views and experiences 
in their investigation of pharmac> led management of chronic pain. Patients randomised to the 
pharmacist prescribing group achieved better pain relief and reported better quality of life 
compared to control (Bruhn et al.. 2011). Thev also had positive views of pharmacist 
prescribing, but some still preferred lo see a doctor (Bond et al.. 2011). The second study was a 
small survey of rheumatology patients with experience of nurse supplementary' prescribing 
experience. Although patients were comfortable with their prescriber and positive about the 
policy, only 38% were informed about non-medical prescribing (Hennel et al.. 2004). The 
findings from this study were however limited by its poor design.
In conclusion, the literature review has shown that so far, no study has rigorously explored 
the views and experiences of nurse and pharmacist prescribers together with chronic pain 
patients in relation to how prescribing is provided in this area. Also no theory exists to explain 
how nurses and pharmacists perceive the barriers and facilitators lhat they come across while 
prescribing for patients w ith chronic pain and how these influence the way patients with chronic 
pain receive care from this group of professionals.
2.6 Research questions
Based on the knowledge gap revealed in the literature review, the following research 
questions were proposed
1. What are the views and experiences of non-medical prescribers (nurses and 
pharmacists) in the treatment and management of chronic pain?
2. I low is prescribing by nurses and pharmacists in the treatment and management 
of chronic pain perceived by patients with chronic pain?
3. In the treatment and management of chronic pain, what are the barriers and 
facilitators influencing the implementation of non-medical prescribing?
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C H A PTER 3 
M ETHODOLOGY
3.1 Introduction
Research has been defined as the processes through which phenomena are investigated in 
a systematic and rigorous manner in a bid to develop and test theories (Bowling, 2009). In this 
chapter. I look at existing methodologies underpinning how research in this area of healthcare is 
carried out. In doing this. I also engage with the ongoing debates that are associated with the 
methodologies under consideration. At every level, care was taken to match the research 
methodologies to the research questions. Following this. I justify why the particular 
methodologies used in the study were selected. In discussing these methodologies. I start with 
brief but general overviews of the approaches that were considered and present the relevant 
debate which outlines important aspects of the approaches that were considered during the 
design phase. I however provide further details about the methodology chosen to underpin the 
study alter a choice had been made. I conclude the chapter by providing an overview1 of the 
various projects which make up this study and how they are related to one another.
3.2 Methodology
In this section. I examine the theory underpinning various approaches to research in 
healthcare. Here I explore the relationships between various relevant paradigms within 
scientific pursuit of knowledge and discuss the different perspectives that various workers have 
used to make their arguments. I start with briefly looking at the argument of qualitative versus 
quantitative research. I then follow this by exploring the benefits and risks associated with using 
both approaches within the same research project. I continue by focusing the discussion on 
qualitative research approaches, due to the prominence of this paradigm within this study, as 
w ill later become clearer. From here onwards I tighten the focus of the discussion on the more 
relevant methodologies to this study, focusing on the grounded theory approach especially the 
constructivist variant. At each stage I still explore other alternatives to the methodologies 
relevant to this study but the emphasis remains on those selected for this study and the reasons 
why they were chosen.
3.2.1 Qualitative or quantitative
Quantitative research in the context of health sciences research refers to the use of 
empirical methods to carry out systematic investigation of social phenomena with the objective 
of testing usually predetermined hypotheses. Crucial to this form of research, is the ability to
measure the relevant phenomena and relate them mathematically to other observable 
phenomena. Quantitative research is also closely associated with the research more commonly 
used in the 'natural sciences' and this is reflected in the more empiricist and positivist approach 
that is employed here (Cresvvell. 2003).
Some researchers contrast quantitative research with qualitative research methods, which 
have been described as more subjective and flexible and with less structure when compared to 
quantitative research methods. It has also been suggested that qualitative data may be more 
suited to exploratory objectives and are more likely to lead to the generation, rather than testing 
of a hypothesis (Blaikie. 2001). Generally speaking, qualitative research refers to methods 
which allow for the use of relatively deeper exploration, to enable a richer description, clearer 
explanation, or better understanding of a circumstance, people, or phenomenon. Kuper and 
colleagues (2008) suggest that they are a collection of methods that tend to answer the questions 
why and how within real life contexts and which also ensures that the research participant's 
voice is significantly reflected.
On the one hand, quantitative research is associated with the more positivist approach 
where one can objectively study a phenomenon from a neutral standpoint and reach 'an absolute 
truth'. On the other hand, qualitative research is associated with a more subjective approach, 
where individuals interpret actions and construct meanings of the realities that they interact with 
(Lincoln and Guba. 1985).
3.2.2 Mixed methods
Although, qualitative and quantitative research seem to be divergent in many ways, as far 
back as half a century ago, researchers already demonstrated an awareness of how these two 
approaches could be used complementarity in answering research questions (Kuhn. 1961). 
Mixed methods research is a term generally used when a strategy' is adopted which includes 
using different research methods or approaches in a synergistic manner, with the aim of 
reaching a common goal (Bryman. 2001). This research goal can be to answer one specific 
research question, or different aspects of the same question, or even different questions within a 
project. Mixing methods has been suggested to have the potential to reduce individual 
limitations associated with using each individual method alone, as well as to enable a more 
comprehensive and rigorous interrogation of the different aspects of a specified area (Gorman 
and Clayton. 2005: Mahoney and Goertz 2006). Some other advantages associated with using 
mixed methods include a means of rapid and more comprehensive skills acquisition, as this 
usually means that users would need to be trained in more than one approach. Also, this strategy 
has been known to help researchers move out of their comfort zones regarding being able to 
now consider research they were not previously used to. On the converse side, adopting this 
approach could turn out to be more expensive and time consuming compared than just using one 
approach or method. (Bazeley. 2004)
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3.2.3 Qualitative research
Qualitative methodology in this context refers to the theory upon which the design of a 
particular study is based on and this is distinguished from methods, which focuses more on the 
processes involved in carrying out research. Ibr instance, technical tools that are used in the 
data collection and analysis (Kelly. 2010).
Because qualitative research focuses on exploring and understanding participants' 
experiences, as well as on explaining the concepts ‘emerging* from the data they provide, the 
concept of subjectivity in central to this form of research.
As such the way that people interpret their ‘world’ and how these interpretations depend 
and interact within various contexts (such as the social context) are integral to this form of 
research. The theory of constructivism assumes that an individual's reality is constructed from 
their interaction with the social and other aspects of their worlds. The concept that realities are 
constructed by individuals, is common within the qualitative paradigm, however, other theories 
that explain how ‘realities' are perceived exist. For instance interactionism which assumes a 
shared reality exists for a collection of people with certain similar characteristics and 
postmodernism which assumes that multiple realities exist in parallel as a result of the 
differences between individuals (Kuper et al., 2008).
At least forty different approaches to qualitative methods had been identified as far 
back as the 1990s (Tesch. 1990). but close inspection reveals that many are slight variations of 
already existing approaches. Some of the better known approaches include: phenomenology 
(Patton. 2002): ethnography (Pope and Mays. 2006): grounded theory (Glaser and Strauss. 
1967): action research (Gibson. 2004): narrative analysis (Edwards. 2006) and discourse 
analysis (Hodges et al.. 2008). Providing a comprehensive overview of qualitative research 
methodologies and approaches is beyond the scope of this work, however the three most 
commonly used qualitative methodologies, namely phenomenology, ethnography and grounded 
theory are discussed below, highlighting some distinguishing characteristics.
Phenomenology is a qualitative methodology used to study what everyday actions or 
experiences mean to individuals. Data are often collected from a 'criterion' sample, which is 
made up of individuals who have experienced the phenomenon uuder investigation. Data 
analysis is aimed at finding ’statements of meaning* and is usually carried out by coding 
categorising and thematizing. The overarching goal in phenomenology is to provide a rich and 
deep description of what the phenomenon under study means to the participants (Patton. 2002: 
Crabtree and Miller. 1999).
Ethnography is used mainly to describe cultural groups, social groups or systems of 
interest. Here, permission is usually gained by the researcher to enter the study group, or sample
and observe and/or interview members of the group ‘in situ'. In ethnography, analysis o f the 
data is carried out by using themes and perspectives to unpick the meanings of social 
interactions, within the culture sharing group. The ultimate goal of the ethnographer is to 
present a holistic portrait o f a study group which incorporates the views of the actors and the 
researcher's interpretation of these views (Pope and Mays. 2006: Savage. 2000).
Grounded theory-, as the name implies is a methodology that uses data collected about a 
particular phenomenon to systematically generate a theory (Glaser and Strauss. 1967). Sonic 
aspects of grounded theory bear some similarity to processes used in phenomenology . For 
instance, data collection here is usually done using interviews. Also, data analysis in the 
grounded dieory approach involves coding and categorizing
However differences exist, for instance while ‘criterion sampling* is often used in 
phenomenology', ‘theoretical sampling* is more often associated with grounded theory. Another 
perhaps more significant difference is in the application of these methodologies. 
Phenomenology is better suited for understanding ‘routine* actions and experiences and can 
help clarify issues and give further insight in an area. It does this by providing a richer 
description than was previously available. Grounded theory on the other hand is better suited to 
generating concepts and theories and is usually used for research areas in need of new insight, 
or where there is a perceived need for alternative theories.
In the last chapter, the literature review revealed a paucity of research regarding how the 
perception of relevant barriers and facilitators influenced nurses and pharmacist prescribing in 
the area of chronic pain combined with how the service they provided was perceived by patients 
with this condition. It was decided that a qualitative methodology was best suited to answer the 
research questions. Furthermore, to address the lack of a theoretical framework in the area. I he 
qualitative approach most appropriate for generating explanatory theory - the grounded theory 
approach was chosen to underpin the study.
3.2.4 Grounded theory
The Grounded theory approach has its origins in medical sociology more than half a 
century ago in America, when two researchers Barney Glaser and Anselm Strauss published 
their ' The discovery of grounded theory: Strategies for qualitative research’ (Glaser and Strauss. 
1967). However, soon after these two theorists parted ways and fathered the first two distinct 
schools which evolved within this methodological genre (Glaser. 1992; Strauss and Corbin. 
1990). Strauss initially developed his genre alone as presented in his book ‘Qualitative Analysis 
for Social Scientists’ (Strauss. 1987) and then with another worker Juliet Corbin in their 
publications ‘Basics of Qualitative analysis. Grounded theory' procedures and techniques’ and 
“Basics of Qualitative analysis’ (Strauss and Corbin.1990;1998). Glaser would also go on to 
present his approach in books such as ‘Theoretical Sensitivity’ (1978). ‘Jargonizing: Using the
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grounded theory vocabulary' (2009) and ’Emerging vs. Forcing: Basics o f Qualitative 
Research (1992). where he systematically attacks the approach to grounded theory prescribed 
by Strauss and C'orbin in their work ’Basics of Qualitative analysis. Grounded theoty 
procedures and techniques’ (Strauss and Corbin, 1990).
In many areas, the Glaserian and Straussian schools o f grounded theoty as they later 
became known (Stem, 1994). seem to have diverged, bul only those aspects considered most 
pertinent to this work will be considered here. Firstly Glaser and Strauss differed in their 
approach to the level of awareness, or knowledge a researcher should have prior to using 
grounded theory in a specific area. Since the original publication of the grounded theory 
approach. Glaser has suggested minimal engagement with knowledge in the subject area. He 
uses phrases like ‘abstract wonderment' to emphasise the importance of not reviewing the 
literature beforehand (Glaser. 1992). The Straussian school is not as rigid. Here there is a more 
flexible approach to a priori know ledge and a more contemporary understanding of its place in 
research today (Strauss and Corbin. 1998). A second area where these two schools diverge is the 
area of data analysis. In severaJ ways, the Glaserian and the Straussian approaches differ in the 
way they prescribe data to be analysed. For instance, while Strauss and Corbin specify a more 
structured approach to coding, involving open, axial and selective coding (Strauss and Corbin. 
1998). the Glaserian approach, though introducing the concept o f ‘theoretical coding' remains 
more closely related to the two levels proposed in the original model. Another important area 
within data analysis where these two schools differ is the use and significance of memoing. 
Memoing or memo writing involves the note taking either electronically or paper based, of 
ideas, reflections, assumptions and relationships identified during the entire analysis process 
(Charmaz. 2006), While Glaser sees memoing as a tool for generating theory and is less 
prescriptive as to what constitutes a memo (Glaser, 1978). the Straussian approach is more 
structured, suggesting that results from the analysis and directions for further work could also be 
classed as memos (Strauss and Corbin. 1998). The third and perhaps most important difference 
in the two approaches is regarding how they conceptualise the application of grounded theory. 
Strauss and Corbin suggest that grounded theory applies u more systematic approach to the 
inductiveness associated with qualitative research, bul despite this, still define grounded theory 
as a methodology situated within qualitative divide of research approaches (Strauss and Corbin. 
1990), Glaser disagrees. The Glaserian view of grounded theory is more as a general method 
which can be used for any type of data, or even a combination of different data types, as far as 
the aim is to inductively generate a theory from the data (Glaser. 1992:2010).
There is no doubt that Glaser and Strauss are regarded by many as the fathers of grounded 
theory. However the debate in grounded theory has since shifted to a wider arena. More 
recently, more variants of the grounded theory method have been developed by other workers. 
Clarke, a student of the Straussian school, champions the use o f a cartographic approach for
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grounded theory analysis, which takes the postmodern turn into consideration. In her book 
■Situational Analysis', she builds on aspects of Strauss’s theory to present the use of maps such 
as positional, situational and social worlds/arenas, to guide researchers in data collection, 
analysis and interpretation (Clarke. 2005).
Another new variant of grounded theory is the Multi grounded theory introduced by 
Goldkuhl and Cronholm as an extension to traditional grounded theory..'They acknowledge the 
traditional grounding processes such as empirical and theoretical grounding but introduce the 
explicit use of already existing theories, which could, for instance, emerge from a literature 
review and suggest that this be included in the grounding process (Goldkuhl and Cronholm. 
2003: Cronholm. 2005).
A third variant to have developed from the original grounded theory is the constructivist 
grounded theory as presented by Kathy Charmaz (also called Charmazian grounded theory). 
The Charmazian variant assumes a more relativist approach which acknowledges multiple 
realities of the researcher and the participants. She argues that these multiple realities as 
constructed by all the parties involved be reflected in the analysis of the data (Charmaz. 2006).
Compared to the other variants, the constructivist grounded theory approach was most 
suitable to underpin this study for several reasons. Firstly, it provided a framework which 
allowed art honest and rigorous engagement of my place within the study, as well as the possible 
influences these may have on the data. Secondly, being a foreign trained pharmacist, this 
approach provided a structure that facilitated appropriate reflection on the potential influence of 
past professional experiences to related aspects of the study. In line with these reasons, the 
reflective account given in the first chapter addresses the relevant aspects in personal and 
professional background that had the potential to influence pans of the study. Thirdly, in the 
UK. demonstration of good know ledge in the proposed research area is necessary to progress to 
the second year of study, as well as gain ethics and governance approvals necessary for 
fieldwork. The Charmazian variant sufficiently addresses this engagement with the relevant 
knowledge prior to commencing collection of the data (Charmaz. 2006).
3.2.5 Constructivist grounded theory
The origins of constructivism lay in the challenge of the previously more dominant 
ontological and epistemologieal models with positivist leanings. Constructivism and other 
related approaches assume the epistemologica! premise that meanings are created on a more 
individualistic basis as a result of engaging with personal ‘worlds' rather than in reference to an 
‘objective truth’(Crotty 1998). Constructivists do not believe that an objective reality exists, but 
that personal meaning and realities are social constructions of the mind created as a result ol the 
interaction between the inquirer and the inquired (Guba and Lincoln. 1989; Candy, 1991). Guba 
and Lincoln (1994). again in reference to the earlier mentioned challenge of the positivist
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paradigm, inferred that a denial of (lie existence of an ‘objective truth’ suggests an assumption 
Of an Ontological relativist position. Constructivists also believe that for individuals, their 
constructed realities as well as being time sensitive are dependent on specific contexts such as 
social cultural and historical aspects of their interactions (Schvvandt. 1904; Merriam el al., 
2002). Constructivist grounded theory can be described as a more recent revision of the original 
grounded theory method, but with a more constructivist approach. This grounded theory 
approach follows Crotty’s (1998) assumption that the constructivist approach to understanding a 
phenomenon, is from an insider's perspective. As such, in the constructivist grounded theory, 
there is not only an acknowledgement that research participants’ meanings are constructions of 
their realities, but also that the understanding and interpretation of these stories by the grounded 
theorist, is in itself a construction (Charmaz. 2006).
Charmaz has contributed significant!) to and is easily identified as the leading proponent 
o f constructivist grounded theory (M ills et al.. 2006: Babchuk. 2009) However there is some 
indication that some of her early work was influenced by the original grounded theory as well as 
the Glaserian school of grounded theory (Charmaz. 1983:1990). Unsurprisingly. Charmaz 
(2006) still agrees with some aspects of the other forms of grounded theory, for instance, that 
grounded theory be considered more of a methodological approach, than a qualitative method 
(Glaser and Strauss. 1967; Glaser. 1992: 2010). though she suggests more flexibility in its 
application. Her assertion that the other forms of grounded theory were also useful in data 
collection and analysis suggests her agreement to their unified application in systematically 
generating theory from data collected (Charmaz. 2009).
In expounding her core principle. Charmaz disagrees with these other variants of 
grounded theorv. Charmaz makes a case for the emergence of a constructivist form of grounded 
theory which accounts for the participation of the researcher and an acknowledgement that their 
interaction with the study participants is reflected in the study (Charmaz. 2000: 2006: 2009). In 
doing this, she criticizes both the Glaserian and the Straussian schools for presenting the 
grounded theorist from a more objectivist perspective which assumes that the researcher 
interacts with *an external social reality’. Channaz (2006) identified aspects of their approach 
that illustrated her assertion or their objectivist approaches. She suggested that Strauss’s use of 
complex rules to guide grounded theory analysis represents an over svstematisation which could 
force the data into predetermined divisions. She also noted that Glaser insisted that grounded 
theorists remain objective and reject all possible influences while ‘discovering* their theoretical 
categories. Her view that the Glaserian and Straussian variants of grounded theory could be 
viewed as having some positivist underpinnings has been shared by others (Babchuk. 2009). 
Charma/ further confirms her assertion of their objectivist leanings by pointing out that in 
Glaser and Strauss' approach to writing about their work they refer to themselves as ‘distanced 
experts’ (Charmaz. 2000). In fact, she argues that the contrary is more appropriate.
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constructivist grounded theory assumes that multiple realities are explored, in which the 
researcher actively participates in their construction and knowledge is produced within the 
appropriate contextual specifications (Charmaz. 2009).
Although the constructivist grounded theory variant was adopted as the primary approach 
underpinning this work, on reflection. I must admit that having studied the others. I may have 
also been influenced them, albeit subliminally. This may have been as a result of the extensive 
reading carried out in this area during the design phase, compounded with having had limited 
experience in this research area, prior to this study.
3.3 The bigger picture
In this study, a mixed methods strategy was employed, whereby the first two projects 
used a qualitative design to generate a theory . This theory was subsequently tested by a 
quantitative survey in another project. Below an explanation is provided to justify the 
employment of this strategy .
From the literature review, it was clear that there was a lack of theories to explain nurses' 
and pharmacists’ perception of facilitators and barriers to their prescribing and how this 
influenced how they prescribed for chronic pain. This was the primary motivation for the study. 
The views and experiences of members of this group were viewed as the starting point to 
generating this theory . Because prescribing is seen as a partnership between the prescriber and 
the • prescribed it made sense that for the theory being generated to be as complete as possible, 
a complementary view of the same picture from the patients’ perspective had to be acquired. As 
such the next project after generating the theory from the prescribers' perspective was to explore 
how patients with chronic pain perceived the prescribing they got from nurses and pharmacists. 
Here again, the lack of any theory to explain the issues at play and how they interacted 
suggested that the adoption of a grounded theory approach for this part of the work would be 
most appropriate.
After a theory is generated, the next logical step is to test that theory. As discussed earlier on 
in this chapter, qualitative research is more concerned with exploration and as such samples are 
kept relatively small to facilitate deeper probing. Being able to test a newly developed theory on 
a bigger sample provides a means of verifying or disproving aspects of that theory. As such, the 
other project included in the study surveyed attitudes of non-medical prescribers. to aspects of 
the developing theory-. Furthermore, carrying out the quantitative survey on another population 
of non-medical prescribers ensured that the findings were triangulated by corroborating results 
from two methodologies as well as two data sources (Sandelowski. 1995; Lincoln and Cuba, 
1985).
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3.4 Chapter summary
In this chapter. I looked al the various approaches used in healthcare research and some 
strategies commonly employed in their application. I compared the qualitative and quantitative 
approaches and explored how they could be employed together in one study. I also looked al 
various qualitative approaches and associated theoretical viewpoints. In each section I gave a 
brief overview of the relevant debate, focusing on the strengths and weaknesses of these 
approaches. As well as providing an overview of the various approaches considered. I explained 
lhe processes undertaken in choosing a methodology for this work. The constructivist grounded 
theory approach chosen was then justified, discussed in more detail and situated within the 
context of the whole study.
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C H APTER 4
A GROUNDED TH EO RY EXPLO RATIO N  O F N U RSES' AND 
PH A RM A C ISTS' V IEW S AND EX PER IEN C ES  O F PR ESC R IB IN G  FOR
CHRO NIC PAIN
4.1 Introduction
Based on the review of (lie literature research carried out. two of the research questions 
that were proposed related to how non-medical prescribers perceived their prescribing for 
chronic pain. The first project of this study answers the first research question by employing a 
grounded theory approach to explore the views and experiences of nurses and pharmacists in the 
treatment and management of chronic pain. In addition to answering the first research question, 
this project also contributes significantly to answering the third research question by starting to 
uncover barriers and facilitators non-medical prescribers perceived to their practice regarding 
how they treated and managed chronic pain.
I present this chapter in three main sections. In the first section, I present the methods 
employed in carrying out this phase of the study. The methods presented here are underpinned 
by the grounded theory approach that was discussed in the last chapter and is reflected in the 
way this section is discussed. In the methods section alternatives considered at each stage are 
discussed and rationales are given for the choices made.
In the second section. 1 present the results from the data that were collected and analysed. 
Here. I include quotes from the research participants extracted from the interviews to enrich the 
descriptions. Additionally, to help clarity certain points, I draw on reflections made during the 
data collection and analysis.
In the third section. I discuss the results of this phase of the study. In this section. I bring 
together the findings presented in the different categories that emerged in the grounded theory 
exploration of non-medical prescribers’ views and experiences. I also discuss these findings 
within the context of the broader picture of existing and relevant work in the area of stud>.
4.2 Methods
In this section I provide a detailed description of the steps and procedures involved in 
gathering and analysing the data central to this work. I start with explaining the processes 
involved in obtaining ethical and research governance approvals, then I describe the sampling 
strategy employed in this phase of the study and give details ofthe tools used in data collection
and analysis. I conclude 111 is section by discussing the strategies employed in ensuring quality 
during these processes.;
4.2.1 Ethics and research governance
Research involving human beings is usually sensitive, as such ethical principles of doing 
good, eschewing harm, acting justly and respecting autonomy must be adhered to. Because this 
project specifically concerned personal experiences relating to how prescribing practices were 
carried out (for prescribers) and issues relating to pain and medication (for patients), these 
ethical considerations were even more important here. Following sponsorship from the 
University via the School of Healthcare's Faculty Office, ethical approval was sought from the 
Leeds West Research Ethics Committee (REC ), using the Integrated Research Application 
System (IR A S). The research team was invited to present the details of the studs to the REC 
and after addressing some concerns raised b\ the REC (see appendix 2). the study was given a 
favourable ethical consideration (see appendix 3).
Based on the ethics approval, research governance approval was then sought from the 
Leeds Teaching Hospitals Trust. The main reason for seeking this approval from the Trust was 
because despite the fact that recruitment was done from a list generated from the university, 
since most non-medical prescribers and their patients interacted through the Nl IS. this approval 
was essential. The first application was put in at the same time that ethics approval was being 
sought from the REC. in a bid to significantly quicken the approvals phase of the whole project. 
This first application was not successful because at that time an approval had not yet been 
received from the REC. A subsequent application including the approval granted from the REC 
was put in and this second approval was successful (see appendix 4). Other related ethics and 
governance approvals and permissions such as amendments to the study, letters o f access and 
the research passport were applied for and approved as the research progressed and they became 
necessary to facilitate various phases o f the work (see appendices 5,6, 7).
Throughout the study, the legal framework provided by the Data Protection Act of 1998 
(OPSI, 2009) played a key role in the ethical considerations underpinning the data management 
phase of the study. As such pertinent issues such as provision of relevant information to 
participants, assurance of confidentiality and anonymity and data encryption were given 
particular attention.
4 .2 .1.1 P ro v id in g  in fo rm a tio n
In line with the above principles, care was taken to provide participants with information 
about the study, as well as their role in it. This was done prior to their participation and was 
achieved by sending their information sheets by email or by post, a few days before their 
scheduled interview. The participants were followed up to ensure that they had actually 
received, read and had the opportunil> to discuss the information sheets, prior to the interviews.
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4.2.1.2 Consent
C onsent for participation in the study was ensured before the interviews were scheduled. 
Prior to the interviews, a copy of the consent form (see appendix 8). was sent to inform the 
participants of what they were consenting to on the day. finally, in addition to the consent 
already achieved on the consent form, just before the interview started, participants were again 
required to reiterate their consent verbally, first to participating and second to being recorded. 
At the end ot the interview, their consent to use the recording was confirmed.
4.2.1.3 Confidentiality and anonymity
Information sheets providing concise details about the research also informed them of the 
levels of confidentiality and anonymity to be expected by participating in the study (see 
appendix 9). Here, they were assured that their personal details and other related information 
provided would be kept confidential, stored securely and only accessed by authorised persons 
such as the lead researcher and the PhD supervisors. They were also informed that their views 
and experiences,. if included in published reports, would not be done in such a way that they 
would be identified, or have these views and experiences traced back to them. These assurances 
were verbally reiterated during the pre and post interview chats that were carried out as routine.
4.2.1.4 Data protection
Interviews were taped with two digital recorders and these were then downloaded to the 
university allocated computer and the memories of the recorders deleted prior to the next 
interview. During the analysis, only the study identification numbers (such as prescriber I ) were 
used. Transcription and analyses were carried out using the secure University of Leeds systems. 
Original recordings of the interviews were saved only on the password protected University of 
Leeds !:M ! drive and all communication that could potentially identify the participants such as 
consent forms, were kept under lock and key in a dedicated office at the university .
4.2.2 Sampling
Here. I discuss the processes as well as the rationales behind the selection of the nurses and 
pharmacists that were recruited to participate in the qualitative phase of this work.
4.2.2.1 Strategy
The association of certain sampling techniques with specific methodologies described in 
the last chapter contributed to development of the sampling strategy. The two sampling methods 
relevant to this study are theoretical sampling and purposive sampling. In setting out the 
principles guiding grounded theory. Glaser and Strauss (1967) developed the concept of 
theoretical sampling as a process whereby data is collected, coded and analysed right from the 
onset and guides subsequent data collection, from which further sampling selection decisions 
are then made. The whole cycle is then repeated continuously until saturation is achieved.
55
purposive sampling refers to the strategy whereby 'information rich’ cases are selected in order 
to provide better information about issues central to the research questions, as well as allow a 
more in-depth exploration of the study area (Patton. 1990).
Although proponents of grounded theory suggest the employment of theoretical sampling, 
in this study, a combination of purposive and theoretical sampling were used. The combination 
of these two strategies was adjudged the best fit. As a literature review had already been carried 
out. there was some indication of where best to begin the data collection. As such it seemed 
more efficient to utilise purposive sampling to select the first few participants. Additionally, 
theoretical sampling depends on constant comparison to generate themes which then suggest 
areas for further exploration. Adopting purposive sampling for the first three interviews allowed 
the generation of a much wider pool of themes which then led to a more robust analysis on 
which the subsequent theoretical sampling continued iteratively.
4.2.2.2 Selection of participants
The initial sampling frame was constituted from past students of the prescribing course at 
the University of Leeds who, on the successful conclusion of their course, consented to being 
contacted for research from the University. From this list, an introductory email providing 
details of the study, soliciting their participation and asking for more information regarding their 
current prescribing status was sent to 58 prescribers. The first three participants were selected 
purposively and when a list of codes and developing themes had been identified, theoretical 
sampling began. Subsequently, the list of participants was divided to aid the selection of 
participants who were most likely to facilitate the investigation of the relevant themes. For 
instance, a division into ‘prescribing for chronic pain*; prescribing, but not for chronic pain*; 
and ‘not yet prescribing* allowed the identification of non-medical prescribers who had 
qualified but had not started using their qualification. This facilitated the probing of relevant 
themes from these groups.
Although theoretical sampling meant that in certain cases there were some specific 
characteristics that were seen as particularly important to aid the exploration of a particular 
theme, certain characteristics were common to all the non-medical prescribers that were 
recruited.
4.2.2 2.1 Inclusion criteria for prescribers
1. Must have qualified as a nurse or a pharmacist
2. Must be registered with their relevant regulatory' body
3. Must have passed the prescribing course
4. Must be working within Yorkshire and the I lumber
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4.2.2.2.2 Exclusion criteria for prescribers
1. Candidates with only extended independent nurse prescribers' qualification
2. Practising outside Yorkshire and the Humber
4 .2 .3  D a ta  co llec tio n
Although they are reported separately here, the data collection and analysis were 
undertaken in the tradition o f  theoretical sam pling and fed into each other iteratively,
4.2.3.1 T opic gu ide
Having reviewed the relevant literature prior to comm encing the data collection in this 
study I was aw are o f  what other workers reported as the important themes from earlier research. 
The initial instinct in developing a topic guide against this backdrop was to find out if  these 
them es also existed w hen nurses and pharmacists prescribed for chronic pain. However, this 
stud) had a different goal, which was the development o f  an explanatory theory rather than 
describing existing practice. As such the strategy employed was to combine the knowledge o f 
the gaps revealed by the literature review, with informal interviews carried out with nurses and 
pharmacists, to develop comprehensive topic guides, whose components could be easily 
am ended o r  focused to enable deeper exploration o f  specific themes.
D uring the interviews, the topic guide developed to facilitate the data collection from 
prescribers (see appendix 10). turned out io serve both purposes. For instance, when the need 
arose to sam ple (theoretical!}) and interview participants who had qualified but not yet 
prescribed, the original topic guide needed little amendment to suit this purpose (see appendix
ID -
4.2.3.2 In terv iew s
In this study data were collected using semi-structured open ended questions in individual 
interviews. O ther data collection methods were considered, for instance, focus groups, where 
selected individuals discuss and comm ent on areas in which they have experience (Powell et al.. 
1996). However, such groups are more relevant when the phenomena under investigation arc 
m ore likely to be thoroughly explored through interaction with other members o f the group. 
Interviews as a data collection tool are commonly used with the grounded theory technique. In 
line with the constructivist approach. Charmaz (2006) suggests that interviews acknowledge the 
participation o f  both the interviewer and the interviewed. She advises interviewers to listen 
actively and use various techniques to encourage the participation o f  the interviewee in the 
conversation. Interviews also allow for deeper immersion in the data and during analysis and 
reporting, ensure that the richness o f  the data and the participants* voices are not lost (Breakwell 
et al.. 1995). This again is in line with the constructivist approach which ensures that the theory 
is grounded in the data. There have however, been some disadvantages associated with using 
interviews as a data collection tool: for instance, interviewing may involve significantly more
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expenditure in term s o f  lime and effort needed to collect and analyse the data (W immer and 
Dominick. 1997), compared to other data collection tools.
In tin's study, participants were all given a choice regarding what time and place they 
preferred to have their interviews conducted. Three o f the non-medical p rescribes preferred to 
com e to the University for their interviews, one preferred to be interviewed at home and the rest 
were interviewed at their offices. All the interviews were conducted by me. However another 
experienced researcher (nurse chronic pain specialist as well as PhD supervisor) observed the 
initial interview. This action was taken for several reasons, firstly , it was done to provide 
support during the interview i f  it was needed. Secondly, as a means o f  ensuring quality, as it had 
been agreed a priori that the first transcripts would be also be independently coded by the PhD 
supervisor. Observing the first interview allowed the second coder to get a better feel for the 
•context' before the analysis. Thirdly, the PhD supervisor having achieved a first hand 
experience o f  the data collection in this study subsequently met regularly with the researcher to 
help with his reflections o f  the field work (debriefing).
Interviews were taped with tw o digital recorders and recordings were then downloaded to 
the university allocated com puter and the memories o f  the recorders deleted. Interviews lasted 
an average o f  45 minutes, with the earlier interviews slightly longer and the later interviews 
slightly shorter. With progressive interviews, the process became sm oother and seemed easier, 
perhaps as a result o f being able to better influence both the environm ent and the pace o f  the 
interviews. As suggested by King (1994). care was always taken before each interview to ensure 
that they were well designed, planned and conducted. For instance by the fourth interview, I 
noticed that pre and post interview chats where conversation centred on issues other than the 
study itself went a  long wav in putting participants at ease. Subsequently. I made sure that I 
used this strategy to make the participants more relaxed and comfortable w ith the idea o f  being 
interviewed. M easures such as this have been identified as important to  ensure participants are 
not exposed to the potential negatives associated with interviews, such as psychological distress 
(“Newman et a!.. 2002).
4 .2 .33 S a tu ra tio n
D uring qualitative data collection, saturation is said to occur when no new ideas or concepts are 
being generated or when the researcher considers sufficient data needed to  develop a theoretical 
fram ework has been collected (G laser and Strauss. 1967; Strauss and Corbin, 1998). It could 
how ever be  argued that this limit is arbitrary (C’harmaz. 2000) as one could easily decide to 
continue com ing up with new concepts with every new interview* o r perhaps go even deeper 
within already developed concepts. Additionally , the irrelevance o f  numeracy in qualitative 
research (Pope and Mays. 2000) renders tools such as power calculations unimportant in this 
context.
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Although data collection started using purposive sampling, theoretical sam pling began when the 
them es started emerging to help tighten the focus o f  the process and to  facilitate grounding o f 
the theory1. This was useful in determining when saturation was reached. For instance, once the 
core category emerged from the data, further interviews paid more attention to specifying its 
characteristics and dimensions and less attention to exploring other less relevant areas. In 
addition to the views expressed by other experienced grounded theorists. I found that coastant 
reflection on the data collected, against the backdrop o f  the research aim and objectives was a 
significant aid in deciding when saturation was achieved. Here, them es in the core category 
started reoccurring frequently from the I6'1' interview. It was decided th a t saturation had been 
reached by the 20"' interview. Two m ore interviews were then carried out to confirm that the 
right decision had been made (m aking a total o f  22 interviews), but yielded no further relevant 
themes.
4 .2 .4  D a ta  a n a ly s is
As mentioned earlier, analysis began during the data collection. The grounded theory 
approach employed meant that once theoretical sampling started, the data had to be analysed in 
order to provide the basis for subsequent recruitment. Although many forms o f  analysis are 
employed with qualitative research, originally the constant comparative technique was 
developed to  be used with the grounded theory approach (Glaser and Strauss. 1967). However, 
various workers have analysed their data using other methods despite using a grounded theory 
approach (Clarke. 2005: Morse et al., 2009).
In the qualitative phase o f  this work, the constant comparative method was used to 
analyse th e  data gathered from participants. The constant comparative method refers to 
analytical units such as codes and them es being constantly compared to each other within 
various contexts, such a s  either within or between interviews, categories, or participants (Glaser 
and Strauss, 1967: Charmaz. 2006). The constant com parative m ethod in effect provides a 
mechanism  whereby within the analytical framework every item o f  data is considered and tested 
against the em erging theory, to ensure that if  suitable, the new data fit into the most appropriate 
position w ithin this developing theoretical framework.
In consideration o f  the various possible methods o f  analysis to be used in this work, 
constant comparative method seemed the best fit for several reasons. Generating a theory was 
the main aim  o f  this research and this influenced the choice o f  the grounded theory approach. 
The constant comparative method provided the best fit to the various processes key to the 
grounded theory approach. For instance, coding in the constant comparative method was more 
consistent with the emerging theory developing from and being grounded in the data as it was 
being collected, compared to the a priori coding associated with other analy tical methods such 
as framework analysis (Ritchie and Spencer, 1994). A lso the constant comparative method
lends iisell well 10 the theoretical sam pling used in grounded theory, because it better facilitates 
the flexibility and modifiability associated with this sampling technique.
4.2.4.! C oding
Although a constructivist grounded theory approach underpinned this study, a slightly 
different approach was employed in the analysis. Here, a multi level yet iterative approach was 
synthesized based mainly on the works o f  Charmaz (2006 h Ci laser (1978; 1992) and Glaser and 
Strauss ( 1967) and to a lesser extent on Strauss and Corbin's (1990) version o f  grounded theory 
analysis. Admittedly it may seem strange that although I follow the constructivist school, here I 
agree with aspects o f  seemingly contrasting arguments for two reasons. Firstly, although many 
analysts may report strictly adhering to  one approach, just as in other areas o f  research my 
(constructivist) opinion is that researchers, in analysing data, also bring ‘influential reading’ to 
the meaning that they  make o f  their data. As such it follows that awareness and familiarity with 
differing*, som etim es opposing arguments will inadvertently influence choices made during 
analysis. This brings us to the next point. Although some o f  these grounded theory schools 
differ significantly, an integration o f aspects o f  their approaches results in a more robust, 
com prehensive and rigorous grounded theory analysis. Here. I describe the analytical journey 
and provide details about which grounded theorist influenced what decision and why I felt 
em ploying such an approach was justified.
C oding in general refers to the unit o f analysis in grounded theory- which categorises 
sections o f  the original data collected. It therefore represents a summary o f that part o f  the 
interview and can be manipulated to make more sense o f  the data. In this work, coding was 
perform ed manually and with the help o f  a softw are programme. For the first three interviews, 
manual coding was performed. Subsequently as more interviews were carried out and the 
incom ing data increased, NVivo. a qualitative data analysis package was used to organise the 
data. As the data analysis continued, a combination o f  data processing by NVivo and manual 
coding, memoing. sorting and diagramming was employed. The manual aspect o f  the analysis 
was carried out using coloured pens, highlighters, post it notes, cards and various sizes o f  paper.
4.2.4 1 1 First level coding
During first level coding the transcripts were read and a combination o f  Mine by line 
coding ' and ’in vivo coding’ were applied to the data. ’Line by line coding’ refers to  the process 
whereby each line was scanned for significant messages, whereas ’in vivo coding’ refers to the 
process whereby small sections were scrutinised for words, phrases or statem ents unique to the 
study area to hint al deeper meanings. This level o f  coding is referred to as initial coding by 
Charm az (2006) and she advises always staying close to the data and keeping things simple.
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Figure I: F irst l,«vd  C oding
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Figure  I sum m arises the inieractions involved in the first level o f  co d ing  in this w ork. In 
addition  to  line by line co d ing  and  in vivo cod ing  that are  consistent with classic (G laser and 
S trauss. 1967) and C harm azian  (2006) grounded theory. I have a lso  indicated that my thought 
p rocesses du ring  the first level o f  coding w ere influenced b> the review  o f  the  literature in the 
substan tive  area. T h is  w as revealed du ring  reflection carried out as part o f  the analysis. Initially, 
the  codes y ielded by the line by line scan w ere com pared to  o ther sim ilar codes y ielded by other 
lines w ithin the  sam e interview s. As in terv iew s progressed and  m ore data becam e available, the 
first level co d ing  evolved from constantly  com paring  lines and codes to  com paring  the codes 
betw een transcript* from  different interviews.
The ultim ate stage o f  the first level co d ing  w as when them es started to em erge from the 
data. T he constant com parison o f  the codes suggested  that som e o f  the them es 'c lustered  
to g e th e r' to  m ake m ore m eaning com pared to  w hen they w ere  considered alone, o r  w ith other 
unrelated  codes. In addition  to the  g rouping o f  these codes, regular reference was m ade to the 
field notes m ade during  th e  interview s, to  ensure that the developm ent o f  the them es was made 
in the  right context.
A nother useful tool in the  developm ent o f  them es from the  initial co d ing  w as the  use ol 
m em os (C harm az, 2006). In this w ork although m em oing com m enced d u rin g  first level coding, 
it rem ained  invaluable throughout the entire  analysis. M em oing o r m em o w riting  involves the 
note tak in g  e ith e r e lectronically  or paper based, o f  ideas, reflections, assum ptions and
relationships identified during the entire analysis process. An example o f  a memo used is 
presented in appendix 12.
M emos in this work served as a vehicle through which the emerging theory was 
continually lormulated, revised and modified through out the evolutionary process.
4.2.4 1.2 Second level coding
Following From the first level coding, a s  themes started emerging, the second level coding 
o f  the grounded theory analysis began. Mere, the coding process focused more on developing 
the em erging categories from the existing and emerging themes. The theoretical sampling which 
had comm enced at this stage enabled the interviews to  shed more light on the characteristics and 
dim ensions that were em erging within these new categories. During the second level coding, 
incoming data though the process o f  constant comparison with already collected data were also 
used to explore the relationships between the emerging categories. The synthesis o f  second level 
coding m ethods used in this project was influenced by the focused coding strategy o f  Glaser 
(,.197.8) and C harm az's interpretation o f  this strategy (2006). Here, the identified analytical 
directions are used to iteratively examine incoming data as well as review already analysed data.
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T he d iagram  above sum m arizes (he p rocesses and interactions that w ere  carried out in the 
second level o f  coding. D uring the second level coding, the constant com parison m ethod was 
used to  identify  and synthesise em erg ing  categories from related them es. T he them es that 
interacted w ith  each o ther to  m ake up categories, w ere  those  w hich  w hen view ed together made 
m ore m eaning com pared  to  w hen they w ere  considered  alone, or w ith o ther unrelated them es. 
As in the  first level coding, reg u la r reference w as m ade to  the field no tes to ensure that the 
categories w ere  developing w ith in  the contexts perceived in the interview s. Also, the som etim es 
non-sequential relationship  betw een the firs t and second coding  levels m eant that incom ing data 
still had to undergo the first level coding, even though the second coding  phase  had 
com m enced , T h e  iterative in teractions betw een the second and first cod ing  levels were 
facilitated  using  m em os.
4.2 .4  1 .3  Third level coding
T he third level co d ing  com m enced once the  core category had been identified; The 
identification  o f  the core category w as based on the follow ing prem ises suggested by G laser 
(I9 7 8 ). Firstly, du ring  the interview s, th is category em erged as the dom inant area o f  interest for 
the participan ts . Secondly  the them es related  to this category occurred  frequently and had 
significant re la tionships w ith the  o ther em erg ing  categories. Thirdly, the them es in the category 
had considerab le  ‘carry th ro u g h ' and clearly explained the  em erging theory. Fourthly, the 
them es in  th is category resonated w ith  participan ts throughout the  data m anagem ent phase.
The third level co d ing  w hich  focused on specify ing and conceptualising  the core category 
w as carried  out by con tinu ing  the constant com parison exp lained  in the  previous levels. Mere, 
m ore  a tten tion  w as focused on the conceptual e lem ents o f  the  em erg ing  theory . In specify ing 
the  characteris tics and  dim ensions o f  the core  category, a  considerab le  effort w as m ade to 
m ain tain  a  contextual descrip tion  o f  the  settings from w hich these  v iew s and  experiences were 
m ade. T h e  u ltim ate  ob jective  o f  th is  cod ing  level w as to  develop the theory.
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F ig u re  3 : T h ird  Level C oding
At this level, gaps in the emerging theory were addressed by further data collection from 
theoretically sam pled participants. Some o f  these new data had to undergo first and second level 
coding, before feeding into the emerging theory. Due 10 the fact that the latter interviews were 
m ore focused, this cyclical feedback relationship progressively got sm aller as the interviews 
neared saturation point.
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In figure 4. ihe relationship between the first, second and third levels o f  coding are now brought 
together to present a clear picture o f the entire data analysis processes. In the diagram, although 
it Is clear that the process flowed from the first through the second to the third level o f  coding, 
these is also evidence that constant iteration was carried out. mainly by memoing.
4 .2 .5  Q u a lity  in  d a ta  m a n a g e m e n t
In this subsection. I present details o f  the various strategies employed to ensure that 
quality was maintained when data were collected from prescribers and analysed. 
Trustworthiness refers to m easures employed to make qualitative research processes more 
dependable and as such ensure that the results achieved from them are more worthy o f 
confidence ( Lincoln and Guba. 1985: Krefting. 1991; Sandelowski 1993). Some o f  the specific 
strategies recommended to attain trustworthiness which were employed in this work include 
seeking out negative cases, peer reviewing, triangulation. audit trails and reflectivity (Lincoln 
and Guba. 1985; Strauss and Corbin. 1998; Patton. 2002).
Even before considering these issues regarding quality in the data management phase o f 
the study , it is necessary to acknowledge the importance o f  choosing the methodology and 
m ethods and ensuring that these are appropriate to the research questions and phenomena under 
investigation. Although these have already been discussed in the earlier sections o f  this thesis, 
their importance in ensuring that quality is maintained during research, cannot be over 
emphasized.
4 .2 .5 .1 Reflectivity
Unlike the positivist perspective where accepting and acknowledging the place o f  the 
researcher is interpreted as bias, in qualitative research, there is a place for ensuring that the 
researchers place in the study as well as their perspectives are properly engaged with (Finlay, 
2002: Hakin and Mykhalovskiy. 2003). In this study, reflectivity was achieved in three major 
ways. Firstly, a reflective journal was kept from the onset o f  this study. In the first chapter of 
this thesis u reflective account was given regarding how aspects o f  professional and personal 
experience and perception had the potential to influence interactions made during the project. 
Sim ilarly, during data collection and analysis, personal reflections made were also recorded and 
these were constantly referred to. to help clarify the researcher’s position.
A nother means o f  ensuring that reflectivity was carried out were the field notes, which 
were recorded during the interview phase. These notes were done immediately after the 
interviews ended, before transcription and coding were done. This was to ensure that all the 
relevant contextual details were captured when they were still fresh in the interviewers mind. 
Referring back to  these field notes was very useful in providing ‘rich descriptions’ during the 
analysis o f  the collected data. An exam ple o f  u field note is presented in appendix 13.
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T he third tool which employed the concept o f  reflectivity, albeit to a much lesser extent 
was the memo. M emos have already been discussed under the section that dealt with coding. 
M emos were used during the study to articulate reflections on which aspects o f  the emerging 
theory were explicit from the interview transcripts and those which developed as a result o f  my 
interpretation o f  the m ore implicit aspects o f  their stories.
4.2.5;2 P ee r review
This form ol trustworthiness was achieved in various ways within this study. Firstly 
during the interviews, weekly meetings were held with at least two out o f  the three experienced 
researchers (supervisors) to discuss and review data collection and analysis. Among these 
supervisors, one had participated in the first interview and had acted as a  second coder during 
the analysis. As such on the one hand the peer review was done with a  colleague with some 
insight to the study (interviews and coding) and on the other hand the review was with a more 
detached colleague. A copy o f  a  meeting note is presented in appendix 14.
O ther forums in which aspects o f  this work have been reviewed were: intra university 
conferences (see appendix 15). one international conference (see appendix 16) and the peer 
review process carried out prior to  being published in an international journal (Adigwe et al.. 
2 0 1 1):
-1.2.5.3 T rian g u la tio n
Triangulation as a means o f  verification in qualitative research refers to the process where 
m ultiple data sources, methods or researchers are used for corroboration in an investigation in 
order to  establish credibility and achieve better understanding (Lincoln and Guba, 1985: 
Sandclowski. 1995). In this study two main strategics were employed to achieve triangulation, 
Firstly, triangulation o f data sources was achieved by collecting data from both prescribers and 
patients. Secondly, triangulation o f  methods was achieved by first exploring prescribers' views 
and experiences using qualitative methods and then subsequently surveying the attitudes o f 
prescribers to the emergent theory, using quantitative methods. I provide further details 
regarding how triangulation o f  methods w as achieved in chapter 5 w here the quantitative project 
is presented. I also explain further how triangulation o f  data sources was achieved in chapter 6 
where the data collection and analysis from patients is dealt with.
•t.2.5.4 A udit tra il
In qualitative research, keeping an audit trail refers to the actions taken by the investigator 
to ensure that an independent reviewer can confirm  the processes employed in the study and that 
the  interpretations and results achieved are supported by the processes (Shenton. 2004). In this 
study, the audit trail was maintained using various strategies. Digital copies o f  the participants' 
interviews downloaded from the main and back up recorders have been saved on the 
University’s *M’ drive. Also verbatim transcripts o f  these interviews have also been saved in
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two different locations pi the University 's information technology systems. Documentary 
evidence such as memos. Held notes and meeting records maintained throughout the data 
collection and analyses have been kept. O ther records o f  the various developmental stages o f  the 
theory such as discussion notes and mind maps have also been retained.
4.2.5.5 Seeking ou t negative cases
Another valuable tool used in ensuring trustworthiness in the study was the search for 
negative evidence. In qualitative research, these are themes, whose emergence may provide 
rival o r conllicling explanations to that emerging from the theory- being developed (M iles and 
Huberman. 1994,). Throughout the study, significant effort was made to seek out and include 
these cases in the em erging theory to ensure that all possible processes and dimensions were 
covered. Seeking out negative cases and outliers was a means o f  m aking certain that the 
em erging theory was not only comprehensive, but also robust.
Although this method o f  increasing trustworthiness in qualitative research has not been 
traditionally associated with grounded theory (G laser and Strauss. 1967). the cyclical and 
iterative relationship between data collection and analysis, as well as the theoretical sam pling 
used here facilitates seeking out these cases. Furthermore, seeking out negative cases as a  form 
o f  rigor contributes to strengthening the ‘carry through* o f  the emerging theory .
4.3 Results
This section presents the results o f  the grounded theory exploration o f  nurses and 
pharm acists’ view s and experiences with respect to their prescribing for chronic pain. In the first 
part o f  this section details o f  the non-medical p rescribes that participated in this project o f  the 
study are provided (see table 1). Following this, the categories that emerged from this project of 
the study are then explored. Figure 5 presents a diagrammatic representation o f  these categories 
that emerged from the third level o f  coding in this project alongside the second level codes that 
generated them . Also, a detailed map which includes the first level codes for each category is 
available in appendix 17.
•M otivation’ explores the different factors which emerged in the interviews that were 
considered by nurses and pharmacists as influential to their decision to qualify as prescribers. 
The next category ’Approaches’ addresses the two distinct approaches that emerged explaining 
how nurses and pharmacists carried out their prescribing practices within certain circumstances. 
In ‘Nature o f  the prescribing environment*, the various individuals and factors that nurses and 
pharm acists perceived interacted in their prescribing environment and how these interactions 
influence their decision to  prescribe for chronic pain are explored. ’Acquiring knowledge* deals 
with how non-medical prescribers engaged with their knowledge acquisition resources and 
processes and ‘reflecting on practice* explores attitudes to reflection, its practice and the
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influence it was perceived lo have on their prescribing for chronic pain. ‘Gaining experience’ 
explores the activities non-medical prescribers engaged in to gain experience necessary for 
prescribing for chronic pain and how this influenced their practice and their willingness to 
prescribe. I he last category explores the access that nurses and pharmacists had to  aspects o f 
health information technology such as electronic prescribing software and electronic health 
records and how these were perceived to influence prescribing for chronic pain.
4.3.1 D em ographies
The table below summarises the characteristics of'the  non-mcdical prescribers that were 
interviewed in this project o f  the study. A total o f  22 non-medical prcscribers were selected 
from the sam pling fram e and their selection was based on certain characteristics identified as 
important at the data colleclionfanalysis stage that they were interviewed.
T ab ic  I : C h arac te ris tic s  o f  non-m edical p rescribvrs
69
P artic ip an t
N um ber
Professional
B ackground
G ender Age
Range
Practice
Setting
Prescrib ing
E xperience
E xperience 
In C hron ic  
Pain
Prescriber 1 Pharmacist Male 40-50 Secondary- 3 Years Y es
Prescriber 2 Nurse Male 30-40 Secondary 2 Years No
Prescriber 3 Nurse Female 30-40 Secondary 2 Years Yes
Prescriber 4 Pharmacist Male 40-50 Primaiy 5 Years No
Prescriber 5 Pharmacist Male 50-60 Community 3 Years No
Prescriber 6 Pharmacist Male 40-50 Primary 5 Years Yes
Prescriber 7 Nurse Female 40-50 Primary’ 2 Years Yes
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Prescriber 8 Nurse Female 50-60 Primary 1 Year Yes
Prescriber 9 Pharmacist Female 40-50 Community 5 Years Yes
Prescriber 10 Nurse Female 40-50 Primary 6  Years Yes
Prescriber 11 Pharm acia Male 30-40 Primary 1 Year No
Prescriber 12 Pharmacist Female 40-50 Primary 2 Years Yes
Prescriber 13 Nurse Female 50-60 Secondary None
Prescriber 14 Pharmacist Female 30-40 Secondary 5 Years No
Prescriber 15 Pharmacist Female 40-50 Secondary 3 Yeats Yes
Prescriber 16 Nurse Female 30-40 Primary 5 Years Yes
Prescriber 17 Pharmacist Male 40-50 Secondary 2 Years Yes
Prescriber 18 Pharmacist Male 40-50 Primary 4  Years Yes
Prescriber 19 Pharm acist Male 30-40 Secondary None
Prescriber 20 Pharmacist Male 40-50 Secondary 5 Years Yes
Prescriber 21 Nurse Female 30-40 Primary 5  Years Yes
Prescriber 22 Nurse Female 40-50 Primary 3 Years Yes
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Thirteen pharmacists, eight nurses and one m idwife who also had a nursing qualification 
agreed to participate in this project o f  the study. Twenty participants had used their qualification 
in practice and tw o had not yet prescribed. The nurses and pharmacists that were recruited 
practised in diverse settings and had varying lengths o f  prescribing experience since 
qualification. This facilitated the manner in which different themes and categories were 
explored.
F ig u re 5 : Dtagi-am o f co d in g — non-m edical p rcsc iih crs  
? NnL E V E L C O D IN q  3 R,) L EV EL  C O D IN K  CORK CA TEG O R Y
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Liberating 
M ore skill 
M eeting expectation 
Being rewarded
•  Innovative
•  Conservative
Developing relationships 
with colleagues 
Relying on colleagues 
Team working 
Relating to  pain patients 
Second checking 
Interacting with management
G aining from others' experience 
Experience with medication 
Experience with pain patients
Reflecting on prescribing 
Using others to reflect 
S e lf reflection
Prescribing electronically 
Accessing patients' records 
Affecting patient care 
Coping mechanisms
M O T IVA T IO N
APPROACHES TO 
PRESCRIBING
IV
NATt (RE OF 
PRESCRIBING 
ENVIRONMENT
/
•  O rganising learning
•  Accessing resources ) ACQURING
•  M aking time / KNOWLEDGE
GAINING
EXPERIENCE
REFLECTING
ON
PRACTICE
HEALTH
INFORMATION
TECHNOLOGY
Prescribing 
in a safe
and
supportive
environment
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4.3.2 M otivation
From the first lew interviews, it became clear that fo r non-medical prescribers. a range o f 
factors m otivated them to make the decision to qualify as and practise as non-medical 
p rescrib es. This category explores w hether non-medical prescribers felt that incentives they had 
been exposed to prior to becoming non-medical prescribers were important and whether it 
influenced they way they practised. Also, it helps better understand what instigated qualified 
non-medical prescribers to use this qualification in their professional practice.
Them es that emerged from the interviews with nurses and pharmacists were grouped 
under sub-categories titled ‘liberating’, "having more skill’, ‘m eeting expectations’ and ‘being 
rew arded '. A few non-medical prcscribers admitted that they were incentivised by at least one 
o f  the above sub-categories. In practice however, it seemed more likely that the non-medical 
prescribers were actually motivated by a  combination o f  two or more o f  the identified 
motivators.
4.3.2.1 L iberating
Before the onset o f  non-medical prescribing, experienced nurses and pharmacists would 
sometimes see patients, carry out the entire consultative process, produce the prescription and 
then wait for the doctor to append their signature following which they would then take the 
signed prescription back to the patient.
“I wav one o f those nurses lluil before non-medical prescribing. I  would walk into doctor with 
a script and say write that, that dose, that many times a day, sign there and lake it hack to the 
patient, that is not safe, this way is much more safe " (Prescriber 3 -  nurse in secondary care 
with 2 years prescribing experience)
Although this represented a system whereby responsibility for prescribing was not 
correctly apportioned and which they perceived as unsafe, until they were able to  qualify and 
practise as non-medical prescribers. they felt that they had no choice but to engage in this 
practice. T o them, in order to provide an acceptable level o f  care for their patients, this practice 
was unavoidable. Their seeming lack o f  choice about this practice, is clearly illustrated by the 
use o f  the word ‘liberating’ which they employed to describe how they felt when they could 
eventually legally prescribe.
” , n was going to liberate my role really. /  wasn't depending on— /  don't have to speak 
to GPs anymore, I  am not hanging on the phone waiting for them, you know... " (Prescriber 8 - 
nurse in primary care w ith I year prescribing experience)
...once I had qualified, it didn I.feel an awful lot different because that \s how I had coped for 
years and years so it wasn t much of a strain, hut il tms liberating the minute I could just do 
it. ’(Prescriber 10 - nurse in prim ary care with 6 years prescribing experience)
For nurses and pharmacists who had engaged in this unofficial prescribing role, having already 
gained som e prescribing experience over the years, albeit unofficially, to finally be able to 
prescribe in their own right was a considerable stimulus to obtain the qualification and legalize 
their prescribing.
Not all nurses and pharmacists had previously practised this unofficial form o f  prescribing.
Some others identified that becoming a prescriber would enable them to provide better care for 
their patients and they saw qualifying as a non-medical prescriber as a means through which 
they could ‘add value" to the services that they already provided as health care practitioners.
"I have been qualified for a long time and doing the prescribing course sort of renewed 
my enthusiasm for community pharmacy for pharmacy practice...! don't want to move up the 
ladder and shuffle papers about. J want to deal with the problem. "(Prescriber 5 - community 
pharmacist with 3 years prescribing experience)
For the above pharmacist, non-medical prescribing provided a means for him to extend 
his role and for him this was enough stimulus to gain the qualification and go on to prescribe. 
This prescriber struck me as som eone who due to the fact that he had been qualified for what he 
felt was a long time and was in need o f  a programme o f  study which not only would provide 
some professional advancement, but also be relevant to how h e  provided services to his patients. 
Non-m edical prescribing ticked both boxes for him.
‘Feeling liberated’ and ‘having renewed enthusiasm ’ described the initial emotions that 
non-medical prescribers felt when they qualified. T his suggested that the non-medical 
prescribers perceived that a new and exciting experience lay ahead in their professional careers. 
However. 1 got the feeling that as existing non-medical prescribers became more experienced 
and nurses and .pharmacists, in general became more aware o f  how non-medical prescribing was 
practised, they realised that in addition to facilitators, there were also barriers to non-medical 
prescribing they were no longer as enthusiastic.
With more experience and better knowledge o f  how non-medical prescribing was carried 
out in practice, nurses and pharmacists began to identify with some other motives for engaging 
in non-medical prescribing. For instance, they revealed that their ability to prescribe meant that 
they could provide their services in a more timely fashion.
"...obviously the merry go round for the patient went round quicker and o f course for  
mvsetf. I was able to deal with patients more quickly und efficiently and get my next one In
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quicker.... so throughput of patients was increased hecuuse of it. " (Prescriber 10 - nurse in 
primary care w ith 6 years prescribing experience)
This in turn impacted on their organisational capacity, in the above case the non-medical 
prescriber lell prescribing resulted in better efficiency in the way ihat she organised her practice.
furtherm ore. because they were now able to prescribe, non-medical prescribers reported 
(hat this ability improved the enjoyment and contentment that they derived from the work they 
did as healthcare professionals
"...1 don't feel that way and I feel that my job satisfaction is much better, I  feel like I’ve 
got a much more important role if I can prescribe. " (Prescriber 4 -  pharmacist in primary care 
with 5 years prescribing experience)
For some, the qualification and the ability to prescribe had become somewhat essential to 
how they planned their career progression.
" ...you know, at the end of the day. I am doing it not for the money and not for the 
handing, it is fo r my practice and having a qualification that allows me to develop my practice 
hut also to manage my career plan for the future, i f  you like..." (Prescriber 2 - nurse in 
secondary care with 2 years prescribing experience)
This prescriber deem ed the new skill so integral to his long term career plans that he was 
prepared to forgo financial reward for the time being, in order to ensure that he carved a niche 
lor himself, using his prescribing skill.
4.3.2.2 H aving  m ore skill
Both nursing and pharmacy are regarded as skilled healthcare professions. I'or individuals 
that go in to these professions, the ability to utilise their knowledge, experience and aptitude to 
accom plish complex tasks in a timely and efficient m anner is important. Undergoing the 
training and qualifying as a non-medical prescriber confers on these already skilled healthcare 
professionals, an additional set o f  skills.
During my interviews. I found that the nurses and pharmacists that participated in the 
research regarded their acquisition o f  more skills as a significant motive for wanting to become 
non-medical prescribers. For them, despite already being skilled, being a non-medical prescriber 
provided additional ability that distinguished them from other nurses and pharmacists.
“...obviously it is some extra qualification, you know, compared to other pharmacists. I 
am not saying that they are not doing a good job. but it is just because they still cunnot do the 
job that we do. " (Prescriber 11 - pharmacist in primary care with I year prescribing experience)
Interestingly, training as a prescriber and gaining the qualification did not seem to be 
enough to be seen a 'bona fide' non-medical prescriber. For some o f  the prescribers that I spoke
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to. il was not enough to have just studied for and passed the course, it was also important to 
have used this skill in practice.
'...because I  have not used it. I do not lend to mention that I am a prescriber. because 1 
suppose... I  almost Jed  a hit fraudulent, having done the qualification... I wouldn't call myself a 
prescriher until /  start prescribing, I might be a prescriber by name, but I  am not a prescriber 
hv action (Prescriber 19 -  pharmacist in secondary care with no prescribing experience)
Personally, com ing from a background that places significant emphasis on qualifications 
and certificates, it was quite interesting to find out that som eone who had successfully passed a 
course was reluctant to ‘bear the title’ just because they had not used the skills in practice. This 
suggested that for nurses and pharmacists the knowledge o f  prescribing skills alone was not 
sufficient to be non-medical prescribers, experience was regarded as equally important.
F<ff som e other participants in the study, they had trained for. gained the qualification and 
even had some ‘de facto' experience o f  prescribing. However, because they were not actually 
writing prescriptions, they felt that they were not practising non-medical prescribing in the true 
sense o f  the term.
"I did the supplementary prescribing coursc in the knowledge that I wouldn't be able to 
do much with the actual prescribing at the end of it. But because I was effectively practicing in 
the way that a clinical management plan will work with supplementary prescribing ideas behind 
it. I  f i l l  it was appropriate for me to do the training to support how I  was already' practicing. So 
I  had a kind o f a qualification to support.... most o f  the time, if  I'm speaking to a GP. they don't 
have any problem taking a recommendation from me. kind o f representing a specialist sendee. 
I think particularly because probably their chronic pain patients are tlteir quite difficult 
patients, so they are welcoming any help, but I think it just shows a hit more... it gives me more 
justification for what I am saying. I think. “ ■(Prescriber M - pharmacist in secondary care with 5 
years prescribing experience)
T his pharmacist knew from the outset that she may not actually write prescriptions in her 
practice, even before training for the qualification. For her. having some certificated training 
that supported the specialist role tliai she was performing by giving advice on chronic pain to 
other healthcare professionals, as well as being recognised by her peers and colleagues as an 
expert in this field contributed to her motivation to qualify as a non-medical prescriber.
For those non-medical prescribers who had qualified and were prescribing, the non­
medical prescribing qualification signified not just to themselves, but perhaps more importantly 
to their peers, that they had acquired considerable expertise in their respective fields o f  practice.
“...you know as a pharmacist you want to continue to develop and get the ... you know as 
you say the recognition, you know, that you at the lop o f  your game, really, that you have
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gotten ax far you can get to." (Prescriber 4 - pharmacist in primary care with 5 years prescribing 
experience)
The above non-mcdical prescriber was well renowned in his field o f  practice and this was 
evidenced by the faci thai he frequently had patients referred to him from other prescribers. I got 
the feeling that for him. the non-medical prescribing qualification represented a kind o f 'b a d g e  
o f  recognition' for his expertise in his specialty area.
Apart from the recognition o f  additional skills that non-medical prescribers got from other 
nurses and pharmacists. I a lso  found that increasingly, other healthcare professionals that came 
in frequent contact with non-medical prescribers had also started recognising the skills level 
possessed by non-medical prescribers. For nurses and pharmacists interviewed, this was also a 
strong motive to gain the qualification and use it.
"...hut 1 think now that I have done it and 1 am 18 months, prescribing now, you know. 
I've gat GPs ringing me up and asking me what to Jo... ’’(Prescriber 8 -  nurse in primary care 
with 2  years prescribing experience)
The above prescriber worked in a team where although she felt supported by most o f  her 
m edical colleagues, there still remained some pockets o f  resistance to  her prescribing. For her 
the fact that GPs from outside her immediate team would ring up to ask her advice was a strong 
and constant inspiration to continue prescribing.
There were also non-medical p rescribes who felt that having trained as a prescriber and 
gone on to use this new set o f  skills, their perceived standing would increase within their 
professional group
“...community pharmacy seems to he in the down (sic) on our hospital colleagues, 
.sometimes, in that all We do is slick labels on boxes and I didn't want to be regarded as that. " 
(Prescriber 5 - community pharmacist with 3 years prescribing experience)
I le fell that among pharmacists, working in the community pharmacy part o f  th e  industry 
was not regarded as challenging and exciting as hospital practice. Hence non-medical 
prescribing was seen as a sort o f  ‘add on ' that made his work more stimulating, lie  perceived 
that non-medical prescribing was a way o f making him a more ‘skilled ' community pharmacist.
413.2.3 M eeting expectations
Initially, there seemed a  strong overlap between this subsection and the first subsection 
‘liberating’. However, as the data collection and analysis continued, the major difference 
became clear, that is. w hile the subsection 'liberating' addressed the motivation to prescribe, as 
an answ er to the nurses* and pharmacists’ own personal expectations, this subsection addressed 
others’ expectations.
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Prior 10 taking up non-medical prescribing some nurses and pharmacists had been 
identified as having the ability to  add more value to the way that they cared for their patients. 
I he first group, we saw in the subsection ‘liberating* where some healthcare professionals 
engaged in this unofficial prescribing role, before they were able to prescribe in their own right. 
There also existed another group o f  nurses and pharmacists whom others such as their patients, 
their m edical colleagues, or their managers, identified as having the capability to provide better 
care for their patients, if  they had additional training.
There was no clear distinction between these tw o groups o f  non-medical prescribers. as 
som e ot these nurses and pharmacists who had been identified by others as having the potential 
to be doing more lor their patients, also engaged in this unofficial prescribing. Where however 
there was a clear distinction was in the motivation to  qualify and practise as a prescriber to meet 
personal expectations (as w as the case in •liberating’ ), as opposed to qualifying and practising, 
because “it was expected o f  them ’ (as is the case in this sub-category).
Non-medical prescribing is a new policy direction being explored by the government and 
from the interviews, there was an indication that some o f  the non-medical prescribers had the 
perception that their organisations wanted to be identified as heing progressive in the uptake o f  
this policy.
"I think they sort o f see it as a feather in the cap o f the unit really; that they have got 
somebody... that they have got this going on in their unit, because it makes them look like they 
are quite a progressive unit... that they have nonmedical prescribing" (Prescriber 17 - 
pharmacist in secondary care with 2  years prescribing experience)
This feeling was not uncommon with the non-medical prescribers interviewed and they 
perceived this a s  a good thing. However a few o f  them questioned how prepared their 
organisations were before actually getting their nurses and pharmacists to undergo the course 
that would enable them get the prescribing qualification. This suggested a lack o f  efficiency in 
the selection o f  healthcare professional for prescribing training and inadequacy in the 
infrastructure to manage them, after qualification.
“ The feeling is that you cannot fulfil all your responsibilities at that hand unless you can 
prescribe as well. Thai's the theory, in practice, obviously it is not that at all. because we do not 
prescribe in hospital and people were going through the course are only going through it if  they 
have a particular specialty that they can actually prescribe in \  Prescriber 4 - pharmacist in 
primary care w ith 5 years prescribing experience).
Additionally, some o f  the non-medical prescribers that I spoke with felt that by the time 
they reached a certain stage in their professional careers they were obligated, or expected by 
people around them to train as and qualify as non-medical prescribers. This suggested that these
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nurses and pharmacists may have been under some form o f  pressure from their organisations to 
becom e prescribers.
In som e circumstances, it was a recommendation from a superior that was the motivation 
for som e participants to become non*medica! prescribers. Usually, it was associated with 
making the healthcare professional more eligible for promotion.
‘7  wanted to head up the maternity assessment centre and it was my team leader who 
suggested that it wotdd he a gaud idea to go on the prescribing course" (Prescriber 13 -  nurse 
in secondary care with no prescribing experience)
This prescriber would not go on to use the qualification due to the fact that after she 
qualified, she felt that despite being nominated to go on the course, she was not adequately 
supported to  practice after she had gained the qualification.
" ... and it wasn t just that, it was all the hoops 1 had to jump through. ... /  wrote to all the 
consultants and asked i f !  could prescribe fo r  their patients, get their permission and then it was 
the clinical management plans and the vicarious liability, there were just so many things I had 
to do to prescribe two paracetamol and it just did not seem worth it. to be honest. “ (Prescriber 
13 -  nurse in secondary care with no prescribing experience)
She expressed disappointment at having trained and qualified as a prescriber. but not 
being able to use the new skills, due to the additional bureaucratic processes that she considered 
excessive.
"The only thing. .. /  was disappointed, but it was my choice not to jump through all those 
hoops...it wasn't worth all the carry-on" (Prescriber 13 - nurse in secondary care with no 
prescribing experience)
This raised the question o f  exactly how motivated she was to become a prescriber, in this 
instance, would she have considered becoming a prescriber al all. if  she had not been 
recom mended by her team  leader?
In certain o ther cases, it was experienced non-medical prescribers that were making the 
recom m endation  In these cases, these healthcare professionals, had both the relevant non­
m edical prescribing qualification and experience.
"... our xervicc manager supports us. I mean I've tried to get somebody down the road, 
somebody in the course every six months to increase our numbers....“ (Prescriber 2 - nurse in 
secondary care with 2  years prescribing experience)
During the interview, the above non-medical prescriber (who was also in management) 
was very passionate about non-medical prescribing and during the interview, he described his 
prescribing environm ent as well supported. It was based on this that he felt confident to
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encourage oilier nurses (mostly his jun ior colleagues) to benefit from the structure that was in 
place in his organisation.
M otivation to become prescribers did not always come from peers and healthcare 
professionals. For the participants interviewed, even before they were legally able to prescribe, 
there was a perception that their patients held them in high regard with respect to being able to 
m anage their care. In line with this idealisation by iheir patients. they were also expected to 
prescribe lo r the patients that they saw. as part o f  the services provided. It has been suggested 
that this idealisation may have contributed lo the unorthodox prescribing lhat was described in 
the first subsection.
"...and it gives the patient so much more confidence in von I f  you're muiiaging their cure 
ai such a high level, to have to run out and get a script, fo r paracetamol, lo run hack in again, I 
think it devalues you. whereas to just write it out yourself, sign ii and handing them thut 
prescription. I think that they think, uvnr /  am with nurse practitioner now. not jus! a nurse. " 
(Prescriber 3 - nurse in secondary care wiih 2 years prescribing experience)
"When liv  started* 1 did a leaflet on what the supplementary prescribing was and I think 
they thought it wav a hit o f a joke, because they thought that I did lhat am’way. because quite 
often. I would go away and sort out their prescription and to them, it did not really matter who 
wrote it, while I was running around the hospital trying to find a doctor lo write the 
prescription, so they jit si assumed I lial I was doing it all along “ (Prescriber 15 - pharmacist in 
secondary care with 3 years prescribing experience)
" /  was able lo provide full packages o f  care, for patients and actually take responsibility 
fo r that and for patients to see that I did not have to go and ask a Doctor because they didn V 
know that often all I was doing was saying please can you just pul your signature on there 
please. " (Prescriber 10 - nurse in primary care with 6 years prescribing experience)
This suggested that these nurses and pharmacists attributed some importance to their 
patients ' views and perception o f  how services were provided.
4.3.2.4 Being rew ard ed
Nurses and pharmacists who qualify as non-medical prescribers not only have more skill 
than iheir peers who cannot prescribe, but they also have more responsibility. Qualified non­
medical prescribers are accountable for the assessment o f  patients with undiagnosed or 
diagnosed conditions and in addition, they can also make clinical management decisions for 
these patients. In fact, in many cases, they are able to diagnose and prescribe without the 
involvem ent o r  a medical practitioner.
It was against this backdrop that I explored ‘being rewarded’ as a motivation for nurses 
and pharmacists to become engaged in prescribing. Some o f  the nurses and pharmacists lhat I
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interv iew ed had strong opinions and w ere em otional about 'b e in g  rew arded’ for becom ing 
an d /o r engag ing  in prescribing. N on-m edical p rescribers that participated in the interview were 
quick  to  identify  that prescribing enhanced their skills base and as a result o f  this, they w ere not 
only ab le  to  im prove serv ices to r  the patients that they saw , but also h ad  the potential to  m ake a 
positive im pact on the healthcare system s that they prescribed from. They w ere a lso  aw are that 
presently , qualify ing  and prescrib ing  w ere  not being rew arded, e ither m onetarily, for instance 
by an increase in salary , o r  by being  autom atically  prom oted. Som e felt that no t being 
rem unerated  o r hav ing  their band ing  increased m eant that their sk ills  W'ere being taken for 
granted.
*7/ makes no difference in terms o f your salary meaning that your skills, the things that 
von can offer extra, they are assumed to he made readily available to the patients and services 
without being remunerated for that. I think h has got up to a point where it can he a de­
motivating factor, maybe at the beginning because you are more focused on trying to improve 
patients' access you mightn 7 worry about it. but after a while when you provide the service and 
you come across how things..., what impact that you are making, I think that that will bring to 
mind that I'm making all this impact, am I being used here as a cheap prescriber? ''(P rescriber
1 -  pharm acist in secondary  care with 3 y ears prescribing experience)
T his suggested  that despite  the fact that im proving patient care m ay have been the 
prim ary  m otive  fo r  becom ing  prescribers. there w as a lso  an expectation  that becom ing 
prescribers w ou ld  e ither have led to  an advancem ent in their careers, enabled them  cam  a  better 
sa lary , o r  both.
Som e o f  the non-m edical p rescribers felt that despite  being  m ore progressive than their 
co lleagues in em b racing  this governm ent policy, they d id  not seem  to  be  better for it.
" ... when agenda for change was sold to nurses, t iv  got told that we would be rewarded 
fo r  our qualifications and our experience and that has not been the case at all. He have just 
been crossed on edge (sic), from  whatever grade you were on previously. to a new equivalent 
grade and we have not had the opportunity to expand that whatever. "  (P rescriber 3 - nurse  in 
secondary  care w ith 2 years prescrib ing  experience)
T hese prescribers seem ed to have been under the im pression that qualify ing as prescribers 
w ould m ean that ihe> w ould be banded h igher than their colleagues w ho were not prescribers. 
O thers that 1 spoke  to  w ere even m ore expressive  and I gathered that they felt that it was unfair 
not to  be rew arded for ach iev ing  their qualification  a s  prescribers.
" /  tm v working with the people who have done no extra training and were paid the same 
as m yself..." (P rescriber 7  - nurse in primary' care w ith 2  y ears prescribing experience)
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They Pell especially so. because even though their healthcare professional colleagues also 
had the opportunity to study and qualify as prescribers. it was them that had made significant 
personal sacrifices to  enrol in. study for and achieve the qualifications to become prescribers.
"... there were people with families and they felt that the studying would he hard and a lot 
o f  work and they did not do it. And then I obviously did it and then did not get any financially 
remuneration at the end " (Prescriber 7 - nurse in primary care with 2 years prescribing 
experience)
While for som e nurses and pharmacists, qualifying as non-medical prescribers entitled 
them to  being rewarded, for others, they felt that they not only had to study and qualify as 
p rescrib es, they also had to  have used the qualifications in practice to the benefit o f  their 
patients.
"I think if you are managing your own caseload, diagnosing your own patients and 
sorting out their own treatment plan, then yes. you should be banded appropriately" (Prescriber 
3 - nurse in secondary care w ith 2 years prescribing experience)
“ .. // depends on what you do with your nonmedical prescribing and I think that as you 
get more experienced and us you gel into the role, there should definitely be an increase fin 
salary), because there is a large amount o f extra responsibility and as you start prescribing, the 
other practitioners See how you can start to fit in and you can take quite a lot o f  the GP load 
away from them and it means that they will see more acute patients, where you are seeing some 
o f  the chronic term patients. That is how I would... I think i f  you haw had a year or so. using 
your nonmedical prescribing, then that is when your salary should increase. ” (Prescriber 12 - 
pharmacist in primary care with 2 years prescribing experience)
For nurses and pharmacists who had started using their qualification, practising as a 
prescriber introduced a level o f  responsibility (in terms o f  patient care) that other nurses and 
pharmacists did not have. This category o f prescribers fell that a combination o f  qualifying as a 
non-medical prescriber and demonstrating that you were able to be responsible for your own 
patients should qualify a non-medical preseriber for reward.
Even though all the nurses and pharmacists that participated in the research had qualified 
as prescribers prior to the interviews, they had strong feelings about how 'be ing  rewarded’ (or 
the lack o f  it) for qualifying and prescribing would influence nurses and pharmacists that may­
be thinking o f  becom ing prescribers. There was the feeling that initially, improvement o f  patient 
services may be a strong motivator, but that this may not be enough on its own.
"I think mostly in the beginning the idea that you can help your patient belter, better 
access to medicines etc it does make you at limes wonder whether you are ..if you are lucking 
that motivation, it can sometimes de-motivaie you." (Prescriber I - pharmacist in secondary 
care with 3 years prescribing experience)
82
Il was suggested that in addition to improving patient services, financial incentives could 
be an additional motivator lor prospective non-medical prescribers.
I-or others, they felt that it was the prospect o f  advancement in position would act as a 
strong m otivator for prospective non-medical prescribers.
‘7  think that's something w’t? are really missing because there isn't a lot of incentive for 
people to continue to develop their clinical expertise and become a specialist prescriber, when 
really, the level that you're going to get to is the same level you would luri'e got to before you 
were prescribing, il doesn't lake you any further. " (Prescriber 4 - pharmacist in primary care 
with 5 years prescribing experience)
In fact, a  non-medical prescriber who. as a result o f  his position as a  manager, was also 
involved in the recruitment for the non-medical prescribing programme in his establishment 
spoke o f  his experience with his colleagues with respect to how 'being rewarded’ influenced 
prospective non-medical prescribers.
"I've had this debate with colleagues... you know. I have approached colleagues within 
the team said, you know, who wants to do the prescribing course next and some have said, do 
we get that extra banding, do we gel an extra .. and I said no and they have said, well no, I'm 
not doing it " (P rescriber2 - nurse in secondary care with 2 years prescribing experience)
In the sam e vein, a non-medical prescriber who had qualified for more than a year, but 
had not started prescribing expressed that he may be more motivated to engage in prescribing if  
he was going to be paid for it
"So say next month, there suddenly was un increment for prescribers, I am sure I 
probably would try to... maybe, in a mercenary way, to do my prescribing, to actually pul my 
prescribing into practice. " (Prescriber 19 -  pharmacist in secondary care with no prescribing 
experience)
These tw o cases seemed to confirm  the feelings expressed by the other non-medical 
prescribers. that improving patient care may not in itself be a sufficient motivation for nurses 
and pharmacists to  take up prescribing. Increasingly, healthcare professionals seemed to be 
asking the question ‘what is in it for m e'?
Not all the participants that were interviewed seemed to be motivated by the prospect o f 
being rewarded for becoming prescribers. One non-medical prescriber expressed why she had 
no expectation o f  reward.
"...wed that s why it s called an extended role, they do not call it advanced, they just 
want to call it extended, so that they do not have to have the money to follow it. But you know 
this... the economy is... in every walk of life...it isn't there, so I  am resigned lo it because /  
understand it. "(Prescriber 10 - nurse in primary care with 6 years prescribing experience)
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Her view s suggested thai while she was not againsi being rewarded, she felt that the 
policy had been deliberately drafted by the Department o f Health in a manner that meant that 
they were not obligated to reward healthcare professionals who look up prescribing.
Even further away from the norm, another non-medical prescriber felt that non-medical 
prescribers should not be paid more, or get better banding for qualifying and prescribing. She 
argued that being a health care professional, increased responsibility should be expected, as part 
o f  the role.
I do not actually work any extra hours and I  actually think that being a pharmacist is a 
really responsible job. So, 1 am probably going to say that I  do not think that we should have 
any extra money. "(Prescriber 9 - community pharmacist with 5 years prescribing experience)
Her view s seemed to support the argument that being able to prescribe should be seen as 
an extension o f  the already ‘skilled and responsible* role o f  the healthcare professional. In 
essence, it helps them do their present jobs better and as such, no further reward should be 
gained.
4.3.2.S C ategory  Sum m ary
This category explored how non-medical prescribers interacted with the various 
factors that motivated them to qualify as preseribers and to use this qualification in practice. 
Four sub-categories emerged which explored tlte factors nurses and pharmacists identified that 
motivated them to quality and prescribe. It was shown that som e non-medical prescribers 
qualified as a result o f  their desire to fulfil their own expectations and the expectations o f 
others such as their colleagues and their patients. Being able to legally prescribe for patients in 
areas they w ere experienced and skilled in. was also regarded as a significant motivator. 
Additionally, prospect o f  acquiring more skill and being rewarded influenced the decision to 
gain and use their qualification^
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4.3.3 A pproaches
As the interviews were being carried out and the data were being analysed, it became 
clear that different approaches existed amongst the non-medical prcscribers. I noticed that the 
various nurses and pharmacists that participated in the research carried out their practice in a 
m anner that was unique to them. For these non-medical prescribers. these differing approaches 
may have been as a  result o f  their personalities, or they may have adopted this particular 
approach as they went through the process o f  developing the skills that enabled them become 
prescribers. In order to better understand the attitudes non-medical prescribers had to their 
prescribing and how these influenced their practice, it became important to  isolate and describe 
these prescribers' approaches. The approaches that emerged from the data analysis were the 
innovative and the conservative. These two approaches that emerged from the interviews are 
described based on the observations that I made, as well as the statements and comments which 
these non-medical prescribers made, which I saw as a reflection o f  their beliefs and perceptions 
in how they and others carried out prescribing.
An important detail that emerged while the concept o f  prescribers’ approaches were 
being explored, was that they seemed to explain the non-medical p rescribes’ attitude to 
prescribing, rather than describing the non-medical prescriber themselves. In some cases, non- 
medical prescribers assum ed an approach as a reaction to a factor o r  factors within their 
prescribing environm ent that they had little or no control over. As such it was possible to find 
that when a factor that a non-medical prescriber perceived as important to their prescribing 
changed, the prescriber themselves would also change to become either more innovative or 
more conservative in those aspects o f  their prescribing. It could be said that they graviiated 
towards one extrem e or the other or remained somewhere along the continuum between the two 
extrem es depending on the external influences they perceived, that existed around them.
In the following subsections. I provide a description by contrasting the tw o approaches 
then give illustrations o f  how they were used in practice, first in carrying out processes 
fundamental to  their prescribing, then in networking with other non-medical prescribers.
4.3.3.1 D escrib ing  the innovative an d  conservative approaches
The Innovative non-medical prescriber that emerged in the interview was characterised as 
a healthcare professional that was eager or inspired to pioneer changes within the environment 
that they worked in as a healthcare professional. In many cases, they may have been the nurse or 
pharmacist within their establishm ent that spear-headed the introduction o f  non-medical 
prescribing, because they saw it as a tool that would enable them to improve patient services, or 
make them  do their job  better
is something that /  wauled to get involved in. the company (hat /  work for initially 
were not very keen, because o f  the cost implications... I  wanted to deal with the problem.” 
(P rescriber 5 - com m unity  pharm acist w ith 3 years prescribing experience)
In m any cases, the changes that w ere inspired by the innovative non-m edical prescriber 
had the potential to  go  on to influence the practice o f  o ther healthcare professionals, in som e 
cases, even  inspire o ther nurses and  pharm acists to  be m ore interested in becom ing non-m edical 
p rescribers
allhough I will say now that I am doing il and I  am earning the company money, some o f 
the people that I  work with are now being more willing... to gel more pharmacists involved, so 
now pharmacists are coming to me saying... how did you gel qualified.... how did you convince 
(name of organisation) So I  am doing quite a bit of coaching people to gei them on the course 
sort o f  thing and telling them the best is to fill iheform. you know, all sons o f  that things like. 
So lots o) people in fname o f organisation) now are seeing my role and thinking irrnr, that's 
something different and they are gelling more and more interested. I  think a few  years ago, 
nothing was happening, everybody was despondent about it. but now that they have actually 
seen me do it they 're thinking oh. maybe we can have a go at it... " (P rescriber 9  - com m unity 
pharm acist w ith 5 y ears prescrib ing  experience)
M any o f  the non-m edical p rescribers that had adopted the m ore innovative approach to 
non-m edical p rescrib ing  did no t actually  set out to be  recognised as 'b e in g  innovative" in their 
respective p ractices. In the above exam ple, the non-m edical prescriber. though w ith little 
encouragem ent from  her employ e rs  se t out to  qualify and use her prescribing in o rder to  better 
her ow n  practice. S h e  w as not aw are that while sh e  w as do ing this, o ther colleagues w ho  had 
been equally interested , but less innovative were w atching her progress. T hese less innovative 
co lleagues w ould  later, w hen she had qualified  and started  prescribing, approach her to  learn 
m ore about h e r experience. Fo r them , sh e  w as a sort o f  'tra ilb lazer’ in th is aspect o f  their 
practice.
The o th er approach that em erged in the research  was that o f  the conservative non-m edical 
prescriber. T h is approach  w as characterised by. am ongst others, a  tendency to adopt a cautious 
attitude to  prescrib ing . T he conservative  non-m edical p rescribers w ere m ore likely to  assum e a 
deliberate approach tow ards the way that they practised non-m edical prescribing, o r  how  they 
perceived that it w as practised a round them . They w ere  less likely, in com parison to  the 
innovative non-m edical prescriber. to be the  leaders o f  innovation in their practice. R egard ing  
their attitude tow ards u tilising  aspects o f  non-m edical prescribing w ith in  their environm ent, 
they w ere  m ore reactive  than proactive.
"...I do admit that I am probably over cautious...I would say' to either one o f  the nurse 
practitioners who would have a  lot of clinical skills, or one iff the GP's, I have seen this patient
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and I wus wondering about this,..., what do you think and to he honest, 1 would probably let 
them prescribe because you know.... 1 hate just to get it vety wrong. I am very conscious, very 
over cautious. J think. (Prescriber 7 -  nurse in primary care with 2 years prescribing 
experience)
In this case, the above non-medical prescriber routinely backed away from prescribing when she 
perceived any risk, or challenge. Even in her own admission, the level o f  caution that she 
adopted towards her prescribing was more than was necessary.
For conservative non-medical prescribers their approach and the level o f  caution that they 
exhibited in their practice seemed to be  a sort o f •system' that they developed to  protect their 
prescribing practice. For instance, conservative non-medical prescribers who perceived that 
their prescribing may be scrutinised as a result o f  their non medical background, made 
significant efforts to have these prescribing decisions ratified by iheir senior colleagues who 
were medical doctors.
" / access my supervisor, who consults within my team. /  access him regularly and I 
discuss every sort o f prescribing contact that I make, anyway, so just because o f  the nature o f  
our work, the controversies if  you tike, surrounding non medical prescribing when it all 
started... "(Prescriber 2 -  nurse in secondary care with 2 years prescribing experience)
Though at first, it seemed that the conservative non-medical prescriber adopted this approach 
in order to ensure their professional survival, more in depth analysis revealed that this was not 
the case. For all healthcare professionals, prescribing medication for patients, involves weighing 
the perceived benefits which the patient will derive from the medication against the risks o f  
untoward effect. For conservative non-medical prescribers. their focus seemed to be on ensuring 
that patient safety was maintained.
"I think that is why I always stay on the side of caution because I think o f the patient's 
safety aspect... " (Prescriber 7 - nurse in primary care with 2 years prescribing experience)
In actual fact, it was m ore likely to have been the risk o f  making prescribing m istakes that 
comprom ised patient safety, as well as being penalised for it, which seemed to  be the reason 
why the conservative non-medical prescribers adopted their cautious attitude.
4.3.3.2 C a rry in g  ou t p rescrib ing  processes using innovative an d  conservative approaches 
One important aspect where innovative and conservative non-medical prescribers 
differed in iheir approaches to prescribing was their attitude towards carrying out the various 
processes involved in their prescribing. These prescribing processes refer to the scries o f  actions 
and procedures which when added up together, contribute to enable a qualified non-medical 
prescriber to produce a legitimate prescription. Many o f  these processes which non-medical 
prescribers engage in exist to guide and support their practice. Some o f  these processes may be
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mandatory to the prescriber’s practice, such as adhering to standard operating procedures o f  
their respective establishments and ensuring that they complete their CPD. Others are 
recommended, such as ensuring good record keeping and maintaining professional indemnity 
insurance. In many cases, the approach adopted towards carrying out these prescribing 
processes had a significant influence on their outcome.
The innovative non-medical prescribcr saw non-medical prescribing as a tool which 
should be manipulated until the best lit for their practice and their patient were achieved. This 
manipulation however had to be done within statutory requirements.
... Wff are quite cautious group, don't you think and I am not saying that f  ain not cautious, hut
I want to...ihis is new so I want to push if as far as I can without breaking any laws, but a lot of 
pharmacists say you cannot do that and f  say. why can't I do it, where does it say that /  can't do 
it and i f  I  can do it. If I can find a way to do it. legally and safely, then I will do it" (Prescriber 9
-  comm unity pharmacist with 5 years prescribing experience)
For the above non-medical prescribcr. her position was that unless non-medical prescriber 
as a policy was adopted enthusiastically, its full potential would not be realised.
A good exam ple o f  how innovative non-medical prescribers achieved this in practice was 
how they ensured that they got access to patient records which they needed for their prescribing. 
This non-medical prescriber practiced as a pharmacist in the hospital and as a prescriber in 
primary care. In h is role as a  prescriber. he did not have access to information that he perceived 
as necessary for his prescribing however as a  hospital pharmacist he could readily access these 
records.
“...well the main thing that n v  haven't got. that would make things better is access to 
patient notes and ulso access to patient blood results, which I  can access the blood result from 
the hospital fo r the patients that I see in primary care, but that is a bit o f  a hack door route, i f f  
was working in primary care, /  wouldn'/ have that access. Thai will make my job much more 
difficult. " (Prescriber 4 - pharmacist in primary care w ith 5 years prescribing experience)
By using the phrase ‘backdoor’ he admits that this approach to accessing patient records 
was less than optim al, however in order to provide what he perceived as the best care fo r his 
patients, he has had to  m anipulate the system to access needed resources.
On the other hand with respect to processes, the conservative non-medical prescriber was 
less likely to m anipulate the system in order to facilitate their prescribing. For them, it was very 
important to ensure that the procedures which among others ensured patient safely and 
protection o f  the prescribers' practice were instituted, properly defined and kept intact.
" ... we were concerned that there would not be the necessary safeguardv in place, to make 
sure that i f  anything did happen that the Trust would support us, so that took a number of
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months before that sorted out. " (Prcscriber 7 - nurse in primary care with 2 years prescribing 
experience)
In some cases, even when the processes that they had to access to carry out their 
prescribing were less than optimal, the conservative approach was to  be less proactive about 
changing o r m anipulating the system to achieve their prescribing goals.
"...it will be nice i f  I could access the same system as the GPs. but that’s an ongoing 
thing. But we Just gel used to the way o f  working..." (Prescriber 8 -  nurse in primary care with I 
sea r prescribing experience)
Similarly, when presented with an opportunity to extend their prescribing practice, the 
conservative non-medical prescriber was less likely to  go beyond what they regarded as their 
‘com fort zone’.
. . . / suid /  was uoi interested in doing anything else and he said well yes. fine, hut i f  you 
want to move on to that, then we can't think about that and I said no, I'm happy not to do 
that.....“ (Prescriber 17 - pharmacist in secondary care with 2 years prescribing experience)
In the above exam ple, the non-medical prescriber was reluctant to undertake prescribing 
in areas that he felt that he was not confident or comfortable with, despite the fact that the 
consultant in his team felt that with his skills, he was competent to undertake those tasks.
Another area where there was a clear distinction in the conservative and innovative 
approaches to processes was the non-medical prescriber’s attitude to completion o f  CPD. In this 
area also, the adoption o f  a particular approach, as a reaction to a factor that these non-medical 
prescribers had little or no control over, is clearly illustrated.
Although C PD  is a legal requirement for both nurses and pharmacists who qualify and 
practice as prescribers. in practice, different arrangements exist regarding how these 
professionals access their CPD. All the nurses that participated in the research had as part of 
their contract with their employ ers. a stipulated time during which their employers paid for them 
to complete their CPD annually. In contrast, only one pharmacist had a sim ilar arrangement. 
The o ther pharmacists that were interviewed had to complete their CPD in their own time. 
Further investigation revealed that while the Nursing and Midwifery Council (NM C) clearly 
stipulate that employers make tim e for nurses to complete CPD as part o f  their job . The General 
Pharmaceutical Council (GPhC) did not.
This situation reflected the different approaches that nurses and pharmacists adopted 
regarding scheduling tim e for. making arrangements and attending CPD they regarded as 
mandatory for their practice.
Regarding CPD. a nurse prescriber had this to say about the regular updates that were 
organised in her establishm ent and -which constituted a major part o f her annual CPD.
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" ...there is (he generalist update that costs a lot o f  money and actually, it is well worth it. 
really. It is nice to he spoon-fed and just have somebody look through alt the evidence, present 
it it) you so that yon are not having to do that (sic)." (Prescriber 10 -  nurse in primary care with 
6 years prescribing experience)
Pharmacist prescribers. who on the other had that did not have access to these updates in 
their work places and were usually not permitted to seek out and attend CPD as part o f  their 
paid work rime, did not have it as easy as the nurse prescriber above.
F or most o f  the pharmacist prescribers that 1 interviewed, in order to fulfil the statutory 
requirements regarding CPD, they had no choice but to adopt a more innovative approach. For 
instance, they first had to carry out a personal analysis o f  the skill that they perceived to 
presently be lacking, but which they needed for their practice.
"...hut if there's a specific skill that you need to develop wilh CPD, you may have to go 
and find that, sometimes, so it depends. Not everything is readily available hut there are some 
things that are readily available, there are some things that you have to go hunt fo r ” (Prescriber
I - pharmacist in secondary care with 3 years prescribing experience)
Then they had to identify where to get the resources to develop these needed skills.
" ...when you finish work, at home, you Just need to he very focused to actually drag 
yourself to do more CPD. I mean. I  try to keep up-to-date with all the newsletters and things 
like that, do more reading and all those other things...hut it is difficult, because you need to do 
research to find out where it is that you can gel more training on certain things... "(Prescriber
I I -  pharmacist in primary care with I year prescribing experience)
Then finally, apart from the time invested in finding the right resources, they also had to 
find the time to attend, or carry out their CPD.
"... training is always useful, the more you do it the belter I think I can only access it out 
o f working hours, because they will not pay for me to have any more time o f f ... " (Prescriber 5 - 
community pharmacist with 3 years prescribing experience)
As such, over time, pharmacist prescribers have had to first assess personal requirements 
in order to  identify needed skills, then research where to get the adequate resources to build up 
these skills and finally, they had to be more efficient, time wise, in order to attend, or complete 
their CPD. It was inevitable that gaining and using these skills made them assume the more 
innovative approach with respect to researching and completing their CPD.
In contrast, in response to perhaps researching and completing CPD in her own lime, this 
nurse prescriber responded.
"I do it in work time, because I  am quite afirm believer... /  don't say I  don't do anything 
out o f work hours, but I  am a firm believer that I come to work, I work very' hard and If I did
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something in the evening, that will he fine, hut then 1 will take the time buck...'' (Prescriber 7 - 
nurse in primary care with 2 years prescribing experience)
The fact that she was reluctant to research and complete the CPD in her own time was not 
as a result o f  her professional background, but rather, as a result o f  being used to having this 
done for her. because that was the standard for nurses.
4.J.3.3 A dopting  the innovative a n d  conservative appro ach es to  using netw orks
Non-medical prescribers like most other professionals, belong to networks where they 
develop and maintain relationships with other non-medical prescribers. Professional networks 
are structures within which people from different establishments interact to share knowledge 
and experience. The contributions that non-medical p rescribes make to, or gain from networks, 
have a considerable influence on how they and other non-medical prescribers learn skills and 
solve problem s within their respective practices.
For non-medical prescribers, using networks to achieve mutual encouragement and 
development o f  personal and professional capabilities means a last, effective and relatively 
informal way o f  achieving their prescribing goals. There were no hard and fast rules as to how 
the non-medical prescribers developed and used their networks. For both innovative and 
conservative non-medical prescribers. this happened both formally and informally. W here there 
was a distinction was how non-medical prescribers employed approaches to network with 
fellow non-medical prescribers.
In their practice, one o f  the m ore conservative wavs that non-medical prescribers made 
use o f  the networks that they had developed, was to  reassure themselves that their prescribing 
practices were being carried out in the right way.
somebody is doing something in certain ways then you are kind of reassured, ah. I am 
doing something the same with other people, which is correct, it is just reassuring. " (Prescriber
11 - pharmacist in primary care with I year prescribing experience)
In this case, although the non-medical prescriber was already earn  ing out their practice in 
line with recommended procedures, the fact that other members o f  their network had a similar 
interpretation o f  the procedures in their own establishment was reassuring to the non-medical 
prescriber.
l or conservative non-medical prescribers. the reassurance that they are able to achieve 
through their networking with other non-medical prcscribers not only served as a se lf 
confirm ation o f  good practice, it also helped them in building their confidence.
"...it just gives you the confidence to go and prescribe and reassures you that you are 
conducting your practice quite well. And that influences your decision making in terms of
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milking you confident la do i/nii." (Prescriber 2 - nurse in secondary care with 2 years 
prescribing experience)
This role o f  networking in helping to reassure non-medical prescribers and to  aid in 
boosting their confidence was especially important to conservative non-medical prescribers 
practising alone. It could however be argued that this approach o f  reassurance by networking 
may hot necessarily guarantee that the practice in question, which other members o f  the network 
agreed with, was correct.
Conservative non-medical prescribers did not just use their networks to ensure that their 
practice was correct and in tandem with that o f  their peers, they also used networks to ensure 
that they were practicing non-medical prescribing inline with the most current legal positions.
"...especially the changes o f law lately, so far we have discussed things like that before, to 
say that.... how are we covered now. what should we he dong, how things have changed . 
(Prescriber 3 - nurse in secondary care with 2 years prescribing experience)
This use o f  their networks was especially important for the conservative non-medical 
prescriber. because the relatively frequent policy changes in non-medical prescribing would 
have meant that irregular updates might lead to uncertainty and risk in their normally cautious 
practice.
Another way that non-m edical prescribers used their network in what could be regarded 
as a m ore conservative approach, was to identify what they perceived as unethical practices.
' /  know for a fact from talking to other prescribers nationally, that some people ure just, 
you know, prescribing and checking their own work ... the national code o f  ethics is pretty dear 
that you do not check your work, unless it was in exceptional circumstances, so..." (Prescriber
19 - pharmacist in secondary care with no prescribing experience)
In this case, a certain practice had been identified though networking and this was not a 
practice engaged in by this conservative non-medical prescriber. Rather, having matched it with 
the set out and defined procedure governing that aspect o f  prescribing, he considered it an 
unsound practice.
Non-medical prescribers have also used their networks in innovative ways. In the first 
subsection we saw some non-medical prescribers exhibiting innovative attributes when they 
spearheaded non-medical prescribing in their establishment. In line with this, it seemed natural 
that these non-medical prescribers would have wanted to share their experiences with other 
’upcoming’ non-medical prescribers. One o f  the forums through which they achieved this was 
by networking.
"I support people undergoing the truining within my team as well, so we share ideas... " 
(Prescriber 2 - nurse in secondary care with 2 years prescribing experience)
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"I am really quite pleased to be helping the others out. so they don 7 have to go through that 
work again, you know the work lhat I had M do...1 mean. I am not going lo do it for them, but / 
do know the research well and III  be saying you need lo read lliis paper, you need to read lhat. 
or I have down loaded this, here you are. have a look at it..." (Prescriber 9 - community 
pharmacist with 5 years prescribing experience)
These I wo non-medical prescribers had expressed a greal passion and enthusiasm lor non­
medical prescribing during their interview's and for them, mentoring their peers meant that they 
could use the knowledge and experience that they had accrued to help colleagues learn needed 
skills quickly and efficiently. However, it is important to note that although some o f the 
innovative non-medical prescribers mentored their colleagues successfully, being an innovative 
non-medical prescriber and being a mentor require a different skill set. For instance, being a 
good listener is seen as an essential characteristic o f  a  good mentor, but riot necessarily true for 
an innovative non-medical prescriber.
For other non-medical preseribers who did not quite go as far as mentoring, their 
networks served as a means o f  disseminating some o f  their knowledge and experiences which 
they perceived would be interesting to  other non-medical prescribers.
" He had a monthly non-medical prescribing meeting where nurses and pharmacists met 
and discussed current topics and that was very useful. And the nurses who would often have 
different problems w  phannacisis, so it was interesting meeting... both meeting in the same 
meeting together to discuss things" (Prescriber 12 -  pharmacist in primary care with 2 years 
prescribing experience)
The monthly meetings mentioned above were one o f  the very few revealed in the 
interviews that had nurse and pharmacist prescribers in the same formal network. What I found 
however was that informal networks developed by individual non-medical prescribers regularly 
included m embers o f  professions other than theirs.
O ther non-medical prescribers who did not have the knowledge or experience to share 
with others also exhibited some level o f  innovation by seeking out other non-medical 
prescribers that they identified as both having the attributes o f  a good mentor, as well as having 
the relevant know ledge and experience to help them develop their practice.
“ I  think what I  am doing al the moment is lhat I'm spending some time with one o f the 
nurse practitioners, because wluit I find  is lhat I he nurse practitioners, as nurses are far more 
approachable and they will make time to help me.-. "(Prescriber 7 - nurse in primary care with 2 
years prescribing experience)
She prescribed in a practice where although other colleagues within the practice were 
GPs, she preferred to seek out a m ember o f her informal network to m entor her in her skills 
acquisition process.
93
An even more assertive use o f  the networks was revealed during the interviews. Some of 
the innovative non-medical prescribers not only shared information, but also went ahead to 
make particular skill sets known to their peers. This led to  them getting referrals from their 
peers for patients for whom it was perceived would receive better care by these referrals.
" ...everybody is fairly new to prescribing and following the meetings. I've got a lot of 
referrals from these nurses who knew what ire could offer in terms o f  prescribing and advice, so 
yes it was good " (Prescriber 12 - pharmacist in primary care with 2  years prescribing 
experience)
4.3.3.4 C ategory sum m ary
This category explored the innovative and the conservative approaches that emerged in 
this project. W hile the innovative approach was associated with driving change w'ithin their 
professional environment, the conservative approach was associated with being cautious and 
focusing on processes that would ensure patient safety and protecl practice. Examples o f  how 
non-medical prescribers adopted these approaches were illustrated by showing how they carried 
out processes essential to their prescribing and utilised their prescribing networks.
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4 .3 .4  N a tu r e  o f  th e  p re s c r ib in g  e n v iro n m e n t
In this category, I explore interactions that nurses and pharmacists had with individuals 
and processes within their prescribing environment that were perceived as influential to their 
practicc. In the first two sub-categories ‘developing relationships with colleagues’ and ‘relying 
on colleagues*. I will explore how non-medical prescribers engaged in relationships building 
within their practice settings. In the next sub-category ‘team-working’, I explore how non­
medical prescribers perceived working in a  team and interacting with colleagues within that 
team. The fourth sub-category 're la ting  with patients with chronic pain’ deals with the 
relationship building process that non-medical prescribers had with their chronic pain patients, 
while the fifth, 'second checking’ focuses on how the processes involved in having their 
prescriptions checked, influenced their prescribing. In the last sub-category ‘interacting with 
m anagem ent’. I look at how non-medical prescribers felt that their prescribing was influenced 
by interacting w ith people seen as having some control over aspects o f  their prescribing 
practice.
4.3.4.1 Developing re la tionsh ips w ith colleagues
Most qualified nurses and pharmacists, who considered prescribing, did so as part o f  a 
team o f  other healthcare professionals, l-'or non-medical prescribers. these relationships with 
team m embers and other healthcare professionals that they relied upon while prescribing, was a 
key part o f  what they considered ideal for their prescribing. There was a keen awareness among 
nurses and pharmacists who considered prescribing, about the necessity o f  developing these 
relationships. This was because the level o f  trustworthiness, reliability and dependability o f  
these relationships were seen as the spine upon which they w-ould base the other characteristics 
that were considered essential for them to practice and develop their prescribing.
Good teamwork was seen as essential to providing better services for patients and non­
m edical prescribers realised that proper integration witliin the team that they prescribed from, 
was necessary to ensure this. For instance, non-medical prescribers considered that because each 
discipline within a team approached a patient’s  treatment from a differing viewpoint, a decision 
that took all these various viewpoints into consideration, before proposing a treatment for a 
patient would be m ore com prehensive than one that had not.
“...when everybody comes from a different perspective, us I said, we are predominantly 
social workers, nurses and Doctor and each discipline will have a different standpoint, but 
when you put them all together and thrash it out. its quite a robust plan that ire pm together. " 
(Prescriber 2 - nurse in secondary care with 2 years prescribing experience)
Non-medical prescribers felt that building a relationship with colleagues within their 
team was dependent on their colleagues understanding o f  the skills possessed by non-medical
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prescribes, In the category 'm otivators ' non-medical prescribers saw themselves as being more 
skilled than their colleagues who could not prescribe and how important it was to them that their 
colleagues recognised these additional skills set that they had. As such, within the team. It was 
crucial for these non-medical prescribers to demonstrate that they had and could use these skills. 
They tell that this would ensure that they were perceived by others to  be a trustworthy member 
o f  the team who was able to deliver for the patient, on behalf o f  the team.
"So it's good dial the nurses do understand what the relationship with pharmacists can he 
and they understand my background. They understand the strength o f the pharmacist knowledge 
is and that is... because when I see the patient, they have already been seen by a nurse and they 
are very involved in the education and disease management side o f things. So we work very 
closely and they..../ rely on them, because I don't get patients unless they refer to me. so it's 
important that they trust me and they know what their patient is going to receive." (Prescriber 4
- pharmacist in primary care with 5 years prescribing experience)
However, the feeling among some non-medical prescribers was that, in their experience* 
not all healthcare professionals that interacted with non-medical prescribers. had an adequate 
understanding o f  who the non-medical prescriber was and what they did.
"I gave a prescription to a patient, the)’ look it to the chemist..., chemist rang me up and 
said “mv do not issue nurse's prescriptions" ooh.., so I rang..... my friend and I said, you 
know... and she said that is rubbish, she said, but because I was so new to it. you start to 
wonder i f  things had changed, don't you . or wlial have you. Rang the chemist hack, explained 
and she said, oh right and you know, she dispensed it ” (Prescriber 8 - nurse in primary care 
with I year prescribing experience)
Even among members o f  the sam e profession, there seemed to be a less than optimum 
awareness o f  what powers their professional colleagues who were qualified to prescribe had and 
through what mechanisms they were allowed to carry out their prescribing.
have had to explain to them, what a supplementary prescriher is and a ciinicul 
management plan is and then they have said well, how do i know lhal you have a clinical 
management plan, I  said, because I am a pharmacist and I am telling you that I have put the 
clinical management plan....and sometimes you want 10 give them a slap don't you 
(laughs)....and I said do you think that as a pharmacist I would issue an illegal prescription,
you know and then...../  have made some friends lhal way. actually, because o f the way that i
talk to them, becuuse they' do not understand about non medical prescribing.....pharmacists
don’t. " (•.Prescriber l> - community pharmacist with 5 years prescribing experience)
Sometimes, being qualified, having all the necessary skill needed prescribe and being able 
to  use them when the need arose, was not perceived by non medical prescriber, as enough to
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ensure their integration within their team. It was sometimes necessary for non-medical 
prescribers be m ore proactive, for instance, demonstrating their capabilities more overtly, or 
consciously spend time interacting with team members, in order to facilitate the development o f  
these relationships.
it .v just in mingle with the GPs more and have more dialogue with them by .showing 
that you actually know your s tu ff and gaining respect from the UPs. you know, you just have to 
spend time to build up trust in that respect from the CPs. "(Prescriber 11 -  pharmacist in primary 
care with 1 year prescribing experience)
" . .. /  work closely wilh llte GPs and they are m y  respectful o f what pharmacists can do 
and /  think it is a question of getting to know the other members o f the medical team and as you 
say, interacting, perhaps giving good advice. It is a slow process but it is very effective in the 
end "(Prescriber 12 - pharmacist in primary care with 2 years prescribing experience)
Overt demonstration o f  relevant skills and conscious interaction with colleagues, in a  bid 
to facilitate an environment conducive for their prescribing, signified a more innovative 
approach to  relationship building by these non-medical prescribers.
Non-medical prescribers felt that other measures may be needed to enhance other 
healthcare professionals' understanding o f  their role. For instance, it was felt that the routine use 
o f  a  title depicting their status as nurse and pharmacist prescribers would improve the 
understanding o f  their role when they interacted with other healthcare professionals.
u...my title? I don't know i f  I even have an official one. it tends to vary, but I think what 
that does is maybe, when talking to people, helps them recognize what skills you might have, 
because I haw rang up the CPs.. .. I have rang them all up and said I'm u pharmacist, the term 
doesn't necessarily mean a lot to them... it might he less o f a battle, me asking them to change 
things, or collaborating with them, or having my views maybe taken more seriously, because I 
work with a lot o f  consultants, some o f  them who know me. that's easier, some o f them who do 
not and then it may he that that title so will help pave the way. " (Prescriber 6 - pharmacist in 
primary care with 5 years prescribing experience)
"I think your qualification needs to be recognized not only by the official bodies, but by 
the colleagues that you work with, so it will he useful to actually inform the department that you 
work in. your specially, that you have got the special skill that you can use and that you are 
using it. it really helps a lot that you are providing some extra special services and that 
e\'cryhodv recognizes the extra special .services. " (Prescriber I -  pharmacist in secondary care 
w ith 3 years prescribing experience)
They felt that this may even have a beneficial impact on the way that non-medical prescribers 
manage their patients.
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"...hul I don't think that (the title) wilt help directly with prescribing, it’s more about 
patient management again, having more roles will make more differences and working at the 
more strategic level to make the differences with who is admitted, when they're admitted, who is 
discharged " (P rescriber 3 -  nurse in secondary care  with 2 years prescribing experience)
In the  relationship build ing process, though non-m edical prescribers placed more 
em phasis on  ensuring  that their reliability  and trustw orthiness is established with their 
colleagues, there w as som e reciprocity in the process and colleagues o f  these non-m edical 
p rescribers w ere  also expected  to  be adequately skilled and trustworthy.
"A safe environment is Hkeminded people who want to help people grow ..and facilitate 
the growth and i f  unsafe practices are identified, can act upon that, hut in the hest way 
possible, .so a safe environment is a trusted person who has the knowledge base and is 
trustworthy really." (Prescriber 10 -  nurse in prim ary care w ith  6 years prescribing experience)
D uring the interview s, many m ore non-m edical prescribers seem ed to concentrate m ore 
on  prov ing  them selves to  their colleagues, suggesting that I hey saw  them selves as ‘the new 
com ers’ com ing into the relationship . This explains why. though they expected  their colleagues 
to  be equally skilful and trustw orthy , they did not seem to  question how equitable the 
con tribu tions o f  their colleagues w ere, to the relationship  developm ent process.
"...for everything new. there are hurdles and it is a question o f  people understanding 
what you can do and how you f i t  into the existing team, so they were hurdles, but they were not 
insurmountable and people were very encouraging."  (P rescriber 12 - pharm acist in primary care 
w ith  2  y ears p rescrib ing  experience)
It a lso  suggests that for som e o f  these p rescribers. they w ere left w ith  little choice than to 
adopt a  m ore innovative approach in build ing  these  re lationships that w ere seen as crucial to 
th e ir prescribing. A s such, non-m edical p rescribers may have had to work harder at building 
these relationships, at least up till the point w here continuous interaction led to  the  attainm ent o f 
an environm ent sa fe  and supportive  enough fo r their prescribing. Thereafter, equitable effort 
from both parties then w ent on to  ensure  the  m aintenance o f  th is environm ent.
"I have always enjoyed working in a team and I  mean, when I first started, it was Doctors 
are gods, do von know what I mean, ther really ...but actually once you get to know them, they 
don't... they know you're a pharmacist, once you have been working with them, didn't actually 
treat you any differently So it is quite good." (P rescriber 9  - com m unity pharm acist w ith 5 
years p rescrib ing  experience)
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4.3.4.2 Relying on colleagues
After pharmacists and nurses qualified as prescribers. there was a  transformation from a 
healthcare professional to a prescribing healthcare professional. While this process was 
happening, non-medical prescribers carried out a conscious determination o f  healthcare 
professionals whom they felt that they could trust and depend upon to facilitate this process o f 
developing as a  prescriber. W eidman and his colleagues call this development process, 
professional socialization. They defined it as the acquisition o f  values such as know ledge, skills 
and norms through subconscious processes resulting in the formation o f  an identity that is 
unique to a particular profession (W eidman et al., 2001).
Non-medical prescribers realised that although they may now prescribe just like their 
medical colleagues, the manner in which non-medical prescribers developed their prescribing 
skills differed from how doctors developed theirs.
" .... their professional socialization andpreceptor-ship for oilier Doctors is that you are a deity, 
you know, so they have .... Some have ..are very cautious, but they have a much more blase 
attitude Id prescribing and the magnitude o f it because it is Just seems as an added thing really 
to that whole diagnostic process that they are king of " ( Prescriber 10 - nurse in primary care 
with 6 years prescribing experience)
" . .. /  think that is vciy different to the medical... il will he very easy for me to take a 
medical... or potent tally be very easy for me to take a medical model, but /  am not doctor and /  
don't want to be a doctor, so as a nurse /  think it's important that I  come from and share my 
experiences with my colleagues and have- them share tlieir experiences with me. "(Prescriber 2 - 
nurse in secondary care w ith  2 years prescribing experience)
As such, most non-medical prescribers, in building up their knowledge, experience and 
confidence, preferred to rely on their fellow non-medical prescribers either within their 
immediate team, or through accessing a network o f  other non-medical prescribers who practised 
in their areas o f  interest.
“....it’s j u s t ......./  know il is being silly, but now that I am spending some lime with her. I
think she will help me to say..,.:well actually, it's fine, you can do il..., you are safe." 
(Prescriber 7 - nurse in primary care with 2 years prescribing experience)
However, the reality for many non-medical prescribers is that they would access 
colleagues who were in close proximity to them and used them as resources in developing their 
practice. Since non-medical prescribers admittedly had different professional socialization from 
these colleagues that they ended up relying on, it seemed quite a strange choice to make. The 
fact however is that this choice was often made as a  pragmatic response to circumstances that 
the non-medical prescriber perceived as being beyond their control. For instance, unavailability
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o f  another non-medical prescriber within ihe sam e team, or a lack o f quick access to networks 
o f  non-medical prescribers practicing within the same specialty.
got the support from] CPs, which I  suppose is not ideal, it would he ideal to get 
support from other experienced independent preserihers, because the issues are different, hut 
there are not enough o f course. 1 was the only one in (name of a bigger practice) and I am the 
only one here and you can get a little hit isolated:" (Prescriber 22 - nurse in primary care with 3 
years prescribing experience)
“—a lot o f  times when we are actually in the practice, rather than discussing with the 
other independent prescribers from elsewhere, we actually discuss things internally with CPs " 
( Prescriber 11 -  pharmacist in primary care \\ ith I year prescribing experience)
These tw o scenarios represented a more innovative approach to accessing resources to aid 
learning in their respective prescribing areas. By learning from colleagues who were not non­
medical prescribers. these prescribers chose to move out o f  their comfort zone to improve their 
practice. The healthcare professionals that non-medical prescribers went to rely on. to support 
their developing prescribing practice were mainly doctors, such as GPs or consultants, as well 
as nurses and pharmacists, who were not necessarily prescribers. or from the same professional 
background.
As the relationship developed, tw o factors seemed important in determining if  a non- 
medical prescriber went on to rely on a particular healthcare professional that they had 
identified as a resource. Firstly, they had to be perceived to have the relevant skill that the non- 
medical prescriber wished to access
"...I am quite happy. .-Is /  say. I have got access to support from some GPs if /  need it and 
we have got the pharmacy.... i f  we have got queries, the pharmacy leads from the PCT..., so I 
know where I  can get information if I  need it. But no, there is nothing I would change, really, I 
am quite happy at work, it works well for me." (Prescriber 16 - nurse in primary care with 5 
years prescribing experience )
and secondly. that they are perceived as being trustworthy and reliable.
"...all the members o f the practice here were encouraging, it is a training practice, they 
are very keen for people to develop their individual skills, so there is no hairier here. Bui in 
other practices, perhaps with different perspectives on pharmacists, there may be some 
resistance." (Prescriber 12 -  pharmacist In primary care with 2 years prescribing experience)
The decision to rely on a colleague was made consciously by the non medical prescriber. 
In this case, the non-medical prescriber would have carried out a self assessment and identified 
an area within their prescribing practice where they perceived a deficiency, such as knowledge
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o r experience. This was then matched with a trusted colleague who was judged to possess that 
relevant skill and was part o f  a developed or developing relationship structure.
"ft I am not sure of.,, or new situations, because in this job. I am getting people through 
the door and you do not know what they are coming fur. it could he something that I have not 
really hud much experience in. so ij I need to. I can.... I can Mill access GPs advice, or see what 
they would normally prescribe in certain situations i f  it is something I am not quite sure about. 
Hut /  suppose, they are less and less as you get more experience in prescribing, so it doesn't 
happen as often. " (Prescriber 16 - nurse in primary care with 5 years prescribing experience)
As the relationship continued and the non-medical prescriber became more proticicnt in 
this particular skill that they had previously relied on a colleague for, the need for continued 
reliance to develop that aspect o f  their prescribing reduced. Alternative!), the non-medical 
prescriber would have made a conscious decision not to use a colleague that they perceive as 
more experienced, more knowledgeable or more confident as a resource. Despite the fact that 
they are qualified to prescribe, they ‘copped out’ o f  prescribing even when they had the basic 
skills and had access to healthcare professionals that could help them develop their prescribing.
son of cop-out is the right word. I would say' to either one o f the nurse practitioners who 
would huve a lot of clinical skills, or one o f the OP's. /  have seen this patient and 1 was
wondering about this.....what do you think and to be honest. 1 would probably let them
prescribe because you know.. " (Prescriber 7 -  nurse in primary care with 2 years prescribing 
experience)
As the non-medical prescriber became more confident in their prescribing abilities their 
role in these relationships evolved. W here previously they sought out colleagues to develop 
relationships with and rely upon, they in turn become resources that could be trusted to  be relied 
upon for know ledge and experience.
" /  do supervise some o f the colleagues that are undertaking training and I think it is 
coming from the same standpoint, you see. you have got the same perspective on how to 
prescribe, what to prescribe and decision-making around tha t. So you are thinking along the 
same lines, you understand each other's practice. ' (Prescriber 2 - nurse in secondary care with
2 years prescribing experience)
In a way. non-medical prescribers were already used to managing and sometimes meeting 
expectations. Earlier we saw how some nurses and pharmacists were able to be motivated to 
qualify, as a result o f  what others expected from them. Here, similarly, as non-medical 
prescribers gain m ore experience, they were ‘expected’ to also be a resource for others to use. 
These expectations seemed implicit and applied more to  those areas where adopting an
innovative approach meant that the non-medical prescrihers had 'broken new ground* that 
others would be interested in.
Also, just as the budding non-medical prescriber had sought out either another non- 
medical prescriber or a colleague who was not a non-medical prescriber, but was in close 
proximity to them, so also did the experienced non-medical prescriber fulfil their role as a 
resource for both groups.
■ /  have a GP colleague who has also become a good friend over lime and have a nice 
situation lhat he will often hob lo hut and say what you think about this, or what would you do in 
this situation, it is a veiy open two way communication " (Prescriber 22 -  nurse in primary care 
with 3 years prescribing experience)
For non- medical prescribers developing a relationship with their colleagues was not in 
itself, enough to constitute a safe environment.
"I think that maybe down to lru.fl and confidence, also maybe down to the prescribing 
supervisors, consultants, doctors, etc. confident that it is robust enough to avoid errors and 
uniil that confidence gets better, /  think they are still going to have p r o b le m s ( Prescriber 2 -  
nurse in secondary care with 2 years prescribing experience)
It was very important to them that the relationship be perceived to be trustworthy and reliable 
and lhat the colleague be recognised a having the  skills base to provide prescribing support 
when this was needed. Ideally, the non-medical prescribcr was also expected to reciprocate 
these values.
43 .4 .3  T eam -w ork ing
Non-medical prescribers often practiced their prescribing within a multidisciplinary team 
o f  healthcare professionals. As mentioned earlier, these healthcare professionals with diverse 
training worked towards a common goal in order to produce a  robust treatment plan for the 
patient. Irrespective o f  their prescribing setting, all the non-medical prescribers that I spoke to 
saw themselves as prescribing from within a structure o f  a team. It did not matter whether they 
were comm unity pharmacists, practice nurses, health visitors, o r  hospital pharmacists.
" /  would certainly say that it Is teamwork, because the key worker comes to me, she's 
based in an office, all referrals haw gone through to the office and I talk to the girls... the key 
workers about drug treatment centre regularly, they talk to me. I  think it has increased my 
involvement in their team. For pharmacy issues, they ring me for advice. " (Prescriber 5 - 
community pharmacist with 3 years prescribing experience)
"...it is multidisciplinary, hut mayhe not as broad, not as many different professions in 
the team as you would gel in the hospital, hut they do have GPs and practice nurses and
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healthcare as.sistaius and myself, so you know, it is tnultidisciplinuiy in that sense, but we see 
ourselves as one team. I suppose, working altogether for the patients. " (Prescriber 16 - nurse in 
primary' care with 5 years prescribing experience)
"...because they really taken into the whole team building, because as apharmacist, you 
actually give a completely different angle, because I work with consultants iuid CJPs and nurses 
and we all have a completely different way o f looking at things. " (Prescriber 9 - community 
pharmacist with 5 years prescribing experience)
Additionally and perhaps for a more pragmatic reason, non-medical prescribers noted that 
due to the way that non-medical prescribing was set up. team working was not ju s t seen as 
optimal, il was perceived to be an essential tool for non-medical prescribing.
"...you can only really he a prescriber i)you are part o f a team, because whether you are 
in the hospital or in primary care, you have to he part o f the team, probably because you need 
access' usually to the whole clinical record this so that you can check that drugs aren't 
interacting. .. check what people have used before." (Prescriber 18 -  pharmacist in primary care 
with 4 years prescribing experience)
Non-medical prescribers felt that being pan o f a team enhanced the relationships that they 
considered crucial to enabling their prescribing from a safe environment. For instance, working 
in a team provided a forum where all team members including the non-medical prescribers 
could work within set parameters and focus on a  common objective.
"...you work with other people, to the same goals, don't you? /  work within u very good 
team, a very structured team, we have very clear objectives, so from that point o f view, it makes 
it very easy to function within the team and within your professional capacity. And /  think uv  all 
feel that. " (Prescriber 15 -  pharmacisi in secondary care with 3 years prescribing experience)
W hile this was happening, there was an opportunity for communication skills to be 
improved and for ‘people skills' to be further developed.
•'/ think il depends on the communication and the context and the willingness of each member o f 
the team to include everyone else. Sometimes certain team members might welcome and review 
the patient, or they just want to review il on their own. they don't want to involve any one else. 
You do learn about options when you work with others. " (Prescriber I - pharmacist in 
secondary care w ith 3 years prescribing experience)
Team working also presented a platform that allowed the skills base o f  the non-medical 
prescribers to be viewed a s strengths. As a result o f  this, non-medical prescribers were better 
recognised and appreciated for their skills and their contribution to the team was better valued.
"...so it is a team that comprises o f nurses, probation workers, social workers, the interesting
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thing Is lhal there isn t a medic in the team, which is why I uni in it. Because I am (lie person 
that knows about c/rugs, So. it involves me liaising willi other learns. So I (Jo quite a lot o f 
liaising with psychiatrists, cm and GPs. although they are not strictly part o f  the team, they 
become the team for that patient. " (Prescriber 6 - pharmacist in primary care with 5 years 
prescribing experience)
W ithin the team, when it was realised that the non-medical prescriber had 'proven their 
professional w orth ', the non-medical prescriber was then seen to ‘earn the respect' o f  their 
colleagues.
"...because they see us as a resource and they want to use us and use my knowledge, so 
absolutely. I  would not work in the practice where /  nay not welcomed and kind o f respected for  
what I do, I would go to unotherone lhal did." (Prescriber 18 - pharmacist in primary care with 
-I years prescribing experience)
*7 work closely with the GPs and they are very respectful o f what pharmacists can do and
I think it is a question of gelling to know the other members o f  the medical team. " (Prescriber 12
- pharmacist in primary care with 2 years prescribing experience)
Non-medical prescribers identified that the way the team was set up as a key facilitator to 
the smooth working o f that team. They fell that i f  the team is set up in a manner whereby there 
is an apparent power structure within the team, this may hinder a  free flow o f  ideas. To them, it 
was important that the team be set up in a non-hierarchical manner. The fact that all team 
m em bers w ere seen as equals was thought to encourage a rigorous exchange o f  ideas without 
fear o f  antagonising colleagues who were seen as higher-up in the pecking order.
" ...H r  try to set it up very much as i f it doesn't have a hierarchy, although we still have 
consultants and whoever leads or consults, along with the managers, who takes overall 
responsibility for the team, but just because o f  the way we work il actually allows the medics lit 
share ideas with the nurses. And we have social workers and psychotherapists and there's a lot 
o f  sharing o f ideas. " ( Prescriber 2 - nurse in secondary care with 2 years prescribing 
experience)
"... we all work as equals, very much so,... some o f the members o f the team, in exactly 
the same way. so there is no hierarchical structure within the team."(Prescriber 15 - pharmacist 
in secondary care with 3 years prescribing experience)
‘ ...but I am working with peers, who 1 do know huve a degree o f respect for my 
knowledge and also I  consider to be peers rather than superiors, that's actually important. I 
think." (Prescriber 20 -  pharmacist in secondary care with 5 years prescribing experience)
However, not all o f  the interactions that non-medical prescribers huve had while working 
in teams had been positive. Non-medical prescribers also experienced some negative attitudes,
which they perceived as a hindrance to their prescribing practice. Though it is perceived that 
other healthcare professional, mainly doctors, were becoming better informed about the non­
medical prescribing policy, there still remained a few medical personnel that are not particularly 
supportive o f  the concept o f  nurses and pharmacists prescribing
...realty heciiii.sc they are a practice that you know.... are veiy much firm believers that 
doctors do doctors things, nurses do nurses things and then not very comfortable with the idea 
of advanced nurses role and prescribing. " (Prescriber 7 - nurse in primary care with 2 years 
prescribing experience)
"...even now in the pockets 1 work with, you know that somebody is not particularly 
...does not particularly like non-medical prescribers, so it's questioning everything that you say, 
but you get other doctors who will just sov... that will actually come to me and ask for advice. " 
(Prescriber 9 - community pharmacist with 5 years prescribing experience)
They arc so friendly, they are so supportive and it pushed me to do all o f this. There is only 
ever been one skitty comment of alih you ‘re going to get prescriher then, mm mm let s just do 
another 20 junior doctors out of a Job then, which was interesting...". (Prescriber 3 - nurse in 
secondary care with 2 years prescribing experience)
It became clear that non-medical prescribers perceived the team as more than a structure 
put in place to aid further developm ent o f  individual relationships with colleagues. For them, it 
was a structure that also enabled them to assess how trustworthy their colleagues were and how 
safe and supported they perceived their prescribing environment to be.
A good example o f  how this happened in practice was illustrated by the processes that 
were involved in arriving at a final treatment plan for a particular patient. Within a  team, 
healthcare professionals from different disciplines within the team often had differing 
viewpoints and these had to be debated in order to reach an agreement. While exchanging ideas, 
challenging o f  one another's viewpoints was expected to occur.
“ . . . u r  challenge each other, there are times when somebody might think one thing and 
somebody might think something else and we might not come to any conclusions. Then a few 
people might took at this person's... and then go see them and see what's going on and come 
back and then go and talk some more and then work around that really "(Prescriber 2 - nurse in 
secondary care with 2 years prescribing experience)
Depending on how this process occurred, non-medical prescribers felt that the process of 
critiquing the viewpoints o f  other team members, as well as having their own viewpoints 
challenged had t he potential to enhance the development o f  the non-medical prescriber. It has
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been suggested, that by engaging in this process, the non-medical prescriber could become more 
experienced, knowledgeable and confident.
"...so n r  share ideas, we challenge each other's prescribing practices , it just gives you 
the confidence to go and prescribe and reassures you that you are conducting your practice 
quite well and that influences your decision making in terms of making you confident to do that 
and the challenging also makes you think, what else could I have done so it makes you think 
differently. "(Prescriber 2 - nurse in secondary' care with 2 years prescribing experience)
With increased capacity in these areas, it was expected that the non-medical prescriber’s 
ability to give and receive critiques would have also been improved, in what might be referred 
to  as a virtuous cycle. However in certain other cases, it was felt that non-medical prescribers 
had been exposed to circumstances where the exchange o f  ideas was done negatively. In these 
cases, the criticising team member may have been perceived as being overly aggressive, or that 
their critique was delivered in a condescending manner bccause the critique was aimed at a non­
medical prescriber.
'' ...but the GP made a point o f  telling her how wrong she was in the middle o f the 
reception, the interesting thing h 'u s . The GPs colleague had done the same thing, so in other 
words, she was following on probably what somebody else had already done and I am assuming 
that the GP did not have to go at his colleague in the middle oj reception " (Prescriber 7 - nurse 
in primary care with 2 years prescribing experience)
Another exam ple is an illustration o f  what followed when a  non-medical prescriber made 
an error while prescribing. In the first two cases, these non-medical prescribers trusted their 
team m em bers and felt adequately supported by them. They knew that i f  they made an error, it 
w ill be dealt with in a non punitive manner and this will ultimately improve their prescribing 
practice.
"...there is never any suggestion o f criticism because o f the., certainly in my 
environment, you know, if something goes wrong, someone will ask you if  you might want to file 
a critical incident form, or take it to the team meeting to discuss it to see... you know, because if 
I’ve made a mistake, which I have done and it is quite likely, it is a system error, or it is 
something that other people are quite likely to gel wrong as well. So I’ve made mistakes und we 
have kind o f discussed it in critical incident meetings and they have made mistakes, which we 
have raised in critical incidents as well, but that's not to blame kind o f culture thing, it works 
very well for us really. " (Prescriber 18 - pharmacist in primary care with 4 years prescribing 
experience)
" /  just think it's important not to be complacent about it. I mean /  can do probably what /  
do stood on my head, but I think there's always new challenges and I think we have always got 
to recognize the fa d  that y/m might miss something, so working as a team, picking up different 
issues, htn'ing questions from the consultants around, having questions from the consultants
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around prescribing issues, il is just fantastic. And I ready probably wouldn't want to work as an 
independent prescriber in isolation. " (Prescribcr 15 - pharmacist in secondary care with 3 years 
prescribing experience)
On the other hand, som e other non-medical prescribers did not feel supported enough in 
their own teams. 'These prescribers were much more worried about what implications they 
would face i f  they made an error in the process o f  carrying out their prescribing duties. This in 
turn influenced their decision to prescribe.
"In the NHS. I do believe that there is an approach o f ...just hang them and /  see il all 
the time, all the time . one error and the next thing, they are suspended and then the 
investigation goes on and that destroys that person." (Prescriber 10 -  nurse in primary care 
with 6 years prescribing experience)
"...hut I'm just worried that if I  get it wrong then yes I  could be struck off. which 
obviously, I do not want to be struck off... "(Prescriber 7 - nurse in primary care with 2 years 
prescribing experience)
For non-medical prescribers, the environment, within which ideas were exchanged and 
the m anner that the criticism was delivered was important in determining how supported they 
felt their prescribing was and how safe it was for them to practise in that environment.
“...in the main, nurses are more cautious, am... and so they' have not been exposed to ....oh 
what did you do that for.... what did you prescribe that ..if it's in an aggressive way like that, 
that would make people close....close down in their thinking, ...and perhaps, noI even 
prescribe." (Prescriber 10 -  nurse in primary care with 6 years prescribing experience)
Although, the prescriber above prescribed in whai she described as a very supportive 
environm ent, she was very vocal about some ‘unsafe environm ents’ that she knew that others 
practised in. T his suggested though a few non-medical prescribers admitted to  feeling unsafe 
within their teams, it was possible that more felt the same way. but may not have admitted it 
during the interviews.
4.3.4.4 R elating  to patien ts w ith  chron ic  pain
The emergence o f  this sub-category was probably the m ost surprising discovery for me 
during the non-medical prescribers’ qualitative data collection phase. I say this because as the 
theory was evolving and ‘nature o f  the prescribing environm ent' began emerging as a categoiy. 
interviews started focusing on exploring its dimensions in terms o f  what the non-medical 
prescribers regarded as important to their prescribing. Naturally. 1 tended to focus on the 
prescriber and their needs, however during the interviews the prescribers persistently steered the 
interviews back to their patients. It became clear that for non-medical prescribers. while
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considering their environment in term s o f  how sale it is to commence, or carry on prescribing, 
the nature o f  their present relationship, or future relationship with patients was also crucial.
As a starting point. I tried to find out what non-medical prescribers felt about how well 
patients with chronic pain were treated and there was a general notion that patients with chronic 
pain may not be receiving the best care available that they could.
" /  think that people with arthritis are fobbed off, especially the elderly and f  think 
sometime* there are things that can be done that may he aren t and I  think they will get u box oj 
paracetamol prescribed, maybe some co-eodamol and that is it." (Prescriber 8 - nurse in 
primary care with I year prescribing experience)
“ ...if somebody comes in with hack ache. You don't Just write them ibuprofen and off they 
go, it is all about finding out all the other things." (Prescriber 9 - community pharmacist w ith 5 
years prescribing experience)
"Because often, with someone with a chronic disease, it's not just the pain that they have 
come to talk to you about, it can be a whole host o f issues and u*<? probably do not do as well as 
n’t* could do " (Prescriber 22 - nurse in primary care with 3 years prescribing experience)
However it was generally agreed lhat with the policy goals behind the non-medical 
prescribing policy and the manner in which it is set up, patients with chronic pain were 
positioned to access the best care available.
“/  think it allows you to sort ofput robust plans together for that service user, il allows you to 
review it regularly to make sure, that your practice is in the best interest o f  the service user and 
that il is safe really. ” (Prescriber 2 - nurse in secondaiy care with 2 years prescribing 
experience)
For non-medical prescribers the starting point in prescribing for patients with chronic pain 
was to develop a relationship with them. It was recognised that patients had some knowledge 
about their conditions and also some power over their decision to actually take their medication. 
It was therefore important to have the patient on board as a prescribing partner.
“...they have to be all on board with it and you have to inform them and educate them on 
why they are doing it, because you need a relationship with them. And we have gone way past 
the world where the doctor says, so I  must do, patients are asking too many questions these 
days, so the way to improve concordance is to educate them. Educate them the reasons why... 
and all o f  a sudden, their concordance and compliance to medication improve. " ( Prescriber 3 - 
nurse in secondary care with 2 years prescribing experience)
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As an acknowledgement to the level o f power and knowledge lhat the non-medical 
prescriber perceived lhat the patient had, the developing relationship with the patient was 
expected to he built on frankness and sincerity.
"It .V fust about heing honest and open with the service user I think it is a safe thing to do 
particularly when you get to more complex areas ojprescribing " (Prescriber 2 -  nurse in 
secondary care with 2 years prescribing experience)
As such, for a non-medical prescriber. the ideal environment for them to prescribe in 
would be one where they knew the patients well and had developed a relationship with them.
" ...so for me a safe environment would be prescribing with a cohort o f patients that I am 
familiar with, that I  understand the disease processes that they are presenting with " (Prescriber
20 - pharmacist in secondary care with 5 years prescribing experience)
However, this was not always the case. Non-medical prescribers sometimes found it 
.difficult to build these relationships in practice lor various reasons, fo r  instance, a non-medical 
prescriber in a surgery who saw a lot o f  patients that presented w ith various disease conditions, 
found it difficult to develop necessary relationships and be familiar with them all.
"...you could see one patient presenting with minor illness, another patient might have 
chronic back pain, another patient might come for contraceptive advice, so it is very varied. So 
we have got quite a lot of specialist interests, so I  do see a lot oj patients for dermatology' 
problems, I've got quite a large role in working In sexual health, I do a tot o f  the family 
planning and sexual health screening and in the past At* worked as a respiratory specialist 
nurse, so I  do see a lot o j patients with chronic disease as well, chronic lung conditions, heart 
conditions etc. So a lot o f  the prescribing is around those needs o f patients. " (Prescriber 21 - 
nurse in primary care w ith 5 years prescribing experience)
Though there is an indication that as non-medical prescribing developed and more non­
medical prescribers started prescribing, there was an increasing awareness amongst patients 
about who the non-medical prescriber is and whal they do.
"...the first clinic that /  worked in. there were 3 non medical prescrihers anyway, so it 
didn V even really particularly have a great deal o f asking other than just explaining that I 
wasn't a nurse, or a doctor, I was a pharmacist and actually that stimulated a lot if  
conversation, they then ask you lots of questions ubout the drugs. " (Prescriber 9 - community 
pharmacist with 5 years prescribing experience)
109
Nevertheless, m aking sure that the patient understood the role o f  the non-medical 
prescribers and how they added value to their treatment was still seen as an integral part o f  the 
relationship building exercise
’ ■ ■-because i f  / see a new patient, the first thing /  do is to introduce myself und say who I 
am and what 1 am... /  am a pharmacist, but I am a prescribing pharmacist working for this GP 
doing what roles, so the patient knows that I  am not a doctor. I am prescribing pharmacist— 
(Prescriber 11 - pharmacist in primary care with I year prescribing experience)
Building a relationship with the patient and ensuring that effective communication exists 
between both parties were probably the first steps towards ensuring that the patient was a 
partner in the prescribing process. For many non-medical prescribers. prescribing in a 
concordant manner was even more important when prescribing for patients with chronic pain. 
This was because, the subjective nature o f the diagnostic process for pain meant that the non­
medical prescriber had to rely on the patient to effectively communicate the nature and severity 
o f  their symptom
”/  think pain itself, because it's not something that you can measure wilh a stethoscope, 
pain is very subjective, you are going to rely on what the patient tells you. without concordance 
within specif ic pain measurement. I  think it might not be very helpful to the patient. You need to 
know what the patient feels, what they think will work better and I think the concordance model 
is really important to be honest, specifically in pain. " (Prescriber I -  pharmacist in secondary 
care w ith 3 years prescribing experience)
T he non-mcdical prescriber also had to build up enough trust to encourage the patient to 
disclose o ther important aspects o f  their condition, such as the psychosocial manifestations o f  
their pain.
"But pain relief is quite complex anyway isn't ii. do you know what I  think it is, because 
the individual is not just about..... if it was high blood pressure, you have got a little triage and 
you just give them that don't you. but i f  somebody is in pain .you've got to,find out about what 
that pain means to them, can they live with that pain and are there any other ways o f easing the 
pain." (Prescriber 9 - community pharmacist with 5 years prescribing experience)
Following on from the diagnosis, developing a  relationship with the patient also helped 
with a more objective approach to planning the treatment. So for instance, going through the 
treatment options with the patient in a manner that ensured that they understood why the chosen 
options were the best for them.
"I do come across patients who do not want to lake drugs and they want you to give them 
some sort o f  instant short term treatment that will rectify everything and it is about managing
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//iaw  exj>eciations really " (Prescriber 10 -  nurse in primary care with 6 years prescribing 
experience)
...ant! .some people's expect at lorn... isr that i f  you prescribe something that the pain 
would just go away, you have just got to tell them that that might not happen and a lot of 
people wunt a tablets rather than going to physiotherapist. which might he more appropriate." 
(P rescriber') - community pharmacist with 5 years prescribing experience)
I1 is about planning with the patient, milestones of.... if we see this we may add this in. 
i f  not this will wail until this point, you know and going through all the options with 
them."(Prescriber 10 - nurse in primary care with 6  years prescribing experience)
This approach was thought to  ensure better adherence with the treatment especially when 
the patient took their medication home.
Despite the benefits associated with the concordance model, there were still some non­
medical prescribers that felt that in certain situations, for instance when there was a risk that the 
patient m ight harm themselves, adopting a more paternalistic approach may have been more 
appropriate for their prescribing.
”/  know that you are supposed to lulk about concordance, aren 7 you. but when its 
something like a pain killer and they are taking loo much o f it and il can damage them, then 
sometimes you have to say ...you can only lake.. I  don't want you taking anymore... you know, 
i f  you need lo lake anymore for the pain..... you need to come back and we need lo look for a 
different solution, so /  am quite strict about the amount o f pain killers that they lake." 
(Prescriber 9 - community pharmacist with 5 years prescribing experience)
Non-medical prescribers also showed that they were aware o f  the implications o f  not 
taking the time and effort to develop a relationship with their patients. Non adherence and 
experimenting by the patients were some outcomes associated with not building a relationship 
and regarding the patient as a prescribing partner.
think il depends- on whether the patients feel that the medicines are working or not 
working for them, i f  they feel lltai they are experimenting, whether or not they feel that the 
prescriber has actually listened to their concerns Because sometimes if they feel that they have 
specific concerns about medicines that the prescriber does not seem to address, they might just 
do il themselves and that might lead lo non-adherence.“ ( Prescriber I - pharmacist in secondary 
care w ith 3 years prescribing experience)
Finally. In addition to medication prescribing for chronic pain patients non-medical 
prescribers agreed that it was valid to explore other routes to help the patient achieve pain relief.
...but some of these people need a 'physio', they do not need a box of pills, you know 
what I mean, they need other things to find Out what is causing the pain " (Prescriber 8 -  nurse 
in primary care with I year prescribing experience)
“So there were a number of befriending schemes. Luckily and n r  had a long chat about 
how they felt about... their sort o f fears and feelings, about how they felt about living alone and 
looked al hying to address some o f  those, which meant that because they were f  eeling happy in 
themselves and they had a different focus, the pain was son of lessened, nr they seem to manage 
the pain.. I can t say that the pain wus lessened, hut they seem to manage the pain a lol better. " 
(Prescriber 2 1 -  nurse in primary care with 5 years prescribing experience)
“...if somebody comes in with hack ache. )*>u don't fust write them ibuprofen and off they 
go. it is ulI about finding out all the oilier things." (Prescriber 9 - community pharmacist with 5 
years prescribing experience)
It was felt that a more broad minded approach was needed in treating chronic pain. For 
me this was a bit surprising. In my experience, manv healthcare professionals who were able to 
prescribe, o r dealt with medication, had a perception that drugs could sort all problems out. The 
fact that these non-medical prescribers considered these measures suggested that rather than a 
‘one size Fits a ll' approach, they were actually tailoring their treatment to patients that they 
knew and perhaps had a relationship with.
4.3.4.S Second-cheeking
This particular sub-category addressed the concerns raised by non-medical prescribers 
with regards to how prescriptions that they produced were checked or would have been checked 
if  they had gone on to prescribe. Second checking is the process whereby pharmacists screen an 
already written prescription in order to ensure that the patient derives the most benefits and is 
protected from any harmful effects that may result from being exposed to the medication 
contained in them. For instance, they ensure that dosages prescribed are correct and that the 
interactions between the individual drugs are not adverse to  the patient.
During the emergence o f this sub-category, the data did not suggest that any o f  the nurse 
prescribers that I interviewed expressed any concerns with how their prescriptions would be 
checked after they had been written. On the other hand most o f  the pharmacists that I spoke to 
expressed a level o f  concern as to how the second checking o f their prescriptions contributed to 
the safety o f  their prescribing environment
As a result o f  this, many pharmacist prescribers felt more vulnerable in their prescribing 
environment, due to the fact that they were not confident that existing policy guidelines were 
robust.
'...the main issue realty is second check and we arc finding that..... obviously as a
pharmacist when tvc go up to the ward we obviously second check for the prescriber, when ice 
as the pharmacist go up to the ward and prescribe, there will be no second check for us, to 
provide some safety net for our prescribing. “ (Prescriber 4 - pharmacist in primary care with 5 
years prescribing experience)
In Other cases, they decided not to prescribe at all. because they Fell that the environment 
was not safe enough to support their prescribing
“...so the safest thing for me to do is actually to rely on the prescribers. And there are 
junior prescribers around most o f the time, so the easiest thing is fo r  me to educate them into 
prescribing properly anyway. So. that is what /  choose to do." (Prescriber 20 - pharmacist in 
secondary care with 5 years prescribing experience)
Although nationally, there did not seem to be any ambiguity in the guidelines set out fur 
pharm acist prescribers. At tim e o f  the interviews, it seemed that standard operating procedures 
for pharmacist prescribers varied from Trust to Trust. As a  result o f  this, pharmacist prescribers 
perceived that there was a  lack o f  consistency.
"/ know fo r  a fact from talking io other prescribers nationally, that some people ure just 
you know, prescribing and checking their own work but i f  your Trust hasn't taken... hasn't 
specifically said that is the position, or what for ever, that we would support you. if something 
goes wrong you haven't got a leg to stand on. because nationally, the national code o f ethics is 
pretty clear that you do not check your work, unless it was in exceptional circumstances. 
so..”.(Prescriber 19 - pharmacist in secondary care with no prescribing experience)
Here, this prescriber felt that with regards to second checking, pharmacists should 
prescribe w ithin not just the guidelines set out by their institutions, but also within the ones set 
out by the national code o f ethics. Other less conservative non-medical prescribers may have 
adhered to one or the other but he decided to adhere to both. To him. this is what would ensure 
his safety, i f  he decided to prescribe.
W ithin some o f  the Trusts, these operating procedures that had been prepared seemed to 
have been developed to account for the many varying settings and scenarios that the pharmacist 
prescribers practiced in. This' however increased the level o f  complexity with which these 
guidelines were viewed.
M... vrc sort oj got our head around it with the idea that /  would se lf check, but the problem 
with se lf checking is. il depends on the type o f drug that you check and the type o f drug you 
prescribe, because M  are in the hospital und we sort o f tend to split drugs into drugs that has 
stocked on the ward and drugs that are not stocked on the ward. So drugs that has stocked on 
the ward, by virtue of tend to be things that 1 used routinely, so because they are routine drugs, 
you sort .of know them, so I am permitted to self check myself, but I  should be prescribing... I
should he prescribing with some cooperation o f  the medical staff or some input from them in 
some "  uv, they're aware o f what /  am doing and they are reviewing, they are not actually meant 
to document that they have seen and they're prohahly checking me, but I'm supposed to do th a t” 
(P rescriber 17 - pharm acist in secondary care with 2 years prescribing experience)
Expectedly* due 10 the inconsistencies in how these guidelines were interpreted, there was 
little agreem ent betw een T rusts, departm ent and even am ong individual pharm acists, about who 
exactly  was in terpreting  the  gu idelines correctly and it w as not for lack o f  try ing , because it was 
evident that pharm acists, at an individual, us well as I rust w ide level w ere th inking o f  this 
s ituation  and w ere a ttem pting to  resolve it by learning from each o thers ' experiences,
" ... because they cannot get their head around how to practice, I know some people haw  
said to... some places have the attitude, that we are just going to run with it and just get on with 
it... J think it's a bit of worrying approach really " (Prescriber 17 - pharm acist in secondary care 
w ith  2 years p rescrib ing  experience)
" sometimes meeting other prescribers who are in the same boat as you and finding out what 
they do may be o f use definitely. And also it might just useful to have an insight of how they 
handle things and how the systems fall into place and work properly." (P rescriber 1 - 
pharm acist in secondary  care with 3 years prescribing experience)
Pharm acist prescribers felt strongly that at this stage, there was a need fo r the 
developm ent o f  a  nationally consistent operating  procedure.
"And !  think the problem is that nobody has really worked otit... no-one. . at the national 
level, no one has really got their head around this. /  think it has not been addressed at the 
national level. I think it needs some addressing somewhere. It needs leadership in such a way 
that it does not basically stop people who have done loads of development from actually 
practicing. Because at the moment. 1 think ft concerns me that it's going to stop people 
practicing. " (P rescriber 17 - pharm acist in secondary care with 2 years prescribing experience)
H ow ever, in the  m eantim e, pharm acist prescribers rem ained w orried that not only was 
their prescrib ing being  hindered or being practiced in an unsafe m anner, bu t that the  process 
may have been underm ining the efficiency o f  the NHS.
“We have lots o f  doctors around and it is much more convenient fo r  me to act as a pharmacist 
(he ward and check a doctor's prescription, albeit one that I have usually recommended, rather 
than me having to write t/te prescription and having another pharmacist coming to check my 
prescription, ft is not a very efficient use o f  my time i f f  do that. " (P rescriber 20  -  pharm acist in 
secondary  care w ith  5 years prescrib ing  experience)
"Now. personally speaking, the whole point Of the independent prescribing pharmacist is (0 
improve the efficiency o f  delivery o f care... and gelling a pharmacist to visit the ward to check
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my work docs not strike me us being wry efficient. " (Prescriber 17 -  pharmacist in secondary 
care w ith 2 years prescribing experience)
Furthermore there were concerns that it' the second checking situation for pharmacist 
prescribers was left unresolved, it may have a negative impact on the way that patients access 
their medication.
"...one is around the ethical issues o f needing to have another pharmacist check your 
work, so the easiest way for me to apply il would be to... on the ward, originally /  was going 
10... drugs that were missing on admission, basic stuff like missing from a prophylaxis, calcium 
supplements, writing TTO's. but then you realize that actually once you prescribed them, even i f  
the patient has brought some o f their own in, you’re going to need to order some more, at that 
point and then you will then need to get another pharmacist to sign it and send down the chart. I 
do not particularly huve another pharmacist, or junior pharmacist that /  work with very closely. 
I would then have to go down to pharmacy and that will introduce delays, certainly with TTO \s 
it would introduce delays." (Prescriber 19 -  pharmacist in secondary care with no prescribing 
experience)
W hen I asked the  pharmacist prescribers to suggest various ways in which the situation 
could be resolved, an interesting point came up. Pharmacist prescribers felt that when the 
guidelines for second checking for pharmacists were drawn up. there might not have been an 
adequate consideration o f the particular skill that sets the pharmacist prescriber apart from both 
the nurse p rescribes and the medical prescriber. th e y  felt that by the time a pharmacist 
qualities as a  prescriber, they must have amassed a considerable amount o f  experience with 
respect to checking prescriptions written by others.
"I have been involved in c hecking that work and advising on that work, for so long, that 
it's ju s t.. prescribing is just an extension o f  that process really- Now instead o f just asking to do 
it. it's really not a case of me no longer asking people to do it and rather doing it myself. But 
you do slightly think about things differently when you're a prescriber." (Prescriber 17 - 
pharmacist in secondary care w ith 2 years prescribing experience)
In addition to this, il was felt that the professional socialization o f  pharmacists may 
protect them from making certain prescribing errors whereas other healthcare professionals w ho 
prescribe may not be similarly protected.
"Whereas doctors see it fKissihly as the least important part o f their role, they see it, as 
secondary, they see themselves as diagnostic and making clinical plans and they are likely 
writing the prescription, that 's the end o f that, but it is seen us least important part of il. So I 
think pharmacists ' attitude to prescribing is far different to that. I don't think WH are as likely to 
make prescribing errors." (Prescriber A - pharmacist in primary care with 5 years prescribing 
experience)
As such for pharmacist prcscribers. in negotiating a nationally consistent operating 
procedure, it was suggested that overlooking second checking o f  prescriptions written by 
pharmacist prescribers should be considered, because without it. they could still prescribe in a 
manner safe enough for patients, provided they were prescribing within their specialty.
"I will like n> have a policy lhat will acknowledge and accept it So I  can prescribe and 
not necessarily have to have that second check, which I accept could he criticized by 
introducing a level of risk, but I think pharmacists prescribe with a different outlook to doctors 
anyway. I  do believe lhat pharmacists are less likely lo make prescribing errors, because itv see 
it for what it is. it's the must important part o f our role " (Prescriber 4 -  pharmacist in primary 
care w iih 5 years prescribing experience)
" /  think there is a real difficulty here, because we fill a ccrtain role as pharmacist with 
our second check o f the prescription and it is a role that we sometimes underestimate, the 
mistakes that, we find, whether they be simple errors and slips, all actual lack o f  knowledge 
errors, mistakes, are significant. And any pharmacist, who is prescribing is as liable to make a 
slip as any other prescriher be ii nurse or doctor. I think nit* are less likely to make knowledge- 
based mistakes, as long as W& are doing M'liat we are currently doing, which is working within 
our specific areas. " (Prescriber 20 - pharmacist in secondary care with 5 years prescribing 
experience)
•J.3.4.6 In terac tin g  w ith m anagem ent
Interacting with management emerged as a sub-category to reflect the importance that the 
non-medical prescribers attached to the interaction between themselves and the people that they 
regarded as having a certain degree o f  control or power within their prescribing environment. 
For nurses and pharmacists, the level o f  support that they perceived from the management was 
seen as crucial to how they w ere able to practice as prescribers.
M ostly, the non-medical prescribers were able to specify o r identify the individual that 
was responsible for controlling a bureaucratic step that was seen as a  facilitator or a barrier to 
their practice. However, sometimes ‘the Trust’, 'th e  P C F  or ‘they’ were used to represent 
officials or individuals lhat they could not or would not identify.
For non-medical prescribers. the role lhat the non-medical prescribing lead played in 
facilitating a safe and supportive environment for Iheir prescribing was a major one. The non­
medical prescribing lead was ihe officer that was responsible for among other duties, developing 
non-medical prescribing within the organisation, maintaining a non-medical prescriber database 
and ensuring that non-medical prescribers were properly registered and practicing in a safe 
manner.
Non-medical prescribers saw them as a key facilitator in determining how non-medical 
prescribing was practiced in each organisation. Some non-medical prescribers were very
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emphatic in attributing the favourable atmosphere that they prescribed from, to the work done 
by their non-medical prescribing leads.
" —/  think the nun-medical prescribing lead did a good job in selling it up initially...we 
are lucky in our Trust because the non-medical prescribing lead has driven it from the onset, he 
was one of the first supplementa)y prescribers and he has driven its right front llte ward go 
really and he has fought long and hard to get it recognized and that's win- we are in the position 
that h v  are in now." (Prescriber 2 - nurse in secondary care with 2 years prescribing 
experience)
"...our initial non-medical prescribing lead was very goad and I think he was a big pan 
o f our job and I hut was vety helpful, but that's all seems lo have been diluted and as I said, it's 
all going lo people like maybe do not understand as much."(Prescriber 6 - pharmacist in 
primary care with 5 years prescribing experience)
Understanding the challenges that non-medical prescribers faced wiihin their various 
differing contexts was seen as important to how non-medical prescribing leads did their job. It 
was important to note that non-medical prescribing leads did not have to be prescribers 
themselves and as such would not always have firsthand experience.
In some other cases, non-medical prescribing leads were seen as less progressive than the 
non-medical prescribers that they looked after and as such may not have appreciated the needs 
o f  these m ore progressive non-medical prescribers.
"...the problem that »‘t* have is that wiihin our PCT, the Pharmacist who is our 
prescribing lead and with no disrespect to her, she has an interest in pharmacists, but obviously 
from a nursing point o f  view and when I did my course. At that point the pharmacists were still 
working with the management plans, so they were nut allowed to be independent prescribers so 
they could only use clinical management plans, so they were in a different position to the nurses 
and to us..." (Prescriber 7 * nurse in primary care w ith 2 years prescribing experience)
In the above case, the non-medical prescriber felt that her practice was hindered because 
though she was qualified to practise independently, the protocols set up by the non-medical 
prescribing lead meant that she could only practise as a supplementary prescriber.
A few non-medical prescribers felt that the processes set up by their non-medical 
prescriber lead made them feel more vulnerable when prescribing. For instance one prescriber 
felt that the structures within her Trust was restrictive to her practice because the non-medical 
prescribing lead did not particularly appreciate the challenges that non-medical prescribers met 
on the field.
"I also believe that there are a lots uf • nonmedical prescribing leads, who are not 
prescribers and do not have a due about what 's it is like out there and they are the ones 
that...they would often ....are keen to have more and more restrictive, bureaucratic structures in 
place " (Prescriber 10 - nurse in primary care w ith 6 years prescribing experience)
She continued by giving the exam ple o f  the 'passport7 suggesting that though non­
medical prescribers may be competent in an area that they did not previously specify in the 
passport, the way some non-medical prescribing leads reacted when non-medical prescribers 
attempted to prescribe in these areas, was perceived as overly aggressive.
“ ...so those few people, they arc pulling in this great big structure and a passport and if 
you prescribe outside of that which you say that you re going in start with and they will he 
pouncing..^questioning why you are.... so then you would have to provide evidence for then 
extending into another arear  (Prescriber 10 - nurse in primary care with 6 years prescribing 
experience)
She concluded by suggesting that these restrictions perceived to be instigated by the non­
medical prescribing leads may even put o ff some qualified non-medical prescribers from 
actually going on to prescribe
■'/ don V think that there are enough safe environments to explore prescribing. I think that there 
are more people interested in stifling and putting in place.... they will call il governance, 
clinical governance. I'll call it restrictions and risk managing before there is any risk It is right 
to assess risk and reduce the potential for it. but when you go so far that you restrict people.
then ......i t s  like.. 1 don t gel paid enough for that and that '.< what I  hear a lot. " (Prescriber 10
- nurse in primary care with 6 years prescribing experience)
The next set o f  people that non-medical prescribers identified as being able to facilitate a 
safe prescribing environment for their prescribing were their clinical leads. The clinical lead was 
the clinician, usually a doctor in  charge o f  other healthcare professionals und they were 
responsible for the delivery o f  clinical services and ensuring that acceptable standards are 
maintained, within that organisation, or their specialty.
Non-medical prescribers felt that right from the onset o f  their prescribing, their clinical 
leads’ support was important in maintaining an environment perceived as conducive for them to 
prescribe in.
"...you got to hove their support, because they can block you at any stage. You know, the 
guy that first said to me... wu're doing nonmedical prescribing, it is good to put 20 junior 
doctors out of a  job, i f  he was the clinical... »tf have Jour consultants, i f  at t hut point, he was the 
clinical lead, he might have stopped it. he might haw said no way you are doing this, I think it
was said in jest and luckily, his colleague was clinical lead and he just went i& him and... face 
up to reality, this is where we are and just sign the papers " (Prescriber 3 - nurse in secondary 
care with 2 years prescribing experience)
This prescribcr then went on to illustrate how this relationship worked in practice, 
whereby after qualification and possibly at intervals, the clinical lead still had to approve certain 
aspects o f  the prescriber’s practice.
'‘...after you've done your non-medical prescribing and il gives you a certificate and a 
qualification to say that you 're allowed to prescribe from anywhere from the BNF, within this 
organization, you have to tell them exactly what you're going to prescribe. You need to list whai 
drugs, what sections o f the BNF. ration out how you've been updated, how do you are going to 
keep updated and that needs approval by a medical consultant, So without their support, you 
will not gel anywhere again." (Prescriber 3 - nurse in secondary care with 2 years prescribing 
experience)
Finally, non-medical prescribers. though having been able to identify a phenomenon 
which hindered their prescribing, did not always specify exactly who was responsible for this 
hindrance. An example was when non-medical prescribers perceived limitations in access to 
records considered essential for their practice.
“...it was only last week that somebody hud rung me from a ward, someone had been 
admitted and they didn 7 have access to the medical notes, they were not clear on what the 
current prescription was. We hud a discharge summary form about mo weeks before that 
detailed the gentleman's prescription, but again, it was unclear il was still current or not. So 
that's were in terms o f  the failings are in our Trust around up to date records and having access 
to //w /"(Prescriber 2 -  nurse in secondary care with 2 years prescribing experience)
"...well the main thing that we haven't got. that would make things better is access to 
patient notes and also access to patient blood results.. ” (Prescriber 4 - pharmacist in primary 
care with 5 years prescribing experience)
In the second example, though this prescriber overcame the barrier in prescribing with 
respect to  his access to patients' records, had he had access to these records, he would have felt 
safer and better supported in his prescribing. Another area o f their practice where non-medical 
prescribers identified sim ilar limitations was in terms o f  their access to electronic prescribing 
software.
'I haw to write that (the prescription) out even week, a prescription with five or six 
items and deliver it to the pharmacy because of the risks of harm Whereas if I had access may 
he to the same electronic prescribing systems as the UPs hud, it would muke my life so much 
easier, because then I'll ju st do it on the computer, send it automatically to community 
pharmacies, which is how GPs work. So I think those systems should be available to community
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teams working in secondary' care:" (Prescriber 6 - pharmacist in primary carc with 5 years 
prescribing experience)
These limitations to resources that would facilitate their prescribing were also seen as 
having the potential to negatively affect the level o f  care received by the patient within their 
prescribing environment. For som e non-medical prescribers. these limitations existed, because 
th e  officers responsible for facilitating these aspects o f  their prescribing were failing in these 
aspects.
For instance, it was fell that organisational support received within their prescribing 
environm ent was not tailored to their needs. They fell that the support that they had was an 
amended version o f  already existing structures (for medical prescribers) rather than a structure 
developed specifically for non-medical prescribers.
" / don V think that the PCTs are interested in non medicoI prescribers. they are still more 
interested in medical prescrihers and everything /list sort o f filters down to us. hut ultimately 
it's all about the doctors../'(P rescriber 10 - nurse in primary care with 6 years prescribing 
experience)
There was an  awareness among non-medical prescribers that even in organisations where 
their prescribing was supported by management, the motives behind the support may not be 
totally altruistic, however, as long as this support made them feel that they were prescribing in a 
safer environm ent, it did not seem to  m atter to them.
"...and again il might he that they want a prescriher, when there no doctors there, but the 
concept is supported. I think And our service manager has come in. he is relatively new to the 
team, although he has worked in other areas, he has seen what we have done with it and he is 
supportive of the nature ojthe work if you like." (Prescriber 2 - nurse in secondary care with 2 
years prescribing experience)
"...I mean, because they are positive in wanting my help to kind o f like manage more 
patients and therefore have more OOF points and therefore anything that I really need they are 
quite co-operative and we work quite well to g e th e r (Prescriber 11 - pharmacist in primary care 
with I year prescribing experience)
Finally, it was suggested that a national standardisation o f  how the non-medical 
prescribing policy is implemented within various host organisations would result in an 
improvement in how supported non-medical prescribers fell in their practice and facilitate how 
they prescribed lor their patients.
" /  guess the only thing that I  would change is by having standards across the country. 1 
think each Trust is allowed to adopt non-medical prescribing within their own guidelines and 
within their remit and I think it lv been good in some areas hut it lias hindered non-medical
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prescribing in some others and it has not allowed them to develop their practice, as they would 
do " (Prescriber 2 - nurse in secondary care with 2 years prescribing experience)
4.3.4.7 C ategory  sum m ary
In ‘nature o f  the prescribing environm ent', the first three sub-categories described how 
non-medical prescribers related with colleagues within their teams and identified that these 
relationships were based on trust and were mutually beneficial. ‘Relating to patients with 
chronic pain ' addressed how interactions with their patients influenced how safe and effective 
nurses and pharmacists perceived their prescribing to be. ‘Second checking’ was periinent only 
to pharmacist prescribers and it explored the dilemma that they faced regarding the procedures 
existing in their organisations to ensure that prescriptions that they wrote were properly 
screened. The final sub-category ‘interacting with management' addressed how interactions 
with non-medical prescribing leads and clinical leads were perceived to influence how safe and 
supported nurses and pharmacists felt in their prescribing.
4.3.5 A cquiring knowledge
Nurses and pharmacists who participated in the research seemed to view the acquisition o f 
knowledge as more than just fulfilling expected requirements o f  CPD in their practice. CPD 
refers to the various activities engaged in to enable maintenance and development o f  prescribing 
and other professional practices. The Nursing and Midwifery' Council (NM C) and the General 
Pharmaceutical Council (GPhC) who regulate practice for these professionals mandate CPD as 
a legal requirement and set out guidelines for requirements in areas o f  practice including 
penalties exist for failing to comply (NM C. 2011a: GPhC. 2011). For the non-medical 
prescribers that I interviewed, there was a more active and voracious engagement with the 
resources that were available to them, that seemed to surpass the normal expectations o f  CPD. 
Additionally, in practice some knowledge acquisition processes non-medical prescribers 
engaged in were perceived as C PD  and others were not. However, irrespective o f whether these 
activities were considered CPD. they were all perceived to contribute to the knowledge 
considered relevant to their prescribing.
A s such, despite the fact that many concepts within this category can be considered CPD. 
I named this category ‘acquiring knowledge’ because this phrase better captures how the data 
emerged from this phase o f  the research. In the grounded theory exploration o f  how non­
medical prescribers engaged with their knowledge acquisition resources and processes. I first 
look at how non-medical prescribers planned and organised their learning, then I look at the 
levels o f  access they perceived they had to learning resources as well as how they made time for 
these activities. Finally , although reflective practice is also regarded as a form o f  CPD and is
admittedly a knowledge acquisition process. I have discussed it in another category and will not 
address it here.
4.3.5.1 O rgan ising  learning
During the interviews, it emerged that non-medical prescrihers developed a  concept o f  a 
‘personal or internal formulary’. The development o f  this "personal formulary'’ was based 
primarily on the experiences that the non-medical prescribers gained while prescribing for 
patients with conditions lhat they came across regularly. Initially during Iheir prescribing, they 
referred lo the guidelines and evidence available to them while prescribing- They then reflected 
on their prescribing and in the process acquired more knowledge to improve past practices, 
which then fed back into subsequent prescribing episodes. With each case that ihe prescriber 
saw. they gained more experience and further developed their internal or personal formularies.
“...because I am aware that prescrihers, they' da have in your head, your own formulary 
and it has a roof in all areas So asthma, diabetes... you know what I mean. 1 feel I  have this 
level where I feel safe. I use those drugs frequently. /  know the side effects inside out . . . "  
(Prescriber 22 - nurse in primary care with 3 years prescribing experience)
In the above case, this non-medical prescriber practised in a rural practice where she had 
to see a variety o f  conditions in many patients within a limited time frame. She felt she had no 
choice but to adopt a more innovative approach to building her ‘personal formulary".
“...and 1 am happy to go to lhat roof To move beyond our roof /  need a  little hit o f 
support; I need a Utile bit of trying out stage, before my roof moves up permanently. " 
(Prescriber 22 -  nurse in primary care with 3 years prescribing experience)
In addition to this. Ihe sam e prescriber admitted relying on a trusted colleague to increase her 
knowledge base.
’7  have a GP colleague who has also become a good friend over time and have a nice 
situation that he will often bob to me and say what you lltink about this, or what would you do in 
this situation, it is a very open two way communication. " (Prescriber 22 - nurse in primary care 
with 3 years prescribing experience)
The fact that she could ‘bob in’ and discuss issues with a colleague she trusted and perceived to 
be knowledgeable seemed to encourage her to be more innovative in her ‘trying out stage' until 
she fell confident lhat her ‘personal formulary’ was robust enough in areas in which she 
prescribed. She also now worked in a much sm aller practice, than where she was when she 
qualified and now had a much bigger workload in terms o f  patients, but she felt that her
prescribing was more efficient and that her ‘personal formulary* was developing a t  a much 
faster rate.
Even in bigger teams there was evidence that non-medical prescribers acquired some o f 
the knowledge that they used in their prescribing by interacting with other healthcare 
professionals within their interdisciplinary team.
.. ivhu wifi comc from different backgrounds, same o f them do not know much about 
medication at all and some of them have their own ideas about whut helps people and what 
doesn 7 and obviously sometimes our ideas are a bit different. And i f  they are working with 
different consultants, we often have very different views about prescribing antidepressants and 
chronic pain to be honest... with the social worker and psychiatrists and another...quite another 
one with the GP" (Prescriber 6 - pharmacist in primary care with 5 years prescribing 
experience)
This form o f  learning was considered more informal, compared lo the traditional CPD 
resources, but was found to be equally useful. The diverse backgrounds that the team members 
came from professionally was seen as a distinct strength by non-medical prescribers learning 
through this route because the different views were seen as synonymous with a  more rigorous 
approach to patient care. Nurses and pharmacists were only likely to organise their prescribing 
learning through tills way if  they saw their teammates as knowledgeable and they perceived 
attributes such as trust and respect as being valued within the team. Additionally, learning 
through team working was seen as complementary to the more traditional forms o f  CPD.
Although nou-medical prescribers learned informally from their colleagues and the teams 
they belonged to . engaging in CPD remained very significant in the way knowledge was 
acquired.
“ ... I  guess there are new things coming out frequently and you need 10 be on top o f what 
is happening out there. And i f  you want lo manage a patient you need to be aware, as much as 
possible, what kind o f formulations they • use. what kind o f  drugs etc. and to be able to do that
vou need to be up to date s o ...../  guess it depends on how when you come across patients with
that pain, how much you have to deal with those patients, i f  you deal with those patients 
regularly then definitely continue CPD. ...So it depends on how much you are using that 
skill..." (Prescribcr I - pharmacist in secondary care w ith 3 years prescribing experience)
In addition to  the resources utilised in learning during CPD. it emerged that considerable 
time and effort were also put into identifying knowledge needs and then organising w hich o f  the 
many CPD activities could be accessed to meet these needs. At first glance it may seem quite a
simple process lor the prescribers to assess their prescribing needs, look lor the resources 
needed to lullll these needs, then utilise this resources until the acquired knowledge is adjudged 
sufficient. In practice, this was not so.
'...more CPD will be better, specific to prescribing. I  do not know. I hove never really 
had any training as such in making records, in record keeping, making notes and patient's 
records, recording consultations... you just gel the/eel for it and you jus I move on. Nobody said 
I'm doing it right, nobody said I'm doing wrong..., am I pulling loo much information in. or not 
enough. /  do not know" (Prescriber 5 -  community pharmacist with 3 years prescribing 
experience)
" . . . /  /eel that my CPD needs are very well met. but maybe no! by traditional pharmacy 
resources, because I feel in a way I  know quite a lot about the drugs, but I  don't know so much 
about the disorder and ull the other treatments and other son o f approaches with people that 
are useful., and you know... risk, understanding what risk means in the context of someone who 
might harm themselves rather than you know...straightforward risk about medication.. " 
(Prescriber 6  -  pharmacist in primary care with 5 years prescribing experience)
Above, in the first case, the non-medical prescriber did not feel supported enough to  make 
satisfactory decisions w ith respect to how he organised and processed his know ledge needs with 
respect to prescribing In the second case, even though the prescriber was confident that her 
‘personal form ulary' was adequate for the medication routinely used in her field, she still felt 
that there were other areas that were lacking and did not feel that the traditional CPD resources 
could help her meet these needs. In both cases, ticking the boxes to meet statutory requirements, 
were not enough.
A cautionary tale o f  a colleague's experience was used to illustrate some o f  the difficulties 
that non-medical prescribers could encounter when they were not adequately supported in 
assessing their needs and organising CPD to  meet those needs.
“...and certainly one o f our GPs recently failed a portfolio. She was training... she was a GP 
and trained in the days when you did not have to have A IRC 'GP certificates. So she's doing it by 
portfolio and one o f the things that she was criticized for was that she did too many in - house 
things and she had not attended enough... Now that is debatable, about what is considered CPD 
and when hv  discuss se lf- directed learning, what makes that more valuable, just became you 
have gone to a venue and you have sat there, you could haw been sal at the back asleep and 
then have a certificate for it. " (Prescriber 10 -  nurse in primary care with 6 years prescribing 
experience)
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In this quote, this prescriber poses an important question, as to which form o f CPD is more 
valuable for a particular prescriber within their specific prescribing context. Reflecting on the 
bigger picture, sim ilar questions arise, as to how learning from colleagues and team working 
(seen in the early purl of this sub-category) could contribute to 'acquiring knowledge* and 
whether they can be considered and documented as CPD.
4.3.S.2 Accessing resources
In the preceding sub-category, when I explored how non-medical prescribers organised 
their learning. I mentioned that many form s o f  CPD existed. At least seven forms o f  learning 
have been identified as CPD for non-medical prescribers. These include individual study, e - 
learning, reading journals and attending organised courses (NMC. 2 0 11 a). In the same way. that 
the forms o f  learning that can be classed a s  CPD vary, the access that non-medical prescribers 
had to these forms o f  learning that they engaged in varied as well. For (he prescribers in this 
study the main routes through which they carried out their CPD were going for relevant 
organised courses and carrying out se lf directed learning. As such, the focus o f  this sub category 
will be on organised courses and se lf directed learning which the research participants perceived 
as doing e - learning and reading relevant journals.
The guidelines from the two relevant regulatory bodies regarding CPD seemed to have some 
impact on some o f  the levels o f  access that these nurses and pharmacists had. The Nursing and 
Midwifery Council issues clear guidelines for the level o f  support regarding CPD. expected o f 
employers o f  nurse prescribers (NM C, 201 la). On the other hand it seemed that for the prescribing 
pharmacists, neither the General Pharmaceutical Council nor the Royal Pharmaceutical Society 
addresses this issue to the same exlent. This support was reflected in the level o f  satisfaction 
expressed by nurse prescribers with respect to access. For instance this nurse prescriber found it 
easy to book and attend CPD courses.
"...mv did haw sort o f some education .sessions, where somebody will actually come in and talk 
... what /  tend to do is. if I  see something that I think will be appropriate, I just tend to get 
myself organized and get booked on. .. fust to keep myself up to date, so technically, f  am meant 
to ask someone for permission. /  think, but I just hook and go." (Prescriber 7 - nurse in primary 
care with 2 years prescribing experience)
While many o f  the nurses that were interviewed had few problems with their level o f  access 
to CPD. most o f the pharmacist prescribers did. However despite the fact that the nurse prescribers 
had relatively good access to their CPD. there were still problems perceived with the specificity. 
For the non-medical prescribers that had access lo organised courses, or formal study days, there 
was a  problem regarding how well these courses suited each individual prescriber.
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“...but (here is nol much out (here specifically for prescribcrs..., [the courses] for 
prescribing. / /  have seen/ are a long way away..., So there have not been many opportunities 
and the ones that have been...[suitable for my needs/, have not always been easily accessible 
for me. so I would be keen to do them, but it is just... there are various barriers that stop w u  
front getting to the ones that I have seen. " (Prescriber 16 -  nurse in primary care with 5 years 
prescribing experience)
The prescribers noted three barriers regarding their access to formal study days. Firstly, 
gening CPD specific to their areas o f  specialty, secondly, getting CPD for prescribers in that 
particular area and thirdly, factors such as timing and geographical location o f  the course.
For pharmacist prescribers. it seemed that a few o f  them had access to attending these 
organised courses
"...we get a lot of online CPD, 1 also attend study days when I  can. I can keep fairly up - 
to - date and I  have good access to training courses and things I  need to access. So yes I am 
happy with that" (Prescriber 4 - pharmacist in primary care with 5 years prescribing experience)
For most other pharmacists there was a significant lack o f  access to these organised 
courses. The major reasons cited for this limited access seemed mostly to be reluctance for 
employers to let them have time off work to attend and funding for the courses.
" /  find it difficult ...training is always useful, the more you do it the better I  think. I can 
only access it out o f working hours, because they will not pay for me to have any more time off 
It is a commercial thing...in pharmacy. /  think n r  need more CPD during (he day We give a 
block of time in the evening ... it's alt done after work and it has always been done after work.... 
"(Prescriber 5 -  community pharmacist with 3 years prescribing experience)
The other main forms o f  learning, through which the non-medical prescribers carried 
out their CPD. were through e - learning and reading relevant journals, by self directed learning. 
Most Of the non-medical prescribers that engaged in self directed learning were pharmacists. 
Initially. I thought that it was because there was limited support for attending organised courses 
from their employers with respect to lime o ff  work and funding, but as the data emerged. I 
found that this was not always the case, as some o f  the prescribers actually preferred se lf 
directed learning because it was the best fit for their needs
"...if 1 am prescribing something. I want to be a hundred percent sure why /  am doing il 
and I will prefer lo make sure, even if it is in my own lime that I  fully understand what I am 
doing. I think it will be easier ... the paid time tends to the general courses and il might be not
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quite specific to \i>u. "(Prescriber 12 - pharmacist in primary care with 2 years prescribing 
experience)
Interestingly there were also nurses who. though used to attending formal study days 
during work tim e for their CPD. expressed a desire to  engage more in se lf directed learning
'7  mean if I was aware of an online update facility. 1 would he equally happy... because 
that might he more time amenable, taking time at work is not always easy, although they are... 
they do support CPD and obviously give us the time when it is needed. But obviously, i f  this is 
something I could do from home, from here it should be equally useful. " (Prescriber 16 - nurse 
in primary care with 5 years prescribing experience)
Again for the prescribers that preferred to carry out the majority o f  their knowledge 
acquisition through se lf directed learning, or in combination with formal study days, the main 
point for them was the specificity o f  these courses to  their needs.
Although the specificity issue could be addressed by self directed learning, this approach 
was not problem free. With se lf directed learning, the prescriber was able to tailor their learning 
to  their needs and ensure that Ihey learned as much as they felt was sufficient for their 
prescribing. However, this was usually done in their personal time and there were still problems 
o f  access for some p rescribes. For instance accessing relevant articles in journals where the 
non-medical p rescribers institution or employer did not have a  subscription.
" ...you might get something and then it is in the BMJ or the Lancet, because Pm not a doctor. I 
have to pay for the articles" (Prescriber 9 - comm unity pharmacist with 5 years prescribing 
experience)
In this case, in addition to the fact that this pharmacist prescriber had to carry out CPD in 
her own time, paying for articles to aid her se lf directed learning meant that she also had to use 
her resources as well.
4.3.S.3 M aking tim e
While exploring the motivators for qualify ing as non-medical prescribers. it was revealed 
that these professionals may still be performing other roles, in addition to their prescribing.
" / think it is u big undertaking with a lot o f responsibility... you just gel this huge amount 
o f responsibility as pari o f your existing role ... " (Prescriber 8 -  nurse in primary care with I 
year prescribing experience)
When this is considered against the backdrop o f  the guidelines suggesting that the full scope o f  
professional practice be covered in their CPD (NM C. 201 la: GPhC. 20 1 1), it means that for
nurses and pharmacists who prescribe, a  considerable amount o f  time is spent carrying out CPD. 
Additionally , in the last sub-category-, it emerged that lor non-medical prescribers even before 
the learning process was carried out, a  considerable amount o f  time had already been expended 
assessing needs and organising learning activities. This illustrates how important the concept o f  
‘m aking tim e ' was for the prescribers in the study.
Although the minimum suggested guidelines regarding the time spent on CPD is roughly an 
hour and a ha lf every month (NMC. 2011a). many o f  the non-medical prescribers that 
participated in the research admitted to spending significantly more time, in knowledge 
acquisition processes.
"I have weekly sessions with a clinical colleague in the practice, while mv talk through 
particular cases, which may he to Jo with chronic jHiin, ar a number o f other conditions and 
talk about the patients, how they presented, what kind o f problems I felt we needed to address 
and use....use sort oj case .study as a nw r to learn from it. Sometimes that might involve us both 
going away and reading up on things and then the next time that we- meet, talking through it. ” 
(Prescriber 21 -  nurse in primary care with 5 years prescribing experience)
Some o f  the reasons w hy non-medical prescribers invested a significant amount o f  time in 
acquiring knowledge are illustrated in the above case. For this non-medical prescriber to further 
develop her prescribing practice there was a  need for her to demonstrate that as time went on. 
she was also becoming a resource that could be relied upon. This process would have been 
occurring at a tim e that she would also be acquiring knowledge to rapidly develop her own 
'personal formulary'.
While discussing access in the last sub-category, we saw the limitations non-medical prescribers 
had to some forms o f  CPD. Those limitations had a knock on effect on how non-medical 
prescribers made time for the knowledge acquisition activities.
"...but it is difficult, because you need to do research to find out where it is that you can 
get more training on certain things.... " (Prescriber 11 -  pharmacist in primary care with I year 
prescribing experience)
"Not every'thing is readily available hut there are some things that are readily available, 
there are some things that you have to go hunt for "(Prescriber 1 - pharmacist in secondary care 
with 3 years prescribing experience)
It meant that for these non-medical prescribers. the time spent searching for CPD to suit 
their needs was tim e they did not spend actually ‘acquiring knowledge' relevant to their
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prescribing for chronic pain. This was particularly important for those we saw  in the last sub­
category lhat could only leam by se lf directed learning.
Despite these challenges to their time management with respeci lo seeking oul relevant 
resources and acquiring knowledge, many non-medical prescribers made a significant effort to 
allocate adequate time to ensure that iheir knowledge needs were met.
"...it is just so busy, when you finish work, at home, you just need lo he wry Joeused to 
actually drug yourself to do more CPD. I mean. /  try to keep up - to -  date with all the 
newsletters and things like that, do more reading and all those other things " (Prescriber 11 - 
pharmacist in primary care with I year prescribing experience)
Due to the level o f  importance accorded to CPD by these prescribers. even when they 
were not entitled to time o ff  work to go for courses, they developed strategies to ‘create’ time 
for organised courses, when they judged that this form o f  CPD would best suit iheir knowledge 
needs.
"... I've only got interrupted, uninterrupted lime if I do lhal in my own lime. After /  work. 
SO there Is an online package. I can work at my own speed, try and fit that in around my job is 
quite difficult, equally for some needs, i f f  am able, sometimes if I  do it. it's a bil o f wrangling. 
To wrangle a little hit oj lime here and there to go on things" (Prescriber 6 - pharmacist in 
primary care with 5 years prescribing experience)
The above prescriber. being a pharmacist was not supported by her employer w ith respect 
to  time o l f  and funding for CPD. In her case, the time she would ‘wrangle* to go for formal 
study days that she may have paid for. was in addition to the personal time that she would have 
routinely dedicated to se lf directed learning. Not all the prescribers fell this way though. Some 
non-medical prescribers were more conservative in the way they made time for CPD.
"I do it in work lime, because I am quite a firm believer... I don't say I don't do anything 
oul o j work hours, but I am a firm believer that 1 come lo work. I work very hard and if I  did 
something in the evening* lhat will be fine, but then I will lake the lime back. And I am fortunate 
in that I  can do that. Bul i f  you sort o f said that there is a really interesting weekend. I would 
mu go ‘YPrescriber 7 -  nurse in primary care w ith 2 years prescribing experience)
Initially, mv feelings were that being a nurse, the above prescriber may have gotten used 
to being ‘spoon-fed*, bul that was not a valid explanation. The same prescriber did little to 
develop relationships in her prescribing environment and she also frequently ‘copped oul of 
prescribing*. Within these contexts, a more valid explanation would be a lack o f  enthusiasm lo
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develop her ’personal form ulary' coupled with a more conservative approach to engaging in less 
traditional forms o f  knowledge acquisition.
4.3.5.4 C a tegory  sum m ary
Acquiring knowledge addressed how non-medical prescribers engaged with knowledge 
acquisition with respect to their prescribing practice. In the first sub-category, ‘organising 
learning', it emerged that non-medical prescribers organised and structured their knowledge 
using a ‘personal form ulary'. In addition to formal CPD. they also learned informally from 
trusted colleagues and team working. In ‘accessing resources' it emerged that access to CPD 
resources differed according to professional background. Pharmacist prescribers were limited in 
their access to formal CPD during paid work lime. Nurses and pharmacists also associated 
certain benefits and limitations with organised courses and se lf directed learning, the main types 
o f  CPD they engaged in. In the third subcategory ’m aking tune’, it emerged that non-medical 
prescribers compared to their colleagues who do not prescribe, had more ‘knowledge needs’ and 
CPD commitments and had developed strategies to overcome challenges in this area.
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4.3.6 Gaining experience
Generali} speaking, experience refers to the process whereby skill is learned through the 
observation o f  a  process, or as a result o f  being exposed to a relevant event. Experience implies 
that a person learns both from events that are mentally processed and those that are not 
immediately mentally processed but reflected upon at a later time. Experience is seen as being 
able to accumulate over time, as long as the individual has undergone sufficient exposure to a 
relevant event. In this category I discuss how non-medical prescribers interacted with the 
concept ol experience and how this influenced the way they developed their prescribing skills 
and their willingness to prescribe. As they are all related to learning, admittedly there is a 
significant relationship between this category, ‘acquiring knowledge’ and * reflecting on 
prescribing*. But each o f  these categories has a different focus.
In 'gaining experience’ I focus on how nurses and pharmacists engaged in activities 
aimed at addressing their level o f experience in various aspects o f  their prescribing. I will 
explore how they perceived experience contributed to their practice and how important they felt 
it was in prescribing for chronic pain. The first sub-category ‘gaining from others’ experience' 
explores interactions with colleagues who are seen as being more experienced. In the second 
sub-category ‘experience with medication*, the relevance and importance non-medical 
prescribers attributed to prior experience w ith the use o f drugs, is explored and the third sub­
category ‘being familiar with patients with chronic pain* discusses the influence gaining 
experience with patients, had on their prescribing practice.
4.3.6.1 Gaining from others’ experience
As non-medical prescribing is a relatively new activity there are not many nurses and 
pharmacists that have accumulated prescribing experience relevant to treating chronic pain. As 
such the data that emerged suggested that prescribing experience although considered important, 
was limited. Earlier we saw how some non-medical prescribers who. by the nature o f  their 
innovative approach, were more likely to push the boundaries o f their prescribing practice. This 
suggested that in certain areas, some p rescribes were always more likely to have more 
experience than their other non-medical prescribing colleagues. Additionally, not all non­
medical prescribers had access to fellow non-medical prescribers from whom they could learn 
although ideally they would rather learn from experienced non-medical prescribers.
T he nurses and pharmacists that were interviewed, in some instances acknowledged that 
there were other non-medical prescribers that may have the relevant experience in the certain 
areas that they were interest in.
“ . . .  we are able to ask questions and get a response from people who have got the 
experience, so it is actually very useful. And Ihere is a national network, which publishes 
guidelines and policies and various other things that you would want to review and somebody 
else has already done the work, so you could potentially save yourself quite a big job. " 
(Prescriber 15 - pharmacist in secondary care with 3 years prescribing experience)
generally gel the answers that I need and I  know that /  am not on my own. I know that 
there is somebody out there that I  can link to... " (Prescriber 8 - nurse in primary care with 1 
year prescribing experience)
Non-medical prescribers perceived that significant benefits could be derived wilh respect 
to savings in time and effort from learning from other non-medical prescribers who had already 
gained the relevant experience. However, not all non-medical prescribers used ‘others' 
experience' to improve their lime and efficiency, as was shown by their adoption o f  different 
approaches to networking.
Another way that non-medical prescribers felt that they gained from others’ experience 
was through the mentoring relationships that some o f them engaged in. This relationship lias 
already been explored in ‘approaches* however related themes are further explored here. One 
such theme was regarding which profession was more likely to engage in mentoring relationship 
and what emerged was that it was nurse prescribers that felt more comfortable being mentored 
and becoming mentors.
"I have talked to colleagues, they do not have anywhere near the level of supervision that we 
have in our Trust. And /  think that can only be a good thing because al least you're ensuring 
that non-medical prescribers are sup/>orted in Iheir decision, are supported in their practice."
(Prescriber 2 - nurse in secondary care with 2 years prescribing experience)
The mentoring relationships that were revealed were not formal or ‘top down' type 
initiatives rather they were informal arrangements which were in most cases, set up by the 
prescribers themselves.
“/  wouldn't have liked to have felt like I was completely on my own. didn't want that at all. even 
though this support I needed was quite minimal, it was nice to know that she was there. That 
was something I set up myself. " (Prescriber 8 - nurse in primary care wilh I year prescribing 
experience)
W hile it could be argued that the informal arrangements may suit the prescribers better in 
developing mentoring relationships that would enable them lo learn from iheir more
experienced colleagues, it may not be a suitable model lor the more conservative prescriher.
"it is not formally, but 1 actually spoke to one of the nurse practitioner and said, look, can I 
spendHome lime with you... J know it is being silly, but now that /  am spending same lime with 
her, I think she will help me to say... well actually, it's fine, yon can do il... "(Prescriber 7 - 
nurse in primary care v\ith 2 years prescribing experience)
For this prescriber. inasmuch as seeking out a m entor and spending time with her had the 
capacity lo enhance her prescribing, the fact that there was no existing formal mechanism to 
support the development o f  a mentoring relationship meant that she had to do it herself. For her. 
doing this meant stepping a bit too far out o f  her comfort zone.
Earlier on. we saw that mentoring relationships were more common among nurse 
prescribers, however although none o f  the pharmacist prescribers interviewed admitted lo 
having gained from others' experience by way o f  mentoring, there was an understanding o f  the 
concept and how il could be helpful to less experienced non-medical prescribers.
'. . . /did not have llial. I  am not familiar with... but I can see like.., for someone who hasn't, 
doesn 'l feel he is 100% and then you refer them lo someone to give them advice, I don 7 see a 
problem with that " (Prescriber I - pharmacist in secondary care with 3 years prescribing 
experience)
Also at least one pharmacist prescriber. whom I got the impression as being innovative 
and who also had considerable experience in community pharmacy indicated that she had 
engaged in relationships where she in effect mentored other non-medical prescribers.
4.3.6.2 E xperience w ith  m edication
In this sub-category. I explore how non-medical prescribers perceived the importance o f 
the level o f  experience that they had with respect to medication used in the management o f 
chronic pain. In doing this. I will also determine how their perception o f this expertise 
influenced their prescribing decisions for patients w ith chronic pain. A primary professional role 
for many pharmacists prior to qualifying as prescribers involved screening prescriptions. In this 
role, pharmacists routinely encountered many different drugs and as such it would be expected 
that they would have a significant familiarity with properties such as side effects and contra - 
indications o f  medication used for chronic pain.
133
This expectation was reflected in the data collected from the study. The pharmacist 
p rescribes who were interviewed suggested that their prior knowledge on medicines, even 
before becoming prescribers was a significant strength.
think the pharmacist prescribe’/- is better positioned, knowing the side effects o f the 
medicines. So for example, i f  a patient comes in with acute pain, within the organization you 
often get morphine, where oxycodone Is probably more appropriate... "(Prescriber 15 - 
pharmacist in secondary care with 3 years prescribing experience)
Also as expected for this group o f p rescribes, the longer that they have been engaged in 
their professional duties, the more experienced that they were perceived to be, both by 
themselves and their colleagues.
"...but I think because I am 25 years qualified, they kind of acknowledge that I probably 
know an awful lot more about prescribing than they do and often because they are much 
younger than me... " (Prescriber 18 - pharmacist in primary care with 4 y e a s  prescribing 
experience)
Interestingly, the nurse prescribes also identified that pharmacists had considerable 
knowledge o f  m edications for chronic pain and even saw them as a resource that they could 
access.
"I have got access to support from CPs i f  I need it and we have got the pharmacy.... if  we 
have got queries, the pharmacy leads from the Pi T .... so I know where I can gel information i f  I 
need it... "(Prescriber 16 - n u s e  in primary care with 5 years prescribing experience)
Subsequently, as more data emerged, it became clear that while being a  pharmacist 
suggested that a prescriber had prior experience with relevant medication and that their y e a s  o f 
experience may give an indication o f how experienced they were, it was not always the case. 
With further interviews and more reflection I realised that before qualifying as prescribes, 
pharmacists may have recently changed areas o f  specialty, even spent a significant proportion o f 
their career in roles that did not require constant and robust contact with relevant medication 
information.
For the pharmacists that had the relevant amount o f  experience before qualifying as 
prescribers. it was evident that it was a significant advantage in their practice. For instance it 
gave them more confidence in their prescribing abilities and ensured that their internal 
formularies were robust enough to enable them to prescribe in an efficient manner. A good
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exam ple to illustrate this is to consider the effect on experience in medication use, on attitudes 
to prescribing controlled drugs.
in taking another look at this quote, we see that this pharm acist based on her experience 
in medication use fell confident enough to criticise the practice, where morphine, rather than 
oxycodone was routinely prescribed by others in her establisliment. Despite being the normal 
practice, because she had the relevant knowledge and experience, she felt confident to assess 
and com m ent on it.
think the pharmacist prescriber is better positioned, knowing the side effects o f  the 
medicines So for example. if a patient comes in with acute pain, within the organization you 
often get morphine, where oxycodone is probably more appropriate... "(Prescriber 15 - 
pharmacist in secondary care with 3 years prescribing experience)
I'he above reaction was typical o f  the kind o f attitudes that other pharmacist prescribers 
had towards controlled drugs. Initially when I compared this to the typical attitudes that many of 
the nurse p rescribes had towards prescribing controlled drugs, exemplified by the quote 
directly below, what seemed to emerge was that the nurse prescribers as a group, were likely to 
be more cautious about prescribing controlled drugs than the pharmacists.
"1 do not think that I am, /  mean if  you take something like diazepam as an example, 
which is classed as a controlled drug, hut it is very good for sort o f spasms... for some chronic 
pain. /  can’t say that I am frightened o f doing that, I think some o f it is to do with your 
experience and building o f competence " (Prescriber 21 - nurse in primary care with 5 years 
prescribing experience)
However, with further probing I found out that this was not the case, in actual fact, when 
it came to prescribing controlled drugs, it was experience with medication, rather than 
professional backgrounds, which determined the level o f  confidence with which prescribers 
approached prescribing controlled drugs.
... /  understand the legality, so I do not have uny worries about that, and in term  of the 
safety aspect, you consider that all o f the time, no matter what you prescribe, you look at the 
safety profile, you would always be trying to prescribe those with the best safety profile, if 
you're moving into an area where there are increased risks, then you proceed cautiously but you 
have got to weigh up the benefits for the patient, against the potential costs o f ...or safely issues, 
that is the way that 1 would he balancing it. /  wouldn't he saying no to a drug, just because it
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has got a poorer safely profile. " (Prescriber 10 - nurse in primary care with 6 years prescribing 
experience)
This nurse prescriber's attitude towards prescribing controlled drugs was sim ilar to that o f 
the pharmacist prescribers. Further contextual investigation showed that she was perceived by 
her peers as very knowledgeable about drugs and this was reflected in her confidence which was 
also observed during the interview.
4.J.6 .3  E xperience with ch ron ic  pain patients
This category explores how non-medical prescribers perceived their experience 
particularly with patients with chronic pain, contributed to their prescribing. Nurses and 
pharmacists in this study agreed that having more experience with their chronic pain patients 
would contribute to the development and maintenance o f  the prescribing relationship.
"... 11 truly makes a huge amount o f  difference, once they have built the. confidence in 
you, they see me more than they see the doctor, more frequently, they know who I am. they know 
I eon sort out their medicines, they know lliey can ask questions" (Prescriber IS - pharmacist in 
secondary- care with 3 years prescribing experience)
There was a perception by the non-medical prescribers. that the more they saw their 
patients, the belter their patients’ confidence in their prescribing abilities became.
In many settings, especially in primary' care, where the non-medical prescribers 
prescribed for their chronic pain patients on a more regular basis, these repeated visits, not 
only enhanced the patient relationship aspect o f  their practice, it also fed into the various 
knowledge acquisition mechanisms used in developing their ‘internal formularies’.
For the hospital based non-medical prescriber, the patient relationship aspect o f  their 
practice was more limited, th is was because the patients that they usually saw for chronic pain 
were not as regular as was the case in primary care. For the prescribers in secondary care more 
emphasis was placed on being familiar with and understanding the condition that their patients 
presented with, rather than on developing a  relationship with the patient.
"...But clearly the most important thing i.s actually knowledge o f what is causing chronic 
pain for the patient and how to treat that. So for example,... choosing different drugs for chronic 
pain caused hv neuropathies, to chronic /fain caused by mechanical reasons perhaps. . so for 
me a safe environment would be prescribing with a cohort of patients that I am familiar with.
I hat I understand the disease processes that they are presenting with " (Prescriber 20 - 
pharmacist in secondary care with 5 years prescribing experience)
The implication was that for the prescriber that did not have regular sessions with the 
sam e patients, though the patient relationship aspect o f  their prescribing may not have been 
developed to their satisfaction, there was more scope for them to develop their internal 
formularies, because ol the variety o f  conditions that they came across.
Continuous interaction with patients helped non-medical prescribers in many ways, such 
as in aiding the development o f  their personal formulary and in achieving a beneficial 
partnership with the patient which is a necessary component o f  what they considered a “safe 
environm ent' for their practice. However, a significant weakness pertaining to how non-medical 
prescribers carried out their prescribing was revealed. When the category 'gaining experience' 
started emerging. I assumed that all aspects o f  the non-medical prescribers prescribing would be 
enhanced as they interacted more with patients. This assumption was wrong. As more data 
emerged, it became clear that some aspects o f  non-medical prescribing were not perceived to 
develop as rapidly as expected, even with their increasing interaction with patients.
I would broadly split the prescribing shills sort uj into two broad areas. I  suppose, 
one is actually knowledge about medicine and prescribing evidence - based medicines and all 
that and the other is communication, consultation skills... What I... and probably a lot oj other 
people lack once they have done the course, is a reassessment o f consultation skills, that is not 
something you can share with other people unless someone witnesses you giving it and I don't 
really know anybody outside the medical profession who has reassessments of their consultation 
skills. GPs, particularly for GP trainers do an awful lot... ongoing stuff around consultation, 
because a huge amount of whut they teach to the registrars and people.... hut pharmacists. I  do 
not think I hat any o f them ever get any ongoing.. "(Prescriber 18 - pharmacist in primary care 
with 4 years prescribing experience)
T his feeling o f  uncertainty regarding best practices with respect to consultation skills was 
especially relevant for non-medical prescribers vs hose prescribing practice was carried out in an 
area, or setting where no other fellow non-medical prescribers were prescribing, as well as in 
scenarios that prescribers did not consider their environment safe enough to learn these skills 
from their more experienced medical colleagues.
I  have never really had any training as such lit making records, in record keeping, making 
notes and patient's records, recording consultations... you just get the feel for il and you just 
move on. Nabodv said I'm doing it right, nobody said I'm doing wrong.... am I putting loo much
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information in. or not enough. I Jo not know" (Prescriber 5 - community1 pharmacist with 3 
years prescribing experience)
In addition, the non-medical prescribers did not express any awareness o f  any mechanism 
to allow them to se lf assess their knowledge needs, with respect to consultation skill, as well as 
o f  clear signposts to CPD sessions to help them address these deficiencies.
4.3.6.4 C ategory  sum m ary
In the first sub-category "gaining from other’s experience" I explored how non-medical 
prescribers related to their more experienced colleagues, when they identified this group as a 
useful resource. These learning relationships were mostly informal and although nurse 
prescribers were more likely to have engaged in these relationships, pharmacist prescribers 
understood and agreed with the concept. In the second subcategory ‘experience with 
medication’, non-medical prescribers perceived that prior experience with drugs influenced their 
current attitudes to prescribing for patients with chronic pain. Here pharmacists were seen as 
advantaged due to their prior experience in scrutinizing prescriptions. Similarly the length o f 
previous related professional experience in dealing with medication was seen as beneficial to 
practice. In the last sub-category 'experience with chronic pain patients’, I looked at the 
importance that the nurses and pharmacists that participated in the study attached to the 
experience that they had with this group o f  patients and how this influenced their practice. In 
this sub-category, prescribers indicated that while certain aspects o f  their practice were 
significantly improved by their sustained interaction with patients, some others were not.
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4.3.7 Reflecting on practice
Professionally, before even becoming prescribers, there is awareness, among nurses and 
pharmacists, o f  the role reflection should play in their practice. For healthcare professionals, 
reflection refers to the process where they engage in a conscious and purposive process aimed at 
retrospectively exam ining aspects o f  their practice. Healthcare professionals are generally 
encouraged to  regard reflection as an integral tool for improving their practice. Additionally , for 
nurses and pharmacists that decide to qualify as non-medical prescribers. as part o f  their training 
they are taught how to use reflection to determine the positives and negatives o f an episode o f 
consultation and prescribing that they have carried out. While training as prcscribers. they also 
learn how to think about the way that they carried out their prescribing, critique their approach 
and use their experiences to  better future prescribing practice.
In this category. I will explore attitudes to reflection that the research participants had 
within the context o f non-medical prescribing for chronic pain. In doing this. I will examine 
what they considered reflection in their prescribing, why they reflected on their practice and 
how they did it. I discuss ‘reflecting’ under three main subcategories. In the first sub-category. I 
explore the importance to prescribing that non-medical prescribers attached to reflecting and the 
benefits they associated with reflection. In the second 'using  others for reflection', I look at how 
non-medical prescribers perceived interaction with their colleagues as a form o f  reflection and 
how their approach and perception o f  prescribing environment influenced this. In the third sub 
category ‘se lf reflection'. 1 discuss the advantages and disadvantages that non-medical 
prescribers associated with reflecting on their practice on their own. I also look al some 
predisposing factors for se lf reflection that emerged from the data.
4.3.7.1 Reflecting on prescribing
The nurses and pharmacists that participated in the research showed a keen understanding 
o f  the concept o f  reflection in practice and how it contributed to their prescribing practice. There 
was awareness that as they were relatively new to prescribing and had sometimes been faced 
with cases where they had limited knowledge and/or experience, reflecting on episodes o f  care 
that they had carried out had the potential to help remedy these deficiencies in a quick and 
efficient manner.
"I do not think that anybody can be an expert al what they do and I  think it is important 
that vou always reflect on things, so if there has been something that has come in.... that you 
haw maybe not been 100% sure about... "(Prescriber 21 -  nurse in primary care with 5 years 
prescribing experience)
In the above example, this non-medical prescriber saw reflection as a means o f  increasing 
confidence in her prescribing and ensuring competence in the various -specialist areas that she 
prescribed in.
Nurses and pharmacists who had qualified and were prescribing, demonstrated that even 
though a s  healthcare professionals, they may have been aware o f  the role that reflecting can plav 
in professional practice, they attributed the concept o f  using reflection to improve their practice 
to their training as non-medical prescribers.
"1 like bouncing Ulcus o ff people unci about the thing I learned in the course was how lo 
reflect on your practice and sometimes when you reflect you need lo talk to people about il as 
well" (Prescriber 9 - community pharmacist with 5 years prescribing experience)
This suggests that these non-medical prescribers retained some o f  the principles, methods 
and objectives o f  reflection in prescribing, as it was taught to them during their training 
programme. It is also possible that they had gone On to adapt them to conform with their 
respective practice settings, in order to suit their needs.
In ‘acquiring knowledge', we saw how non-medical prescribers used their know ledge and 
experience to develop their own 'personal formulary’. For some o f  the non-medical prescribers. 
reflection on their prescribing was a useful tool in building this formulary .
" /  think it informs your own formulary that you are building up in your head. And you 
create anecdotal evidence about what works for certain people, certain groups o f people that 
will make you-more confident in the future lo try that again. And the converse is true as well, 
why you think... no, that was the wrong choice, that caused that side effect and had an impact 
on their day - to - day life, you know, thal kind o f thing, yes. " (Prescriber 22 - nurse in primary 
care with 3 years prescribing experience)
The ‘personal or internal formulary* is a formulary that the non-medical prescriber developed 
through the knowledge thal they acquired and the experience that they gained in the area o f 
chronic pain. It is a dynamic formulary, because as new evidence regarding treatment became 
known to the prescriber. perhaps through CPD. the new evidence informed their ‘personal 
formulary* and it was adapted to accommodate this new evidence. As such, the suggestion of 
the above prescriber. is not totally accurate, as we will see in the following subcategories, 
reflection involves challenging personal practice with the best evidence that the prescriber has 
access to.
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4.3.7.2 Using O th ers  fo r Reflection
This sub-category explores the practice where non-medical prescribers accessed other 
prescribers and engaged with them as a kind o f  ’sounding board4 for reflection on their 
prescribing, 'd ie  healthcare professionals that they approached may have been fellow non­
medical prescribers. or other prescribers in their team. For non-medical prescribers who used 
their colleagues within their team for reflection, it was an indication thai the non-medical 
prescriber considered their prescribing environment safe enough for this practice to take place.
This is illustrated in a quote from the first sub-category, where we saw a non-medical 
prescriber say that although she learnt how to reflect on her practice on the prescribing course, 
in practice she preferred to use 'bounce' her ideas o ff  people.
I like bouncing ideas off people and about the thing I  learned in the course was how to 
reflect on your practice and sometimes when you reflect you need to talk to people about it as 
well" (Prescriber 9 - community pharmacist with 5 years prescribing experience)
As well a s  being an indication o f  how safe they felt in their prescribing environment, for a non- 
medical prescriber to "use others for reflection', they would have been assuming the profile o f  
the more innovative non-medical prescriber. In this instance, the more innovative non-medical 
prescriber w as using this relationship to extend their practice. A more conservative approach 
would have been where the non-medical prescribers used this reflection relationship to reaffirm 
existing practice.
"... it just gives you the confidence lo go and prescribe and reassures you that you are 
conducting your practice quite well and that influences your decision making in terms of 
making you confident to do that" (Prescriber 2 -  nurse in secondary care with 2 years 
prescribing experience)
In some other cases, non-medical prescribers indicated that in 'using others to reflect’, it was the 
unique viewpoint that prescribing colleagues from different professional backgrounds had, that 
was helpful to their practice.
"But I think as well within the organization, we have not had a lot o f  formal support, you know, 
it is like., we did have a prescribing group, which was very useful, it was wilh a pharmacist 
and vi’c viv/y able lo ....discuss the situation, about things that have happened" (Prescriber 7 - 
nurse in primary care with 2 years prescribing experience)
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For other non-medical prescribers. it was just the process o f  sharing with trusted colleagues, 
how they had carried out their prescribing and exploring other options that they may have used 
in that episode o f  care that was important to them.
"...even after your package o f care for a patient and you are happy with it and the 
outcomes are good, it feels good to talk about cases and what you have done and what 
somebody else may have done differently, that's always bene/icial" (Prescriber 10 -  nurse in 
primary' care with 6 years prescribing experience)
In general, it appeared that the non-medical prescribers that used others for their reflection were 
relatively ‘open m inded' about the approach to patient care. Using others for reflection also 
created a forum for prescribers to appreciate the strengths and value o f  the other members o f  
their teams from a different professional background (as we saw earlier in ‘team working”). In 
the above case, this forum was discontinued and this meant that the prescriber above could no 
longer derive the benefits that came from building these important relationships.
4.3.7.3 Self reflection
As well as using others to reflect, non-medical prescribers also engaged in se lf reflection. Self 
reflection in this context refers to the process where the non-medical prescriber carried out an 
introspective examination o f  their practice after they had completed the episode(s) of 
prescribing. In doing this, the main objective was to carry out an assessment o f  prescribing 
experiences retrospectively and use this to seek out new knowledge that would lead to a more 
efficient development in both their prescribing skill and their specialist areas.
"...or it sort o f  has raised some sort of fears o f some concerns, hut you actually make a 
note oj it and then use it sort o f reflect on il. And that again, whether it is reflecting on your 
own, or actually talking through the whole cycle with another colleague. " (Prescriber 21 -  nurse 
in primary care w ith 5 years prescribing experience)
However, for these prescribers. certain important factors are considered in determining 
whether they would se lf reflect, or use others for reflection. For instance some o f  the non­
medical prescribers that participated in the research carried out their reflection quite often. In 
some cases, the frequency o f their reflection meant that there were no other healthcare 
professional with relevant knowledge and experience in prescribing, in close proximity, to carry 
out this reflection with. In such cases, the non-medical prescribers engaged in se lf reflection.
"] think /  reflect on a daily basis, perhaps a bit too much in some ways, I lake il home 
with me and think about what I could do... what I have done and what I could do better. " 
(Prescriber 22 -  nurse in primary care with 3 years prescribing experience)
Apart Irom having access to knowledgeable and experienced colleagues with whom to share 
their prescribing experiences and practicing in close proximity to them, other factors are 
considered when deciding what type o f  reflection to c a m  out. Trust is another important factor 
that was considered, for instance, though a colleague may be knowledgeable and experienced in 
the relevant area of prescribing, they may not have been used because they were not considered 
trustworthy enough.
One of the benefits o f  se lf  reflection has been illustrated in the above example where the non­
medical prescribers said that she reflected on a daily basis, l or her, it meant frequent contact 
with new evidence in her areas o f  practice and as such, she was often in a position to acquire 
new know ledge and perhaps, even more importantly, by taking it home with her, she did it at 
her own time, at a pace that she dictated.
Sometimes, non-medical prescribers felt that due to the fact that the wanted to go deeper in 
their reflection, the more appropriate choice would be to se lf - reflect.
"...but I guess it's good in a « w , because it gives you a chance to think about things, 
think about what kind of scenarios you are going to be in and how vou can do it " (Prescriber I
-  pharm acist in secondary care with 3 years prescribing experience)
In the above case, the prescriber suggested that in his reflection, after carrying out a 
retrospective assessment o f  his prescribing and acquiring relevant knowledge, he would also 
want to visualize how he could use the new knowledge that he had gained in various 
hypothetical scenarios that he may have been likely to come across. This suggested a more 
thorough and time consuming process, as such the likely model o f  reflection would be the self 
reflection model.
Other non-medical p rescribes that were more likely to carry out se lf reflection were non- 
medical prescribers who were generally more conservative in their approach. By only engaging 
in se lf reflection, they would no doubt gain associated benefits such as reflecting on their 
practice at a tim e and place o f  their choosing and the liberty to be as thorough as they wish. 
However, by deciding not to use others as a 'resource' to reflect, they also miss out on some 
important aspects o f  reflection such as being able to learn from others' experience (except when 
these accounts are published and they have access to the relevant journals).
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4 J .7 .4  C ategory  sum m ary
T his category dealt with how non-medical prescribers perceived and approached 
reflection in their prescribing. The first ’reflecting on prescribing’ explored how non-medical 
prescribers perceived reflection as a concepi and what they used it for. Reflection was seen as a 
tool which could be used to improve competency and confidence, as well as aid in the 
development o f  their 'personal formulary’. In the second subcategory ’using others to reflect’, a 
more innovative form o f  reflection emerged, where non-medical prescribers used relationships 
with colleagues seen as trustworthy and knowledgeable, to reflect on their practice. The last 
subcategory, ’se lf reflection’, represented the form o f  reflection carried out internally by non­
medical prescribers. Here their reflections were deeper, more frequent and could be carried out 
anywhere and at any time. This form o f  reflection was also used when prescribers were not 
confident enough to approach other colleagues, o r in scenarios where they were not sure their 
prescribing environm ent was safe enough.
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4.3.8 Health inform ation technology
In this pari o f  the study, tw o types o f  health information technology emerged as important 
to how nurses and pharmacists carried out their prescribing - electronic prescribing and 
accessing electronic health records.
Electronic prescribing can be defined as any system that enables prescribers to access 
‘knowiedge-support' electronically, interact with decision-support regarding choice o f  treatment 
and medication, as well as facilitate communication with other relevant parties such as a 
community pharmacy within a network. Electronic prescribing systems also allow prescribers 
to carry out medication checks more efficiently and reduce errors due to illegibility o f 
prescriptions.
Electronic health records in this context cover all systems that allow the health 
information o f  a patient lo be retained In a form that can be processed by a computer. They 
allow healthcare professionals access to relevant medical histories, request m onitor and view 
laboratory test results and aid the maintenance o f  complete and up to date information 
pertaining to all aspects o f  a patient's health needs, They also allow healthcare professionals to 
access decision support software, local treatment guidelines and enable the detection o f 
unwanted drug interactions.
In this category I explore the access that non-medical prescribers perceived they had to 
health information technology in the various settings in which they worked and how it affected 
both their decision to prescribe and how they actually carried out their prescribing. Mere. I also 
explore the various measures taken by non-medical prescribers. who felt that their access to 
health information technology was inadequate.
The following subcategories ‘prescribing electronically', ‘accessing patients' records', 
‘affecting patient care ' and ‘coping mechanisms’,  emerged from the exploration o f  the non­
medical prescribers perception o f  the aspects o f  their prescribing that were related to health 
information technology.
43.8 .1  P resc rib in g  electronically
Am ong the non-medical prescribers interviewed, there was a  general agreement, that 
having access to electronic prescribing systems enabled them to carry out their prescribing 
practices fo r instance facilitate medication checks and generate prescriptions. Among non- 
medical prescribers in primary care, one o f  the groups that perceived they had less access to 
what they considered an optimum level o f  electronic prescribing systems were nurse prescribers 
in the community.
“Unfortunately no. ire are supposed to he going onto SystmOne. which is the GPs use 
hut at the moment, our services are a hit of a dinosaur really. It is all by phone and fax."
(Prcscriber 8 - nurse in primary care with I year prescribing experience)
In addition to the lack o f access that they felt hindered their prescribing, the) also had to 
make additional effort to ensure that the record keeping aspect o f  their prescribing met the 
standards for good prescribing practices. This suggests that the efficiency o f  their prescribing 
practice may also be affected by this.
Although some o f  the non medical prescribers that prescribed in secondary care had the 
same level o f  access to electronic prescribing systems as their medical colleagues, in some 
cases, the facilities that they had access to, were also regarded as inadequate.
7  suppose what will make life easier, would be having software to prescribe, push a 
button and the script will come out just like you do when you’re in a GP's surgery . so yes. I 
suppose that would make life easier. But that's the only thing really" (Prescriber 3 -  nurse in 
secondary care w ith  2 years prescribing experience)
For these non-medical prescribers in secondary care, there was also an indication that the) 
were aware o f  the limitations o f  their current system and that they felt an improvement o f these 
systems would facilitate their practice.
Am ong the non-tnedical prescribers that were interviewed, those in primary care that 
prescribed from G P 's  surgeries not only had access to the same prescribing systems that their 
GP colleagues did. they also expressed satisfaction with how current their systems were and 
how this contributed to their prescribing practice.
‘7  can print them off, the other practice where I work in, they have a different system in 
there... KM IS. we also use., we now use SystmOne here and for both o f them has always been 
able to print off prescriptions, it has not been a problem for me" (Prescriber 16 -  nurse in 
primaty care with 5 years prescribing experience)
In a few cases however, where they have had to prescribe outside the surgery, for 
instance, during a home visit, their access to these systems became limited and they have had to 
resort to hand writing prescriptions.
"... that is fine as well, there is nothing, as I say. that is all setup. I  can print them off. so 
I don't have to worn about handwritten prescriptions, unless maybe /  am on a home visit, 
sometimes I  do a handwritten prescription..." (Prescriber 16 - nurse in primary care with 5 
years prescribing experience)
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For the non medical prescribers interviewed, the best access to  electronic prescribing 
systems for non-medical prescribers seemed to be in primary care, GP surgeries to be more 
specific. They not only had access to the most sophisticated systems, but they also considered 
their access equitable to that o f  their medical colleagues. This level o f access that non-medical 
prescribers had in this setting contributed to how supported they felt that that their prescribing 
environment was. This is illustrated by the following quote from a pharmacist who had 
experience o f  prescribing in the community tor the PCT and also in a GP surgery.
"The biggest problem 1 hail which wax really .....did stop me doing one o f the services
that I wanted to set up straight mruy. was that the PCT didn't know how to order my 
prescriptions, so when /  was working in the GP practice, they could set the computer up so that 
my prescriptions were generated and they did that straight away. " (Prescriber 9 -  community 
pharmacist with 5 years prescribing experience)
For her. the fact that the PCT could not set her up to access their electronic prescribing 
system while she was working in that environment was a significant barrier to her practice. For 
her. the G P 's surgery where she was set up straight away to have equitable access to electronic 
prescribing represented a safer environment for her to prescribe in because she could access 
relevant resources to support her prescribing.
4.3.S.2 Accessing pa tien t records
Access to patient records, where information about a patient's care can be shared 
between the non-medical prescribers and other healthcare professionals responsible various 
aspects o f  a patient's care was a considered a key determinant to the way that patient's care was 
delivered. As such, it was felt that the speed and efficiency with which a patient received care 
could be influenced by the level o f access that their non-medical prescriber had to relevant 
records and how communications were carried out with other healthcare professionals 
responsible for that patient.
For the non-medical prescribers who participated in the research, their perception was that 
within the NHS. access to patient records was varied and the manner in which information was 
shared was inadequate. These factors were seen as a significant barrier to their prescribing 
practice.
“7 think that is my main challenge in the area /  work in. to get the GP. inpatient 
consultant, outpatient consultant and me all singing from the same hymn sheet, .Tv prescribing 
goes, it is vt-vr difficult especially with IT systems with the way they are at the moment." 
(Prescriber 6 - pharmacist in primary care with 5 years prescribing experience)
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Non m edical p rescribers specified som e areas w hich they fell may have contributed lo 
these inadequacies. These a reas o f  concern include the lack o f  standards regarding types o f  
inform ation technology system s used w ithin the  NITS and the varying levels o f  access that these 
non-m edical p rescribers had through their organisations. A s a  result, non-m edical prescribers 
felt that they w ere  som etim es kept out o f  their p a tien t's  inform ation loop, despite  being 
responsible for som e crucial aspects o f  that patients care.
"HV referred this person to ihe chronic pain team, now somewhere in name loop, it has 
been missed out that I have been involved in the prescribing and the Jact that /  prescribe in the 
community for this person, so I never got any information back from the pain team at all about 
what they were doing.... 1 have written lo them and I am waiting to hear:" (P rescriber 6 - 
pharm acist in primary care  w ith 5 years prescribing experience)
Even in cases w here they felt they w ere alw ays kept in the loop with respect to the 
treatm ent their patients w ere  receiving, there w ere still problem s with access to patient records. 
In th is case, non-m edical prescribers had access to  som e information to support their 
prescribing, but the inform ation that they had access to. w as not alw ays considered adequate, 
fo r  instance, this prescriber felt that although w hen patients w ere referred to him he a lso  got a 
sum m ary o f  th e ir records, better access to their records, for instance to laboratory resu lts would 
have enabled him to  prescribe better for his patients.
"Well the main thing that we haven't got. that would make things better is access to 
patient notes and also access to patient blood results ... when people come to me. I  have a 
referral which is usually written by the nurse, which is a summar)r o j their background, again a 
snapshot, it's not u complete lisi o f  background medical history " (Prescriber 4 - pharm acist in 
primary care w ith 5  years  prescribing experience)
As such, som e non-m edical prescribers felt that if  they had better, m ore equitable access 
to  p a tien ts ' records, for instance, the sam e level o f  access as their m edical colleagues, their 
p rescrib ing  w ould  be im proved. This w as found to  be the  case in som e scenarios, f o r  instance 
these prescribers had equal access to  patients ' records, a s  their m edical colleagues and 
expressed satisfaction  with the  way inform ation was shared in their prescribing settings.
“ IKe use proton, which is an old system and probably good... and the organization has 
recognized that and is working for lhat to be upgraded, all the other systems lhat are in the 
organization are excellent.......absolutely, yes. we have access 10 all patient records, clinic
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notes. . . “ (P rescriber 15 - pharm acist in secondary care w ith 3 years prescribing experience)
"...because we are on SystinOne, we converse by e - mail and we both have access lo the 
records and the clinical management plan that is on there" (Prescriber 5 - com m unity 
pharm acist w ith  3  y ears prescrib ing  experience)
H ow ever, in som e o ther .establishm ents, even w hen non-m edical prescribers and their 
m edical colleagues had equ itab le  access to patien ts ' records and were able to share inform ation 
electronically , there w ere still som e concerns. For instance, there w ere still questions about how 
com plete  and up to  d a te  these records were.
"We do have a computer program that gives access to patient's records and we have been 
using that for about IK months or so, however, service user records do not go,...they are not 
entirely on the system, so there are still a lot of hand writ ten notes flying around the Trust and 
in clinics and in outpatient clinics and various sort of places. So we do not always have up lo 
date records o f the service user." (P rescriber 2 - nurse in secondary care w ith 2  years 
p rescrib ing  experience)
A nother a rea  o f  concern  that em erged in this area w as the various m easures that no n ­
m edical prescribers had to resort to, to update patien ts ' records. Som e non m edical prescribers. 
who d id  not have access to e lectronic health records o f  patients, still have to resort to  using the 
phone and fax to  update changes in the patients’ m edical status.
"I would have lo drive to the clinics and fax something off, or I  ring the girls at admin 
here and say will you send a fax to Doctor. So-and-so. this is what I have allered.'\ Prescriber 8
- nurse in primary care w ith I y ear prescribing experience)
The nurse prescribers that had to  utilise the above m easures to update patient records felt 
that they were exposed to  significant risk regarding th is aspect o f  their prescribing. A lso the 
additional effort involved in m aking sure that these records w ere updated in a  tim ely m anner 
influenced the efficiency o f  their prescribing.
4.3 .8J  A ffccting  p a tie n t c a re
In the  p reced ing  sub-category I briefly m entioned that the level o f  access to  relevant 
records that non-m edical prescribers had and the way they com m unicated with other healthcare 
professionals w ho shared responsibility for a  patient could  influence how that patient received 
services. In th is sub-category , I further explore these consequences, with respect to patient care, 
which resulted from lim itations perceived by non-incdicat prescribers. in their access to
prescribing systems and patients* records.
TTie level oil access, non-medical prescribers had to prescribing systems and electronic 
health records within their organisations, was perceived to have an effect on the service that 
they provided for patients with chronic pain. This quote illustrated a good example o f  how this 
happened in practice, whereby due to the incomplete and outdated nature o f the available patient 
records, there was a potential for delays in the patient’s access to treatment.
"... we do not always have up to date records o f the service user, so I think lhal that could 
he improved. There are times whcn.„.it was only last week lhal somebody hud rung me from a 
ward, someone had been admitted and they didn 7 have access to the medical notes, they were 
not dear on whot the current prescription was. We had a discharge stmmary from about two 
weeks before that detailed the gentleman's prescription, but again, il was unclear if it was still 
current or not " (Prescriber 2 - nurse in secondary care w ith 2 years prescribing experience)
In this example where the nurse prescribed in secondary care, he perceived that in 
addition to delays for patients, i f  at the point o f  prescribing, the medical notes still had not been 
located there was an increased chance o f  committing a prescribing error. Similarly, in those 
cases where non-medical prescribers have been left out o f  the information loop regarding a 
patient's care, it meant that that the patient was at risk o f being prescribed for by a prescriber 
that may not have had a  complete picture o f their health status.
"It delay’s things massively and also when my patients are often admitted to hospital, for 
short admissions and they come back out. everything has changed and I  am not always 
informed and also things that should actually not have been changed in the first 
place ".(Prescriber 6 -  pharmacist in primary care with 5 years prescribing experience)
In this exam ple, the pharmacist prescribed in primary care. The limitations in 
communicating with other healthcare professionals equally had the potential to cause delay s. In 
a few cases, the problems associated with being able to prescribe electronically and having 
adequate access to patient records, limited their ability to practice so much that these non­
medical prescriber decided not to prescribe for chronic pain.
"Incidentally that is one o f  the reasons why f  do not generally get involved in chronic
pain prescribing.......so i f  they hai'e respiratory problems. I don't have any information on lhal.
if they are on rheumatology\ /  don't have anything on that at all and so I would feel 
uncomfortable because of my' lack o f information. I would feel that I don't have a background 
information to make any prescribing decision. (Prescriber 4 - pharmacist in primary care with 5 
years prescribing experience)
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Although the pharmacist prescriber above admitted to having a  considerable level of 
expertise with respect to the conditions and medications for chronic pain, he would not 
prescribe in that area due to the Fact that his access to relevant records were perceived to be 
inadequate, l ie  also admitted that in his practice, he had seen patients.
"So people do. I kntnv people do have chronic pain, sometimes they will discuss it and 
sometimes other patients won't discuss it. I personally will try not to get too involved with 
chronic pain side o f things, ai the moment. "(Prescriber 4 -  pharmacist in primary care with 5 
years prescribing experience)
These were patients who due to a relationship developed over tim e and the level o f 
expertise that they perceived that the non-medical prescriber had. expected him to be able to 
prescribe for their chronic pain. T his pharmacist did not meet these expectations by prescribing 
I'or their chronic pain. As such they had to expend further resources in terms o f  time, effort and 
money to go to other healthcare professionals to resolve their pain.
In the way the perceived lack o f  access discouraged non-medical prescribers for 
prescribing for chronic pain patients, when their access to prescribing systems and patient 
records were facilitated, there was evidence that this improved the way that they w<ere able to 
provide services for their patients.
Earlier on. we saw  how being facilitated to prescribe electronically in a  GP‘s surgery, 
contributed to how safe this prescriber felt in her prescribing practice. For her. electronic 
prescribing not only aided her development as a prescriber. it also enabled her to prescribe for 
her patients in a more efficient manner.
"JTte biggest problem that I  had. which was really .. did stop me doing one oj the 
services that I wanted to set up straight aw av. was thal the PCT didn 7 know how to order my 
prescriptions, so when I was working in the CP practice, lliey could set the computer up so that 
my prescriptions were generated and they• did that straight away" (Prescriber 9 - community 
pharmacist with 5 years prescribing experience)
In the category •motivation' we saw patients* expectations emerge as a significant 
motivation to nurses and pharmacists, qualifying and practising as prescribers. We also saw in 
•nature o f  the prescribing environm ent’, the importance attributed by non-medical prescribers to 
the development o f  a frank and trustworthy relationship with their patients. These tw o issues 
further complicated the way patient services could have been affected as a result to the non­
medical prescribers’ limited access to prescribing systems and patient records. On the one hand.
despite  be ing  able to. the  prescriber may have adopted a  m ore conservative approach and 
declined  prescribing fo r chronic pain, preferring to  refer their patients to  other prescribers with 
better access to the m edical records. On the other hand, they could have been more innovative 
and engaged in ‘coping m echanism s’ to ensure that their pa tien ts ' chronic pain was resolved.
4.3.8.4 C o p in g  m ech an ism s
In th is sub-category. I w ill explore the coping m echanism s that non-m edical prescribers 
engaged in. in order to be able to prescribe for their patients. In the context o f  this study, coping 
m echanism s re fer to  the various m easures that non-m edical prescribers used in overcom ing the 
barriers that they w ere faced w ith in their prescribing practice due to lim ited access to 
prescrib ing  system s and patien t records, C oping m echanism s were m ostly used by the m ore 
innovative prescribers. The m ore innovative approach w as to  m anipulate aspects o f  their access 
to  prescrib ing  system s and patient records to ensure  that they were able to prescribe for their 
patients. T heir exploration o f  these available options w as alw ays perceived to  be w ithin the 
boundaries o f  leg itim ate prescrib ing  practices.
In the category 'ap p ro ach es '. I show ed how a pharm acist p rescriber used the ‘back d o o r  
to  'm an ip u la te ' the access to patient records that he needed to ensure  that his environm ent was 
safe enough for his prescribing.
"...well the main thing i /m  wi* haven't gut, iliat would make things better is access to 
patient notes and also access to patient blood results, which I can access the blood result from  
the hospital for the patients that I see in primary care, but that is a bit o f  a hack door route, i f  I 
was working in primary cure. I wouldn’t hare that access. That will make my job much more 
difficult " ( Prescriber 4  - pharm acist in primary care with 5 years prescribing experience)
T his p rescriber was already entitled to  this access, but no t w ithin the setting  from w hich 
he w as prescribing. M aking su re  that he had the relevant inform ation to enable him to prescribe 
for h is patients m eant that he had to frequently go  back and forth, at h is ow n expense, to this 
•back door access* each tim e the need arose.
In certain  cases, even perform ing the more m undane, yet im portant aspects o f  prescribing 
proves to be som ew hat challenging for non-m edical prescribers, due to  the  lim itations in access 
that they have. E arlier on. while exploring  the level o f  access that non-m edical prescribers had 
to  patients’ records, we saw  that this prescriber had to  resort to  what most would have 
considered cum bersom e and outdated m easures, in updating records a fte r she prescribed.
I would have to drive to the clinics and fax something o ff  or I ring the girls at admin 
here and say will you send a fax to Doctor So - and ■ so, this is what I  haveuhered."(Prescriber 
8 - nurse in prim ary care  with I year prescribing experience)
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She went on  to  adm it that sh e  w as aw are o f  the personal sacrifices that this entailed and 
the lim itations that engaging in these cum bersom e and outdated m easures had on her practice.
doesn't stop me doing il, but il is a hit o f a nuisance. in this day and age isn V it. 
you know, hut I have to have some evidence o f what /  have done and the GPs to have it. " 
(P rescriber 8 -  nurse in prim ary care w ith I y ear prescribing experience)
I low ever. she a lso  considered m aking sure that her colleagues knew what she was doing, 
w ere updated with respect to  the p a tien t's  health status and this m eant that she would be seen  as 
a  trustw orthy prescribing professional. In her case, we can see that both the desire to ensure that 
her patients were taken care of. as well as m aintain the safety o f her prescribing environm ent, 
have com e into play.
In the tw o cases, w e  have seen these tw o prescribers m ove out o f  w hat could be 
considered their ‘com fort z o n e ' w ith respect to  accessing prescribing system s and patient 
records. T h ey  were still w ith in  w hat they considered legitim ate and safe prescribing. Had they 
decided  to adopt a m ore conservative approach, they may have “copped ou t’ until they 
perceived appropria te  access to  relevant system s.
4.3.8.5 Category summary
N on-m edical prescribers’ access lo electronic prescrib ing  system s varied depending on 
w here  they prescribed from and  it w as perceived that better access to  these system s would 
facilitate their prescribing practice. R egarding pa tien ts ' records, non-m edical prescribers were 
excluded from com m unication  and perceived inadequate access to  relevant inform ation. Even 
w hen there  was equ itab le  access to records, there were concerns regarding how recent and 
com plete  these  records w ere. N urses and pharm acists felt that the  level o f  access that they (the 
prescriber) had to prescribing system s and patient records affected the level o f  care that their 
chronic pain patients received. Delays to  w hen patients got treated for their chronic pain were 
identified as an exam ple as to how  patient care could be affected.. In this category, it em erged 
that in certain  cases non-m edical prescribers overcam e lim itations in access by going beyond 
their ‘jo b  descrip tions' to  ensure  that they could prescribe for their patients. A lthough this 
(innovative) group o f  prescribers went outside their norm al scope o f  practice to facilitate their 
p rescribing, they still rem ained w ithin legal boundaries
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4.4 Discussion
This section discusses th e  findings o f  the project that explored nurses' and pharmacists' 
view s and experiences regarding how prescribing for chronic pain is carried out. This project 
aimed at answering two Of the three research questions proposed to address the knowledge gap 
revealed by literature review in the second chapter. These were:
t .  What are Ihe views and experiences o f  non-medical prescribers (nurses and 
pharmacists) in the treatment and management o f chronic pain?
2. In the treatment and management o f  chronic pain, what are barriers and 
facilitators influencing the implementation o f non-medical prescribing?
Following the grounded theory exploration, seven categories emerged which explained 
how nurses and pharmacists prescribed for chronic pain and the barriers and facilitators 
perceived in their practice. Together they indicated the core category o r  this wrork 'safety and 
support within the prescribing environm ent'. The categories that emerged in this chapter are 
discussed w ithin the context o f  the available literature in Ihe study area.
The theory ‘safety and support within the prescribing environm ent' lhat emerged from 
this project together with the integrated discussion that links these findings to those o f  the other 
two projects (chapter 5 and chapter 6) is presented in chapter 7.
4 .4 .1  A p p ro a c h e s
Non-medical prescribers employed two main approaches in the way they engaged with 
various aspects o f  their prescribing practice -  the innovative and the conservative approach. For 
a prescriber who adopted the innovative approach, there was usually a desire for a more 
'adventurous’ exploration o f  processes and protocols guiding their practice. These prescribers 
were more likely to 'push boundaries’ and engage in relatively new processes or practices to 
achieve their prescribing goals. On the other hand, the prescriber who adopted the conservative 
approach, usually placed more emphasis on ensuring that they practised within recommended 
guidelines with respect to patient safety and competencies required to practice in a specific area. 
Prescribers adopting the conservative approach were also more likely to be stricter and more 
formal in interpreting relevant guidelines with respect to how they related to their peers and how 
they carried out their prescribing for their patients. Although non-medical prescribers that adopt 
these differing approaches may have sim ilar goals (usually providing adequate care for their 
patients and enhancing their skills), these two approaches do not often involve using the same
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steps to achieving these objectives and  may actually be seen by some as being diametrically 
opposed in iheir mechanisms o f  action.
The notion that non-medical prescribers could differ in their approaches to prescribing 
within a particular setting is novel. Until now, no other study on non-medical prescribing for 
chronic pain has theorised that nurses and pharmacists varied in how they approached their 
practice. The closest existing theory to this is the dissemination o f innovation theory (Rogers. 
2003). This theory describes the processes involved when an individual encounters a new idea. 
It expounds the decision making processes and attitudes involved and suggests how these 
influence the level o f  acceptance/adoption o r rejection made by that individual regarding the 
new idea. There is evidence however that this concept is not new. Almost half a century ago. 
Coleman Katz and M en/el ( 1966.) looked at the processes involved in doctors’ adoption o f  a 
new drug and were able to determine which doctors were patient, research or professionally 
oriented. Using this categorisation, they were able to describe attributes o f  those more likely to 
prescribe tetracycline. Roger’s (2003) categorisation o f  individuals ranges from innovators at 
one end o f  the continuum, lo laggards at the other end. His description o f  innovators as 
individuals, who were more willing to challenge the system, is similar lo the innovative 
approach adopted by non-medical prescribers in this study. None o f  R oger's (2003) other 
categories quite captures the non-medical prescribers who adopted conservative approach in this 
study. Furthermore his theory focused on individuals with respect to how they adopted new 
innovations, whereas the findings o f  this work suggest thal the approach adopted determined 
how nurses and pharmacists prescribed under certain conditions, rather than describing the 
profile o f  an individual prescriber.
This new way o f looking at how non-medical prescribers approach their prescribing 
practice begins to give an insight to why some nurses and pharmacists would prescribe in 
certain scenarios and others would not. It also starts to explain why some non medical 
prescribers interacted with the various factors within their prescribing environments to ensure 
they could prescribe, while others let the extant circumstances and conditions determine 
whether to prescribe or not.
4 .4 .2  M o tiv a tio n
Even before nurses and pharmacists become non medical prescribers. various factors 
within their professional environment exist which motivated them to  gain this qualification and 
perhaps go on to prescribe in their areas o f  practice. The findings from this work showed that 
motivation played a significant role in the qualification as prescribers and subsequent use o f 
these prescribing rights. The way a healthcare professional was motivated also played a role in 
determining to a certain extent, how non-medical prescribers would eventually approach their
prescribing responsibilities. ‘Liberating prescribing practice' and ‘Having more skill’ emerged 
as the more dominant motivators probably because they enabled them take responsibility for 
their prescribing, be recognised for their contribution for their patients' treatment and plan their 
career progression. 'L iberating prescribing practice’ as a motivator however seemed more 
significant In the initial implementation period o f the non-medical prescribing policy. ‘Meeting 
expectations', as a motivator was not as dominant as the earlier two. but it was important 
nonetheless. In addition to m otivating nurses and pharmacists, it gave an early indication of the 
level o f  importance these professionals attributed to relating with relationships with their peers, 
patients and senior colleagues. Although these motivators emerged and have been discussed as 
separate factors, there was some indication that nurses and pharmacists, in practice, could be 
motivated to become non-medical prescribers by more than one o f  these factors at the same 
time.
The evidence from this project o f  the study suggests that there is some connection 
between the factors that motivate non-medical prescribers and certain aspects o f  their 
prescribing practice after they qualify. For instance, the approach that they may choose to adopt 
when they encounter certain barriers in their prescribing practice, may depend on some o f  the 
more dominant motivators they were influenced by. Non-medical prescribers who expected to 
be rewarded after qualifying may be predisposed to adopting a more conservative approach in 
their prescribing environment unless financial incentives were introduced. Also nurses and 
pharmacists who were primarily motivated to become non-medical prescribers as a means o f 
gaining more skills were more likely to be innovative in the way they learned from and 
mentored other through networks they belonged to.
In the existing non-medical prescribing literature, other studies have also found that 
nurses and pharmacists found that prescribing allowed them use their skills better for their 
patients, be more responsible for the role they played in the providing healthcare serv ices and be 
adequately recognised for their contribution. The pharmacists in Weiss. Sutton and A dam 's 
study (2006) described supplementary prescribing as 'rew arding'. Nurses in Scotland described 
prescribing as a means o f  improving their professional development and achieving job 
satisfaction. They also associated prescribing with being better recognised and respected 
(W atterson et al.. 2009). Similarly, the nurses in Fisher's study (2009) reported that they felt 
that they were bener respected by pharmacists because they could now prescribe.
Although not as dominant as ‘liberating' and ‘meeting expectation', ‘being rewarded’ has 
also been identified as important in how non-medical prescribers were motivated. More than 
ha lf o f  the pharmacists in one study reported that not being remunerated for their prescribing 
was a  barrier to  their practice (Dapar el al.. 2 0 10). Although the findings from this study suggest 
that ’being rewarded’ is important, it does not support the level o f  significance that Dapar and
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his associates suggest. Another perspective in the literature was that although financial reward 
was a motivator, it was not important (W archal et al.. 2006).
An important finding in this part o f  the study is the discovery o f  a factor thal up until now 
was not considered important to how nurses and pharmacists were motivated to qualify as 
prescribers. It has not emerged in any o f the existing non-medical prescribing literature that 
nurses and pharmacists found the expectations o f  their patients, their peers and their senior 
colleagues important in (heir consideration to become prescribers. The emergence o f  this new 
motivator buttresses the importance o f  relationships developed by non-medical prescribers in 
Iheir prescribing environments. It also gives an important insight into characteristics o f  nurses 
and pharmacists who decide to become prescribers. In addition to motivating nurses and 
pharmacists, the factors identified gave an insight to approaches non-medical prescribers 
adopted and as well as how important they considered relationships to their practice.
4.4.3 Acquiring know ledge and reflecting on prescribing
Non-medical prescribers in this study demonsirated that although engaging in CPD 
remained important to the way they acquired knowledge for their practice in chronic pain, they 
also learnt informally from their colleagues and through leam-working. Also, it emerged thal 
non-medical prescribers were increasingly constrained for time needed lo both organise and 
engage in knowledge acquisition processes. This seemed to  be due to the fact that these nurses 
and pharmacists in addition to prescribing were expected to continue other professional duties 
they had prior to prescribing. Additionally, they were expected to keep acquiring the knowledge 
required to maintain competence in prescribing and these other professional areas.
T his study also gave an insight to how non-medical prescribers in the area o f  chronic pain 
built up the knowledge component o f  Iheir competence. Non-medical prescribers created 
personal or internal knowledge armamentariums which they built up incrementally, using 
various learning processes. There was an indication that non-medical prescribers engaged in 
formal (for instance, organised courses) o r informal (for instance, learning from colleagues) 
knowledge acquisition processes as a means o f  developing and maintaining competence. An 
important tool employed by non-medical prescribers in building up iheir internal knowledge 
armamentariums was reflecting. Non-medical prescribers demonstrated that the practice o f  
reflection learnt during their training as prescribers was used in their prescribing to among 
others, acquire knowledge, gain competence and plan CPD. In practice, depending on the 
peculiarities o f  their needs and environment, prescribers either self reflected, or used others to 
reflect.
Non-medical prescribers also showed that they varied in their approach, regarding how 
they acquired knowledge. Although pharmacists appeared more innovative in researching and
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organising their CPD, it may have been as a result o f  their limitations to accessing courses 
during paid work time. Findings suggest that depending on their prescribing environment, 
informal learning using knowledgeable colleagues was useful to non-medical prescribers' 
practice. I he perception that their prescribing environments were safe and that their colleagues 
could be trusted was a determinant o f  whether non-medical p rescribes would consider using 
others to reflect.
O ther researchers have also identified a number o f  the issues discussed here. In two recent 
studies, time constraints have also been identified as a barrier to non-medical prescribing 
(Shrestha et al., 2011: Mac I., ure et at., 2 0 1 1). Although one o f the studies explored both nurse 
and pharmacist p rescrib es ' views (Shrestha et al.. 2011), this study's focus on chronic pain 
even goes further to identify that this problem exists within this specialty. Furthermore, by 
comparing nurse and pharmacist prescribing, this project identifies limitations pharmacists had 
to CPD. Regarding access to formal CPD. the only studies found with similar themes, had 
explored only nurse prescribers’ views. Even then, there were indications that comparability 
across specialties was not feasible. Although a national survey o f  nurse prescribers' CPD needs 
found significant limitations in access to formal CPD (Latter et al.. 2007), another which 
focused on nurse prescribers' CPD needs in diabetes, suggested that almost all p rescribes in 
this area could access relevant courses (Carey and Courtney. 2009). One study in a related area 
had some sim ilar findings to that o f  this study. O tw ay 's (200h  findings about the benefits o f  
informal reflection and sharing experience, on nurse prescribing, reflect the views expressed by 
non-medical p rescribes in this study.
In this area, this project gives an insight to how nurses and pharmacists who prescribe or 
intend to  prescribe for chronic pain build up the knowledge necessary to gain and maintain 
competence in this area. In addition to  uncovering the importance that nurses and pharmacists 
who prescribe for chronic pain attribute to CPD activities and informal learning, it also 
identifies facilitators and h a rrie s  that these professionals found in their practice. Furthermore, 
exploring both nurses' and pharmacists' views and experiences regarding prescribing for 
chronic pain, enabled an unforced emergence o f  relevant themes from the grounded theory 
phase. This enabled the articulation o f the similarities and differences o f  the knowledge 
acquisition needs o f  these two professional groups.
4.4.4 The role o f gaining experience
‘Gaining experience' emerged as important for non-medical p rescribes, perhaps probably 
because prescribing is a relatively new professional direction for nurses and pharmacists. The 
findings in this category revealed further differences between nurse and pharmacist prescribes.
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Although both agreed that in their prescribing for chronic pain, gaining from others' experience, 
such as mentoring was valid, it was nurse prescribers who were more likely to do so in practice. 
Also there was little evidence o f structured mentoring relationships among non-medical 
prescribers that practised for chronic pain. The types o f experience considered most important 
by non-medical prescribers for chronic pain were experience in drugs and experience with 
patients. Pharmacist prescribes who had accumulated significantly more medication experience 
due to previous professional background were advantaged compared to nurse prescribers. 
Although some nurse prescribes seemed apprehensive with respect to medication, with more 
experience, they seemed to become more confident. In prescribing for chronic pain, the second 
type o f  experience was considered just as important. “'Experience with patients’ revealed the 
importance prescribers attributed to relating with their chronic pain patients. Evidence suggests 
pharmacists considered inexperience with patients more o f  a barrier to their prescribing for 
chronic pain, compared to lack o f  medication experience.
Turner’s (2011) description o f  the impact o f  a peer group set up to supervise non-medical 
prescribers in one NIIS Trust is similar to some o f  the important themes that emerged in this 
area o f  the research. The support system put in place in that Trust by the peer supervision group 
is sim ilar to the mentoring model through which non-medical prescribes learnt from others’ 
experience, in their prescribing for chronic pain. In other areas related to experience. Bradley 
and her colleagues (2007) found lhat about a quarter o f  qualified nurse prescribes had not yet 
started prescribing in part because, they may have been overly cauiious and aware o f the safely 
implications o f  their prescribing. The findings o f  this study help to explain why this is the case. 
Among our research participants, those n u se s  with little medication experience were also very 
cautious, whereas n u se s  who had considerably more experience with medication exhibited no 
such traits.
Regarding how pharmacists and n u se s  differed in their prescribing for chronic pain, some key 
findings o f  this study are similar to those o f  an earlier study. Buckley and associates (2006). 
while com paring professional perspectives in non-medical prescriber within an NHS Trust, 
found that while nurses’ experience with patients was perceived to be an advantage to their 
prescribing, they were seen as being limited in their know ledge o f  the pharmacological aspects 
o f  prescribing. On the other hand, pharmacists, w ho were acknow ledged as medication experts, 
were perceived lo be limited by their lack o f  patient experience and diagnostic skills.
This work suggests that these issues are also important in n u se  and pharmacist 
prescribing for chronic pain. Although the findings in this area are not new. the grounded theory 
approach used in this project o f  the study confirms the relevance o f these findings by adopting a 
methodology previously unemployed in this area and for this population.
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4.4.5 Health inform ation technology
In this area, the two important themes that non-medical prescribers identified as important 
to their practice were being able to prescribe electronically and having access to patient records. 
The evidence from ibis study suggested that regarding being able to prescribe electronically, 
non-medical prescribers in the community were most likely to have the least access, while those 
practising in GP surgeries were likely to have the most. An interesting finding in the way non­
medical prescribers approached health information technology, was the influence o f the 
perception oi access and equity. For nurses and pharmacists, it was not just access that was 
important to them. These professionals felt safe and supported in their prescribing if  they 
perceived that they had the same level o f  access as their medical colleagues. However, nurses 
and pharmacists had further concerns regarding how recent and complete patients’ records were. 
Non-medical prescribers also perceived that the kind o f  access that they had. both to patient 
records and prescribing systems had the potential to influence the kind o f  care that they were 
able to provide for their chronic pain patients. As such, there was some evidence that depending 
on the approach adopted, some non-medical prescribers routinely made personal sacrifices and 
developed strategies to cope with perceived barriers in this area
Other researchers in non-medical prescribing have also considered a few o f  the issues 
discussed here. Warchal and colleagues (2006) also found that access to patient records was 
considered a barrier by supplementary prescribers in community pharmacy. For nurse 
prescribers, Bradley and colleagues (2007) found that although they regarded IT systems as 
helpful to their prescribing, there were limitations in access to these systems, particularly for 
prescribers within the community. This also mirrors findings from Scotland where an evaluation 
revealed sim ilar limitations in access to system s required to computerise prescriptions 
(W atterson et al., 2009). More relevant to this study, Stenner and Courtenay (2007) found that 
among nurse supplementary prescribers in pain, there was inequitable access to patient history 
and records. They also found that the research participants felt that this had an influence on the 
overall picture they had o f  their patients care.
Non-medical prescribers in this project o f  the study indicated that access to prescribing 
software and patients' records was important to their practice. Adequate and equitable access to 
prescribing software and patients* records were regarded as facilitators to prescribing for 
chronic pain. The findings also suggest that non-medical prescribers may have developed 
strategies to overcome barriers created by lack o f access.
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4.4.6 N ature of the prescribing environm ent
I lie emergence o f this category represents a novel way o f understanding the theoretical 
basis o | non-medical prescriber’s relationships and related aspects which influence how they 
perceive their prescribing environment.
4.4.6.1 R elationships an d  team w ork
T he first three ‘developing relationships with colleagues’, ‘relying on colleagues' and 
•team-working’, are strongly related to each oilier and are indicative o f  the role non-medical 
prescribers perceive that these play in the development o f  their prescribing practice. These first 
three components embody the relationship building processes that non-medical prescribers 
undertake, the tools they use in building them and the kind o f  qualities expected within these 
relationships. After qualify ing, non-medical prescribers begin to develop new relationships, to 
support their prescribing practice. Even when nurses and pharmacists begin to prescribe in 
settings they worked in prior to prescribing, the evidence suggests that they still have to build 
these relationships. An important relationship building tool that emerged in this study was the 
multi disciplinary team. Non-medical prescribers in the study saw multi disciplinary teams as 
supportive to their relationship building processes. Teams helped non-medical prescribers assess 
developing relationships and ensured that their skills were useful to achieving team goals. This 
was especially important in the light that some 11011-medical prescribers still fell that their 
colleagues* awareness o f  their skills and capabilities were inadequate. Although mulii 
disciplinary teams were seen as useful, the characteristics o f  the team were also important, as 
depending on the structure and functioning o f the team, the non-medical preserver's 
development could either be facilitated or hindered. Non-hierarchical teams within which duties 
were clearly delegated and debate not perceived as ‘overly aggressive’ were seen as important 
facilitators for non-medical prescribing.
Another important finding o f  this study relates to the manner in which the non-medical 
prescribers related to their colleagues within their teams and prescribing env ironments. Non­
medical prescribers in the study wanted to be sure that they could trust and rely on their 
colleagues for support in their practice especially for knowledge and experience. The trust 
bestowed on their colleagues was also expected to be reciprocated by the non-medical 
prescribers. They perceived that their colleagues in tum  expected them to have the relevant 
skills to carry out their prescribing duties and lo develop their practice to such a level that they 
could provide knowledge and experience support for other colleagues.
Other researchers have considered a few o f  the components discussed here. Warchal and 
associates (2006) identified that the lack o f  support expressed by primary care supplementary 
prescribing pharmacists had the potential to influence their prescribing practice. Similarly. 
Weiss and colleagues (2006) found that good working relationships with colleagues facilitated
i n
prescribing and that the supplementary prescribing pharmacists in the community who had less 
learn working experience fell isolated compared to their colleagues in hospital practice. Similar 
findings had also been reported with nurse prescribers. A survey o f  extended formulary nurse 
prescribers suggested that up to a third reported not having enough support and supervision lor 
their prescribing (Latter et al.. 2007); These three studies were however carried out with 
extended formulary and supplementary prescribers. Due to the less collaborative nature o f  
independent prescribing compared to  supplementary prescribing, it could be argued that this 
group would require less support. Findings from this work suggest otherwise. The majority of 
the participants in this study were qualified as and used independent prescribing, but still 
expressed the need to interact with supportive colleagues within a team structure.
Until recently, the role o f  trust among colleagues has remained a little researched area 
within non-medical prescribing. In Fishers' (2009) exploration o f  relationships in nurse 
prescribing, there was some evidence that trust among colleagues contributed to the feeling o f 
being supported. The team pharmacist reported trusting that the nurse prescribcrs had the 
appropriate skill for their prescribing responsibilities and the nurse p rescribes fell adequately 
supported by ihe pharmacist. He however also found that issues concerning power, control and 
bureaucracy within team s may lead to problems in relationships. In another study that 
investigated pharmacy led management o f  chronic pain in primary care. GPs interviewed 
expressed some level o f  trust and respect for their pharmacy colleagues (Bond el ah. 20 1 1). This 
project however goes further in establishing the role thal trustworthiness plays in the prescribing 
environment, in term s o f  ensuring that their environment was supportive and that skills within 
their teams were used efficiently. The findings from this project indicate that for both nurses 
and pharmacists prescribing for chronic pain across various care settings, working with 
colleagues regarded as trustworthy and supportive influenced how they perceived their practice.
4.4.6.2 In terac tin g  with m anagem ent
T his component o f the non*medical p rescribers prescribing environment reflects how 
their interaction with management was seen to  influence their prescribing practice. The 
relationship that non-medical prescribers had with two main management figures, the non­
medical prescribing lead and the clinical leads were seen as pivotal to how supported nurses and 
pharmacists felt in their prescribing environment. In this study, there was an indication that non­
medical prescribing leads were perceived as limited in their awareness o f  the barriers that nurses 
and pharmacists may come across in specific practice settings. It was felt thal a non-medical 
prescribing lead with first hand experience o f  the two existing models o f  non-medical 
prescribing would better understand iheir problems and be easier to relate with.
For non-medical prescribers that worked in teams where there was a clinical lead, there 
was also a perception the clinical lead 's level o f  awareness, o f  both the non-medical prescribing 
policy and roles o f  the non-medical prescriber. could either facilitate or hinder their practice. In
maddition to this awareness, belonging to teams where the clinical leads were supportive o f  non­
medical prescribing was seen as a significant facilitator to their prescribing practice. Non­
medical prescribers felt that their prescribing practice would be facilitated if  the support 
provided by management was more specific to their needs rather than amended from support 
provided for medical prescribers that these managers were more used to providing.
Some o f  the existing literature has explored the views o f  doctors and managers and how 
these relationships may influence non-medical prescribing. Thrutle (2009) focused on health 
visitors in an NHS Trust and found that nurses fell let down by inconsistencies in non-medical 
prescribing policy adopted by management and this meant they felt unsupported in their 
prescribing. M ore recent findings in another Trust found that almost half o f the doctors who 
participated in their evaluation o f  non-medical prescribing had concerns about boundary 
encroachment (Sreetha et al.. 2011), suggesting that doctors still viewed non-medical 
prescribing with some suspicion. On a much wider scale. Watterson and associates (2009) in the 
evaluation o f  nurse prescribing in Scotland, found that while some doctors and GPs had been 
identified as supportive o f  non-medical prescribing, a  significant number o f  Trusts as well as 
specialties did not have non-medical prescribing leads. Similarly, in an even more 
comprehensive evaluation o f  non-medical prescribing in England, it was found that the level o f  
awareness o f  non-medical prescribing among doctors was suboptimal. Also, il emerged that 
some doctors were still unclear about aspects o f  nurse and pharmacist prescribing (Latter et al.. 
2010). Although the findings o f  this study reflect some o f  the findings in existing literature 
within the specialty o f  chronic pain, it drills down to identify the key management figures that 
were seen by nurses and pharmacists as most influential, It also establishes that maintaining a 
relationship with these figures was crucial to how safe they fell in their prescribing. 
Furthermore, it identifies important attributes that non-medical prescribers considered desirable 
for individuals holding these positions.
4.4.6 J  R elating w ith patien ts w ith chron ic  pain
In the first chapter o f  this thesis where chronic pain was introduced, the literature showed 
thal that the standard o f  care regarding treatment and management o f  chronic pain was less than 
optimum. The non-medical prescribers in this study agreed with this evidence and admitted that 
within the environments that they practiced in. similar problems existed in the way that chronic 
pain was managed. They however felt that that non-medical prescribing had the potential to 
improve the way that care was provided in this area.
An important area that nurses and pharmacists identified as a facilitator to how efficiency 
and quality o f  care could be improved in this area was the development and maintenance o f a 
relationship between the prescriber and the patient. Being open and trustworthy was seen as 
being integral to the development and maintenance o f  these prescribing relationships.
From tiie non-medical prescribers' perspective, achieving successful prescribing 
relationships with patients with chronic pain was beneficial to their practice because they 
depended on their patients for certain important aspects o f  their treatment plan, for instance 
diagnosing the nature, duration and intensity o f the pain. The non-mcdical prescribers in this 
study also identified the implications o f  failing to develop and maintain prescribing 
relationships with their chronic pain patients. Non adherence and experimenting by the patients 
were some negative outcomes associated with not building a relationship and disregarding the 
patient as a prescribing partner. Despite being aware o f  the advantages and disadvantages 
associated with partnering with their chronic pain patients, developing prescribing relationships 
was not always possible fo r non-medical prescribers. Time constraints; work load commitments 
and  perceived harm to the patients were some factors perceived to influence the nature o f the 
relationship developed between the prescriber and the patient.
Understanding the specific needs o f  an individual patient and relating with that patient 
based on the understanding o f  their needs is not a new concept in heath care. ‘Knowing the 
patient' is a well known concept in nursing whereby the nurse is encouraged to acquire an 
understanding o f  their specific patient as a unique individual. This approach has been associated 
with an increase in the efficiency with which nursing care is provided for that patient and 
consequently an Improvement in clinical outcomes (Radw in. 1996). Buckley and associates first 
linked this concept with non-medical prescribing when they explored stakeholders' views On 
non-medical prescribing in one NHS Trust. Their study found that there were fears regarding 
how well pharmacists would engage with this concept in their prescribing (Buckley ct al.. 
2006). Some aspects o f  their findings regarding pharmacists* lack o f  experience with patients 
were also applicable to how pharmacists in this study regarded their experience with chronic 
pain patients (this has already been discussed in 'gaining experience'). However, despite the 
lack o f  patient experience that limited pharmacists, this project demonstrated that they (as well 
as the  nurses) nevertheless had a keen understanding o f  the mechanisms involved in developing 
these partnerships, as well as the associated benefits (or pitfalls-if they failed to achieve a 
relationship).
Some o f  the other benefits associated with developing prescribing relationships with 
patients have also been identified by others. Although Stenner and Courtney (2008a) explored 
only nurse prescribers’ views, they also found that good relationship and communication 
between nurses and the patients facilitated the way that acute and chronic pain were managed. 
The factors non-medical prescribers in this study identified as barriers to their ability to develop 
these relationships have also been identified in other studies. Though not specific to time needed 
to develop prescribing partnerships, pharmacists in Shrestha et al (201 l) ’s and Warchal et al 
(2006)'s studies reported limitations in their prescribing due to the time they were able to spend 
with patients.
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The findings from this project show ihat the prescribing relationship between the patient 
and the non-medical prescriber is considered an essential component in prescribing for chronic 
pain. It also shows that both nurses and pharmacists regarded this partnership as important and 
knew the consequences to their practice o f  either developing these relationships, or disregarding 
the patient as a  prescribing partner.
4.4.6.4 Second checking
Second checking' relates to how pharmacists perceived that their practice was affected 
b> the measures in place lor their prescriptions to be screened, i f  and when they decided to 
produce them. For the pharmacist prescribers that participated in the study, the uncertainty 
about the protocols in place for how prescriptions would be checked after they had been 
generated by themselves or by other pharmacists emerged as a  cause for concern. While some 
pharmacists identified the source fo rih is  as their own particular establishment, others felt that 
the national guidelines in place were either not clear enough, or did not cover all the settings 
Irom which pharmacists prescribed. In many cases, particularly with hospital pharmacists, this 
was seen as a threat to how they perceived their prescribing environment and in some cases 
even prevented them Irom using their prescribing qualification within the specific setting they 
practised from. In the cases where they did not prescribe, there were either no protocols set up 
to address 'second checking’ issues, or pharmacists conscientiously declined to prescribe 
because they felt that these protocols were not robust enough. These issues were seen as having 
a negative influence 011 how pharmacists perceived their prescribing environment, their ability 
to provide services for patients and the efficiency o f  the NHS.
So far very little has appeared in the evidence regarding how pharmacist prescribing is 
influenced by guidelines and arrangements in place for checking their prescriptions. Although 
some inconsistencies across Trusts regarding various aspects o f  non-medical prescriber has 
come up in the literature (Latter et al., 2010) this was not focused on how guidelines related to 
'second checking’ influenced pharmacist prescribers’ decision to prescribe. Shortly after the 
introduction o f  prescribing for pharmacists in the UK, a study exploring the views of 
pharmacists and their mentors on the introduction o f  supplementary prescribing revealed 
concerns about protocols in place to ensure that pharmacists’ prescriptions were properly 
checked (Lloyd and Hughes. 2006).
This study is the first to identify that pharmacists considered measures in place regarding how 
their prescriptions would be checked and that this consideration had the potential to influence 
whether they would go ahead and prescribe. There is no evidence that other professional 
disciplines involved in prescribing have this consideration. The findings from this study also 
suggest that this issue constitutes a barrier to how pharmacist prescribers viewed their 
prescribing environment when they considered prescribing for chronic pain.
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4 .5  C h a p te r  su m m a ry
T his chapter presented the qualitative exploration o f  nurse and pharmacist prescribers* views 
and experiences regarding prescribing for chronic pain. Details o f the methods used in the 
grounded theory exploration were provided. Here, details o f  ethical and research governance 
approvals that were applied for and granted were given. An account o f  the how the data were 
collected and analysed as well as measures undertaken to  ensure quality were provided. The 
results were presented under the seven categories that emerged from this project o f  the study. 
Together, these categories indicated an emerging theory ‘safety and support within the 
prescribing environment’ .The findings were then discussed within the context o f  the wider 
literature in the relevant areas.
Factors were identified that motivated nurses and pharmacists to qualify and prescribe. It also 
emerged that they considered the nature o f  their environment in relation to how safe and 
supported they felt to  prescribe for chronic pain. Learning was also important to how non­
medical prescribers developed their practice. The main themes that emerged here were how they 
acquired knowledge, gained experience and reflected on their practice. Access to health 
information technology was seen as crucial to their practice. The type and level o f  access to 
prescribing software and patients' access were perceived to influence the effectiveness o f  their 
prescribing. It also emerged that nurses and pharmacists could be innovative or conservative in 
the approach they adopted in iheir prescribing.
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CHAPTER 5 
SURVEY O F NON-MEDICAL PRESCRIBERS 
5.1 Introduction
The preceding chapter presented details o f the grounded theory exploration o f the views 
and experiences o f  nurses and pharmacists in the treatment and management o f  chronic pain. In 
that project, a  theory ‘safety and support within ihe prescribing environment' emerged which 
explained how nurses and pharmacists perceived their prescribing for chronic pain and indicated 
what they perceived as barriers and facilitators to their practice. The overall mixed methods 
design thus included a second project designed to quantitatively test the validity o f this 
emerging theory.
The project presented in this chapter aimed at surveying non-medical prescribers in order 
to determine their level o f  agreement to themes em erging from the grounded theory in the last 
project. Additionally. the survey aimed at establishing which factors were perceived as 
facilitators or barriers by nurses and pharmacists who prescribe for chronic pain as well as 
determine the level o f  importance and relevance to their practice they attributed to these factors.
I present this chapter in three main sections. In the first section, methods. I present the 
series o f  steps employed in the design and execution o f  this phase o f  the study. I also justify the 
choice o f  the techniques used in each step. In the next section I present the results from this 
phase o f  the study. Mere. I use tables and figures to present the results. In the final section. I 
conclude the chapter, by discussing the results from this phase. [Hie results from this phase are 
discussed against the backdrop o f the findings from the grounded theory exploration o f  nurses 
and pharmacists presented in the last chapter.
5.2 M ethods
The processes undertaken in the data collection and analysis o f  the phase are presented 
below,
5.2.1 Q uestionnaire design
An online questionnaire was developed based on the themes that emerged from the 
grounded theory project which explored nurses’ and pharmacists’ views and experiences in 
prescribing for chronic pain. At the planning stages, a postal questionnaire had been proposed, 
however challenges associated with recruitment (this is discussed further in the next subsection) 
resulted in a change from a postal to a web based survey. As such before the recruitment for this
project commenced, further ethics approval for a substantial amendment, was applied for and 
received (see appendix 5).
The online questionnaire contained five item s on demographics and professional 
background and nine items on non-medical p rescribes’ current prescribing status in the area o f  
chronic pain, at the time o f  the survey. Levels o f  agreement associated with competence in 
prescribing for chronic pain and with information relating Id CPD needs were measured on live 
point Liken scales (strongly agree to strongly disagree) (Oppenheim. 1992). Levels of 
importance attributed to aspects o f  their prescribing environment and information technology 
needs were also measured by live point l.iken scales (very important to very unimportant). 
Three other items were included to determine resources used in prescribing for chronic pain, 
resources used in CPD and factors perceived as facilitators to prescribing for chronic pain. 
Sections were included to capture respondents’ comments on relevant issues that had not been 
included in the design and the penultimate item invited any other comment on non-medical 
prescribing for chronic pain. The final item measured the approximate amount o f lime used lo 
complete the queslionnaire. A copy o f  the questionnaire is available in appendix 18.
5.2.2 Q uality
Here I focus the measures taken to ensure quality in this project. The two relevant 
concepts discussed here are validity and reliability, due to their applicability to  the quantitative 
approach employed in this project. The triangulation that results from using two distinct 
methods within th e  same research project is also discussed here.
5.2.2.1 Reliability
The questionnaire that was used to collect data in this survey had not been used prior to 
this study. As such it was important to ensure that the psychometric properties o f  this tool be 
subjected lo relevant tests.. Reliability refers to  the extent to which the views, opinions and 
altitudes which the measurement tool measured remains consistent when repeatedly subjected to 
the same or sim ilar conditions (Carmines and Zeller. 1979: Kirk and Miller. 1986). Internal 
consistency reliability assesses I he consistency, o f  the components that make up ihe items in the 
data collection tool. Since the data collection tool used in this survey was a  questionnaire and 
was made up o f  several sections which are informed by different them es and aimed at extracting 
different forms o f  data, applying the Cronbach's alpha will enable the determination o f  the 
internal consistency o f  the instrument (Gliem and Gliem. 2003). In this phase o f  the study, the 
CronbaclTs alpha was applied to the survey tool using the SPSS (version 17). The Cronbachs 
alpha calculated for the related items yielded scores between 0 .71 and 0.88. suggesting strong 
internal consistency (De Vaus, 2004).
Although other reliability lests exist, not all were applicable to this study. Inter rater 
reliability or inter rater agreement, which focuses on homogeneity amongst iwo or more data
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collecting units (Le Breton and Senter. 2008: Landis and Koch, 1977) was not applicable to  this 
particular combination o f  data collection tool and scenario and so was not carried Out in this 
study. Similarly, test -  retest reliability that assesses the correlation between results o f  tests 
administered at two separate times (Otter et al.. 1995) was also not carried out for the same 
reason.
5.2.2.2 Validity
Validity is a concept that focuses on testing the correctness, or precision o f  a data 
collection tool. It is mainly concerned with determining the degree with which a data collection 
tool actually measures the phenomena that it intends, or claims to m easure (Carmines and 
Zeller. 1979; Lew is and Ritchie. 2003 ). In this phase o f  the study, two types o f  validity testing 
were carried out. '1 he first, face validity , is concerned with the design o f  the data collection tool 
and its ability to reliably and accurately measure the phenomenon which it was designed to 
measure (I-ink. 1995). The second, content validity refers to the degree, or extent to which the 
data collection tool represents all the components o f  an intended domain o f  content (Carmines 
and Zeller. 1991),
In quantitative research carried out in the healthcare sector, expert panels have been 
identified as an efficient and acceptable resource (Davies. 1992). It has also been demonstrated 
in other studies, that expert panels are reliable in determining face and content validity (Hyrkas 
et al.. 2003). After the questionnaire had been designed, it was tested for face and content 
validity by an expert panel o f  three researcher academics.
The first member, a Fellow o f  the Royal Pharmaceutical Society and the Higher 
Education Authority, is an expert in non-medical prescribing and has experience in designing 
and analysing quantitative surveys. The second member has held a Professorial chair for 12 
years and been in full tim e research lor over 25 years with expertise in methodology, research 
design and long-term conditions. The third member o f  the panel has expertise in symptom 
management and long-term conditions as well as in the use o f  the Grounded Theory and other 
qualitative approaches within studies o f  mixed method design. Based on the comments from the 
panel, corrections were made on the initial questionnaire (see appendix 19), resulting in the final 
copy which met the approval o f  the expert panel and was used for the survey (see appendix 18).
Other tests for validation in quantitative research exist- Forms o f  validity testing such as 
criterion and convergent validity (Trochim. 2006) were not carried out. This was because due to 
the attitudinal nature o f  many o f  the variables to be measured, fulfilling the requisite parameters 
for their measurement would not have been possible.
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5.2.2.3 T riangu lation  (m ethod)
In the methodology chapter (chapter 3). the mixing o f research methodologies was 
introduced. There also, it was revealed that a major advantage o f  employing mixed methods was 
that triangulation enhanced the validity o f  the study. In chapter 4 I introduced the two methods 
o f  triangulation employed in this study. Here I further discuss triangulation that results from 
using two methods within the same study. In this case, the grounded theory approach 
(qualitative) used in the last project and the cross sectional survey (quantitative) used in this 
project.
In the qualitative phase, the grounded theory approach and the context in which it was 
used in this study, is situated firmly within qualitative paradigm o f  scientific research. Some o f 
the m ajor criticisms o f  this approach have included lack o f  numbers, structure and the 
subjectivity within data collection and analysis (Paley and Lilford. 2 0 1 1). Employing the cross 
sectional survey (a quantitative method), in this phase, introduces more objectivity and structure 
in the data management. It also means that a larger sample is used in answering the research 
questions. The 'm ixing *of these two methods within a study with a common goal suggests 
more comprehensive and robust exploration o f  the research questions. It also ensures that the 
inherent weaknesses associated with using either method alone, are compensated for (Gorman 
and Clayton. 2005). Additionally, although reliability is traditionally a better measure for 
consistency. Lincoln and Guba (2005) suggest that triangulating methods achieves a similar 
purpose within the bigger picture o f the entire study.
5 .2 .3  P ilo tin g
Following the validation o f  the questionnaire, a pilot o f  the survey was carried out in 
February 2011 on a convenience sample o f 20 non-medical prescribers. using suggested 
guidelines (Sudman and Bradburn, 1982; Czaja and Blair. 2005). A request far feedback 
relating to any difficulties in completing the questionnaire was also sent to the non-medical 
prescriber alongside the questionnaire. Piloting resulted in no major changes to the 
questionnaire and the data collected were included in the overall results.
5.2.4 Sam ple
The study participants were nurses, pharmacists and other healthcare professionals that 
had qualified as non-medical prescribers and were registered to prescribe in their various Trusts. 
The initial sampling strategy proposed, was to select a random sample o f  all nurses and 
pharmacists qualified and registered as non-medical prescribers in the United Kingdom from 
their respective registers held by The Nursing and Midwifery Council (NM C) and the General 
Pharmaceutical Council (GPhC) (Formerly the Royal Pharmaceutical Society o f  Great 
Britain). At the time that this phase o f  the study was being planned, both institutions declined to
i n
collaborate, perhaps due to ongoing changes with respect to data protection in their research 
collaboration policies and restructuring o f the RPSGB to form the GPhC. In the mean time, 
while designing the study, an alternative strategy had already been proposed and was being 
explored a l the same time as the above strategy. As part o f this, the non-medical prescribing 
lead for Yorkshire and the Humber was approached and a list o f all the non-medical prescribing 
leads in the constituent Trusts was obtained. Emails and reminders (see appendix 20) were sent 
to all 35 Trusts inviting the non-medical prescriber leads to assist in the study by forwarding the 
online survey to all non-medical prescribers registered in their respective Trusts.
O f all 35 Trusts invited, only ten non-medical prescribing leads agreed to forward the 
survey to their non-medical prescribers. For the rest, thirteen did not reply alter the reminders: 
seven resulted in mail delivery failure: two non-medical prescribing leads were in Trusts that 
were undergoing structural changes such as merging; one was on holiday, and two Trusts were 
still processing governance approval, at the time that the survey was carried out. The ten non- 
medical prescribing leads that agreed to assist in the study sent the online survey out to 545 non­
medical prescribers in total and sent an e-mail reminder to the same non-medical prescribers.
5 .2 .5  In c lu s io n  a n d  ex c lu s io n  c r ite r ia
The following criteria were employed in determining the sample to which the online 
questionnaire was sent;
Inclusion criteria:
•  Q ualified as a  health  care  p rac titione r (fo r instance nurses, pharm acists and 
physio therap ists)
• Practising within the Yorkshire and Humber region
•  Have registered with relevant bodies as a non-medical prescriber.
Exclusion criteria:
•  Medical prescribers (doctors and dentists)
•  Student pharmacist and nurses
•  Prescribing students (not yet qualified)
•  Recently qualified prescribers without Trust and regulatory body registrations.
5 .2 .6  D a ta  co llec tio n
The survey commenced in March 2011 and the online questionnaire was sent to the non­
medical prescribing leads for forwarding to their respective non-medical prescribers. After two 
weeks, reminders were sent to the non-medical prescribing leads for forwarding. Since the 
emails were untracked, the reminders were sent to all 545 non-medical prescribers, thanking 
those that had already completed the questionnaire and urging those who had not to participate
in the  survey. A further three w eeks was allow ed for com pletion, before the survey w as c losed. 
T he total d a ta  collection period lasted 10 weeks, this was due to the fact that tw o  non-m edical 
p rescrib ing  leads becam e available for the survey later than others and one non-m edical 
prescribing lead was on  holiday at the tim e the rem inder was m eant to  g o  out. T h e  data 
collection stage o f  the survey w as concluded in May 2 0 1 1
T he online survey tool that w as used to distribute th is questionnaire was Kwik survey. O ther 
online survey tools such a s  Bristol Surveys and Survey M onkey were considered, how ever 
K w ik survey w as chosen because it w asco st efficient and had certain o ther unique features. O ne 
o f  such features w as question  and  page skipping w hich m eant that participants w ere 
autom atically  directed to  appropriate questions, based on their previous answers, rather than 
being signposted. A lthough Kwik survey offered a free service, the paid option w as chosen to  
elim inate adverts w hich w ere  considered distracting  during the validation, as well as to access 
enhanced support during  the study.
5.2 .7  D a ta  an a ly s is
T h e  data that were collected were imported into SPSS (version 17) from the Kwik survey 
account. The data w ere prepared for analysis by ensuring that all the variables were defined and 
converted to the  nom inal form. U nivariate analysis was carried out on  the collected data to yield 
descrip tive statistics. A ssociations betw een variables were tested for using cross tabulations, all 
results were subjected to statistical tests such as C hi-square lests and f ish e r 's  exact tests. The 
choice  o f  the relevant tests applied depended on the analysis being  carried out. For instance. 
F isher’s exact test w as used  w henever one o r m ore o f  the num bers in th e  contingency table 
b e in g  considered were very sm all (any num ber less than about six). A stepw ise m ultivariate 
logistic regression analysis w as a lso  carried out to  investigate the relationship betw een relevant 
variables and prescrib ing  for chronic pain. T his was done both individually and in adjustm ent 
w ith other relevant variables. Before the analysis com m enced it was decided that a p  value o f
0.05 or less represented the threshold for statistical significance. Finally, m issing data were 
com piled  for each item. M issingness analysis w as then carried out by cross referencing with 
relevant variables to  identify any possible trends.
5.3  R esu lts
T he results in this section are presented to fit w ith the categories developed in chapter 4 . rather 
than in the chronological progression thal exists on the questionnaire. This has been done for 
tw o reasons. First, the objective o f  th is phase  o f  the study was to test aspects o f  the developing 
theory. Presenting and d iscussing  the results in line w ith the findings from chapter 4 ensures 
that the focus is on the theory . Secondly, th is m anner o f  presentation enhanced the readability 
and im proves the flow o f  the entire thesis.
173
174
D em ographics
The response rate in the survey carried out was 180/545 (33%). In table 2, the participants' 
demographics and information related to their prescribing status are summarised. More than 
three quarters o f  the survey respondents were nurse prescribers (141) and women (136). 109 of 
the respondents had qualified as non-medica! prescribers over two years ago and there seemed 
to be a trend in the qualification o f  non medical prescribers indicating a slight rise in the uptake 
four years ago and then a decline since then. 150/180 o f  the survey participants had practiced 
prescribing since they qualified. O f the 150 non-medical prescribers who were prescribing, 67 
reported that they were prescribing for chronic pain (45%). It was not possible to compare the 
characteristics o f  the responders to that o f  the participants that did not respond to the survey. 
This was hecause data protection guidelines prevented non-medical prescribing leads from 
providing this information.
Table 2: Respondent dem ographic* and  prescrib ing  sta tus
D em ographic
Prim ary Profession N  (%)
Nurse 141 (79°*)
Pliarmacist 27 (15%)
Other I I ( 6%)
•$** N (%)
Female 136(89%)
Male 17(11%)
D uration o f  prescribing qualification N (% )
Less than 1 year 19(13%)
1 year to 2 years 24(16%)
25 months to 4 years 63(41% )
More than 4 years 46 (30%)
Prescrib ing  status N (%)
Prescribed since qualified 150 (97%)
Not prescribed since qualified 5(3% )
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Experience in chronic pain prescribing N {%)
Prescribed for chronic pain 67(45%)
Did not prescribe for chronic pain 81 (55%)
* N =180 (some respondents did not complete all sections)
5 .3 .2  N a tu re  o f  Ih e  p re sc r ib in g  e n v iro n m e n t
Table 3 shows the level o f importance non-medical prescribers attributed to what they 
considered an environment safe enough for their prescribing- Fhe majority o f the non-medical 
prescribers who had prescribed felt that mutual respect with their colleagues (113/150) and 
being able to count on their colleagues for knowledge ( 114/150) relevant to their prescribing 
was important or very important to their perception o f  a  safe and supportive environment. On 
the other hand. 11/150 (7.4% ) reported that being in an environment where they would be 
respected more than their colleagues who do not prescribe was important or very important to 
them.
Ninety-nine out o f  a hundred and fifty o f these prescribers (66%) identified working in a 'no 
blame culture* as important or very important to the consideration o f  how safe their prescribing 
environment was and 69/150 (46%) felt that being told o ff  for mistakes was unsafe for their 
prescribing.
T able  3: C om ponents o f a ‘safe env ironm en t’ with respect to p rescrib ing
Response, n (%)
Statement Very
Important.
Important. Neutral ifn
important
Very
unimportant
Missing
Mutual respect witli 
colleagues
59 (39.3) 54 (36.0) 6 (4.0) 1(0.7) 0 (0.0) 30 (20.0)
Support from colleagues 63 (42.0) 51 (34.0) 4 (2.7) 0 (0.0) 0 (0.0) 32 (21.3)
Working in no blame culture 59 (39.3) 40 (26.7) 15 ( io:o) 5(3.3) 0 (0.0) 31 (20.7)
Not being told.-off for 
mistakes
30 (20,0) 39 (26.0) 34 (22.7) 12(8.0) 2(1.3) 33 (22.0)
Respected more than others 
who don't prescribe
1 (0.7) 10(6.7) 41 (27.3) 40 (26.7) 26(17.3) 32 (21.3)
In exp loring  w hich Factors non-m edical prescribers regarded as facilitators to prescribing for 
chronic pain, nine statem ents relating  to the nature o f  the prescribing env ironm ent, knowledge, 
experience, access to  health inform ation technology, rem uneration and status w ere put to the 
respondents. The results presented in the figure below  are the responses m ade by non-m edical 
prescrihers regarding various factors which they regarded as facilitators to prescribing for 
chronic pain.
F ig u re  6: F a c ilita tu rs  to p re sc r ib in g  fo r  c h ro n ic  pa in
176
I raining, access to know ledge sources and relevant netw orks were m ore relevant as facilitators 
to  prescribing for chronic pain com pared to factors such as rem uneration for and being 
respected as a  result o f  qualifying as prescribers. Furtherm ore ju st 9/81(11% ) o f  non-m edical 
prescribers w ho had not y e t prescribed for chronic pain agreed that only chronic pain specialists 
should prescribe for patients with chronic pain. T his suggests that non-m edical prescribers 
considered o ther factors in addition to know ledge and experience when they considered w hether 
to  practise in th is area.
O f  the facilitators to prescribing for chronic pain shown in figure 6  the opinions o f  
p rescribers for chronic pain w ere  com pared to  the opinions o f  prescribers who had an interest, 
but had not started prescrib ing for chronic pain. It w as found that ‘prescribing in an 
environm ent w here they could  trust their colleagues’ distinguished these two groups.
Prescribers for chronic pain (51%) were more likely to attribute ‘trusting colleagues' as a 
facilitator for their prescribing, compared to their colleagues who had no experience in chronic 
pain prescribing (10% ). This result was statistically significant (Chi-Square lest. p<0.05) (see 
table 4).
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T a b le  4: T ru s t  as it fa c ili ta to r  tn p re sc r ib in g  fo r  c h ro n ic  pain
‘Trusting Colleagues' As A Facilitator For Prescribing n*(%)
Respondents with experience in prescribing for chronic pain 34 67 (51%)
Respondents without experience in prescribing for chronic pain 5/51 (10%)
Chi-Square test 0.000
n * - some respondents may not have completed relevant item(s)
After cross tabulation, the individual Chi-Square test indicated that live oiher variables were 
statistically significant, hui because these were nine variables thal were being subjected lo the 
same tests, further analysis in the form o f Bonferroni's correction had to be applied. After the 
correction, only three variables remained statistically significant.
For ‘access to CPD specific to chronic pain '. 49/67 (73%) o f  the prescribers for chronic pain 
saw this as a facilitator, compared to  23/51 (45%) o f  those not currently prescribing for chronic 
pain (Chi-Square test, p <0.05). W hereas 27/67 (40% ) o f those prescribing for chronic pain saw 
‘better access to patients medical records’ as a facilitator to their practice, compared to 
7 /5 1(14% ) o f  those not currently prescribing for chronic pain (Chi-Square test, p  <0.05). "An 
environment where colleagues could be trusted’, also remained significant after Bonferroni's 
correction.
5 .3 .3  A c q u ir in g  k n o w le d g e
In the investigation o f  factors that made non-medical prescribers feel safe and supported, all 
those that prescribed for chronic pain fell that being able to rely on their colleagues who were 
perceived as knowledgeable, for support in their prescribing was important. I lowever. on further 
exploration o f  the support that they perceived that they had in their prescribing. 29/56 (52%) 
agreed that they actually relied on these colleagues for support.
CPD is a major part o f  how non-medical prescribers acquired knowledge for their prescribing. 
Table 5 presents the level o f  agreement thal non-medical prescribers had regarding various 
aspects o f  iheir CPD.
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T ab ic  5; I-c\ cl o f  iigrrcnK 'ni lo  s ta te m e n t re la tin g  hi C I’D needs in  p rescrib ing
Response, n (%)
Statement Strongly
agree
Agree Neutral Disagree Strongly
disagree
Missing
Can attend CPD in work time 20(13,3) 43 (28.7) 22(14.7) 23(15.3) 11 (7 3 ) 31 (20.7)
Feel they should be allowed 
work time for CPD
58(38 .7 ) 52 (34.7) 5 (3.3) 1 (0-7) 1 (0.7) 3 3 (2 2 )
Prefer to do CPD  in own 
tim e
5  (3.3) 20(1 3 .3 ) 40  (26.7) 47 (31.3) 4 (2.7) 34 (22.7)
Do not think CPD  is 
necessar)
0 (0,0) 0 (0.0) 3 (2.0) 21 (14.0) 92(61.3) 34 (22.7)
Further analysis revealed that while 6/9 (67% ) o f  pharm acist prescribers w ere pharm acists who 
w ere not allow ed to  access C PD  during paid w ork time, 16/80 nurse prescribers reported that 
this applied to  them (20% ) (See figure 7). However, a  significant num ber o f  both nurse (95% ) 
and pharm acist prescribers (100% ) agreed that they should be allow ed paid w ork tim e for CPD  
(see figure 8);
F ig u re  7; A ccess to  C P I)  d u r in g  pa id  w o rk  tim e
■NurMpmctfew 
■  Riorrracbt prwcrtwr
Are actually allowed soma work lima for CPD
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H ow ever, w ith  respect to  m ak in g  tim e  fo r C P D , n u rses  and  p harm acis ts  w ere  very  s im ila r in 
th e ir  v iew s w ith  respect to  d o in g  C P D  in th e ir ow n tim e. S im ila r p roportions o f  n u rses  and 
pharm acis ts  d isag reed  that they  p referred  co m p le tin g  C P D  in th e ir ow n tim e  (44% ). w hereas, 
16/78 (2 1 % ) nu rse  p rescribers  an d  3 /9  (3 3 % ) pharm acist p rescribers  reported  that they preferred  
to  d o  C P D  in th e ir ow n lim e (see  figure 9 )
Figure 9: Preference regard ing  e a r n  ing out ( PI) in own time
■ Mm pratcrtxr 
B Rtvtmcal preserver
Strongly Agres Miutral Omotm Strongly AaorM
Prefer to do CPO In own time
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feel that they should be allowed soma work time for C PO
The various ways through which the non-medical prescribers carried out their CPD were also 
surveyed and the results are presented in figure 10. Attending in house sessions organised in 
their establishments and reading the journals that they found relevant to their prescribing in pain 
were the most common forms o f  CPD that non-medical prescribers engaged in.
Further analysis considered how non-medical prescribers carried out their CPD. the results 
showed that there were some differences in how nurse and pharmacist prescribers gained 
knowledge through CPD. Seventy percent o f  nurse prescribers compared lo 33% o f  pharmacist 
prescribers carried out their CPD by attending in house sessions, whereas 44%  o f nurse 
prescribers compared to 50%  o f  pharmacist prescribers carried out their CPD by accessing 
websiies that specialised on chronic pain. These differences were however not statistically 
significant < Fisher's exacl test >0.05).
Figure 10: F o rm s of CPD  ca rried  ou t In non-m edical p m c r ib c r t .
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body
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Forms of CPD engaged in
O ther items relating to  how non-medical prescribers gained knowledge used in their 
prescribing for chronic pain included the guidelines they used as resources for their prescribing; 
All non-medical prescribers who prescribed for chronic pain reported using some form o f  
guidance. Specifically, all reported using the BNF for their prescribing for chronic pain, more 
than three-quarters used NICE guidelines (84%) and two thirds used formularies or guidelines 
produced by their establishment (66%),
5.3 .3  G a in in g  ex p erien ce
Forts-tw o  out o f  sixty-seven (63% ) o f  non-m edical prescribe rs reported thal they had 
access to  netw orks o f  prescribers for chronic pain. 34/68 o f  non-m edical prescribers that 
prescribed for chronic pain (50% ) felt they could  they could  learn from others w ith relevant 
experience who they could access through their netw orks. How ever, not all o f  these prescribers 
had access to such networks.
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T a b le  6 : L ev e l o f  a g re e m e n t  to  s ta te m e n t  r e g a r d in g  g a in in g  e x p e r ie n c e
Statement Strongly 
agree n 
(%)
Agree n 
(%)
Neutral n 
(%)
Disagree
n(% )
Strongly 
disagree n 
(%)
Missing n 
(%)
Feel they can learn from 
others' experience through 
networks
4(4 .5) 30
(44.8)
11 (16.4) 10
(14.9)
1 12(17.9)
Can access networks o f  other 
prescribes for chronic pain
13(19.4) 29
(43.3)
12(17.9) 2 (3 ) 0 (0 ) II (16.4)
N on-m edical prescribers w ho were not prescribing for chronic pain were surveyed to 
identify factors that they perceived as barriers. T he results showed that lack o f  experience in 
various aspects o f  their prescribing was seen as lim iting factors to  their prescribing for chronic 
pain.:
A m ong non-m edical prescribers w ho had an interest, but had not started prescribing for 
chronic pain a  third (33% ) indicated that lack o f  experience with patients with chronic pain and 
a  quarter (28% ) indicated that lack o f  experience with the m edication used for chronic pain, 
w ere am ong the  reasons they had no t prescribed in th is area.
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1'ljiui‘v 1 1: Luck f»t re le v a n t e x p e rien ce  a s  si h a r r i e r  lu p re sc r ib in g  fo r  c h ro n ic  pa in
In this same group, a comparison o f  pharmacist prescribers and nurse prescribers revealed 
a difference in the way they perceived these limited their prescribing. The proportion o f  nurse 
prescribers that indicated lack o f  experience with chronic pain patients as a barrier to their 
practice in the area o f chronic pain (39% ) was similar to the proportion lhat indicated that lack 
o f  experience with chronic pain drugs as a  barrier to their practice in chronic pain (36%). 
However for pharmacist prescribers. while 21% indicated thai a lack o f  experience with chronic 
pain patients was a limitation to their practice in chronic pain, a considerably smaller proportion 
(7% ) indicated that inadequate experience with chronic pain drugs was a limitation for them 
(see figure 11).
Further analysis revealed lhai ihe differences between nurse prescribers and pharmacist 
prescribers seen in the perception that inadequate experience with chronic pain drugs was a 
barrier, was statistically significant according to Fisher’s exact test (p<0.05), T he differences 
seen in ihe perception that inadequate experience with chronic pain patients limited iheir 
practice in chronic pain was not statistically significant, according to the Fisher's exact test 
applied (p>0.05).
5 .3 .4  H e a lth  in fo rm a tio n  technology
The survey also included the views lhat nurse and pharmacist prescribers had with respect to 
how essential they felt various aspects o f  health information technology were to their
prescribing. Table 7 presents u sum m ary o f  their prescribing needs and the levels o f  importance 
attributed to  various aspects o f  health inform ation technology.
T a b le  7t Level o f  im p o rta n ce  a t t r ib u te d  to  aspects o f  h ea lth  in fo rm a tio n  technology
Statement Very 
Important, 
n (%)
Important.
n{%)
Neutral n 
(%)
Un 
Important 
n (%)
Very
unimportant
n (%)
Missing
n(% )
Access lo prescribing software 14(9.3) 22(14.7) 28 (18.7) 42 (28.0) 12(8.0) 32 (21.3)
Authority to perform further 
tests
23(15.3) 52 (34.7) 31(20.7) 8 (5.3) 3 (2.0) 33 (22.0)
Full access to patients’ records 00(60.0) 24(16.0) 5(3.3) 0 (0.0) 1 (0.7) 30 (20.0)
In relation to  health inform ation technology needs, analysis show ed a difference in the 
attitudes o f  nurses and pharm acists with experience o f  prescribing for chronic pain com pared to 
those o f  non-m edical prescribers w ho had no experience in chronic pain prescribing.
R egarding access to prescribing softw are, 18/67 (26.9% ) non-m edical prescribers with 
chronic pain experience reported that this was a facilitator to  their prescribing, com pared to  7/51 
( I.>.7%) o f  (hose who did not have the  experience, but w ere interested in prescribing for chronic 
pain. This d ifference w as how ever not statistically significant (C hi-Square test. p>0.05) (see 
table  8). O n  the other hand 27 /67 (40.3% ) prescribers w ith chronic pain experience reported 
access to  patient records as facilitators to  their practice, com pared to  7/51 (13.7% ) o f  those who 
w ere interested in prescrib ing  for chronic pain, but had no experience. In this case, the 
d ifference in attitudes to access to  patien ts ' records as a  facilitator to  prescribing for chronic 
pain w as statistically  significant (C hi-Square test, p<0.05) (see table 9).
f a b le  8: A ccess to  p re sc r ib in g  so ftw a re  ms fa c ilita to r  fo r p re sc rib in g  fo r  c h ro n ic  pain
A ccess to  p ro scrib in g  so ftw are  as fac ilita to r fo r p rescrib in g  fo r ch ron ic  p a in n*(% )
Respondents with experience in prescribing for chronic pain 18/67 (26.9%)
Respondents w ithout experience in prescribing for chronic pain 7/51 (13.7%)
Chi-Square test 0.084
n •  - some respondents may not have completed relevant item(s)
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T a b le  9 : A c ce ss to  patients* re co rd s  as fa c ili ta to r  lo r  p re sc r ib in g  fo r ch ro n ic  pa in
Access to  pa tien ts  reco rd s as fac ilita to r fo r  p re scrib in g  fo r  ch ron ic  pain n*(% )
Respondents with experience in prescribing for chronic pain 27/67 (403% )
Respondents without experience in prescribing for chronic pain 7/51 (13-7%)
Chi-Square test Q.O02
n * - some respondents may not have completed relevant item(s)
5.3 .5  L o g istic  reg ression
Further analysis carried out on the  data collected attem pted to  explore the developm ent o f  
a  tentative m odel. In line w ith this, logistic regression was undertaken using all relevant 
variables to  determ ine their relationship w ith tak ing  up prescribing for chronic pain after 
qualification. The variables w ere  first regressed individually whereby the significance o f  each 
item  w as considered on ils own (considering the variables ‘not in equation’). Since the 
questionnaire design meant that item s w ere  presented in sections where they w ere grouped with 
other related item s, they then had to  be regressed ‘in the equation’ with these related item s to 
com pensate for the e lfects o f  these relationships.
T hese tw o  steps w ere carried ou t for each relevant item and this yielded three significant 
variables -  ‘p revious professional background*, ‘authorisation to prescribe controlled d rugs' and 
‘w orking in an  environm ent where colleagues can be trusted’. T o  further ensure that their 
significance was not due to  any  relationship arising  from being presented together, they were 
then regressed in equation w ith each other. T he result w as that only ‘working in an  environm ent 
w here colleagues can  be trusted’ rem ained significant. (See tab le  10)
T a b le  II): L ogistic  reg ress io n  show ing  s ign ifican t v a riab le s  (in  the  eq u atio n )
V ariab le S ignificance 
p  values
Previous professional background 0.88
Authorisation to prescribe controlled drugs 0.22
Working in an environment where colleagues can be trusted 0.00
5 .3 .6  M issingness
In quantitative data collection and analysis, w henever the  value o f  any o f  the  variables is 
m issing o r incom plete, m issingness, o r  m issing data is said to  occur wiihin that data 
m anagem ent scenario (M adow e t al.. 1983). O f  the various types o f  m issingness that occur in 
quantitative research, two types apply to  this work. First is the planned m issingess as a result o f  
the questionnaire design (M itofsk>. 2000) and the second, m issing  com pletely at random (Little 
and R ubin. 1987). The first, planned m issingness refers m issing data due to  data collection 
design, whereby various versions o f  the sam e questionnaires are presented to the respondents 
(M itofskv. 2000). In this questionnaire, som e item s w ere com m on lo all respondents (for 
instance, item s I. 22 and 23) and were used to collect inform ation relevant lo all respondents 
w hereas the  o ther item s were structured to collect daia com m on to su bsets o f  respondents. The 
d iagram  (flow chart) presenting a breakdow n o f  the progressive categorisation  that gave rise to 
the various subsets o f  respondents in the survey, is available in appendix 21.
A fter accounting  for the planned m issingnes during  the data analysis, som e data remained 
m issing. Here, a  m issingness analysis had to be conducted to  identify the specific type o f 
m issingness that occurred and determ ine the im plications o f  th is  to the analysis o f  the survey 
phase. F irstly , the m issing cases for each relevant questionnaire item were extracted from the 
data set. Follow ing this, baseline distributions and attitudes o f  the m issing cases w ere compared 
to  those  o f  the respondent to the relevant items. T he result was that no significant differences 
w ere  revealed  and this led to the conclusion ihat the second type o f  m issingness was 
m issingness com pletely at random . As such, although som e o f  the  above results have been 
presented w ith the m issing cases, primarily to  reflect transparency in result presentation, in 
o ther cases w here including a m issing section may com plicate the presentation, case analysis 
has been em ployed.
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1 he theory 'safety and support within the prescribing environment" emerged in the last 
chapter to explain how nurses and pharmacists perceived prescribing for chronic pain and to 
identify factors considered barriers and facilitators to their practice. This began to answer the 
following research questions aimed at addressing the knowledge gap revealed in the literature 
review:
1. What are the views and experiences o f  non-medical prescribers (nurses and 
pharmacists) in the treatment and management o f chronic pain?
2. In the treatment and management o f  chronic pain, what are the barriers and 
facilitators influencing the implementation o f  non-medical prescribing?
The findings o f  this project build on the emerging theory by testing nurses' and 
pharmacists* level o f agreement to aspects o f  the theory. Furthermore, the survey in this project 
measured the level o f  importance nurses and pharmacists attributed to factors perceived as 
hindering or facilitating their practice.
The findings from the quantitative survey, although independent are discussed in line with 
the theory emerging from the grounded theory exploration in chapter 4 to clearly indicate how 
the attitudes in the survey related to the original themes that emerged in the grounded theory 
exploration.
In the last chapter, the discussion o f  the thesis integrates the findings o f  this chapter with 
those o f  the two that qualitatively explored non-medical prescribers* and patients" vlews and 
experiences (chapter -4 and chapter 6). This survey 's findings also contribute to  the theoretical 
model presented in that chapter.
5.4.1 D em ographics
Nurses, pharmacists and other professionals who were registered to prescribe were invited 
to participate in the survey. These other professionals (such as physiotherapists) were included 
initially to limit the access o f  the research team to personal data o f  the participants, while 
facilitating the dissemination o f the questionnaire. Since nurses and pharmacists have had 
prescribing rights for longer, only 6%  o f the non medical prescribes surveyed were not within 
these professions. As prescribers who were neither nurses nor pharmacists were not of interest 
to this study, no relevant questions were put to this group. In essence once they indicated that 
they were not nurses or pharmacists, ihey w ere guided to the end o f  the questionnaire.
5.4 Discussion
Only about 10% o f  the respondents to this survey were male, hut this does not mirror the 
data collected in the qualitative phase. In that phase almost half o f  the sample interviewed was 
male. However, the sampling in the qualitative phase was done purposively/theoretically and 
the aim was not to  present a representative picture. While the sampling in this phase was not 
random, it was more representative than the sampling in the qualitative phase. Similarly, in 
considering the prescribing experience o f  the survey respondents, this phase also portrays a 
more representative picture o f  the non-medical prescribers than that o f  the qualitative phase. 
I he trend in the survey suggests thal there was an increase in the number o f  nurses and 
pharmacists qualifying as non-mcdical prescribers between 2005 and 2007. The uptake o f  non­
medical prescribing for this region seems to  have declined since 2007.
Nearly all the respondents reported having prescribed since they qualified. Although this 
is sim ilar to the percentage o f  participants who also had started prescribing prior to being 
interviewed in the qualitative phase, in that phase, those participants were recruited purposively 
to explore em erging themes. In the survey significant effort was made to capture all qualified 
non-mcdical prescribers, including those who had not commenced prescribing. The two 
regulatory bodies (The Nursing and Midwifery Council (NMC) and the General Pharmaceutical 
Council (GPhC) (Formerly the Royal Pharmaceutical Society o f  Great Britain) contacted for 
collaboration declined. The second strategy was to survey the non-medical prescribers through 
their non medical prescribing leads in this region. Although these leads are expected to maintain 
a comprehensive list o f  nurses and pharmacists qualified in their various Trusts, it is possible 
that some qualified non-medical prescribers who have not started prescribing may not have 
registered.
O f the non-medical prescribers that had started prescribing, 55% had not prescribed for 
chronic pain, but this did not seem to be solely as a  result o f  their lack o f  expertise in the area, 
as just 11% believed only experts in chronic pain should be allowed to prescribe in this area. 
45%  o f the surveyed prescribers reported that they had prescribed for chronic pain. This 
proportion is significantly less than the proportion o f interviewed non medical prescribers in the 
qualitative project. Again, in the qualitative project, many o f  the themes explored were more 
pertinent to prescribing for chronic pain and as such the purposive/theoretical sampling 
expectedly produced more prescribers with experience in chronic pain. In this survey, the 
percentage who reported having experience in chronic pain is a more realistic reflection o f  the 
proportion o f  non-medical prescribers who prescribe for chronic pain.
5.4.2 N atu re  o f  th e  p rescrib ing  env ironm ent
Many o f  the themes that emerged in the grounded theory exploration were confirmed 
by this quantitative project. In the qualitative project, it emerged thal non-medical prescribers 
considered a mutually beneficial relationships with their colleagues as important to their 
prescribing practice, even to the point o f  adopting various strategies to ensure that these
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relationships were developed and maintained. A majority o f  the non-medical prescribers in the 
survey seemed to agree with the concept o f  having an environment safe enough for their 
prescribing. In their responses, they acknowledged that mutual respect, trustworthiness and 
support, were some o f Ihe values important to their prescribing environment. They also agreed 
with some ol the barriers that emerged during the qualitative exploration. A significant 
proportion indicated that their idea o f an environment safe enough to prescribe would be one 
that did not loster a 'blam e culture, or where criticisms were harsh and unconstructive.
The qualitative project revealed that non-medical prescribers. while interacting with 
colleagues, used strategies such as 'overt skills demonstration' and ‘playing up specific 
strengths’. This survey clarified the motives behind these actions. For non-medical prescribers. 
maintaining a  sate enough environment to prescribe from was more important than achieving a 
higher status. In the same vein, although remuneration for prescribing emerged as a  motivator 
during the grounded theory project, this survey revealed lhat when compared to other factors, 
non-medical prescribers did not consider it as important.
Trustworthiness played a dominant theme in how non-medical prescribers considered 
safety and support for their prescribing. In the grounded theory exploration, relationship 
building, relying on others and their interaction with others all highlighted the importance of 
trust to the non-medical prescriber. It is interesting that the survey also produced a  similar 
result. To ensure independence o f  both phases, during the questionnaire design care was taken 
not to allow the dominant themes in the emerging theory influence survey respondents. As the 
emerging theory was not a concept already known to these prescribers, reflecting the dominance 
o f  the core category ‘safety and support within the prescribing environment' in the 
questionnaire would have introduced some bias in the way responses were made. Despite this, 
trustworthiness still emerged as the single most significant variable. In the survey, 'prescribing 
in an environment where colleagues are trusted' emerged as the sole explanatory variable for 
taking up prescribing for chronic pain, after qualifying. The use o f  these distinct methods for the 
investigation was included a priori, in the design to amongst other things, ensure quality (in 
term s o f  triangulation). The emergence o f  these identical outcomes from two independent 
phases increases the validity o f  the findings o f  the study.
5.4.3 A cqu iring  know ledge
Some of the main differences with respect to professional background emerged in the 
exploration o f  non-medical prescribers’ attitudes to acquiring knowledge. The survey showed 
that whereas almost all the nurse and pharmacists agreed that they should be able to access CPD 
during paid work time, in reality, two thirds o f  the pharmacists (67%), compared to a small 
proportion o f  the nurses (20%) were not allowed this access. It was also clear that this affected 
the methods o f CPD that they decided to engage in. While two thirds o f  the nurses reported 
doing in house courses (70%). only one third o f  the pharmacists reported this (33%). There were
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indications however, that despite the differences in how they accessed and carried out their 
CPD. prescribers Irom the two professions were sim ilar in some o f their preferences regarding 
making lime for CPD.
Apart from how nurses and pharmacists accessed and carried out their CPD, in other areas they 
were similar in how they acquired knowledge. During the qualitative phase, the three most 
common forms o f  CPD that emerged were attending courses, online CPD and reading relevant 
journals. I he survey however specified: in house courses: reading journals: and accessing pain 
specific websites, as the most common means through which non-medical prescribers carried 
out their CPD. The type o f  resources non-medical prescribers use in the chronic pain prescribing 
came up in the interviews but was not a  major theme in the qualitative phase. The survey 
however revealed that all prescribers with chronic pain experience prescribed with guidelines. 
While th e  British National Formulary (BNF) was the most commonly used resource for chronic 
pain prescribing. NICE guidelines and Organisation specific guidelines were also used.
The survey shed more light to how informal learning strategies contributed to the 
development and maintenance o f  safety in the prescribing environment. In the qualitative phase, 
we 'saw how the sub category ‘organising learning' revealed the importance that non-medical 
prescribers attached to being able to learn from their colleagues. In the survey, this particular 
mode o f  learning was clearly confirmed by the proportion o f uon-medical prescribers who 
agreed that relying on supportive (and knowledgeable) colleagues was important to their 
practice. The evidence however suggests that not all prescribers for chronic pain perceived their 
prescribing environment safe enough for this practice to take place.
5.4.4 G ain in g  experience
It could be argued that the emergence o f  'gaining experience’ as a category in the 
qualitative phase should not have been particularly surprising. For nurses and pharmacists, 
prescribing is relatively new compared to medical prescribers. In the survey, a significant 
proportion o f non-medical prescribers who had an interest, but had not started prescribing for 
chronic pain indicated that lack o f  experience contributed to why they did not prescribe in this 
area.
Jusi as we saw in ‘acquiring knowledge’, here as well, some differences with respect to 
professional background emerged in the exploration o f non-medical prescribers' attitudes to 
gaining experience. The perception that the pharmacist prescribcr w as advantaged by their prior 
professional experience with drugs which emerged in the qualitative project, was corroborated 
by the survey. Here, a smaller proportion o f  pharmacist prescribers indicated their lack o f 
medication experience as a barrier to their practice compared to nurse prescribers.
Another important theme that emerged from the qualitative phase was experience with 
patients with chronic pain. In the survey 21%  o f  the pharmacist prescribers and 39%  o f  the
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nurse prescribers who were interested in prescribing for chronic pain, reported this inexperience 
as a barrier. Interestingly, while similar proportions o f  nurses reported lack o f  experience with 
chronic pain medication (36% ) and with patients (39%) as a limitation to their prescribing, this 
was not so with the pharmacists. For the pharmacists, more felt limited by not having patient 
experience (21%). compared to those felt limited b \ inadequate medication experience (7%).
In the qualitative project, it also emerged that prescribers found learning from others' 
experience important to their prescribing practice. The percentage o f  non-medical prescribers in 
the survey who indicated interest in learning from other’s experience (50%) suggested that this 
may be an important finding. However. 37%  o f the same population were limited in the access 
they had to networks o f colleagues with the relevant experience, suggesting that despite the 
interest o f  the prescribers, limitations in access might be a  hindrance to those interested in 
learning through this means.
5.4.5 H ealth  in fo rm ation  technology
Despite limitations in access to electronic prescribing systems and patient records, non-medical 
prescribers in the qualitative phase all agreed that these facilitated their prescribing. Here also, a 
significant proportion o f  the non-medical prescribers surveyed indicated that access to 
electronic systems and patient records facilitated their practice.
Although in the grounded theory project it was unclear which o f  these two barriers were 
more important to  their practice, in the survey non-medical prescribers clearly indicated that 
lack o f access to patient records was more o f  a barrier to their practice than access to prescribing 
software. Interestingly, this access lo patient records seemed more important to prescribcrs with 
chronic pain experience than to their colleagues who had not vet started prescribing for chronic 
pain. Although it is not clear why this is, the related themes that emerged in the grounded theory 
project ('affecting patient care ' and ‘coping mechanism s') which centred on their patients, may 
give an indication as to why access to patient records was the more significant barrier.
5.5 C h a p te r  su m m ary
Non-medical prescribers were surveyed to determine their attitudes to themes that emerged in 
the grounded theory exploration in the first project. The chapter begins by describing the 
methods used in this project. Here, details o f  the questionnaire design, validation and piloting 
are given. Accounts o f  the sampling strategy employed as well as how the data were collected 
and analysed are provided. The results were presented and discussed in relation to the themes 
that emerged in the grounded theory exploration in chapter 4.
Non-medical prescribers agreed with the emerging theory regarding how (he perception of 
safety and support within their environment influenced altitudes to prescribing. The survey 
revealed trustworthiness in the prescribing environment as important in determining whether to
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prescribe for chronic pain. Although nurses and pharmacists were similar in their attitudes 
towards CPD. pharmacists were limited in their access to organised courses during paid work 
time. Non-medical prescribers also agreed that learning informally from colleagues supported 
their prescribing but were restricted by issues with trust and access. The survey also confirmed 
that in prescribing for chronic pain, pharmacists were limited by their lack o f  patient experience 
while nurses were limited by their lack o f  medication experience. For nurses and pharmacists 
prescribing for chronic pain having access to patients' records was more important to their 
practice than using prescribing software.
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C H A P T E R  6 
A G R O U N D E D  T H E O R Y  E X PL O R A T IO N  O F  PA TIEN T S’ V IE W S AND 
E X P E R IE N C E S  O F  PR E SC R IB IN G  BY N U R SES AND PH A R M A C ISTS FOR 
T H E IR  C H R O N IC  PAIN 
6.1 In troduc tion
Following a  literature review (chapter 2) it emerged that very few non-medical 
prescribing studies had considered the views and experiences o f chronic pain patients. 
I: urthermore. the work done in this area had mainly been presented from the perspective o f  the 
healthcare professionals indicating a neglect of the patient’s perspective. To address these gaps, 
one research question o f  this thesis focused on exploring how patients with chronic pain 
perceived the prescribing service provided by nurses and pharmacists.
A key message from the project that interviewed non-medical prescribers (chapter 4) was 
that developing and maintaining a relationship with their chronic pain patients was important to 
how they prescribed in this area. This finding further confirmed the need for a project to explore 
(he views and experiences o f chronic pain patients. Firstly, this project would ensure that the 
chronic pain patient's voice was reflected in the study and would represent a more complete 
story compared to presenting only the prescribers' perspective. Secondly, it would determine 
where (he views and experiences o f  patients wilh chronic pain agreed with, or mismatched those 
o f  their prescribers.
Although this phase was carried out independently, this project is reported in relation to 
the earlier project with non-medical prescribers. In telling the patients' stories this wav. (he 
methods and findings o f  this project are better contextualised and concisely presented. Firstly, I 
present the methods used in this project o f  the study. Due to the fact that similar methods to the 
prescribers' project were used, to avoid repetition only areas with significant differences are 
explored in detail. In the next section I present the results from the grounded theory exploration 
o f  patients' views and experiences. I then conclude this chapter by discussing the results within 
the context o f  existing and relevant literature.
6.2 M ethods
This section presents the methods used to collect and analyse the data from patients with 
chronic pain. The sam e methods used in this project were used in the prescribers' project and 
were similarly underpinned by the constructivist grounded theory approach discussed in the
third chapter. As such, a brief overview is provided here but with more detail in areas where the 
steps and procedures differ significantly from the account provided in chapter 4.
6.2.1 E th ic s  a n d  g o v e rn an ce
Approvals for ethics and research governance for this project were sought for and given 
for the overall PhD study. As such, the details o f  the processes and approvals provided in the 
preservers' project apply to this project as well. Related issues such as provision o f relevant 
information to participants, assurance o f  confidentiality and anonymity and data encryption 
were also complied with in this project. Patients were sent the information sheets by email or by 
post, a few days before their scheduled interview and followed up to ensure that they had 
actually received, read and discuss them before the interviews (sec appendix 22). A copy o f  the 
consent form was also sent ahead to the patients (see appendix 23). The same level o f  care 
described in chapter 4 was also applied to  the protection o f  the data collected from patients at all 
stages o f  recording, transcription and analysis.
6 .2.2 S am p lin g
In this project us well, a similar sampling strategy to the one described in chapter 4 was 
employed. Two sampling methods were also used in this project, theoretical sampling and 
purposive sampling. For the same reasons as outlined earlier in chapter 4. the strategy employed 
involved purposive sampling to select the first three participants and generate the initial themes, 
then the subsequent employment o f  the theoretical sampling method to further develop the 
emerging themes.
6 .2 .2 .1 Selection  o f  p a tie n ts
During the recruitment o f  chronic pain some practical difficulties existed that were not 
encountered during the prescribers' project.
Firstly, in the design, the non-medical prescribers who had been recruited in the first 
project were expected to assist in recruiting patients that they had seen for chronic pain. This did 
not occur as planned. Allhough many o f  the prescribers were enthusiastic about assisting, due to 
other work commitments they made few referrals initially. Secondly, during the ethics review 
meeting, assurances w ere made that recruitment o f  patients would only be carried out through a 
healthcare professional responsible for their care. This approach through a gate-keeper was 
suggested to ensure that patients were not unduly pressured, or exposed to unethical practices 
but this affected recruitment. For instance, follow ing a meeting with the coordinator o f  a pain 
patients group, she expressed enthusiasm in assisting with recruitment. This line o f  recruitment 
was not followed up because this coordinator was not a healthcare professional and did not meet 
the predetermined guideline.
194
195
Following constant canvassing, healthcare professionals (including one non-medical 
prescriber that had been interviewed) provided contact details o f  patients who after reading the 
information leaflet, indicated that they could be approached to discuss participating in the study. 
Eventually three recruitment sites were used to select participants, a pain clinic in West 
Yorkshire, a surgery in West Yorkshire and a surgery in East Yorkshire. Patients who had seen 
a non- medical prescriber for chronic pain, were approached by either their prescriber or their 
practice manager and asked if  they were interested in participating in the study. All those who 
had given their consent to be approached by the research team were then included in the 
sampling frame from where they were selected during this phase o f  the project. Below are the 
criteria employed in the selection o f  the research participants.
6  2.2.1 1 Inclusion critena for patients
1. Had suffered from moderate or severe pain in the past month
2. Had suffered chronic pain for more than six months
3. Was above 18 years
4. Resided in Yorkshire and the Humber region o f  the United Kingdom
6.2.2.1.2 Exclusion criteria for patients
1. Suffering from life shortening conditions
2. Suffering from a terminal illness
3. Cannot communicate in English
Although this was not embedded in the design, only about a  third o f  the patients that were 
recruited had seen a non-medical prcscriber who had previously participated in the study. The 
findings from this group were compared to the findings from patients that were recruited 
through other healthcare professionals with no connection to the study and there were no 
significant differences.
6.2.3 D ata collection
The data collection and analysis during this project were carried out iteratively at the 
same time, as was done during the prescribers* project. Here also, a topic guide was developed 
to guide the interviews (see appendix 24) used to collect the data from patients. Although all the 
chronic pain patients were given a choice regarding what time and place they preferred to have 
their interviews conducted, all except one were interviewed in their homes. The one who was 
not interviewed at her home already had a meeting scheduled at her surgery as such her 
interview was carried out at the surgery . All the patients* interviews were conducted by me and 
a PhD supervisor observed the initial interview for the same reason she anended the first 
prescriber interview. During the interviews for this project, pre and post interview chats were
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used to pul I he patients at ease. All the interviews here were also taped with two digital 
recorders and recordings downloaded to the university allocated computer alter each interview 
following which the memory was then deleted.
For the patients, themes in the core category ‘relating with non-medical p rescribes” started 
reoccurring from the 8"' interview and it was decided that saturation had been reached by the 
12"' interview. Unlike the prescriber’s project, here I did not need to carr> out any further 
interviews to confirm that the core category was saturated. On reflection I realised that was 
more conversant with the concept o f saturation due to experience achieved at this stage.
6.2.4 D ata analysis and  ensu ring  quality'
Coding started immediately after the data collection commenced and three levels o f 
coding were also carried out here a s  well. Coding here was done using a combination o f  data 
processing (with NVivo software) and manual coding. Memos and other tools such as 
diagramming and sorting were used to formulate, modify and revise the emerging categories. 
Throughout the data collection and analysis similar measures to  those employed in the 
prescribers' project were used here. Here as well tools such as the field journal and lield notes 
were used for reflection. During this project, meetings with supervisors were also used to 
review ihc ongoing data management processes. An audit trail was maintained by saving the 
recordings and transcripts o f  the I 'n iv es ity ’s *M' drive as well as maintaining documents such 
as field notes, meeting records, discussion notes and mind maps.
In chapters 4 and 5 triangulation o f  methods has been discussed. Another form of 
triangulation -  triangulation o f  data sources was achieved by collecting data from both 
prescribers and patients. In this study, data were collected from both prescribers and patients as 
a means o f verifying aspects o f  the theory relating to how prescribing for chronic pain was 
carried out and how this prescribing was perceived. For both the p rescribes’ and the patients' 
phases, all aspects o f  the study (from the development o f the interview guides up to the 
generation o f the grounded theory) were carried out independently. During the patients' 
interviews which commenced after the prescribes” project had been concluded, care was taken 
to  allow themes to emerge from the data collected from their interviews. The results o f  the 
patients' project were only presented in relation to the results from prescribes’ project, after 
data collection and analysis had been completed. As such, themes such as building relationships 
which emerged in both projects emerged independently.
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This section presents the results ol the grounded theory exploration o f patients with 
chronic pain regarding their views and experiences about how their condition was prescribed 
for. Details ol the patients that participated in this project o f  the study are presented in table 11 . 
I his is followed by the categories that emerged from the data collected and analysed from 
patients with chronic pain. A summary o f  the categories and their component sub categories 
which emerged from this project o f  the study is shown in figure 12. Also a  coding map detailing 
the emergence ol the categories from the first and second coding levels is available in appendix 
25.
In the first category. I explore how patients interacted with non-medical prescribers that 
prescribed for their chronic pain. I then go on. in the second category, to explore the feelings 
that patients had about the prescribing process and the medication that were prescribed for them. 
In the last category. I look at the other measures used in managing chronic pain, which emerged 
in this project and how the patients engaged with them. In presenting these results. I shall quote 
the patients, from transcripts o f  the recorded interviews, as well as refer to observations that I 
recorded in field journal. This is intended to provide contextual description and help illustrate 
important points.
6.3.1 D em ographics
The table below summarises the characteristics o f the patients that were interviewed in 
this project o f  the studs. A total o f 12 patients with chronic pain were selected from the 
sampling frame and their selection was based on certain characteristics regarded as important at 
the data collection/analysis stage that they were interviewed.
6.3 Results
T a b le  I I ;  C h a ra c te r is t ic s  o f  p a tie n ts
Participant
Number
Gender Age
Range
Location Educational
Background
Work experience
Patient 1 Female 80-90 West Yorkshire Secondary
Patient 2 Female 70-80 West Yorkshire Secondary Semi skilled- factory
Patient 3 Male 40-50 East Yorkshire Diploma Semi skilled/student
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Patient 4 Female 70-80 West Yorkshire Secondary Managerial- Food shop
Patient 5 Female 70-80 West Yorkshire Diploma Healthcare - Nursing
Patient 6 Female 60-70 East Yorkshire Secondary' Managerial
Patient 7 Female 60-70 East Yorkshire Secondary Carer
Patient 8 Female 30-40 West Yorkshire Secondary Skilled -  white collar
Patient 9 Male 50-60 West Yorkshire Secondary Self employed
Patient 10 Male 60-70 West Yorkshire Postgraduate Managerial -Healthcare
Patient 11 Female 70-80 East Yorkshire Secondary
Patient 12 Female 60-70 East Yorkshire Secondary Semi skilled -  catering
The patients interviewed were predominantly female with just three men participating in 
the study. They were all drawn from either West or East Yorkshire and most had a  secondary 
school qualification. They had a widely varied jo b  history with at least three having managerial 
experience and Iwo having worked in the healthcare sector.
Figure 12: D ini'ram  o f  coding -  chrom e pain pulicitls 
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Understanding
non-medical
prescribing
Valuing
Evaluating
service
Dealing with 
side effects 
Using power
Using other 
remedies 
Relying on 
other
relationships
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6 .3 .2  In te ra c t in g  w ith  n o n -m ed ica l p rc sc r ib e rs
In many cases, for a Irealthcare professional to have carried out a consultation and 
subsequently prescribed for a patient with chronic pain, some form o f  association, involving 
both parties would have usually taken place. While exploring the views and experiences o f non- 
medical prescribers. we saw ’relating with patients with chronic pain’ emerge as an important 
sub-category. In it we saw non-medical prescribers helieve that partnering with their patients 
resulted in a  mutually beneficial relationship where their prescribing was more efficient and the 
patient's pain perceived to be better managed. We also saw how miscommunication had the 
potential to lead to pain relief not being achieved for the patient.
In this category I further explore how patients interacted with the non-medical prescribers who 
prescribed for them and the ways that they engaged w ith them while trying to achieve relief for 
their chronic pain. In the first sub-category I probe the level o f understanding that patients had 
o f  the policy and practitioners. In the second sub-category I explore the perception that patients 
had o f  their non-medical prescriber and what they valued in the way they related with 
prescribers. In the third sub-category. I investigate patients' expectations with respect to how 
their pain was managed by nurses and pharmacists as well as how they evaluated the service 
provided.
6.3.2.1 Understanding non-medical prescribing
From the prescribers' phase o f  the study. I came away with the impression that patients 
automatically knew who a non-medical prescriber was and had a good understanding o f  their 
role. I had gotten this impression because during my interaction with the non-medical 
prescribers. I felt that a considerable amount o f  effort had been put into educating the patients 
about the policy.
“„.a.s a prescriber, /  always ensure that when I'm offering to prescribe far a service user, 
bui I hey are comfortable with . a nurse prescribing for I hem. they all used to doctors' 
prescribing. I  always ensure that they are confident and comfortable with me doing that. We 
also have published a little leaflet about non-medical prescribing. So I always have them at 
hand for service users if  they want" (Nurse in secondary care with 2 years prescribing 
experience).
This assumption that I made was an incorrect one and I found this out due to the mixed 
reactions that I had during my early interviews with patients. For some o f  the patients, a non- 
medical prescriber was a practitioner that treated patients using alternative medicine.
I would lliink it wus one o f  these health things, that... like the health shops and things 
like that, I  would have thought it was something like that, you know, not using the proper 
medical medicine, hut the health sort of thing, so that will he what I  would he thinking " (Patient
7 -  female patient with secondary education with unskilled work background, in her sixties).
For other patients, non-medical prescribing referred to the use o f  substances and drugs 
oilier than pharmaceuticals to achieve pain relief.
''...people using other medication, or drugs, or alcohol, or whatever, to alleviate their 
distress, emotional and psychological and physical pain" (Patient 10 -  male patient with 
postgraduate degree and managerial background and is in his sixties)
There were a few patients that had a significant understanding about what the policy was 
and how it related to the prescriber that was treating their chronic pain.
" . .. /  work., the totty /  normally work things out, is literarilv a prescribe/4 that is not medical, so 
therefore they have mu gotten medical qualification, that is the way /  will think o f it, so not the 
Doctor...,. /  wouldn’t think a nurse practitioner would fall under that, but /  would think someone 
like pharmacist would fall under that category, you know, yes" (Patient 8 - female patient with 
secondary education and a w hite collar job  in her thirties)
This particular patient was relatively more informed but this may have been as a result of 
working within a research environment. It seemed that her work experience may have 
influenced her more systematic approach in understanding this mode o f  prescribing. However, 
her approach gave an insight as to how patients ‘worked things ou t'. In her case and in many 
other interviews. I got the feeling that as well as being confused about the terminology, the 
"non’ in non-medical prescribing may have had negative connotations for patients.
For those that had an adequate understanding o f  what the non-medical prescribing policy 
was. who the non-medical prescriber was and how it was that they were able to prescribe for 
them. I probed further, as to how they had this understanding.
"...I was just. I was just curious, because al that point-... because /  knew the other nurses 
saw me, gave me flu jabs, look the blood tests, but they could not do anything and /  was. about 
my medication, but she could. So I. ., and I also learned that she was a partner In the practice 
and /  have never heard o f  this, so I  asked her how do you get to this position and she told 
me. "(Patient 10 - male patient with postgraduate degree and managerial background and is in 
his sixties)
This patient was also more educated than the other patients that I had seen and had carried 
out some research as part o f  his masters degree. It was clear that his understanding o f  non­
medical prescribing was adequate, but what struck me was that despite having being a
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prescribed fo r by a  non-m edical prescriber for a while, his aw areness was due to  the fact that he 
had m ade the  e ffo rt to kno\v m ore about it.
In m any o f  the interview s, I had to m ake considerable effort lo ensure that the patients 
understood the concept o f  nurses and pharm acists prescribing, even though they were already 
being  prescribed for by them. Overall. I got the impression that patients were largely confused 
about the term and the policy. I felt that that patients had been left to ‘w ork  things o u t' for 
them selves and in som e cases, they just received their pain re lie f from the healthcare 
professional they had been referred to  without understanding the  concept behind it.
T h is m irrored an opinion that had been m ade during the p re sc r ib e d  phase o f  the study 
w here it w as suggested that patients did not really care who prescribed for them , as long  as they 
got their prescriptions.
"when we .started. I did a leaflet on what the supplementary prescribing was and I think 
they thought it was a bit of a joke, because they thought that /  did that anyway, because quite 
of ten. /  would go away and sort out their prescription and to them, it did not really matter who 
wrote it.", (Pharm acist in secondary care with 3 years prescribing experience)
The im pression 1 got w as that though patients may have been perceived not to care ‘who 
w rote  i r  w hen they seem ed to  be  in desperate need o f  the service, il w as c lear that in the 
com fort o f  their hom es, as I took the tim e lo explain the policy, they w ere very interested and 
already had som e opinions about it. The notions that they had about non-m edical prescribing 
how ever w ere  not alw ays correct. For instance this patient had form ed her im pression o f  the 
scope o f  practice and  pow ers that non-m edical prescribers had. based on her observation o f  her 
prescriber.
"I do not think that they specialize. !  think il is the other way around, i f  I wanted 
something more specific, then /  would probably see the GP. I think they are good generally, so 
you know, day to day things really... /  don't think tJiey have been in the position where they have 
had to leave the room and gel a prescription from the Doctor., so on that basis, il seems that 
they cun prescribe for anything that they see you for really, yes.../ would think that they can see 
you fo r  pretty much many things, maybe not mental illness and that kind of thing, maybe there is 
a limit, but cm... I would say the generalized things, the day-to-day things, then yes, I think that 
they would be able lo see you fo r  that. "(Patient 8 -  fem ale patient with secondary education and 
a  w hite collar jo b  in her thirties)
File im pression she had o f  non-m edical prescribing w as not an accurate one. because non- 
m edical prescribers are only allow ed to prescribe in areas where they were com petent, 
suggesting  a  m ore specific, rather than a  general practice.
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6.3.2.2 Valuing
In the last sub-category we saw how patients with chronic pain may not have actually had 
a comprehensive understanding o f  the terminology, or the policy backing non-medical 
prescribing, as at the time they were being prescribed lor. by these professionals. Nevertheless, 
during the interviews it emerged that this lack o f  understanding did not seem to affect their 
ability to asses the value o f  their interaction with their prescribers and maximise the benefits 
that they felt could be derived from these relationships.
Many ol the patients, who reported having a relationship with the non-medical prescriber 
that dealt ssith their chronic pain, seemed to have developed these relationships over a period of 
time.
"...and he said. haw long have yon known me and I have known him a lot o f years, he had 
the chemist shop around the corner for a lot o f years, so I am comfortable. more comfortable 
with him " ( Patient 11 -  female patient with secondary education in her seventies)
For this group o f  patients, there were tangible benefits that they could identify, as having 
resulted from these relationships. One o f  these benefits was that the feeling that their prescriber 
had a  significant understanding o f  not only their pain, but also its effects on their lives.
", ..the empathy, the empathy and I think the understanding as well o f what you're actually 
going through. She does not treat you as if  you're going there for something minor, you know " 
(Patient 9  -  male patient with secondary education, was self employed and is in his fifties)
"I think that is an element, definitely, yes, you do not feel as rushed, at all. or whether it is 
because the... to be honest I don't know where the personal side o f it comes in, but they do seem 
10 be more empathetic towards you and yes, they don't seem to be rushing you out. really. “ 
(Patient 8 -  female patient with secondary education and a white collar job  in her thirties)
That these non-medical prescribers whom they had a relationship with could empathise 
with their health and its associated problems seemed especially importanl for patients with 
chronic pain. I felt that the chronic nature o f  their condition and the subjectivity involved in the 
diagnosis had a part to play. As such a relationship in which their account would be trusted and 
believed and their problems regarded seriously was important to  them.
In a  similar vein, it seemed important to patients with chronic pain that their non-medical 
prescribers have the time to listen to their complaints and deal with their problems.
find that she listens more. I  don't feel as rushed when I speuk to her, us I  would with 
the doctor, a GP. I feel that whenever /  speak to her about the problem o f mine, she actually 
listens to that problem and it's the same that /  found with all o f nurse practitioners. ... they have 
listened to what I  have got to say. they've remember things that I  have said in the pust as well.
so 1 do find it is more personal with the nurse practitioner" (Patient 8 -  female patient with 
secondary education and a white collar job  in her thirties)
I got the feeling that patients were wary about trusting that their prescriber would be 
patient enough to deal with their chronic pain over a long period o f time and at the same time 
keep an open mind and remain objective lor each subsequent visit.
For the patients that had identified these characteristics in the non-medical prescribers that 
saw them for their pain, they were prepared to display considerable loyalty regarding who they 
preferred to prescribe for them.
"...then she went off to another area and she's moved to yet another area and I have to 
travel la lhat other area and I don't think that the nurses here appreciate that, or the 
receptionist down here appreciate that very much, whal am I doing going down In see her there, 
hut she is my practitioner and it is just difficult lo do ilie coordinating" (Patient 10 - male 
patient with postgraduate degree and managerial background and is in his sixties)
"7 wouldn't see anyone else, hut her. because she has given me continuity oj treatment, 
because I have known her for maybe 5, 6 years. She knows my case history, I  have gol the 
continuity o f care with her and she's always well-versed on whal she is going lo suggest, even to 
Ihe point that i f  she didn't particularly know, she has always read up on it before hand...I have 
got 100% confidence in her abilities and I would only go to a doctor if I was being referred to 
maybe a consultant or a specialist doctor, but fo r  general purposes, mi. I would not". (Pa tien tl)
— male patient with secondary education, was se lf employed and is in his fifties)
The attachm ent that these individuals had to their prescribcr was particularly surprising, 
because I had always regarded this form o f  loyalty with doctors, as in the case o f  ‘personal 
physicians*, hi effect the relationship that they had developed with their respective non-medical 
prescribers meant that they regarded them as their ‘personal non-medical prescribers’.
Not all o f the patients that I interviewed regarded these traits as beneficial though. For 
some, ju st listening and being patient was not sufficient to stimulate a relationship building 
process.
“I  think ihe nurse has. I'm no! sure about that... she seems lo sit and listen, bul she doesn't 
seem to have much come back. So she goes oh..., I will gel... I'll see the doctor..., but the next 
time... but when she sees Doctor (name o f the doctor).... I  don't know whal ii is, because /  
never... you know whal I  mean, since I  went fo r  the Iasi injections, which I  think were in... about 
April or May. /  haven't heard anything from anybody" (Patient 4 -  female patient with 
secondary education and managerial work experience in her seventies)
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The above patient com plained that her chronic pain had not yet been resolved and did not 
display the  loyalty that the  other patients did. In fact she did not even rem em ber the nam e o f  the 
non-m edical prescriber and  did not seem satisfied or happy with the service that she had been 
getting. A s such I tell that for patients, the desire to  build relationships with non-m edical 
prescribers w as a lso  results oriented.
Not all o f  the relationships that patients felt they had with their prescribers had been 
developed by continuous interaction over a period o f  lim e. In som e cases, patients have 
identified non-m edical prescribers nurses and pharm acists that they perceived as being  skilful 
and actively built up  links to them .
" /  mean, the lady pharmacist that retired from  here, she was an the hall and when I first 
met her. we had a stand-up dehate in the chemist shop, because 1 was on two different pain 
controls, it was way back before things gat so had... and she said you cannot have both and  vi't> 
had quite a debate, I said, I can. because I take that when the pain is not too had and I  take that 
when the pain is awful. But then, the upshot was that she got my measure and I  got her measure 
and after that she was wonderful,"  (Patient 5 -  fem ale patient with diplom a qualification and 
healthcare background in her seventies)
T his patient how ever had a  healthcare background and as such had som e know ledge with 
which she could carry o u t a  quick  assessm ent o f  the  pharm acists skills before decid ing  to  link 
up with her. Apart from being proactive in initiating these relationships, there was evidence that 
patients som etim es had to be proactive in m aintaining them.
"...unless you're just pushy, you've got to insist that you want to get in, that doesn't 
always work, they Just say go to the... these new centres, the walk-in centre 1 am not too keen 
on, ju st walking into see a stranger, I you. you want to go where you I used to going, so... 
(Patient 12 • fem ale patient w ith secondary education and blue collar background, in her sixties)
Here the patient adm its to being a bit assertive in ensuring thal she continues to  see a 
prescriber that she a lready know s and  that know s her. rather than attending a  w alk in centre.
6.3.2.3 E valuating service
O ne o f  the m ore difficult skills to acquire while interview ing  patients is getting them  to  be 
critical about their non-m edical prescriber shortly a fte r they have been asked if  they wanted 
their surgeries notified that they were participating in a  study. It was helpful that I had acquired 
the relevant skills by going for courses and a lso  carrying out the prescribers' interviews before I 
go t to  th is stage. Taking tim e to chat with patients for a  while before the interview  com m enced 
also  helped to  put them  at ease and  assure them  thal their views w ere go ing to  be kept 
confidential. A s a  result. I discovered that patients were constantly evaluating the services that 
they go t from non-m edical prescribers. Though they may not have understood the policy as 
m entioned earlier on . many patients had strong opinions about who did what correctly and who
did not. These opinions that the patients had about how their service was delivered influenced 
who they fell comfortable relating with.
One interesting theme thui emerged in this category was how patients evaluated the skills 
level ol their prescribers with respect to knowledge and experience in chronic pain. Patients 
constantly wanted to be reassured that their prescribers had the relevant knowledge and 
experience, not just to deal with their pain, but also to answer any queries that they might have 
about their condition. Some o f the patients demonstrated that they were aware that non-medical 
prescribers had to have an extra qualification before they could prescribe.
" /  H'tf.v aware, cm., only by chance, I luid a previous nurse practitioner that I  used lo see 
that worked in a different medical centre, in fact, I think it's the same one and I remember her 
telling me that she was taking this course that would enable her to prescribe, because at the 
time she was getting doctors, you know, to sign the prescriptions, so /  did... I was w a re  that 
there was a course that she had to take. I didn't know what qualification it gave her, but I was 
aware that you have to take some sort o f course in order to be able to prescribe medication " 
(Patient 8 female patient with secondary education and a white collar job  in her thirties)
There was also evidence that patients were aware that some non-medical prescribers such 
as pharmacists would as a result o f  their professional background be more know ledgeable with 
medication.
"...when ! met him and 1 found out he was nearly as... well on the medication as a 
Doctor was. I think more so, maybe better... lie gets more into your medication and he asks you 
how you feel, i f  the medication is working well, so yes, I think he's quite good. yes... " (Patient 6
- female patient with secondary education and managerial work experience in her sixties)
But the most interesting aspect o f  how patients evaluated non-medical prescribers skills 
was that they were very comfortable relating with prescribers who were open enough to admit 
that there were certain aspects o f  chronic pain that they did not know.
"...and she's always well-versed on what she is going to suggest, even to the point that i f  
she didn't particularly know, she has always read up on it before hand " (Patient 9 -  male 
patient with secondary education- was self employed and is in liis fillies)
"...and she looks things up in a hook for me. you know, maybe it's....... /  can't remember
what for. hut she has looked many a thing up for me in the hook." (Patient 2 -  female patient 
with secondary education and blue collar background in her seventies)
It seemed that regarding knowledge and experience, what was important was not just that 
their non-medical prescriber knew, but could be trusted to admit when they did not know and 
work towards gaining the relevant knowledge or experience. When patients felt that this was the
I I !
case, they were encouraged to engage with that prescriber. For instance, when non-medical 
prescribers seemed reluctant to answer questions, patients became suspicious.
"well the Iasi one lhal came. 1 wouldn't have paid her used Iram tickets, if 'you know whai 
I mean... there was something else that I asked her, ....oh, I  am in a hurry, 1 am hi u hurry and 
then of course I  wanted lo ask a something else, she said oh I  haven't lime, 1 said well you are 
poor nurse. you are supposed to sit and answer questions, so I hope 1 don't see her again, or 
else . . ." (Patient I -  female patient w ith secondary education in her eighties )
In the above example the patient had just started seeing a new prescriber because her 
former prescriber with whom she had a good relationship, no longer worked in her area. In this 
case, she was not encouraged to develop a relationship w ith this new non-medical prescriber.
In other cases, patients had been critical o f  the way that the various healthcare 
professionals that were responsible for their care communicated with each other and how this 
affected the service they got,
"well, il is... they always seem to have lo refer hack to the GP and go through ihe GP 
and o f course the GP ... on the prescription, hut having said that, having at least increased the 
dosage, when the pain has been... so perhaps if they are in such a position and they know the 
patient belter than the GP does, perhaps il would be better if  they could sort of. not to have to 
have all this... there can be a time lag... "(Patient 5 -  female patient with diploma qualification 
and healthcare background, in her seventies).
Mere, though th e  patient may not have known what the model was. she was in effect 
describing the supplementary prescribing model. She also noted that communicating with the 
GP meant delays in the way that she received service from her prescriber. A similar point arose 
in the prescribers' phase where with respect to health information technology prescribes felt 
that communication problems caused delays for patients.
Other areas where patients had opinions about their service were provided by non-medical 
prescribes included the use o f  diagnostics aids and consultation tools.
"...she was a lovely girl and with knowing her, I  could talk to her and she realized what I 
was like and she used to say. you know, I to 10 out o f pain, what is your pain like and 1 used to 
say that getting out o f bed was 1 to 14. (and laughs) and /  said, as the day goes on. many a time, 
the hack pain eases, you know, wilhoul movements, il eases, but me knees never eases " (Patient 
I -  female patient with secondary education in her eighties)
"... but the pharmacist, he definitely takes his lime, whereas you can go lo the doctors 
and she doesn't bother us far us taking your blood pressure and seeing your pulse Is okay and 
weighing you, he does all lhal. whereas ihe doctor does not. And I think he lakes his lime and
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asks you i f  there am- problems...am! that's good". (Patient 7 -  female patient with secondary 
education with unskilled work background, in her sixties)
Apart from the fact that using diagnostics aids and consultation tools suggested a better 
and more thorough consultation. I felt that patients were under the impression that prescribers 
who used them were more professional.
6.3.2.4 C ategory sum m ary
A less than optimal level o f  understanding o f  non-medical prescribing exists among 
patients. This did not however affect patients' ability to identify characteristics that they 
considered desirable in nurse and pharmacist prescribing for their chronic pain. Patients 
demonstrated that when they perceive these attributes to exist in a prescribing relationship. They 
were ready to reciprocate by being loyal. It also emerged that during prescribing, there was an 
ongoing evaluation o f  aspects o f the prescribers practice including their knowledge skills and 
professionalism.
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6.3.3 D ealing w ith  m edication
Many o f  the participants in this phase o f  the study were elderly patients and this is 
reflected in their average age (about seventy). It was expected that a significant proportion o f  
them had some co-morbidities alongside their chronic pain. This meant that they were also 
taking medication lor these other illnesses, in addition to their medication for chronic pain. 
Additionally, some had been taking drugs for chronic pain for a considerable number o f  years 
and had experienced the many different classes o f drugs available for their health problems.
I got the feeling that among other things, these two factors made the patients in the study 
feel that they had som e level o f  expertise in interprering the way that these chronic pain 
medications and other drugs interacted with their bodies. In this category'. I explore how patients 
engaged with the medications that were prescribed for their chronic pain. I look at the effects 
that patients felt that these medications had on their quality o f  life and how they tailored the 
medication taking process to suit their needs. In the first sub category ’dealing with side effects'
I focus on some o f  the side effects patients associated with these drugs and how they dealt with 
them. In the second sub category ‘using power' I explore how patients saw themselves in the 
medication taking process and how they used this position to achieve their aims.
6.3.3.1 Dealing with side effects
The patients in this phase o f  the study reported a range o f unpleasant side effects o f  the 
chronic pain medication and varied in the ways that they dealt with these adverse effects. One 
o f  the more prominent themes that emerged in this area was how patients felt that these adverse 
effects complicated their already compromised health profiles.
" /  believe so. the actual painkillers that /  am on are only paracetamol, but only because 
the [other] painkillers make me feel ill and /  don't see the point. /  am bad enough with the pain, 
without feeling sick and dizzy and other problems as well. So /  would rather stick with the 
paracetamol ...and the diclofenac, fo r the anti-inflammatory, so that is what I stick with." 
(Patient 11 -  female patient with secondary education in her seventies)
This patient had tried a number o f  ‘stronger* painkillers but the side effects associated 
with those able to completely relieve her pain were too much to bear. For her. she would rather 
take those painkillers that did not have such severe side effects, but also did not relieve all the 
pain.
Apart from the case above where adverse effects could make the patients feel worse, in 
some other instances, patients also complained that these side effects further compromised their 
the quality o f life by affecting other areas, such as their relationships w ith their families.
“I used to get very drowsy and forgetful as though I  was drunk. I used to get like a drunk 
feeling and forget a lot o f  things, a  lot o f conversations that my partner and I have had. /  could 
he talking to him one minute and then completely forget that we have had that conversation and 
then ask him the same ugain and again... the codeine. I was always reluctant to take that, 
because I  knew what that would do to me and /  would only ever take it when it was absolutely 
necessary, mainly because o f that factor, you know I did not like thal feeling. "(Patient 8 
fem ale patient with secondary education and a  white collar jo b  in her thirties)
In her own case, she suffered the com plications to her health by these side effects, a s  well 
a s  having the enjoym ent o f  her family being severely dim inished by them also. In our pre 
interview  chat, sh e  adm itted that both her chronic pain and the com plicating side effects limited 
her from play ing with her kids. She said that m issing this part o f  h e r life was the biggest regret 
sh e  had about her illness.
D ealing with side effects w as a very em otional subject for som e o f  the patients. I felt that 
for those that had reacted to m any drugs, they perceived that there w as som e sort o f  ‘trial and 
e rro r ' approach to their m anagem ent by their prescribers. The patient below  com plained bitterly 
throughout her interview  about the lack o f  success that her prescriber had in her pain relief. She 
reported thal she had tried m any treatm ents but reacted to all. except paracetam ol.
"...not particularly, no. I like lo know a bit more, i f  there is. . I just can't believe that 
eveiyhody else in the British Isles can take them tablets (sic), apart from  me. I cannot be that 
special ..."  (Patient *1 -  fem ale patient with secondary education and m anagerial work 
experience in her seventies)
In her case, she w as also on a  lot o f  other m edication which may have significantly 
affected the treatm ent choices available for her chronic pain. The result was that she felt 
frustrated about the treatm ent that she was undergoing.
For others, finding out m ore about their m edication and the side  effects seem ed to be a 
useful way o f  approaching the issue.
"...and that's when I started feeling it. so I knew was the codeine And then o f  course 
reading the information sheet, does tell you what the side effects are so you can kind of say... 
yes, yes, I have got that, you know '1 (Patient 8 -  female patient w ith secondary education and a 
white collar jo b  in her thirties)
G etting m ore know ledge in this case helped the patient isolate which o f  her medication 
w as responsible for the adverse effects and she subsequently had her prescriber substitute this 
particular drug.
There w as also som e ev idence that patients were system atic in m aking choices regarding what 
level o f  adverse effects to put up wilh when Hiking their chronic pain m edication.
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"one o f  them upsets me, my stomach really, hut then again it's one of the major side 
effects of taking that, that drug, hut I tried different ones and because o f  the nature o f the drugs, 
they all have the same side effect. I can he a little hit drowsy at rimes, hut again, that is part and 
parcel o f it. hut nothing too untoward ... hut I pul up with it. (laughs) cope with it. because the 
benefits that I get from the cotnhinution at the moment, far outweigh any o f the... what I would 
call small side effects really. " (Patient 9 -  male patient with secondary education, was se lf 
employed and is in his fifties)
In the above case, this patient had carried out an analysis where he had compared the risks 
and benefits o f  continuing with his combination o f  drugs. He then made the decision to carry on 
with the combination, irrespective o f  the side effects.
Apart from the way that patients dealt with side effects, another important theme that 
emerged from in this area, was the kind o f  side effect that patients felt that they could put up 
with. Patients seemed to be particularly concerned when the medications that they took for 
chronic pain seemed to affect their mental state. For them, being alert seemed to be very 
important and many o f  the drugs that they regarded with suspicion were those affected their 
state o f  wakefulness, or their mental abilities.
"Now. I  take paracetamol for the pain, they ure not strong enough, but all the others that 
the doctor tried me on. they made me like a zombie, you know. I knew what I was doing, hut I 
wasn't there, if  you know what 1 mean. So they have been too strong. " (Patient I -  female 
patient w ith secondary education in her eighties)
"... I  must admit that I am a bit reluctant, I have oramorph for breakthrough pain during 
the day, I ever reluctant to take it too often, became I..., it's only a personal opinion, I  feel that /  
would he sitting, zonked out half the time and I don't want that, so /  try not to take loo much of 
the orumorph" (Patient 5 -  female patient with diploma qualification and healthcare 
background in her seventies)
Being alert, maintaining a state o f wakefulness and being in control o f  their mental abilities 
were regarded as being even more important as one became more elderly.
"...because I am getting... I am an old person and /  don't want to he...em... /  want to be 
aware and alert of everything that goes on, because 1 am 68 now and /  do not want any tablets 
to interfere with my reasoning, 1 don't need it." (Patient 6 - female patient with secondary 
education and managerial work experience in her sixties)
(*.3.3.2 Using power
In the last sub-category w hile discussing how patients dealt with their side effects, we saw 
som e cases where patients due to  adverse effects o f  the m edications that the) were on. either 
decided to  reduce their intake o f  these drugs, o r  even stop  them  altogether and ask their 
prescriber for alternatives. In th is sub-category. I further explore how patients interacted with 
decision m aking ability that they had over the m edication taking process.
D uring the interviews. I perceived that patients were acutely aw are o f  the control they had 
over the m edication taking aspect o f  the treatm ent. Unlike the scenario in ‘evaluating service* 
w here they w ere initially reluctant to  criticize their prescribers, here, when they reported 
engaging in behaviours contrary to  agreed patterns with th e ir  prescribers, they did not show any 
apprehension.
/  would want il seen id  straightaway, because it is mv health and I don't want 
anybody messing about with my... and I would make it clear ubout what I wanted and i f  they 
didn't, well then maybe I  would find  somebody else..." (Patient 7  — female patient with 
secondary education with unskilled work background, in her sixties)
T he above case illustrates how strongly patients felt about exercising som e level o f  
control regarding their m edication. This patient was ready to term inate the prescribing 
relationship  and go elsew here, if  they felt that they w ere not being taken seriously. There was a 
feeling that since it w as their health in question, they felt justified  in taking and exercising som e 
control.
O ne o f  the ways that patients asserted their control over m edication taking was by taking 
d rugs m ore frequently, o r  w hen they w ere not meant to. They engaged in this, in order to  derive 
certain  benefits, even though they w ere  aw are that it m ight be risky for their health.
".. .andso as I say. diclofenac, they are the ones that ease il. but... then I used lo take one 
a morning and I  could feel the benefits o f  it. Anyway, they said I  haven’t taken any more, but I 
have a few and i f  /  am going out anyway, I  take it. I  had one this morning, because it was 
shocking, was the pain and just hobbling about like this... " (Patient I -  fem ale patient with 
secondary education in her eighties)
T his patient due to  possible interactions with her other m edication, had probably been 
advised to  discontinue d iclofenac. She adm itted being aw are o f  the risks, but still took it when 
she felt that the  benefits that she w ould derive from it was worth the risk.
On the flip side, patients a lso  used this pow er to stop o r a lter m edication that they were 
uncom fortable w ith. In th is p a tien t's  case, she adm itted that she would am end o r even 
d iscontinue her m edication, w ithout necessarily go ing back to  the prescriber.
*'/ would probably avoid taking the tablets, the medication unless it is absolutely 
necessary-. So I  will put down (sic), so it my nurse uuv saying take them three times a day, I 
would only lake them as and when I need it to. which is a bit o f a double-edged sword, because 
obviously you're supposed to load your medication up, which I know about, but you know and 
that's point o f taking the medication, you think I can go without that, /  don't need that feeling, so 
I do tend to skip, rather than go back. " (Patient 8 - female patient with secondary education and 
a white collar job  in her thirties)
In some other instances, this authority was exercised to adjust their regimen to suit aspects 
o f  their lifestyle. For instance amending the frequency o f  dosing to tally with how much activity' 
they had during that day.
" ...well, I would just take them when I  am really in pain. I do not take them like every few  
hours throughout the day. I just take them, maybe in the morning when I get up, or ,«rr /  have 
been on my legs a lot during the day. /  take a couple before I go to bed so I can go to sleep and 
that's more or less it" (Patient 12 - female patient with secondary education and blue collar 
background, in her sixties)
The patients admitted that this sometimes happened without advice from their prescribers. 
or any scientific evidence.
Another interesting way that patients used this control over their medication taking, 
related specifically to when they had drugs with the potential for addiction prescribed for them.
"...in your nursing career, you have seen people will be utterly dependent on drugs and 
addicted and socially, you know that addiction is not u good thing and I think that you have got 
this in your mind, am 1... what is happening, i f  it is 5mg eveiy two hours now, is it going lo be 
10 mg every few  hour and if it is going lo progress... I do not want to go down that route. " 
(Patient 5 -  female patient with diploma qualification and healthcare background in her 
seventies)
This patient was very conscious o f  her oramorph and would regularly skip doses, even 
when she was in some pain. It seemed that the opiophobia she expressed may have been a s  a 
result o f  her healthcare background. T here was no evidence that the other patients consciously 
decided to reduce their opiod based medication because they were afraid o f  being addicted to 
them,
6.3.3.2 C ategory  sum m ary
Patients modified prescribed medication without necessarily consulting with their non­
medical prescriber. I hey felt that amending the way they took their medication allowed them 
limit their exposure to side effects, get more from their treatment, or forestall future implications
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associated with taking such drugs. Although patients expected to get information about the side 
effects o f  their medication from their non-medical prcscriber. they also made significant effort 
to work things out for themselves, either bv reading up about them, or by experimenting. Some 
side effects were less acceptablc than others and medication that had an effect on menial 
alertness seemed to be least tolerable, especially lor the older patients
6 .3 .4  E x p lo rin g  o th e r  nicsisures
In the  project that Ibcused on prescribers' views and experiences, it was revealed that 
these professionals were open about exploring non drug m easures when treating  patients with 
chronic pain. Here. I explore a  sim ilar them e that em erged from the patients’ phase o f  the 
study, but in this section, in addition to  lifestyle changes 'o ther m easures’ also refers to 
com plem entary and alternative m edicines, spiritual beliefs and social/fam ilial support w hen 
these w ere seen by the patient as being able to help with their chronic pain.
The patients that participated in the study had  a  robust experience o f  these other measures 
and this em erged very early on in the interviews. In fact during som e pre  interview chats, on 
learning about my professional background, patients wanted my advice on som e new product or 
intervention that they had recently com e across. I w as alw ays careful lo neither persuade nor 
d issuade them , but refer them  back to  their prescribers or relevant authorities lo r advice.
T his how ever suggested to me that w ith respect to how they m anaged their chronic pain, 
patients were open to. am ong others: engage in activities, use unorthodox therapy and access 
social and familial support to achieve their objectives. In this category. I explore how patients 
engaged w ith these other m easures that they believed may o r may not have an effect on  the way 
they m anaged their chronic pain. In the first sub-category “using other rem edies’ I explore 
patients’ beliefs with respect to herbal rem edies and distraction therapy. In the second sub­
category ‘depending on o th ers '. I explore how patients interacted with support from family and 
social netw orks, including the place o f  their spiritual beliefs, when they perceived that these 
factors could  help them  m anage their pain.
6.3.4.1 Using o ther remedies
W hereas in the prescribers’ project, the  openness in exploring non drug m easures 
suggested to me a  m ore open m inded approach to  prescribing for their patients, this w as not the 
sam e im pression that I got for patients that considered using other rem edies. Especially 
pertaining herbal rem edies, the im pression that patients gave w as that they were more prepared 
to explore when they felt that they w ere not achieving desired goals regarding their pain re lief 
through the orthodox prescriber. T he next tw o quotes from the same patient clearly illustrate 
this point.
Initially, w hen asked the place o f  o th er rem edies in his m anagem ent o f  chronic pain, he 
adm itted using  herbal products.
" /  tried il years ago. I went lo this Chinese herbalist shop, they seem to be springing up 
everywhere, I  paid like 10 pounds fo r  a little ho tile o f  tablets fo r  arthritis, it did nothing, 
absolutely nothing, they might as well have given me smarties (laughs). So I gave that one
mup..." (Patient 3 -  male patient with diploma with blue collar work experience and in his 
forties)
By comparing the herbal product to ‘smarties’ (a brand o f  sweet/chocolate), he clearly did 
not feel that the product helped his pain and further probing then revealed the reasons why. in 
the first instance, he sought pain relief from this source.
"...well, I wasn't on this sort o f  medication. I was only fust been diagnosed with 
osteoarthritis and that was eight years ago and I  thought /  would try them, because originally, 
the doctor was fust giving me paracetamols and all the usual co-codamols, you know and they 
were not doing anything, so I sort of reached out and tried other alternatives, which didn't work 
and eventually I worked my way up to morphine and gubupentin. which I am quite happy with 
now. . . " (Patient 3 -  male patient with diploma with blue collar work experience and in his 
forties)
As soon as realised that these product did not work for him, he felt less comfortable 
experimenting with them. Incidentally, he started achieving his objectives through 
pharmaceutical products prescribed for him. Other patients seemed to have an open mind 
regarding herbal products.
"...not long ago, lhe.se cm... Asian people rang me up and they asked me. you know, what 
pain /  have got, and I  told (hem .you know, in my sides and all that. I says, but I am with the 
doctor... on (hem. you know and (he hospitals... and she said well... she gave me some good 
advice actually and she said to have you tried olive oil. so I  says no. so she says well try it. gel a 
bottle o f  olive oil and warm it, she say's and rub it on areas where your pain is... " (Patient 2 -  
female patient with secondary education and blue collar background in her seventies)
There however were also patients who used herbal products as form o f  Mop-up' to their 
prescribed medication.
M... well I  would noI lake unything, you know, internally. I would always ask. This is 
where it is where matron was very good, I  had seen this advert fo r this rubbing oil and it 
sounded... you know, il sounded sensible. But she went through the trouble o f ringing them up 
and finding out what (he ingredients were and funny enough, the man that ran (he.... I suppose 
he owned it. was very good and he looked it up and he say>s I cannot tell you what the basic oil 
is, because that is our secret, you know, hut he said (here's geraniums and all sorts of different 
things and o f course she knew what medication I was on and between them, she said no, there is 
nothing that can do you any hurm. So I  feel quite confident using it then. "(Patient 5 -  female 
patient with diploma qualification and healthcare background in her seventies)
This patient was open to  using herbal products, but m ade it c lear that they would only use 
them  i f  they agreed with the treatm ent that they were already getting for their chronic pain. She 
a lso  a lw ays m ade sure that she got her non-m edical prescriber's advice before using them.
1 he final group o f  patients had the attitude, that if  it was not prescribed by their non­
m edical prescriber, o r  by a  doctor, then they would not have any confidence in the product.
/  wouldn't lake ihcnt, unless I  were really sure about it. I wouldn't take anything other 
than whal I've been prescribed and sticking to now. /  wouldn’t touch it with a barge pole " 
(Patient 7 -  fem ale patient w ith secondary education w ith unskilled work background, in her 
sixties)
" ... I don't know, I think I  lake enough medication, I don't need anymore added on to my 
medication. I  think sometime* I take... /  think /  tint.taking too many tablets, really, but you have 
just got to take them." (Patient 6  -  fem ale patient with secondary education and managerial 
w ork experience in her sixties)
T he second patient struck m e as som e one who pul considerable effort and tim e in finding out 
about her m edication  and keeping up lo dale with her health issues. I felt that she did not want 
to  go  through it all again  in order to assess i f  the herbal m edicines were good for her.
Apart from exploring w ith herbal rem edies, patients also dem onstrated that they were 
aw are o f  the place o f  lifesty le m odifications, in the treatm ent o f  their chronic pain. This patient 
had earlier described the herbal tablets he look as innocuous as ‘sm arties’. but he  went on  to 
engage in physical exercise and found it beneficial.
"...hut other complemeniaries that I have done, I used lo go to the pain management 
clinic up the road here and it taught me ways o f  physically... fo r  the arthritis, you know, like lai 
chi and stuff ' and I find that very helpful, you know, fo r  the... relaxing the muscles, easing the 
aches and pains... " (Patient 3  -  m ale patient w ith diplom a with blue collar work experience 
and in h is forties)
This suggested that patients evaluated these ‘other m easures' the sam e way they evaluated 
the serv ice that they got from prescribers.
L ifestyle m odifications, though seen as beneficial, were not suitable for every patient. 
This o ther patient was advised to take up w alking to help with her chronic pain, but she also had 
severe breathing problem s and felt that the suggestion was unsuitable for her.
" ...it is supposed lo get your circulation going, as they said while you're walking, well I 
had to laugh. /  says. walking. /  says you are joking aren't you. so he says no. we want you to 
walk a lot, so /  says. /  am going lo walk with this chest complaints. /  says it takes me a long time
lo walk to the kitchen and back.. “ (Patient 2 -  fem ale patient with secondary education and 
blue collar background in her seventies)
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A s a  result she did not engage in these recom m ended exercises.
Patients also fell that iheir spiritual beliefs helped in the  way they m anaged their pain. 
These two patients w ere Christians and they believed that their faith in God was beneficial in 
their approach to  their health problems.
" /  -don't know. I just think it is., it's just that there is something there, you know, there's 
someone is there, there is someone you con talk lo and he can talk lo you somewhere, you know, 
so /  think..." (Patient 4  - fem ale patient with secondary education and managerial work 
experience in her seventies)
"I think that faith is a great support, but I  wouldn't lake the Way of... sort of... one lime, 
when things looked very had and the doctor said lo you think thal you are depressed, perhaps 
we should put you on antidepressunis and I resist that, because I  do not want thal. but /  think 
that the faith helps a lot and you say, dear Clod, how much more... or shall we have merely to 
rest now, hut I do not think... /  think il helps. I think it helps. " (Patient 5 -  fem ale patient with 
diplom a qualification and healthcare background in her seventies)
In th is area, I go t the im pression that thal these patients did not actually feel that their belief 
alleviated their pain rather it helped them cope better with living with their condition.
O ther m easures that patients either engaged in o r  had explored were m ostly distraction 
therapies. The m ore com m on ones m entioned by patients was listening to m usic and engaging 
in m entally challenging activities.
"If I'm in bed. or i f  I am silting here in the armchair reading, listening lo music... 1 can 
manage without the pain. So sometimes I  don't even need more than one or two... one or two 
sets o f  tablets, not four times anymore"  (Patient 10 male patient with postgraduate degree and 
m anagerial background and  is in his sixties)
" ....sometimes I do and when I do. I feel... hut em ...... no. I am...I don't really know how
to say this. . I  think i f  /  keep... /  do look of crosswords and quizzes, that keeps me... that takes my 
mind off the pain, that's how I  do it. I go to a quiz night on a Tuesday and my friend takes me 
and tha l.. I do enjoy lhal and I listen to music a lot. which /  find  very therapeutic " (Patient 6  - 
fem ale patient wilh secondary education and m anagerial work experience in her sixties)
It seem ed thut these other m easures that patients engaged in enabled them adjust their 
m edication w ithout m issing the tablets too much.
In a  sim ilar m anner to  the earlier exam ple w here  we saw a  patient evaluate the physical 
activity suggested to  her by her prescriber and refused to  engage in it. here also, som e form s o f 
distraction therapy suggested to  patients have not been found useful.
"...it's was very shocking, well It'S nine years ago on Saturday coming up, but 1 lost him. 
it was a terrible shock and obviously I was in a bit o f  the state and  /  went to the doctors and he
218
z n
suggested retail therapy. And that's.., I just felt like walking out. what is retail therapy going to 
do?... you know, that annoyed me at the time... " (Patient 11 female patient with secondary 
education in her seventies)
6.3.4.2 R e ly ing  on  o th e r  re la tio n sh ip s
Earlier in this chapter, we saw how patients felt that having a relationship with their 
prescribers was important to them achieving their objectives with respect to their chronic pain. 
The emergence o f  values like empathy, trust and loyalty suggests how important these 
relationships were to patients with chronic pain. There were however other relationships that 
were also important to patients in the way that they managed their chronic pain. These were the 
relationships thal they had with their families and within their social networks.
All the patients that I interviewed lived in their own homes and despite the fact that some 
were relatively unwell they all still had a considerable level o f independence. For this group o f 
patients, despite their independence, it was also important to have someone or some people, 
they interacted with, who they felt could be counted on to support them in various aspects of 
their lives. The impression I got was that this made them feel better about their health and more 
confident in the way they fell that their pain was managed. For these patients, this person they 
felt that they could rely on w-as probably a family member, close friend or social contacts with 
whom a personal relationship had been developed.
Though the support (hat they wanted to  be reassured o f  was not needed at that immediate 
time, it seemed important to them that they be sure that they could count on it whenever the 
need arose. The fact that they had someone, who cared and was ready to support them, if 
necessary seemed to be just as important to them as actually being supported.
Although many patients, who had families, usually used them as their support system, this 
was not always the case. For those with no families, o r who were not living in the same areas as 
their families, other relationships that they had. were seen in the same light as that o f  those with 
families.
"...and i f  any o f  the... things in the village, i f  they're having any bring and buys, or 
anything like that, they send for me, I  always do their raffle. It’s my way of helping, because I 
can't do much otherwise, /  used to do. I am the eldest member o f our church, I was three weeks 
old the first day I  was sent lo church and I still go. they come for me, you know, they always 
come lo me in the car and lake me in the wheelchair" (Patient I - female patient with secondary 
education in her eighties)
...when I see a Ml o f  people I gel... friends and people, yes, I think il does. I think lit 
helps) your well being in itself yes, 1 think il does". (Patient 6  - fem ale patient with secondary 
education and m anagerial work experience in her sixties)
Som etim es, it was ju st very helpful to  these patients, to  have people around them. Even 
ju st being  able to  interact w ith people they had som e connection lo, seemed helpful. For these 
patients, in addition to  know ing that they had these connections, they a lso  fell that the 
interaction and  the relationship building process helped im prove their well being. In the Iasi 
sub-category, we saw how patients used distraction therapies ifi their pain m anagem ent. Here 
also, I felt that for patients who engaged in these relationships, these interactions may have been 
used to  achieve ihe sam e objective. Interestingly, there were prescribers for chronic pain who 
seem ed to  have a sim ilar view . A s we saw  in the prescribers phase, one nurse prescriber in 
primary care used befriending schem es lo successfully help one o f  her patients m anage their 
chronic pain.
"So there were a number o f befriending schemes. Luckily and we had a long chat about 
how they fe lt about... their sort o f fears and feelings, about how they fe lt about Irving alone and 
looked at trying in address some o f  those, which meant that because they were feeling happy in 
themselves and they had a different focus, ihe pain was sort of lessened, or they seem to manage 
the pain.. I can 7 say lhal the pain was lessened, but they seem to manage the pain a lot belter. " 
(N urse in primary care w ith 5 years prescribing experience)
In a few cases, relationships with healthcare professionals may have been seen by 
patients, as surrogate for relationship w ith family and friends.
“...and ihe nurses, both Ihe male and female nurses, used to come in and... because you 
know. /  didn't have any visitors, with the children living away and working and they used to 
come in and... haven’t you sweets. They always knew that they will have a sweet before they 
went to out And they' used to love to hear me talk about the olden days, when I was younger and 
a treat me as a  friend, I wus not just a number, which you get in a lot o f  places now don’t you, 
you are a number not a person. "(Patient I - fem ale patient w ith secondary education in her 
eighties)
In th is case, the patient felt better when she felt that the nurses related to  her in a personal 
capacity, especially w hen her own family and friends w ere not able to  visit her.
A nother im portant them e that em erged in th is area w as the desire these patients expressed 
about rem aining independent for as long as possible. They tried to ensure that their lives carried 
on as normally as they could, in order to m aintain th is independence.
220
/  do try and keep on the go. because 1 do not want to give up. like someone said to me. 
that 1 could do with a stair lift, you know, you could do with this stair lift and I  said well I was 
advised about one, but I don't want to give up yet, if I can walk up the stairs, 1 am getting the 
exercise, so /  don't want to give up ye t"  (Patient 11 - fem ale patient with secondary education in 
her seventies)
In try ing  to  m aintain this independence, there w as a  conscious effort not to  com plain, or 
be seen as suffering. In som e cases, they had to endure som e o f  the pain that they w ere going 
though in order to  achieve th is picture o f  independence.
“...So 1 quite have a lot o f  family and I don't want lo be a nuisance, so unless I... I try to 
do things in the house, you know my daughter goes "mom leave it alone ", but I do because /  
want to keep going. /  don't want to be an invalid and I don't want every lime they come in, I am 
moaning o f my pains. I don't bother telling anybody, you know, I just gel on with it. You know 
because 1 think well, they can tell, no matter how much I tell them, they're noi going io be able 
to ease it. so I just don't. 1 don't bother telling them, I just carry on with all. " (Patient 4 - female 
patient with secondary' education and managerial work experience in her seventies)
Initially, it seem ed paradoxical that patients to whom  it w as im portant to  m aintain these 
important relationships would not tap into the support at the earliest possible opportunity, but 
would rather keep try ing  to rem ain independent. H ow ever as the them e developed further it 
becam e clear why. For these patients having th is support system  and being reassured that it was 
robust and in place, but not using it. suggested that they w ere saving it for a  tim e when they felt 
they had no choice but to tap into it.
*7 cannot just say... oh this is how I'm feeling, can you, do this for me. /  can't do it So 
when he says you have got family, I  am thinking yes. /  have a beautiful family, but I don't want 
lo.., there will be a lime. I mean, say I'm ~3 now, there will be a time when I really... /  may live 
till I  am hundred, I might need them to drop everything and and see to me. but not yet. " (Patient
11 -  fem ale patient w ith secondary education in her seventies)
T h is  m ay explain why in som e cases, these patients, in updating their family (and others 
they could count on for support), m ainly did so a fte r they felt that they had successfully 
m anaged a  difficult episode.
“..you know when the children ring up. which they do regularly and they ,<W}> how are you 
and I said well I am a lot better than what was the other day. why didn't you let us know, why 
didn't you ring us and lei us know that you are not well, well. /  can be better by the time you 
arrive here, so 1 don't bother them. 1 just go straight to the headquarters as you say... "(Patient 
I -  fem ale patient w ith secondary education in her e ighties )
I l l
It seemed that telling her children about her crisis, 'after the fact’ was proof that that at 
that time, she was doing her best to take care o f  herself. This suggested that when she would ask 
for their help, it was because she had to, not because she wanted to.
Although having these close relationships that they could rely on were mostly perceived 
as a good thing by the patients, they could also lead to an exacerbation o f the patient's 
condition, rather than helping them manage their pain.
"... when my father died two years ago. when I came back from the hospital, /  was having 
migraine after migraine, because /  was just sort of stressed out..." (Patient 7 -  female patient 
with secondary education with unskilled work background, in her sixties)
The stress o f  losing someone close to  her meant that this patient’s  management o f  her
chronic pain was also affected negatively.
6.3.43 Category summary
This category explored patients’ relationship with other measures. In addition to 
prescribed medication, patients resorted to complementary and alternative medicines and 
measures such as distraction therapy and spiritual belief to deal with their pain. Although some 
were prepared to experiment with herbal drugs when not achieving satisfactory pain relief, some 
would only take them if  they felt that it would not interact badly with their prescribed 
medication or i f  their non-medical prescriber agreed with this addition. There were patients that 
would not take any medication not prescribed for them by a healthcare professional.
Patients also relied on support from family, friends and others in dealing with their 
chronic pain. For many being assured o f  this support was just as important as having the 
support. There was also some evidence that patients wanted to remain independent o f  others 
until they could no longer manage on their own. To have this support and not immediately 
access it seemed paradoxical, but could be explained by the fact that patients may be using this 
strategy to accumulate some form o f  ‘credit’ until they did not have a choice to use it.
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This section discusses the findings o f  the project that explored how chronic pain patients 
perceived prescribing fo r their condition by nurses and pharmacists. In the overall research 
design, this project was included to address the knowledge gap revealed in the review o f  the 
literature. This was (research question 2):
•  How is  prescribing by nurses and pharmacists in the treatment and management 
o f  chronic pain perceived by patients with chronic pain?
The grounded theory exploration led to  the emergence o f three categories which explained how 
chronic pain patients perceived non-medical prescribing and how this influenced the way they 
managed their chronic pain. Together they contribute to the overarching category o f  this project 
relating with non-medical prescribers (see figure 12). This project found that patients regarded 
their relationships with their non-medical prescribers as important to their pain management 
strategy and this in turn influenced other measures they considered lo manage their chronic 
pain.
Patients considered the medicines prescribed by nurses and pharmacists and the way the service 
was provided. Both were perceived to influence relief for their chronic pain, the overall strategy 
for managing it and other aspects o f  their lives. Patients additionally considered using other 
measures in the way they managed their pain and this was influenced by both their relationships 
with their non-medical prescribers and the perceived effects o f  the medicines prescribed. This 
discussion situates these findings within the context o f  the work that already exists in this study 
area.
In chapter 7. ’Relating to non-medical prescribers' that emerged as the overarching theme 
from this project is integrated with the findings o f  the two projects that explored and surveyed 
non-medical prescribers (chapters 4 and 5).
6.4.1 Non-medical prescribing and using medicines
In their interaction with non-medical prescribers. the chronic pain patients in this project 
demonstrated that they had a less than optimal level o f  understanding o f non-medical 
prescribing. Furthermore, for those that had an opinion about non-medical prescribing, there 
was an incorrect perception o f the policy and in certain cases the title had negative connotations 
for the patient. It appeared that many patients had been left to their own devices regarding how 
they understood the mechanism that allowed nurses and pharmacists to provide this service and
6.4 Discussion
as such, curiosity and level ol education had an influence to their level o f  understanding o f  the 
policy.
The findings of this study reflect reports from other studies, Tlennel et al (2004) reported that 
38%  of their rheumatology patients with nurse supplementary prescribing experience had some 
awareness of new prescribing laws. Similarly, although Earle and associates (2011) focused on 
mental health they also found that more than half o f  their study participants were not aware of 
the non-medical prescribing policy and how it was used to provide services. There were 
however indications that in some populations there may be an appreciable understanding o f  the 
non-medical prescribing policy . A survey o f  the awareness o f  the non-medical prescribing in 
Scotland revealed that about 50% o f the general public were aware that health professionals 
such as nurses and pharmacists with the relevant training could prescribe (Stewart et al.. 2009).
Until now, little exploration hus been carried out regarding the connotations patients with 
chronic pain had about non-medical prescribing and whether this influenced the way they 
interacted with nurse and pharmacist prescribers. Although the patients in this study had a poor 
understanding o f  non-medical prescribing, this did not seem to limit their ability to identity 
certain attributes they considered desirable in their relationships with the nurses and pharmacists 
who prescribed for their chronic pain. Patients demonstrated that when attributes such as 
empathy, patience, understanding and open-mindedness were identified, they reciprocated by 
showing the prescriber the same level o f loyalty previously only associated with GPs (Family 
Doctors). It also emerged that during prescribing, patients evaluated aspects of the prescribers 
practice including their knowledge, experience, professionalism, communications skills and 
ability to  properly follow through unresolved issues regarding treatment or information 
requested by the patient. In reporting their assessments o f  the nurses and pharmacists that 
prescribed for them, the evidence suggests that they inadvertently compared the service to that 
they had previously received from doctors such as their GPs or from other non-medical 
prescribers.
Patients in other studies have also been able to identify similar attributes to the ones 
identified in this study. In an exploration o f  non-medical prescribing, patients in one study 
identified empathy and trustworthiness as important to the way their pharmacist prescribed for 
them (Stewart et al.. 2009). The diabetes patients in another study also identified trustworthiness 
as well as patience and approachability as integral in how they interaeied with (heir prescribers 
(Stenner et al.. 201 lb). Patients in other studies also demonstrated that they performed some 
form o f  evaluation o f the service they received from non-medical prescribers. In one study 
although patients admitted being confident in the abilities o f  the nurses who prescribed for 
them, (hey still compared aspects o f  non medical prescribers' knowledge and professionalism to 
that o f  G Ps (Courtenay et al., 2011).
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Poor adherence with prescribed medication has been associated with several 
consequences, lor instance, the therapeutic effect of the medications may not be achieved and 
treatment ol the condition may incur significant costs for the healthcare system (Cortet and 
Benichou, 2006; Broekmans et al.. 2009). In this project patients rather than adhering to 
prescriptions sometimes modified their medication to suit their own requirements and lifestyles. 
Other objectives for modifying medication included avoiding side effects, maximising 
perceived benefits and preventing long term effects. These changes to their medication were not 
always communicated to their prescribers. The aspect of their medication that patients seemed 
most concerned about were side effects and particularly for the elderly, medication that caused 
drowsiness and reduced alertness. They however also demonstrated that they engaged in some 
form of risk benefit assessment to ascertain which medication they would take for their pain 
despite any adverse effects that may result. Also, although they expected to be informed about 
their medication by their prescriber. patients made significant efforts to work things out for 
themselves by either reading up about them or by experimenting. Although not related to non­
medical prescribing, other studies in chronic pain have reported similar findings. Intentional 
non-adherence in the form of underuse and overuse of medication by patients was been 
identified as a measure employed by elderly patients to avoid side effects (Hughes, 2004; 
Broekmans et al., 2009). Another study associated patients’ non-adherence with long term 
effects and the level of trust they had in the doctors who prescribed their medication (Rosser et 
II,. 2011).
6.4.2 Using other measures
The findings Of this project suggested that chronic pain patients did not perceive the medication 
prescribed by their nurses and pharmacists as the only way to relieve their pain. Rather, 
receiving the prescription and using the medication was one strand of their strategy for 
managing their chronic pain. Other strands of the patients’ pain management strategy that 
emerged in the study included using herbal products, distraction therapy, spiritual beliefs and 
relying on social and familial support.
Existing evidence suggests that the use of complementary and alternative medicines is prevalent 
among patients with chronic pain (Rosenberg et ah. 2008; Ndao-Brumblay and Green. 2010). 
The evidence regarding how effective and safe this is for patients is unclear. On the one hand, it 
has been suggested that people with chronic pain that use complementary and alternative 
medicine in addition to their prescribed medication managed their, condition better (Foltz el al..
2005). On the other hand, concerns regarding how safe this is for patients with chronic pain, 
have been raised (Konvicka et al.. 2008).
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The literature also suggests that patients with chronic pain would usually seek relief from 
complementary and alternative medicines when they were not achieving pain relief from 
prescribed medication without their doctor being aware (Pappas and Perlman, 2002: Brunelli 
and Gorson. 2004). Some findings of this project reflect those from previous studies, Regarding 
using herbal remedies three approaches emerged in the study. The first group were prepared to 
experiment with herbal drugs when not achieving satisfactory pain relief. The second group 
would consider taking them if it would complement their prescribed medication and would 
sometimes do this in conjunction with their prescriber*s aw-areness and input. The third group 
would not take any complementary' and alternative medicines and may sometimes regard claims 
of efficacy with some scepticism.
I his project has further revealed previously unknow n factors which influenced whether and 
how chronic pain patients treated by nurses and pharmacists, resorted to these measures. The 
way that the patients related to their prescribers contributed to their decision making processes 
regarding using other measures. For instance patients that perceived their prescribers to be 
trustworthy, open minded and able to satisfy their information needs, were more likely to 
discuss complementary and alternative medicines. This suggests that in their overall pain 
management strategy the nature of the relationship between the patient and their prescriber 
influenced their consideration of complementary and alternative medicines.
Chronic pain patients in this project employed some measures which they reported were helpful 
in coping with their condition. The use of coping strategies by patients who suffer from chronic 
pain is a well researched area (Jensen et al.. 1991: Boothby et all.-, 1999: Jensen. 2009) however 
little is known about how this is combined with prescribing by nurses and pharmacists. In this 
study, patients with chronic pain identified exercise, distraction therapy and engaging in 
spiritual activities as some important coping measures used in their strategy to maintain some 
level of control over how they lived with their condition. Evidence suggests that some coping 
measures are an effective means of self management in chronic pain, for instance distraction 
therapy has been associated w ith analgesic effects and has been considered as a useful tool in 
the way that patients self manage their pain (Campbell et al.. 2010; Bradshaw et al.. 2011).
In addition to these measures, patients also indicated that their access to social support was 
helpful in the way they managed their condition. In this area relationships identified were with 
family members, friends, members of social or religious circles and others perceived to be part 
of their support network. There was evidence that chronic pain patients adopted strategies to 
cultivate and maintain their support network. An example of this was by informing members of 
the network of health crises after they had been dealt with. This ensured they were accumulating 
‘credit’ and also keeping members informed about their current health status-
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Although hot directly related to non-medical prescribing, other studies have explored the use of 
coping strategies. Jamison and Virts (1990) found that patients with access to support from 
family members seemed better able to deal with chronic pain. Their study also revealed that 
patients with large support networks took steps to cultivate and maintain them. Similarly, 
another study found that associations with higher levels of social support and decreases in 
depression and pain intensity (Lopez-Martinez et al.. 2008). In their study. Holtzman and 
associates (2004) found evidence that patients with access to social support felt encouraged to 
explore a greater variety of coping strategics and this seemed to enable them manage their pain 
better.
These findings mirror strategies that patients in this project used to manage their pain and begin 
to explain why some found these measures effective. Evidence from this study confirms that 
chronic pain patients seen by nurses and pharmacists found coping strategies and social support 
helpful. The findings also suggests that the way these were used in pain management strategies 
in relation to non-medical prescribing were similar to how they were used by patients seen by 
doctors.
6.5 Chapter summary'
Patients’ views and experiences regarding how nurses and pharmacists prescribed for their 
chronic pain were explored in this chapter. An overview of the methods used in the grounded 
theory' exploration was provided including an account of the strategy employed in recruiting 
participants. The results were presented under the three categories that emerged from this 
project of the study. The findings of this project were then discussed in the context of the wider 
literature.
The main finding in this project was that patients regarded their relationships with their non- 
medical prcscribers as important and this influenced their strategy for managing their pain. 
Patients lacked an optimal understanding of non-medical prescribing, but had developed 
strategies to develop and maintain relationships with non-medical prescribers. In their 
interaction with nurses and pharmacists patients identified attributes important to how they 
perceived the service was provided. They also showed that in addition to depending on 
prescribed medicines, herbal remedies, alternative medicines and other measures were 
considered and used in managing their pain. Social support from family, friends and others was 
also helpful in their overall pain management strategy.
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C H A PTER  7
IN TEG RA T ED  DISCUSSION AND CONCLUSION
7.1 Introduction
This chapter presents the discussion and conclusion of this studs. The chapter begins with 
the presentation of the theoretical model that emerged from the three projects discussed earlier. 
The theoretical model gives an overview of the findings of this study and forms the basis for the 
integrated discussion of this thesis. Findings from the three independent projects, the grounded 
theory exploration and survey of non-medical prescribers. as well as the project which focused 
on chronic pain patients are brought together to explain how non-medical prescribing for 
chronic pain is carried out and perceived. Facilitators and barriers to how nurses and 
pharmacists prescribe for chronic pain are also revealed.
The possible limitations of this work are then discussed and this is followed by the 
conclusion of the thesis. Recommendations are provided for further research, as well as to 
stakeholders in policy, practice and education. The final section presents the strategy for 
disseminating the findings reached and recommendations given.
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F igure  13: The integrated m odel fo r 'safety and support w ith in  the prescrib ing environm ent'
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Figure 13 presents the findings of this study as an integrated theoretical model. At the 
centre of this model is the ‘nature of the prescribing environment* depicted by the green 
hexagon. Three components of the prescribing environment 'developing relationships with 
colleagues . 'relying on colleagues* and 'team-working', explain how non-medical prescribes 
related with colleagues and interacted within their teams. Two further components deal with 
how nurses and pharmacists interacted with management and their patients and how these 
interactions influenced their prescribing practice. The final component ‘second checking* relates 
only to pharmacists and explains how their prescribing was affected by the measures in place 
for Iheir prescriptions to be screened, if and when they decided to produce them (these 
individual components are not shown in the model but are further explained in section 7.3).
Surrounding the ‘nature of the prescribing environment* are four important themes which 
emerged as factors non-medical prescribers engaged with and perceived as necessary to support 
their prescribing for clironic pain. Three of these factors ‘acquiring knowledge*, gaining 
experience’ and ■reflecting’ related to aspects of their learning regarded as necessary to achieve 
and maintain competence in the specific areas they prescribed in. One factor related to the 
nature and level of access to prescribing software and patients’ records and how these were 
perceived to influence their practice and the care they could provide for their patients.
In practice, the way that the non-medical prescriber engaged with each of these factors 
individually influenced their interaction with the other factors. This indicated that these factors 
were related to each other. On the periphery of the circle, the relationship which non medical 
prescribers had with the chronic pain patients they considered prescribing for is depicted by the 
beige parallelogram. In considering whether and how to prescribe for chronic pain, nurses and 
pharmacists were not only influenced by their relationship with patients but also by how much 
experience and knowledge they had. with respect to the condition, medication and treatment 
options. The likelihood of the patient resorting to other measures, rather than adhering to these 
medicines as w'ell as the effectiveness of the medicines prescribed, was also influenced by the 
nature of this prescribing partnership.
The white double headed block arrows indicate the relationships that exist between these 
factors and the nature of the prescribing environment. These block arrows represent the 
approaches that non-medical prescribers adopted depending on their personal and professional 
orientation, as well as on the nature of the environments that they prescribed from. The two 
approaches that emerged in this study are the innovative and Ihe conservative approaches. The 
four triangles situated between the circle representing ‘being a non-medical prescriber* and the 
rounded rectangle representing 'previous professional background* illustrate the motives that 
emerged in this study, as significant to the prescribing practices of nurses and pharmacists. 
'Liberating prescribing practice’, 'gaining more skill’, ‘meeting expectations’ and ‘being
7.2 Theoretical model
rewarded were identified as factors that motivated nurses and pharmacists to qualify as 
prescribers. They also had some influence on their practice after these professionals had 
qualified as prescribers. At the bottom of the model, three rectangles show the most common 
outcomes for non-medical prescribers who considered prescribing for chronic pain. In practice, 
the outcome achieved depended on the interaction between the various factors and on the nature 
of the prescribing environment. The approach that the nurse or pharmacist decided to adopt 
within this scenario also contributed to the final outcome. Based on these factors, their approach 
and the nature ol their prescribing environment there were three possible outcomes for qualified 
non-medical prescribers who considered prescribing for chronic pain. At one extreme, nurses 
and pharmacists even though qualified, would not prescribe and at the other, the perception of 
practising in an environment considered safe and supportive enough enabled nurses and 
pharmacists to prescribe for chronic pain.
7.3 Integrated discussion
The work in this thesis began with a comprehensive review of the literature. There it was 
revealed little was known regarding how nurses and pharmacists prescribed in the area of 
chronic pain and how this was perceived by the patients who received this service. Three 
research questions were thus proposed to address this gap.
1. What are the views and experiences of non-medical prescribers (nurses and 
pharmacists) in the treatment and management of chronic pain?
2. How is prescribing by nurses and pharmacists in the treatment and management 
of chronic pain perceived by patients with chronic pain?
3. In the treatment and management of chronic pain, what arc the barriers and 
facilitators influencing the implementation of non-medical prescribing?
The theoty ‘safety and support within the prescribing environment’ which emerged 
addresses the research questions by showing that non-medical prescribers considered the safety 
of their prescribing environment as well as support in terms of learning and being informed. It 
was shown that the effectiveness of their prescribing for chronic pain is influenced by the nature 
of the relationship they had with patients. The prescribing partnership also impacted on patients’ 
consideration to use other measures to manage their chronic pain. The theory also outlines 
factors perceived to promote or hinder non-medical prescribing for chronic pain and explains 
how they relate to each other to influence practice in this area.
7.3.1 Nature o f the prescribing environment
The theory suggests lhat the development and maintenance of relationships with colleagues, 
management and patients played a significant role in how nurses and pharmacists perceived
their prescribing environments. Developing relationships with colleagues, being able to rely on 
these colleagues and interacting w ith others in their teams were all determining factors to how 
they perceived their environments. Key themes thal emerged in these relationships were 
trustworthiness and respect for knowledge and ability.
Trustworthiness emerged as an important factor for relationship building during the grounded 
theory exploration and its significance was confirmed in the survey. Non-medical prescribers in 
the stnd> wanted to be sure that they could trust and relv on their colleagues for support in their 
practice especially lor knowledge and experience. In addition to possessing the skills necessary 
for their prescribing, non-medical prescribers were also expected to be trustworthy and to 
reciprocate the support received. For pharmacist prescribes, concerns around ‘second checking' 
influenced their prescribing practice. Current guidelines and protocols were perceived as either 
unclear or not relevant to all the various settings that pharmacists prescribed from.
Team-working and interaction with management were also identified as important to the 
development of non-medical prescribers’ practice. The structure and functioning of 
interdisciplinary teams could facilitate or hinder non-medical prescribers' development. Teams 
that were non-hierarchical and where duties were clearly delegated were seen as facilitators. 
Teams that were seen as barriers to practice were those that fostered a ‘blame’ culture or which 
encouraged unconstructive criticism and aggressive debate. Managers perceived as influential to 
their practice were non-medical prescribing and clinical leads. It was perceived that experience, 
awareness and attitudes with respect to non-medical prescribing could influence the practice of 
nurses and pharmacists they managed.
In light of the recent consultations to further develop the policy and extend prescribing powers 
to other professional groups (DoTL 2010). determining what constitutes safe and supportive 
environments for new prescribers, especially outside the medical profession becomes even more 
important. As this thesis has shown, there is a need for healthcare professionals that work in the 
same environment with non-medical prescribers to have sufficient awareness of their skills and 
potential contribution. Additionally. the support provided for non-medical prescribers needs to 
be assessed to ensure that these match their needs.
The United Kingdom has been identified as a forerunner in harnessing non-medical prescribers' 
skills to address healthcare needs (Bhanbhro et al.. 2011). There is evidence that stakeholders in 
other healthcare systems may be monitoring the unfolding of this policy (Weeks el al.. 2010; 
Hoti et al.. 2011; Adigwe et al., 2011). In addition to ensuring the development of the policy in 
a safe and efficient manner, determining what constitutes a safe and supportive environment for 
UK non-medical prescribers can also provide a veritable road map for other healthcare systems 
considering this policy direction.
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73.2 Approaches: innovative vs. conservative
Non-medical prescribers differed in the way that they approached various aspects of their 
prescribing. Nurses and pharmacists that adopted a conservative approach were more likely to 
be rigorous and prioritised protection of their practice and patient safety. Non-medical 
prescribers who adopted an innovative approach ‘pushed the boundaries' in their prescribing 
and were more likely to prescribe despite perceiving threats to their practice.
Depending on the circumstances, the approach adopted by the non-medical prescriber could 
predict the outcome both for prescribers and their patients. Non-medical prescribers that 
adopted a conservative approach In unsupportive or unsafe environments may decline to 
prescribe and this may mean delays for the patient. On the other hand adopting an innovative 
approach may ensure treatment in a timely manner. Although the innovative approach is usually 
adopted within the limits of the law, compared to the conservative approach it was riskier in 
terms of protecting prescribers' practice and ensuring patient safety.
Although these approaches revealed in theory are new to non-medical prescribing, it may help 
to explain how nurses and pharmacists who qualify as prescribers react to their prescribing 
environments. There is evidence that not all nurses and pharmacists that qualify go on to 
prescribe. More than six months alter they qualified, up to 50% of pharmacists and 25% of 
nurses in their respective cohorts had not yet prescribed (George et al.. 2007: Bradley et al..
2007). Understanding the approaches non-medical prescribers have to prescribing may provide 
better insight to why under certain circumstances, some will prescribe but others will not.
7.3.3 Knowledge and experience
Factors related to learning processes and activities were identified as important to how 
prescribing for chronic pain was carried out. Compared to nurses, pharmacist prescribers were 
less likely to have access to CPD during paid work time and were more constrained regarding 
the lime needed to research and access CPD. The Nursing and Midwifery Council provides 
clear guidance regarding nurses' access to continuing professional development at work (NMC. 
201 la) and this supports the level of support nurse prescribers reported in this area. This is not 
so for pharmacists. Recent calls have been made for an improvement in the current guidance 
and for better support for pharmacists' access to continuing professional development in the 
workplace (Donyai et al.. 2010). This study reinforces the need for better provision of time and 
access to enable pharmacists to gain and maintain competence to prescribe.
Non-medical prescribers demonstrated that they were able to acquire knowledge through 
both CPD and informal means. In the literature. CPD and other the formal means through which 
non-medical prescriber acquire knowledge and experience in their prescribing have been well
explored (Latter et al., 2007: Carey & Courtenay. 2009; Winstanley, 2009). Little is known 
pertaining to how informal learning is carried out in non-medical prescribing and whether it is 
practiced in an evidence based manner. This study showed that informal mentoring contributed 
to the way non-medical prescribers acquired knowledge. With the necessary evaluation, this 
mode of learning may be used as a resource to support non-medical prescribers.
Pharmacists were more likely to be limited by lack of patient experience, whereas nurses 
were more likely to be limited by their lack of medication experience. Although not specific to 
chronic pain, similar weaknesses have been identified (George et al.. 2006: Buckley et al.. 2006: 
Jones and Harbome, 2009). So far there is little evidence to suggest these issues are being 
addressed. Pharmacists and nurses considering prescribing for chronic pain might benefit from 
training that specifically addresses these deficiencies.
7.3.4 Health information technology
In relation to how their access to health information technology influenced their prescribing 
non-medical prescribers identified inequity and limitations in access to patients' records and 
prescribing software as barriers to their practice. The results were that nurses and pharmacists 
who prescribed for chronic pain felt excluded from important communication and this 
threatened the level of care provided for their patients. In this area, these findings confirm those 
of other studies that identified lack of similar access as barrier to prescribing (Thrutle et al. 
2007: Stenner and Courtney. 2007). This study identifies that in terms of non-medical 
prescribing for chronic pain, access to patients' records was considered more important than 
using prescribing software. This knowledge can help organisations with limited resources 
prioritise their planning and support in the development of non-medical prescribing
7.3.5 Motivation
The study showed for the first time that nurses and pharmacists considered the expectations of 
their patients, peers and senior colleagues when contemplating whether to take up prescribing. 
Other factors were also revealed in this study which motivated nurses and pharmacists to 
qualify and prescribe. Gaining more skill and liberating their prescribing practice were two 
important motivators for nurses and pharmacists considering prescribing for chronic pain. 
These two motivators confirm the achievement of the policy objective which predicted that non­
medical prescribing would enable a better use of the skills mix of healthcare professionals 
(DoH. 2008).
So far. the evidence regarding the place of financial remuneration and promotion as motivators 
is unclear. One study considered financial remuneration important to non-medical prescribing 
(Dapar et al.. 2010). Another suggests that it was not significant as a motivator ( Warchal et al..
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2006). This study contributes to the debate by showing that although non-medical prescribers 
expected to be rewarded for their qualification and the added responsibility it entailed, it was 
not as important as the other motivators. This revelation may be used in healthcare planning to 
further develop non-medical prescribing particular!} in T rusts or specialties where the uptake of 
the policy is below target.
7.3.6 Relationships between chronic pain patients and non-medical prescribers
This thesis represents the first time non-medical prescribing for chronic pain has been
explored from the perspectives of the patients as well as those of the prescribers. This approach 
enabled the revelation of a significant resonance in their views regarding the importance 
attributed to developing and maintaining a prescribing relationship. It emerged that mutual 
openness, good communication and trustworthiness were seen as key to achieving successful 
prescribing relationships. However, non-medical prescribers particularly pharmacists were 
limited in their ability to develop these relationships due to time constraints, heavy workload 
and inexperience. From the patients' perspective, other values such as empathy, patience and 
understanding were considered important in the prescribing partnership. Patients had also 
developed a system for evaluating the service received and were loyal to prescribers who they 
identified with these values. This was despite being under informed about and somewhat 
confused about certain aspects of non-medical prescribing policy.
The findings of this study regarding patients’ knowledge of the policy reflects those of 
other studies (Weiss et al.. 2006: Hobson et al.. 2010: Earle et al.. 2011) indicating a need to 
better inform patients about non-medical prescribing and how it enabled healthcare 
professionals prescribe for their condition. Communication between the prescribcr and the 
patient was another important issue that impacted on how their service was perceived. This too 
has been identified in the literature (Breivik et al., 2006: Walsh et al,, 2008). Training non­
medical prescribers to better communicate with their chronic pain patients and ensuring time 
and workload issues are addressed can facilitate prescribing partnerships and may in turn 
improve treatment objectives.
7.3.7 Depending on other measures
Patients in this study demonstrated that they did not depend solely on prescribed 
medication to achieve pain relief. Rather, using medication prescribed by nurses and 
pharmacists represented part of a bigger strategy. However, the way chronic pain patients 
interacted with individual components of their overall pain management strategy was influenced 
by their relationship with the prescriber. Aspects of their pain management strategy that were 
influenced by the nature of the prescribing partnership included their adherence to prescribed
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medication, their consideration of other measures and their openness (with their non-medical 
prescriber) about their pain management strategy.
In addition to their prescribed medicine, patients used complementary and alternative 
measures well as a range of coping measures. Those identified in this study include herbal 
medicines, physical exercise, spiritual activities, distraction therapy and social support. For 
patients who considered herbal remedies, the likelihood of using them increased when the 
patient was either not achieving satisfactory pain relief, or not happy with the service received 
from their prescriber. Depending on the nature of their relationship with their prescriber. the 
consideration of herbal remedies and other measures was made known to their nurse or 
pharmacist prescriber. Social support was another important component of the strategy revealed 
in this study. There was an indication that patients had developed strategies in their cultivation 
and accumulation of social support from family friends and others.
The findings of this study reflect existing evidence regarding chronic pain patients' use of 
prescribed medication alongside complementary and alternative medicines (Haetzman et al.. 
2003). Although these strategies developed by patients may seem innocuous, there are 
significant risks with this approach. So far, evidence regarding the therapeutic effects of 
complementary and alternative medicines is unclear (Gagnier et al., 2006; Khadilkar el al..
2008) and as such non udherence to prescribed medication may limit therapeutic benefits, 
prolong treatment and constitute a waste of resources for the patient and the healthcare system. 
This suggests a need for non-medical prescribers to be aware of patients' pain management 
strategies and consider them in the way they approach treatment for this group. Better 
relationships between prescribers and their patients might improve nurses' and pharmacists’ 
awareness of these strategies.
7.4 Lim itations o f the thesis
The strategy employed in carrying out this study was a mixed methods approach. Although 
this method has been associated with enabling quality in the study and facilitating acquisition of 
research skills for users, limitations exist. Using mixed methods has been associated with 
significantly more resources, in terms of time, finance and manpower, compared with using one 
approach. These are all limited in a PhD and it is possible lhat this study may have been 
concluded in a more timely fashion if only one method had been used.
The constructivist grounded theory approach chosen as the underpinning methodology for 
this work has also been associated with some disadvantages. It has been suggested that the 
difficulties associated with using grounded theory renders it unsuitable for beginner researchers, 
especially in light of the significant time and resource limitations of a PhD. Additionally, 
criticisms levelled against the qualitative research paradigm include the subjectivity and
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employment of inductive reasoning associated with this methodology. The constructivist 
approach employed in this work is perhaps even more associated with these criticisms. The 
choice nt this approach as the underpinning methodology for this study may be seen by some as 
biased.
In this study, although both non-medical prescribers and patients who arc the major 
partners in the prescribing relationship participated in the research, some of the themes that 
emerged were relevant to medical prescribers. For instance in their evaluation processes, 
patients sometimes compared the service they received from non-medical prescribers to that 
they had earlier received from medical prescribers. Also some of the support that non-mcdical 
prescribers accessed in their prescribing environment was from doctors. As such, exploring the 
views and experiences of doctors with respect to non-medical prescribing for chronic pain may 
have provided further insight as to how some of these processes were carried out.
Following the development of the theory from the first project, the questionnaire was 
designed and used to survey prescribing nurses and pharmacists. Due to the fact that many of 
the themes and concepts that emerged from the first phase were novel, the questionnaire that 
was developed could only test some of the themes that non-medical prescribers were familiar 
with. Furthermore non-medical prescribers in the UK are limited and the research exploring 
their views and experiences have increased significantly in recent years. In order to ensure that a 
significant proportion responded to the questionnaire, it had to be designed in a way that the 
items were presented clearly and concisely, as such some of the more complex themes and 
relationships may not have been adequately reflected.
Considerably fewer pharmacists have qualified as prescribers. compared to nurses. Although 
this proportion was expected to be reflected in the survey, the relatively small number of 
pharmacists in the study limited the sophistication of analysis that the data collected for the 
prescribers could be subjected to. Additionally, the sampling used for the survey was not the 
preferred option. Had the survey had been carried out on a randomly selected prescribers from a 
nationally held sampling frame of registered prescribers the results would have given better 
external validity. For instance, although the survey suggested that there were only a few 
qualified prescribes who had never prescribed, that finding should be regarded with caution. It 
is possible that this population was not adequately represented in the survey.
In the project thal aimed at exploring patients” views and experiences, the sampling 
strategy was aimed at identifying characteristics that would facilitate a rigorous exploration of 
emerging themes. However, the participants that were selected in this project were mostly 
elderly females. It is possible that this may have led to the exploration and emergence of themes 
more relevant to this population. Also, patients were accessed through a gatekeeper to ensure 
protection from undue pressure and unethical practices. It is possible that using this approach 
may have excluded some chronic pain patients w ho had experienced non-medical prescribing.
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Following the grounded theory exploration of nurses’ and pharmacists* views and 
experiences, a survey was carried oul with non-medical prescribers to measure their attitudes 
based oil the themes that emerged from the theory. Designing and carrying out a similar survey 
with chronic pain patients would have tested the relevant issues that emerged from the grounded 
theory project that explored their views and experiences. It is possible that, this may have shed 
more light on how they related to non-medical prescribers and other important aspects of how 
they managed their pain.
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7.4 Conclusion
The evidence is clear that for nurses and pharmacists, the safet) and support within the 
environments that they prescribed from was of great importance. Non-medical prescribers that 
had developed trustworthy, reliable and supportive relationships with colleagues, management 
and their patients were more likely to prescribe for chronic pain. The absence of certain 
components perceived as essential to safely prescribe meant that the non-medical prescriber 
declined to prescribe. Some nurses and pharmacists who adopted an innovative approach to 
their prescribing would however prescribe regardless. Being innovative meant pushing the 
boundaries and overcoming barriers. In contrast a conservative approach was synonymous with 
a strict adherence to recommended guidelines relating to professional practice and patient 
safety. Also, the potential that issues relating to ‘second checking’ introduced to the prescribing 
environment influenced pharmacists' decision to prescribe.
In relation to learning and information technology perceived as necessary to support their 
prescribing, the study showed that nurse prescribers were more likely to initiate and use 
informal mentoring relationships but were limited by their inexperience with medication. 
Pharmacists on the other hand were limited by their inexperience with patients. Although both 
professional groups were similar in their CPD needs, pharmacists were limited by their lack of 
access lo onianised courses during paid work time. Non-medical prescribers identified access to 
prescribing software and patients records as important to their practice. In addition, equity in 
access to these systems was identified as a problem in some settings.
A mutually beneficial relationship based on trust and other values was identified as crucial to 
meeting treatment objectives (from the prescribed perspective) and achieving pain relief (from 
the patient's perspective). Prescribers were however limited in developing these relationships by 
time and work commitments. Patients with chronic pain on the other hand showed that the> had 
developed strategies to maintain prescribing relationships in which desirable values had been 
identified. This was despite the fact that patients lacked information and misunderstood the non­
medical prescribing policy. The nature of these relationships also had an influence on whether 
patients adhered to prescribed medication, resorted to complementary therapy and used coping
measures. It also influenced how open ihey were to their prescriber about considering these 
other strands ot their pain management strategies. In addition to being pain tree, other 
objectives of the patients’ pain management strategies were to avoid adverse long term effects. 
Patients also found support from family, friends and others helpful and had developed strategies 
to cultivate and accumulate social support.
Recently, following a comprehensive evaluation of nurse and pharmacist independent 
prescribing in England (Latter et al.. 2010). it was suggested that further development of the 
policy should consider non-medical prescribing across conditions for patients with co­
morbidities. Although this policy direction has the potential to significantly impact on how 
chronic pain is managed, the readiness in this specialty for this and other policy changes has to 
be questioned. Unless the issues concerning the safety and support raised in this thesis are 
addressed, there is a danger of increasing inefficiency in the system, as a significant number 
who qualify may not prescribe. Furthermore, it is possible that unless barriers are addressed and 
motivators instituted, other healthcare professionals may be discouraged from becoming 
prescribers. Important issues have been raised by chronic pain patients regarding how they 
perceived non-medical prescribing. Neglecting these issues risks further widening the 
communication gap and missing out on a valuable resource that can help improve non-medical 
prescribing in this area. Also, a lack of understanding of patients’ overall pain management 
strategies can undermine treatment objectives, waste resources and even threaten patient safety. 
By taking account of the barriers and facilitators identified in this thesis, care of patients with 
chronic pain can be better managed by improving access to professional help including 
prescribing of appropriate medication.
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7.5 Recommendations
The following recommendations are made based on the findings of this study.
7.5.1 Fo r research
1. More work is needed to determine the relevance and applicability of the theory to other 
specialties as well as other healthcare systems.
2. Views and experiences of doctors and clinical leads need to be explored to gain a better 
understanding of their perception of non-medical prescribing for chronic pain.
3. A quantitative survey is needed to measure chronic pain patients' attitudes to themes 
that emerged in this study regarding their pain management strategies and how this 
relates to the prescribing relationship with nurses and pharmacists.
4. Further exploration is needed of motivators to nurses and pharmacists considering 
qualifying as prescribers and how it may influence aspects of their practice after 
qualification.
5. More work is needed lo determine the relevance and applicability of the identified 
approaches to non-medical prescribing areas.
7.5.2 For policy
1. Informal and informal mentoring relationships need to be facilitated to enable less 
experienced non-medical prescribers to learn from more experienced peers.
2. Identified motivators for prescribing for chronic pain need to be facilitated to provide 
better care for patients with chronic pain, in terms of availability and choice.
3. There is a need to address the lack of awareness of the non-medical prescribing poliey 
among healthcare professionals and patients to improve understanding and facilitate 
how care is provided.
4. Patients should be involved in making the policies that affect their services. There is 
significant scope to involve them in evaluating the way that prescribing is carried out.
5. Existing guidelines for checking prescriptions written by pharmacists should be 
reviewed to ensure adequate robustness and clarity.
6. The General Pharmaceutical Council needs to provide better guidance to employers of 
pharmacist prescribers regarding accessing CPD during paid work time to adequately 
reflect their knowledge needs and time constraints due to their role.
7.5.3 Fo r practice
1. An assessment tool based on the theory should be used to assist non-medical prescribers 
and their employers identify specific barriers within their prescribing environment and 
the possible ways to overcome them.
2. Non-medical prescribing leads need to be more aware of the variability in the needs of 
non-medical prescriber. Where possible, individuals with significant experience of non­
medical prescribing should be appointed as leads.
3. Non-medical prescribers' roles need to be reviewed to ensure that their particular skills 
set are used efficiently. Selection and training of prospective non-medical prescribers 
needs to be reorganised to facilitate their prescribing once they are qualified.
4. Better and more equitable access to prescribing software and patients' records needs to 
be provided for non-medical prescribers.
5. Clinical leads and doctors that regularly interact with non-medical prescribers need to 
be better informed about non-medical prescribing and new developments in policy.
7.5.4 Fo r education
1. Nurse and pharmacist prescribers' deficiencies in medication and patient-related 
experience should be addressed by designing appropriate workshops.
2. Relevant resources such as day courses and webinars specific to chronic pain and 
tailored for non medical prescribers should be developed. Better signposting to these 
resources should also be considered in their development.
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3. More should he done to train non-medical prescribers on the skills needed to develop 
and maintain relationships with colleagues and patients.
4. There is scope for stakeholders to engage with the informal means that non-medical 
prescribers for chronic pain have demonstrated that they carry out some of their 
learning activities through.
7.6 Dissemination strategy
The strategy being adopted for the dissemination of the lindings of this study is twofold. 
Firstly, during the period of stud), extensive links to various relevant professional bodies here 
in the UK were established. Using these research networks, some findings of this study were 
disseminated through conferences and scientific meeting. Recently, an abstract presenting the 
findings from the grounded theory prescribers phase of this stud) was accepted for presentation 
following peer review at the Joint Annual Scientific Meeting of the British and Canadian Pain 
Societies in 2011 (see appendix 19).
Secondly, findings from this study have also been disseminated in international journals 
that target policymakers and healthcare professionals in health care systems situated in 
developing countries. The objective is that the debate in those systems regarding more efficient 
use of limited healthcare resources may benefit from research into the non-medical prescribing 
policy experience in England. Recently, an outline of the impact of pharmacists prescribing in 
the UK and the likely implications of such a policy in Nigeria was communicated with a 
publication in their peer reviewed national pharmacy journal (Adigwe et al.. 2011)
l urther planned articles based on this dissemination strategy are summarised in table 12 
Table 12: Publication plan
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Proposed Title Target Journal/Media Submission Date
‘Playing safe’ - exploring the environment of 
nurse and pharmacist prescribing for chronic pain
International Journal Of 
Pharmacy Practice
May 2012
The nurse prescribing policy in England: 
implications for Nigerian nurses
Nigerian Journal o f Nursing June 2012
What do patients reall) know about non-medical 
prescribing?
Patient UK May 2012
Non-medical prescribing for chronic non* 
malignant pain: new insights
Pain/ Journal of pain and 
symptom management
July 2012
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Appendix 1: Hits for literature search
Embase search 1996 -  2011 week 50 -  Nurse and pharmacist prescribing
Search no. Search term Hits Kept
I view*.rop. 216324 p ma
2 experienc*.mp. 508898 -
3 perce* .nip. 576084 *
4 1 or 2 or 3 1197387 -
5 nurse*, mp. 157919 *
6 prescrib’ .mp. 76340 *
7 5 and 6 3083 -
8 4 and 7 952 *
9 limit 8 to english language 902
10 limit 9 to yr="2004 -Current" 676 89
]| phannacist*,mp 40599 s
12 prescrib*.mp. 76340 -
13 I I  and 12 3898
14 4 and 13 1018 -
15 limit 14 to english language 924 r
is limit 15 to yr="2006 -Current" 633 '0
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Medline search 1996 — 2011 week 3 — Nurse and pharmacist prescribing
Search no. Search term Hits Kept
I view*.mp. 166239 -
2 experiencVmp. 379350
3 perce*.mp. 489589 *
4 1 or 2 or 3 950785
5 nurse*.mp. 138584 -
6 prescribe.inp. 52135 -
7 5 and 6 2146
8 4 and 7 632 -
9 limit 8 to cnglish language 599 -
10 limit 9 ioyr="2004 -Current" 413 71
11 pharmacist*.mp 12009 -
12 prescrib*.mp. 52135 -
13 H  and 12 1678 *
14 4 and 13 441 -
P limit 14 to english language 399 *
16 limit 15 to yr="2006 -Current" 222 35
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IPA search 1996 2011 week 3 — Nurse and pharm acist prescribing
Search no. Search term Hits Kept
1 view*.mp.
2 experienc*.mp.
perce* ,inp.
4 1 or 2 or 3
nurse* .mp.
6 prescrib*.mp.
7 5 and 6
8 4 and?
9 limit 8 to engjish language
Id: limit 9:io:-yr="2004 -Current''
i f pharmacist*.mp
12 prescrib*.mp.
13: 11 and 12
14 4 and 13
IS limit 14 to engliish language
16 limit 15 to yr="2006 -Current"
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PsycINFO scarch 2002 to December Week 3 2011- Nurse and pharmacist prescribing
Search no. Search term Hits Kept
i view*jnp. 89133 *
:2 experienc*.mp. 201678 -
J perce*.mpr 204347 -
4 1 or 2 oi* 3 419473 *
5 nurse*, mp. 21940 -
6 prescrib*.mp. 10863 -
i 5 and 6 505 -
8 4 and 7 219 -
9 limit 8 to english language 217 -
i l limit 9 to yr="2004 -Current" 201 -
II pharmacist *.mp 1033 -
12 prescrib*.mp. 10863 -
13 11 and 12 217 -
14 4 and 13 78 -
1$; limit 14 to english language 77 -
16 limit 15 to yr="2006-Current" 66 -
All relevant studies had already been identified by the searches on the Medline and Embase 
databases.
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Index to Theses search 2004 lo 2011— Nurse and pharmacist prescribing
Search no. Search term Hits Kept
1 Prescribing 1718 " i f l
j limit 1 toyr="2004 - 2011" 529 10
$- prcscrib* and nurse* 52
4 limit 3 to yr="2004 - 2011" 29 No further studies
$: prescrib* and pharmacist* 92 1 9
6 limit 5 to yr="2004 - 2011" 40 No further studies
Appendix 2: Letter from ethics meeting
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National Research Ethics Service
Leeds (W est) Research Ethics Committee
Room 22 
Floor CO, Block 40 
King Edward Home 
uesds General Infirmary 
Leeds 
LS13EX
Telephone; 01133823181 
Facsimile'. 0113 3926799
14 January 2010
Mr Obi P. Adigwe 
PhD Student 
Room 3.35
School of Healthcare, Baines Wing 
University of Leeds.
LS2 9UT
Dear Mr Adigwe
Study Title: NON MEDICAL PRESCRIB ING  IN CHRONIC NON
MALIGNANT PAIN 
REC reference number: 10/H1307/2 
Protocol number: 1
The Research Ethics Committee reviewed the above application at the meeting held on 08 
January 2010. Thank you for attending to discuss the study.
Discussion took place on the recruitment procedure; you explained that all the nurses and 
pharmacists had expressed an interest in taking part in research and they would approach 
potential participants on your behalf. The Committee was reassured that you do not intend 
to contact participants without their consent.
The Committee queried the amount and type of training you h;we received: you explained 
that as well as an external course and a modulo on your PhD course, you have received 
substantial in house training. Dr Briggs explained to the Committee that if any emotional 
distress is felt by any participants, the department has links to psychologists, who could 
offer support.
The Committee queried your procedure if detail of unprofessional conduct is revealed to you 
during interviews; you confirmed that you have not considered this issue.
The role of Action for Pain w as raised; you explained that information sheets would be given 
out by your supervisor and the clinician involved In the study as a way of aiding recruitment; 
members suggested this may lead to a biased sample.
Documents reviewed
The documents reviewed at the meeting were:
jflocu/ncfif Version Date |
10/H1307/2
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Page 2
REC application 2.5 24 November 2009
Protocol 1 24 November 2009
Investigator CV 1 03 November 2009
participant Information Sheet Prescriber Information Sheet 1 24 November 2009
Participant Information Sheet Patient Information Sheet 1.0 24 November 2009
participant Consent Form: Prescribing for Chronic Pam by Nurses & 
Pharmasists
Evidence of insurance or indemnity
Referees or other scientific critique report
Interview Schedules/Topic Guides
Questionnaire
Questionnaire
Covering Letter 1 09 December 2009
REC application 2.5 24 November 2009
Protocol 1 24 November 2009
Investigator CV 1 03 November 2009
Participant Information Sheet Prescriber Information Sheet 1 24 November 2009
Participant Information Sheet Patient Information Sheet 1.0 24 November 2009
Participant Consent Form Prescribing for Chronic Pain by Nurses & 
Pharmacists
1.0 24 November 2009
Evidence of insurance or indemnity 1 08 October 2009
Referees or other scientific critique report 1 24 September 2009
Interview Schedules/Topic Guides 1.0 24 November 2009
Questionnaire. On Prescribing for Chronic Pain by Nurses and 
Pharmacists
t.0 24 November 2009
Questionnaire: On Non Medical Prescribing in Chronic Non 
Malignant Pain
1.0 24 November 2009
Topic Guide for Interviews (Non Medical Prescribers) 1-0 24 November 2009
CV - Michelle Briggs 1 09 November 2009
CV - Jose Closs 1 03 November 2009
CV - Barry Strickland-Hodge 03 November 2009
Provisional opinion
The Committee would be content to give a favourable ethical opinion of the research, 
subject to receiving a complete response to the request for further information set out 
below.
The Committee delegated authority to confirm its final opinion on the application to a 
meeting of the sub-committee of the REC.
Further information or clarification required
1 A procedure should be identified should sensitive information be disclosed at 
interview
2 Please confirm that patients with life shortening conditions will be excluded.
3 A GP letter should be provided, participants may seek advice from their GP. or 
mention the study to them.
6/R1307/Z Page 3
4 Please confirm which medication can be prescribed by pharmacists and nurse 
prescribers. they should have a formulary.
5 The data of those who withdraw from the study will be destroyed.
6 Consent for the interview should be taken at the start, not the end.
7 The participant information sheet should state that direct quotes may be used to 
develop the questionnaire, these should be anonymised.
8 The participant information sheet for patients should state that their GP will be 
informed.
g The consent forms should be revised as follows:
When submitting your response to the Committee, please send revised documentation 
where appropriate underlining or otherwise highlighting the changes you have made and 
giving revised version numbers and dates.
If the committee has asked for clarification or changes to any answers given in the 
application form, please do not submit a revised copy of the application form; these can be 
addressed in a covering letter to the REC.
The Committee will confirm the final ethical opinion within a maximum of 60 days from the 
date of initial receipt of the application, excluding the time taken by you to respond fully to 
the above points. A response should be submitted by no later than 14 May 2010.
Membership of the Committee
The members of the Committee who were present at the meeting are listed on the attached 
sheet.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
10/H1307/2_________________Please quote this number on all correspondence_________ J
Yours sincerely
• They should include the mandatory section on regulatory authorities.
• Provision should be made to consent to the recording of interviews.
• They should be proof read.
• Consent to notify the GP should be included on the patients' form.
r * u* rwi
i * Chair
Dr Rhona Bratt
Email; Elaine.hazell@leedsth.nhs.uk
10/H1307/2
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Page 4
Enclosures:
Copy to:
List of names and professions of members who were present at the 
meeting and those who submitted written comments.
Mrs Rachel De Souza
R&D Deportment. Leeds Teaching Hospitals NHS Trust
10/H1307/2 Pa8«
Leeds (West) Research Ethics Committee
Attendance at Committee meeting on 08 January 2010
267
Committee Members:
Name Profession Present Notes
Miss Brygitta Atraszkiewicz Information Analyst Yes
Professor Howard Bird Consultant
Rheumatologist
Yes
Dr Rhona Bratt Retired Multimedia 
Project Manager
Yes
Mr Stephen Bush Consultant in Emergency 
Medicine
Yes
Dr Sheila E Fisher NCRI Associate Director 
for PPI
Yes
Dr Stella Kwan Senior Lecturer in Dental 
Public Health
No
Mr Peter Margerison Retired Solicitor No
Miss Eve Miles Medical student Yes
Dr Wendy Neil Consultant Psychiatrist No
Dr Vera Neumann Consultant in 
Rehabilitation Medicine
Yes
Dr Jane Orton Consultant Oncologist Yes
Dr Michael Rivlin Medical Ethics Lecturer 
Lay Member.
No
Dr Ken Shenderey General Practitioner No
Revd. Chris Swift Hospital Chaplain | Yes
Also in attendance:
Name Position (or reason for attending)
Mrs Elaine Hazel! REC Co-ordinator
Ms Claire Kelly Assistant Co-ordinator
Written comments received from:
Name Position
Mr Peter Margerison Retired Solicitor
Appendix 3: Favourable ethical opinion
National Research Ethics Service
Leeds (W est) Research Ethics Committee
Room 22 
Floor CO, Block 40 
Krng Edward Home 
Leeds General Infirmary 
Leeds 
L81 3EX
telephone: 0113 3923181 
Facsimile: 0113 3926799
10 February 2010
Mr Obi P. Adigwe 
PhD Student 
Room 3.35
School of Healthcare, Baines Wing 
University of Leeds.
LS2 9UT
Dear Mr Adigwe
Study Title: NON MEDICAL PRESCRIBING IN CHRONIC NON
MALIGNANT PAIN 
REC reference number: 10/H1307/2 
Protocol number: 1
Thank you for your letter of 29 January 2010. responding to the Committee's request for 
further information on the above research and submitting revised documentation.
The further information was considered in correspondence by a sub-committee of the REC 
A list of the sub-committee members is attached.
Confirmation of ethical opinion
Or behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below
Ethical review of research sites
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below).
Conditions of the favourable opinion
The favourable opinion is subject to the following conditions being met prior to the start of 
the study.
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned
For NHS research sites only, management permission for research (“R&D approval*) should
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governance arrangements. Guidance on applying for NHS permission for research is 
available in the Integrated Research Application System or at http;//www.rdforum.nhs.uk. 
Where the only involvement of the N H S organisation is as a Participant Identification 
Centre, management permission for research is not required but the R&D office should be 
notified of the study. Guidance should be sought from the R&D office where necessary 
Sponsors are not required to notify the Committee of approvals from host organisations. 
The consent form for prescnbers should also have been revised to comply with the 
Committee's comments. Please ensure that it is amended and a new version is sent to the 
REC  office.
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable).
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Version Date
Covering Letter 1 09 December 2009
REC application 2.5 24 November 2009
Protocol 1 24 November 2009
Investigator CV 1 03 November 2009
Participant Information Sheet: Prescriber Information Sheet 1 24 November 2009
Participant Consent Form: Prescribing for Chronic Pain by Nurses & 
Pharmacists
1.0 24 November 2009
Evidence of insurance or indemnity 1 08 October 2009
Referees or other scientific critique report 1 24 September 2009
Interview Schedules/Topic Guides 1.0 24 November 2009
Questionnaire: On Non Medical Prescribing in Chronic Non 
Malignant Pain
1.0 24 November 2009
Topic Guide for Interviews (Non Medical Prescribers) 1.0 24 November 2009
CV - Michelle Briggs i 09 November 2009
CV - Jose Closs i 03 November 2000
CV - Barry Strickland-Hodge | 03 November 2009
Participant Information Sheet 2 22 January 2010
Participant Consent Form 2 22 January 2010
GP/Consultant Information Sheets 1 22 January 2010
Response to Request for Further Information 29 January 2010
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
After ethical review
Now that you have completed the application process please visit the National Research 
Ethics Service website > After Review
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You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the website.
The attached document “After ethical review-guidance for researchers'' gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including:
• Notifying substantial amendments
• Adding new sites and investigators
• Progress and safety reports
• Notifying the end of the study
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.
We would also like to inform you that we consult regularly with stakeholders to improve our 
service, if you would like to join our Reference Group please email 
fderenceoroup@nres.nDsa.nhs.uk.
110/H1307/2 Please quote this number on all correspondence
Yours sincerely
/Scl-v-e 
. .DrRhona Bratt
1 Chair
Email: Elaine.hazell@leedsth.nhs.uk
Enclosures: List of names and professions of members who were present at the 
meeting and those who submitted written comments
"After ethical review - guidance for researchers"
Copy to: Mrs Rachel De Souza 
R&D, Leeds Teaching Hospitals NHS Trust
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Leeds (West) Research Ethics Committee 
Attendance at Sub-Committee of the REC meeting on 08 February 2010
Committee Members:
Name Profession Present Notes
Miss Brygitta Atraszkiewicz Information Analyst Yes
Dr Rhona Bratt Retired Multimedia 
Project Manager
Yes
National Patient Safety Agency
National Researrh Ethir* Service
RESEARCH  IN HUMAN SU B JEC T S  OTHER THAN CLINICAL TRIALS OF 
INVESTIGATIONAL M EDICINAL PRODUCTS
After ethical review -  guidance for sponsors and investigators
This document sets out important guidance for sponsors and investigators on the
conduct and management of research with a favourable opinion from a NHS
Research Ethics Committee. Please read the guidance carefully. A failure to follow
the guidance could lead to the committee reviewing its opinion on the research.
1. Further communications with the Research Ethics Committee
1.1 Further communications during the research with the Research Ethics 
Committee that gave the favourable ethical opinion (hereafter referred to in 
this document as "the Committee") are the personal responsibility of the Chief 
Investigator.
2. Commencement of the research
2 .1 It is assumed that the research will commence within 12 months of the date of 
the favourable ethical opinion.
2.2 The research must not commence at any site until the local Principal 
Investigator (PI) or research collaborator has obtained management 
permission or approval from the organisation with responsibility for the 
research participants at the site
2.3 Should the research not commence within 12 months, the Chief Investigator 
should give a written explanation for the delay
2 4 Should the research not commence within 24 months, the Committee may 
review its opinion.
3. Duration of ethical approval
3.1 The favourable opinion for the research generally applies for the duration of 
the research. If it is proposed to extend the duration of the study as specified 
in the application form, the Committee should be notified.
SL-AR2 After ethical review - research other than CTIMP 
Version 4.0 April 2009
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3.2 Where the research involves the use of "relevant material" for the purposes of 
the Human Tissue Act 2004, authority to hold the material under the terms of 
the ethical approval applies until the end of the period declared in the 
application and approved by the Committee.
4. Progress reports
4.1 Research Ethics Committees are expected to keep a favourable opinion 
under review in the light of progress reports and any developments in the 
study. The Chief Investigator should submit a progress report to the 
Committee 12 months after the date on which the favourable opinion was 
given. Annual progress reports should be submitted thereafter.
4.2 Progress reports should be in the format prescribed by IMRES and published 
on the website (see www.nres.nDsa.nhs.uk/aPDlicants/after-ethical-review/) .
4.3 The Chief Investigator may be requested to attend a meeting of the 
Committee or Sub-Committee to discuss the progress of the research.
5. Amendments
5.1 If it is proposed to make a substantial amendment to the research, the Chief 
Investigator should submit a notice of amendment to the Committee.
5.2 A substantial amendment Is any amendment to the terms of the application 
for ethical review, or to the protocol or other supporting documentation 
approved by the Committee, that is likely to affect to a significant degree:
(a) the safety or physical or mental integrity of the trial participants
(b) the scientific value of the trial
(c) the conduct or management of the trial.
5.3 Notices of amendment should be in the format prescribed by N RES and 
published on the website, and should be personally signed by the Chief 
Investigator. The agreement of the sponsor should be sought before 
submitting the notice of amendment.
5.4 A substantial amendment should not be implemented until a favourable 
ethical opinion has been given by the Committee, unless the changes to the 
research are urgent safety measures (see section 7). The Committee is 
required to give an opinion within 35 days of the date of receiving a valid 
notice of amendment.
5.5 Amendments that are not substantial amendments (“minor amendments') 
may be made at any time and do not need to be notified to the Committee.
6. Changes to sites 
Management permission (all studies)
SL-AR2 After ethical review - research other than CTIMP 
Version 4.0 April 2009
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6.1 For all studies, management permission should be obtained from the host 
organisation where it is proposed to:
• include a new site in the research, not included in the list of proposed 
research sites in the original REC application
• appoint a new PI or Local Collaborator at a research site
• make any other significant change to the conduct or management of a 
research site.
In the case of any new NHS site, the Site-Specific Information (SSI) Form 
should be submitted to the R&D office for review as part of the R&D 
application.
Site-specific assessment (where required)
6.2 The following guidance applies only to studies requiring site-specific 
assessment (SSA) as part of ethical review.
6.3 In the case of NHS/HSC sites. SSA responsibilities are undertaken on behalf 
of the REC by the relevant R&D office as part of the research governance 
review. The Committee's favourable opinion for the study will apply to any 
new sites and other changes at sites provided that management permission is 
obtained. There is no need to notify the Committee (or any other REC) about 
new sites or other changes, or to provide a copy of the SSI Form.
6.4 Changes at non-NHS sites require review by the local REC responsible for 
site-specific assessment (SSA REC). Please submit the SSI Form (or revised 
SSI Form as appropriate) to the SSA REC together with relevant supporting 
documentation. The SSA REC will advise the main REC whether it has any 
objection to the new site/PI or other change. The main REC will notify the 
Chief Investigator and sponsor of its opinion within a maximum of 35 days 
from the date on which a valid SSA application has been received by the SSA 
REG.
Studies not requiring SSA
6.5 For studies designated by the Committee as not requiring SSA, there is no 
requirement to notify the Committee of the inclusion of new sites or other 
changes at sites, either for NHS or non-NHS sites. However, management 
permission should still be obtained from the responsible host organisation 
(see 6.1 above).
7. Urgent safety measures
71 The sponsor or the Chief Investigator, or the local Principal Investigator at a 
trial site, may take appropriate urgent safety measures in order to protect 
research participants against any immediate hazard to their health or safety.
7.2 The Committee must be notified within three days that such measures have 
been taken, the reasons why and the plan for further action.
8. Serious Adverse Events
SL-AR2 After ethical review - research other than CTIMP 
Version 4 0 April 2009
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Appendix 4: Research governance approval
The Leeds Teaching Hospitals
Trust
08/03/2010 Leeds Teaching Hospitals NHS Trust
Mr Obi Adigwe 
University of Leeds 
Room 3.35
School of Healthcare, Baines Wing 
University of Leeds
3A Hyde Terrorp 
IS2 9lN
Tel 332 28ft> 
M x  0113 392 639?
f M ® lfleU uh; ntjsilUt 
wv'ww.leedsteacfunt)('is«p!ifllvf»WnLeeds 
LS2 9UT
Dear Mr Obi Adigwe
Re: LTHT R&D Approval of: Non medical prescribing in chronic non 
malignant pain
LTHT R&D Number: UI10/9218 
REC: 10/H1307/02
I confirm that this study has R&D approval and the study may proceed at The Leeds 
Teaching Hospitals NHS Trust (LTHT). This organisational level approval is given 
based on the information provided in the documents listed below.
In undertaking this research you must comply with the requirements of the Research 
Governance Framework for Health and Social Care whioh is mandatory for all NHS 
employees. This document may be accessed on the R&D website 
htto://www.leedsth,nhs.uk/sites/research and development/
R&D approval Is given on the understanding that you comply with the requirements 
of the Framework as listed in the attached sheet "Conditions of Approval".
If you have any queries about this approval please do not hesitate to contact the 
R&D Department on telephone 0113 392 2878.
Indemnify Arrangements
The Leeds Teaching Hospitals NHS Trust participates in the NHS risk pooling 
scheme administered by the NHS Litigation Authority 'Clinical Negligence Scheme 
for NHS Trusts' for: (I) medical professional and/or medical malpractice liability; and
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(jj) general liability. NHS Indemnity for negligent harm is extended to researchers 
with an employment contract (substantive or honorary) with the Trust. The Trust 
only accepts liability for research activity that has been managerialiy approved by the 
R&D Department.
The Trust therefore accepts liability for the above research project and extends 
indemnity for negligent harm to cover you as principal investigator and the 
researchers listed on the Site Specific Information form. Should there be any 
changes to the research team please ensure that you inform the R&D Department 
and that s/he obtains an employment contract with the Trust if required.
Yours sincerely /
Dr D R/Norfolk 
Associate Director of R&D
Approved documents
The documents reviewed and approved are listed as follows
Document Version Date of document
NHS R&D Form 2.5 03.03.2010
SSI Form 2.5 24.11.2009
Directorate Approval 23.11.2009
Protocol 1.0 24.11.2009
REC Letter confirming favourable opinion 10.02.2010
Evidence of Insurance 08.10.2009
Patient Information sheet (REC Approved) 10 22.01.2010
Consent form (REC Approved) 2.0 22.01.2010
QP Letter (REC Approved) 1.0 22.01.2010
Questionnaire (REC Approved) 1.0 24.11.2009
277
Conditions of R&O Approval
• Approval from your Directorate must be obtained before starting the study.
o Approval of the appropriate Research Ethics Committee, where necessary, must 
be obtained before starting the study. Any changes made to the project during 
ethical review must be reviewed and approved by the R&D Department to 
maintain R&D Approval status.
• Arrangements must be made to ensure that all members of the research team, 
where applicable, have employment contracts with the Trust (either full or 
honorary).
o Agreements must be in place with appropriate support departments regarding the 
sen/ices required to undertake the project and arrangements must be in place to 
recompense them for the costs of their services.
• Arrangements must be In place for the management of financial and other 
resources provided for the study, including intellectual property arising from the 
work.
• Priority should be given at all times to the dignity, rights, safety and well being of 
participants in the study
o Healthcare staff should be suitably informed about the research their patients are 
taking part in and information specifically relevant to their care arising from the 
study should be communicated promptly.
• Each member of the research team must be qualified by education, training and 
experience to discharge his/her role in the study. Students and new researchers 
must have adequate supervision, support and training.
• The research must follow the protocol approved by the relevant research ethics 
committee. Any proposed amendments to or deviations from the protocol must be 
submitted for approval to the Research Ethics Committee, the research sponsor, 
regulatory authority and any other appropriate body. The R&D Department 
should be informed where the amendment has resource implications within the 
Directorate and the Directorate research lead/clinical director notified.
• Adverse Events in clinical trials of investigational medicinal products must be 
reported in accordance with the Medicines for Human Use (Clinical Trials) 
Regulations 2004.
• Complete and return 6 monthly Study Status Reports to the R&D Department 
within 28 days of receipt as requested. (NB Failure to comply to such request 
with the requirement will lead to suspension of R&D Approval.)
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• Procedures should be in place to ensure collection of high quality, accurate data 
and the integrity and confidentiality of data during processing and storage.
• Arrangements must be made for the appropriate archiving of data when the 
research has finished. Records must normally be kept for 15 years.
« All data and documentation associated with the study must be available for audit 
at the request of the appropriate auditing authority. Projects are randomly 
selected for audit by the R&D Department. You will be informed by letter if your 
study is selected.
t Findings from the study should be disseminated promptly and fed back as agreed 
to research participants.
• Findings from the study should be exposed to critical review through accepted 
scientific and professional channels.
• All members of the research team must ensure that the process of informed 
consent adheres to the standards GCP outlined in the UK Clinical Trials 
Regulations. Investigators are directed to the R&D website for further information 
and training availability.
• Where applicable, this managerial approval inciudes aspects of the study 
previously covered by the NRES Site Specific Assessment (S'SA) process.
Commercially Sponsored Trials
if the study is commercially sponsored approval is given subject to provision of the 
following documents.
• Clinical Trials Agreement - agreed and signed off by the R&D Department (on 
behalf of the Leeds Teaching Hospitals NHS Trust) and the Sponsor. 
Investigators do not have the authority to sign contract on behalf of the Trust.
• Indemnity agreement, if not included in the Clinical Trials Agreement- (standard 
ABPI no fault arrangements apply) signed by the R&D Department and the 
Sponsor
It is essential that ail the responsibilities set out in the Research Governance 
Framework, including those outlined above are fulfilled. The Trust reserves the right 
to withdraw R&D approval where the above criteria are not being met. The Trust will 
not accept liability for any activity that has not been fully approved.
Appendix 5: Ethics amendment letter “
Jfjg
National Research Ethics Service
Leeds (W est) Research Ethics Committee
Ffrsl Floor 
MiDslda 
Mill Pond Lane 
Leads 
LSB4RA
Tel- 0113 3050122 
Fax:
23 February 2011
Mr Obi P. Adigwe 
PhD Student 
Room 3-35
School of Healthcare, Baines Wing 
University of Leeds.
LS29UT
Dear Mr Adigwe
Study title: NON MEDICAL PRESC RIBIN G  IN CHRONIC NON
the above amendment was reviewed by the Sub-Committee in correspondence.
Ethical opinion
The members of the Committee taking part in the review gave a favourable ethical opinion 
of Ihe amendment on the basis described in the notice of amendment form and supporting 
documentation.
Approved documents
The documents reviewed and approved at the meeting were:
Document Version Date
Hard copy of online survey 1 12 February 2011
Protocol 2 12 February 2011
Notice of Substantial Amendment (non-CTIMPs) ¥ 16 February 2011
Membership of the Committee
The members of the Committee who took part In the review are listed on the attached 
sheet.
R&D approval
REC reference: 
Protocol number: 
Amendment number: 
Amendment date:
MALIGNANT PAIN 
10/H1307/2 
N/A 
1
16 February 2011
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All investigators and research collaborators in the NHS should notify the R&D office for the 
relevant NHS care organisation of this amendment and check whether it affects R&D 
approval of the research.
Statement of com pliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (Ju ly 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
10/H1307/2:__________________________ Please quote this number on all correspondence_______
Yours sincerely
13
Mrs Elaine Hazel I 
Committee Co-ordinator
E-mail: Elaine.hazell@leedsthnhs.uk
Enclosures: List of names and professions of members who took part in the
review
Copy to: Mrs Rachel E  de Souza
R&D. Leeds Teaching Hospitals N H S Trust
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Leeds (West) Research Ethics Committee
Attendance at Sub-Committee of the REC meeting on 22 February 2011
Name Profession Capacity
Rhona Bratt Retired Multimedia Project Manager Lay Plus
"j5r Sheila E. Fisher NCR! Associate Director for PPI Expert
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Appendix 6: Research passport
S i  l& U f
Research Passport Application Form -Version 2 04703/10 
Please refer to the guidance notes before completing the form.
porename(s):
Home Address:
Surname: ■Mi 16)1^ 5-
o & i P-ercK
ProfD DrQ MrQJ MrsD 
Miss □  MsQ OlherQ
\U  S c o t t  i-vavu- A ) l& b $ t L s n  t-i+ h
Work Tel: Mobile: Email: Uc« pc (3> Ic t J f • At • vtfc
Dale of birth: Gender: Male 0 " Female Q
National Insurance number: „ .
3 Professional registration details (if applicable): N/AfvT
Employer or place of study: ^  try- U ^ D T
Work Address/Place of Study: iW 6, Un i vJeflJiTY oF t-cEti s y  g. ^  kT-
Post or status held: p h ^
What type of Research Passport do you need? Project-specific jvT" Multf-project Q
II you will be conducting one project only please complete the details below. If you anticipate that you will 
be undertaking more than one project at any one time, please give details in the Appendix.
Project Title: NcW pKf^ >\Cfn. {***£?«*< # ||J 5 jN  p h iti
Project Start Date: q  ( 11 J" | p.© X O End Date: 3 o  /H o  { «3-o4 
Proposed start and end date of three-year Research Passport: Start Date: End Date:
NHS organisations): Dept(s): Proposed 
research activities:
Manager in NHS 
organisation:
nt#k f^T-«'r CUb •
L < * « T  (jit* I r u f  i  • l^ 'fevvWV f
Y es ( j N o ^Have you ever been refused an honorary research contract?
Yes □  No E2THave you ever had an honorary research contract revoked?
If yes to either question, please give details:
consent to the information provided as part of this Research Passport and attached documents being used, 
worded and stored by authorised staff of the NHS organisations where 1 will be conducting research.
For researchers undertaking regulated activity as from July 2010, and mandatory as from November 2010: I 
(understand that the Information I have provided may be used by my employer and the NHS to access the ISA 
on-line sen/ice to receive updates on my ISA-registration status.
®@5r" t (Dale: it l \ I 7-o | o
The Research Passport: Version 2
1
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jy^^TO88^pji@6m®ra8^fl^S«SS^roP®^^ff^Zn®7M0«8^OTS^^qEgigp^griySS9g^iJ<l.^ ft-4?j.p
7.8 Will this person 8 research activity mean thal they may be undertaking regulated activity (please use the Research Passport algorithm to make this judgement) >'es □  No S '
7.b 1 am satisfied that the above named Individual is suitably trained and experienced to undertake the duties associated with the.research activities outlined In this Research Passport form.
Signed: (£ ^ \ X c $ S * *  U / U / z o r o
mm C  S i C RO SS’ Job Title: 1\ (USi*< \
Department and Organisation:
I I K S  6 f
Managerial responsibility for the applicant:'^  
S u p 2^ iM d V -
AddrBSS'B ^ V v Q T  U u )c € > S lU j d  jL e a o b  L ^ aA s  L ^ . ^ 1
TeTNo: |gggg ^ 3  4 , - 7 7 3
Bnail: ^ .‘\. e to s y  @  . u^ c
Mew}SrB0drh^m^b^&^piet0Mb^^sWiphe/ShoOldWiyvar/Jith3^omktQWe:Mpr^pMbMei^ bn^t6
W ^o^& ed^^^^^M w £^pM dM ^se^rc^^s^D ^s^tf^Bieffip fQ yeJ^g^ 'g f§ f^ {^1^t¥^^M
Does this individual's research involve Regulated Activity: □  Yes 
IS  No
For Regulated Activity:
To be completed for RP applications supported by enhanced CRE 
disclosures certificates issued between 12°* October 2009 and 25th Ju ly 2010 
only
If yes to the above, has the individual been checked against ISA barred lists foi 
vulnerable adults and / or children, as appropriate and have you receivec 
confirmation via the CRB disclosure that the person Is not barred from working 
with children or vulnerable adults?
[NB individuals who are barred from working with children or vulnerable adults 
vUst not undertake a regulated activity within the NHS, and you must not submit a 
Research Passport form In such cases)
Checked against ISA 
Vulnerable Adults List?
Y e sd N o d  N/AO
Checked against ISA 
Children's List?
Yes □  No □  N/A □
For Regulated Activity:
To be completed for RP applications supported by enhanced CRB 
disclosures certificates Issued after 26th Ju ly 2010 only 
I yes to the above, can you confirm that you have registered the individual with 
he ISA as their employer / place of study, and that you will continue to monitor the 
registration status of this Individual and withdraw them Immediately from any 
regulated activity should their registration status change.
MB ISA registration Is mandatory from November 2010 for researchers 
undertaking regulated activity
ISA Registered for 
Vulnerable Adults? 
Yes □  No Q  N/A □
ISA Registered for 
Children?
Yes □  No □  N/A □
Can you confirm that a dear criminal record disclosure has been obtained for the 
above-named individual, with no subsequent reports from the individual of 
changes to this record?
NB for Regulated Activity this must be an enhanced CRB. For non-regulated 
activity, ensure the CRB Is at the mandated level
Yes □  No □  N/A □
The Research Passport: Version 2
2
If yes, please provide details o f the clear disclosure 
Date of disclosure: 4010 
Type of disclosure: ENHANCED
Organisation that requested disclosure: TWfNJTV foot .56*6/0 WO£il\l6
CRB Disclosure Reference No, OOl-2-9*f 312b li.
Researcher's ISA Unique ID: tJ I A .
9. Have the pre-engagement checks described below been carried out with regard to the above-named 
Individual?
• Employment/student screening; 
o ID with photograph 
o two references
o verification of permission to work/study in the UK 
o exploration of any gaps In employment
Yes
Yes
Yes
Yes
3Wo
^No
[PfNo
1 
U
U
U
U
/
• Evidence of current professional reaistration Yes |Nn N/AR
• Evidence of qualifications Yes W No
* Occupational health screening / clearance YesJB'Mo
Is the named individual on a fixed term contract or Yes □  No EfeT 
is the contract end Imminent?
Please indicate current oontract end-date Date:
% * d: 4 4  b u f f i*  , Date: l5 /»/lO
AuM£-rt\A*.i£ Job T A \e:fflu ju )f SCHOOL IYYW46££
Organisation;
Uf\/IV€fcSlTV Of- L€£PS
Department:
FflCOLTV Of- M £blC\*J£ AMH HEALTH/
Address: lO .llO , U£V£L 10, l A ) A )IlD M 6  , l££DS, L S I Q NL.
Te,No: OH3 a n & k & lh  Email: a .rV\. # le& feM  Uk.
Please Indicate which of the following documents are attached to this Research Passport;
Current curriculum vitae, including details of qualifications 
registration (please use the template C.V. at 
htto^/www.rdforum.nhs.uk/docs/temDlate cv.doc)
training and professional Yes 0  No □
Researcher's copy of criminal record disclosure:
Disclosures issued before 2601 July 2010 only: Criminal record disclosure includes 
confirmation of check against the appropriate Barred List(s)
Disclosures Issued after 26th July 2010 only: Criminal record disclosure confirms 
appropriate ISA registration. NB where appropriate, ISA registration is mandatory 
after November 2010.
Yes K  No □  N/AD 
Yes O  No O  N/A 0  
Yes □  No □  N/A £3
Evidence of occupational health screening 1 clearance Y es®  No □  N/AD
Appendix Appendix numbers:
n/a D
The Research Passport: Version 2
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Phase send the completed form and original documents to the Lead R&D office. The completed form end 
original documents will be returned to you. This package of documents will be used to validate your completed 
Research Passport form. You may then, and where relevant, provide the Research Passport to other NHS
You must inform all NHS organisations that have received this Research Passport of any changes to the 
information supplied above. Failure to do so may result In withdrawal of your honorary research 
contract or letter of access. As part of the quality control procedures for the Research Passport, random 
checks on the accuracy of the Information held on this Research Passport may be made.______________
The following additional checks have been completed:
Having confirmed that the necessary additional pre-engagement checks have been completed, I am satisfied that 
[he above named researcher is suitable to carry out the duties associated with their research activity outlined in 
'this Research Passport._________________________
Signed: Date:
Name: Job Title:
Organisation: D epartm en t
Email:
« 8 lS B ® g 8 B B 8M 8 M
Evidence o f'q tia 1 1 fic iB to n ft?i^ ^ # ^ I I B I l l I l l reyjgwe'd^ i
0 ^ 5 p a fl8 ^ a |i]p a l^ \ j^ S^
Q lea ra fic# e^ |ew ecli7 j^ ^
C n m ih i% ^ i§ M ;0 ^ I S
G R B jE ^ c ff^ S r^ p ^ P  
Ceriificaie N o .."
immidialely^s
f e W M p i j w p l
B M h I
Ccniirmstion^of vajih: R e s ^ c h '^ ^ p o r tK P r o j^ ^ p e c i f ic  EJ-. JTtyee^year G ^ Q th e r .E n d  date □ . j  v.: V
lags mm mm mmsmmm mm mm
The Research Passport: Version 2 
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The Leeds Teaching Hospitals
NHS Trust 
RECRUITMENT SERVICE
Ground Floor, Trust Headquarters, S t Jam es’s Hospital, Beckett Street,
Leeds, LS9 7TF
Private and Confidential
Obi Peter Adigwe 
111 Scott Hall Road 
Leeds 
LS72HH
Enquiries to: 
Direct Line: 
Our Ref: 
Date:
Jennifer Tate 
(0113)2066548 
LOA/JT
29th November 2010
Dear Obi,
Letter of access for research *• Project Title: Non Medical Prescribing in 
Chronic Non Malignant Pain
This letter confirms your right of access to conduct research through The Leeds 
Teaching Hospitals NHS Trust for the purpose and on the terms and conditions set 
out below. This right of access commences on 1st November 2010 and ends on 
30th October 2012 unless terminated earlier in accordance with the clauses below.
You have a right of access to conduct such research as confirmed in writing in the 
letter of permission for research from this NHS organisation. Please note that you 
cannot start the research until the Principal Investigator for the research project has 
received a letter from us giving permission to conduct the project.
The information supplied about your role in research at The Leeds Teaching 
Hospitals NHS Trust has been reviewed and you do not require an honorary 
research contract with this NHS organisation. We are satisfied that such pre­
engagement checks as we consider necessary have been carried out.
You are considered to be a legal visitor to The Leeds Teaching Hospitals NHS Trust 
premises. You are not entitled to any form of payment or access to other benefits 
provided by this NHS organisation to employees and this letter does not give rise to 
any other relationship between you and this NHS organisation, in particular that of an 
employee.
While undertaking research through The Leeds Teaching Hospitals NHS Trust, you 
will remain accountable to your place of study University of Leeds but you are 
required to follow the reasonable instructions of Chris Acomb in this NHS 
organisation or those given on her/his behalf in relation to the terms of this right of 
access.
Where any third party claim is made, whether or not legal proceedings are issued, 
arising out of or in connection with your right of access, you are required lo co­
operate fully with any investigation by this NHS organisation in connection with any
Yours sincerely 287
Jennifer Tate 
Recruitment Assistant
cc; R&D office at Leeds Teaching Hospitals NHS Trust
HR department of the substantive employer (and provider of honorary clinical 
contract, where applicable)
__ 288Appendix 8: Prescribers’ consent form
Faculty of Medicine and Health,
School of Healthcare 
Prescriber Consent Form
PRESCRIBING FOR CHRONIC PAIN BY NURSES AND PHARMACISTS
THIS FORM IS TO BE COMPLETED BY THE PRESCRIBER
S/NO Statement Please initial 
below
1 1 have read, understood and kept a copy of the information sheet.
I 1 have had the opportunity to ask questions and discuss the study and 1 have received 
satisfactory answers to my questions and sufficient information about the study.
9 1 understand that 1 am free to withdraw from the study at anytime and do not have to give a 
reason for withdrawing.
4 1 understand my personal details and other information 1 provide will be kept confidential, 
stored securely and only accessed by authorised persons.
5 1 understand that information 1 give may be included in published reports, but 1 will not be 
Identified, or have such information traced back to me.
1
1 understand that relevant sections of data collected during the study may be looked at by 
individuals from the University of Leeds, from the regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. 1 give permission for these 
individuals to have access to my records.
1 1 agree to have my interview audio recorded.
I agree to take part in this study
Prescriber Signature..--- ------------  Date.
Name of Prescriber
Researcher Signature..----------- - Date.
Name of Researcher
Thank you for agreeing to take part in this study. 
Prescriber Consent Form Version 1.0 18/03/2010 Ref: 10/H1307/2
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Appendix 9: P rescribe™ 1 inform ation sheet
Faculty o f M edicine an d  Health, 
School o f H ea lthcare  
PRESCRIBER INFORMATION SHEET
Non Medical Prescribing in Chronic Non Malignant Pain
I would like to invite you to take part in a research study. Before you decide whether to take part 
you need to understand why the research is being done and what it will involve. Please read the 
following information carefully and talk to others about the study if you wish.
What is the purpose of this study?
To explore the views and experiences of Non Medical Prescribers, in this instance, nurses and 
pharmacists, in the treatment of Chronic Non Malignant Pain, as well as determine barriers and 
facilitators influencing the implementation of Non Medical Prescribing in the treatment of Chronic 
Non Malignant Pain.
Who is carrying out the study?
The study is being carried out by Obi Adigwe, a PhD Student in the School of Healthcare at the 
University of Leeds. The study is supervised by a team of three experienced researchers led by 
Professor Jose Closs
Why have I been chosen?
You have been asked to participate because you are a nurse or pharmacist prescriber 
Do I have to take part?
The decision to take part is entirely voluntary. You do not have to take part if you do not want to. 
What will happen if I choose to take part?
If you do decide to take part, I will contact you to discuss the study and invite you to an informal 
interview during which I would talk to you about your views and experiences of prescribing with 
respect to chronic non malignant pain. The interview will last approximately one hour, and will be 
arranged at a time and place of your convenience. With your permission the interview will be tape 
recorded so that it can be transcribed.
What are the advantages and disadvantages of taking part?
Participating In the study will help us understand more about what barriers and facilitators nurses 
and pharmacists face when prescribing for people with chronic pain. The results of the research may 
lead to an improvement in how non medical prescribing is perceived and carried out in the 
management of chronic pain
The interview will involve you giving up approximately one hour of your time. I have undergone 
appropriate training specifically for this study and I appreciate that issues regarding how you 
prescribe may be sensitive.
Can I withdraw from the study at anytime?
You are free to withdraw from the study during or at the end of the interview and you do not have 
to give a reason. If you decide to withdraw from the study, any information that you have given with 
consent will be used. However, no further data collection will be carried out.
Will the information I give be kept confidential?
The information that you tell me in the interview will be treated in the strictest confidence. Only my 
supervisors and I will have access to your personal data such as your name and contact details. The 
Interview will be stored securely and separately from your personal details. Only my supervisors and 
I will have access to the interview transcripts. These will be made anonymous and any identifying 
features will be removed. The tapes will be destroyed after they have been transcribed and the 
transcripts will be stored securely for 5 years.
All data will be stored in a secure and locked location in accordance with data protection 
requirements and all information collected about you during the study will be stored securely in a 
locked office and on a password protected computer.
What will happen to the results of the study?
The study is for my PhD and the results will form a part of this. The results may also be reported in 
scientific and academic journals and during conference proceedings. No individual will be able to be 
identified from details in any reports, papers or presentations that come out of the study.
Who has reviewed this study?
This study has been reviewed and approved by the appropriate regulatory bodies that have been set 
up by the government to protect the interests of patients and research participants. These include 
National Research Ethics Service (NRES) and National Health Service (NHS) Research Ethics Committees.
If you agree to take part, would like more information or have any questions or concerns about 
the study please contact me:
Obi Adigwe (PhD Student)
Room 3.08
School of Healthcare, Baines Wing 
University of Leeds, LEEDS LS2 9UT
Tel: 0113 343 7366 
email: hcooaOleeds.ac.uk
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Thank you for taking the time to read this information sheet.
291
Appendix 10: Topic guide for non-mcdical prescribers
Introduction:
Introduction of the interviewer, the study and its objectives
Briefly mention their place in the study (The study will explore how nurses and pharmacists 
perceive non medical prescribing, their attitudes to analgesics and other medication 
(including controlled drugs) and what they perceive to be battlers and facilitators to NP in 
CP)
Assure anonymity and confidentiality in the course of the study 
Ask for permission to use the tape recorder
Background information
Could we just start by asking you to say a bit about yourself and your prescribing 
experience?
Prompts
• How long since qualification (as professional and as prescriber)
• What part of the healthcare service do you work in (primary care, secondary care, 
community pharmacy etc)
• Whether you have specialist training in any pain management 
(chronic/acute/palliative etc)
• Work history and experience in prescribing
Factors affecting N P in the management of C P
In your experience, what factors have you found influence your prescribing practices in CP? 
Prompts
• Are you able to access CPD relevant to CP?
• How has continuing professional development affected your prescribing?
• What are your views on the preparation of the Clinical Management Plan in
supplementary prescribing in CP (barrier or facilitator) to fulfilling your role as a 
prescriber?
• Do you feel that networking with other NPs will affect your prescribing?
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• Do you feel that increased/reduced clinical supervision will affect your prescribing 
capability?
• How do you feel about interdisciplinary collaboration in CP treatment and 
management?
• What kind of infrastructural support is presently in place to support your prescribing 
(software, pads, remuneration, official recognition. CPD etc)?
• What kind of infrastructural support do you think will improve your prescribing in CP?
• What will improve your status as a NP in CP?
Patients
How would you describe your experience in prescribing for patients suffering from CP?
Prompts
• What are your views regarding patients with CP in terms of adherence/compliance?
• What do you feel about the concordance model in prescribing for patients with CP?
• Do you use any tools to aid your consultation, if so what are they?
• Do you feel that present prescribing practices In for you personally CP are adequate 
(time, space, tools, infrastructural support etc), if not what do you suggest could 
improve them
Treatment and Medication
What are your feelings about the present management and treatment of CP?
Prompts
• What are your opinions about patients' access to appropriate medicines in CP?
• What are you views about the various forms of NP for CP (for instance:
Supplementary Prescribing and the Clinical Management Plan: no controlled drugs 
for Pharmacist IP, all prescribing within your 'competence' etc)?
• Can you tell us a bit more about your relationship with CP patients regarding 
controlled drugs and other medication with potential for addiction?
• What do you feel about non drug measures in the treatment and management of 
CP?
• Which if any non pharmacologic interventions do you recommend as part of pain 
management?
• Do you discuss side effects and their management with your patient, if so. how?
• What are the commonly encountered side effects to medicines prescribed for CP, 
and how have they affected your prescribing practices?
• Does the price of medication affect your decision to prescribe specific product? If so. 
how?
Conclusion
If you could influence how prescribing practices for patients with CP were delivered, what 
messages would you like to provide policymakers regarding how NP could be made safer, 
more effective and easier for patients to access in the treatment and management of CP 
Prompts
• Training and/or infrastructural needs of NP's specific to management and treatment 
of CP that need to be scaled down/stopped. Improved upon, or introduced.
• Any changes required in the current system to better meet the needs of people with 
CP
• Are there any factors that have not been mentioned already that would prevent, 
suppress or hinder your provision of these services?
Thank you.
Please be assured that everything we've discussed will be treated confidentially and 
that nothing will be reported in such a way that will make the people that said them 
identifiable.
Appendix 1 1: Topic guide nurses and pharmacists not prescribing for chronic pain 
Introduction:
Introduction of the interviewer, the study and its objectives
Briefly mention their place in the study (The study will explore how nurses and pharmacists 
perceive non medical prescribing, their attitudes medicines (including controlled drugs) and 
what they perceive to be barriers and facilitators to NP)
Assure anonymity and confidentiality in the course of the study
Ask for permission to use the tape recorder
Background information
• How long since qualification (as professional and as prescriber)
• Are you both S P  and IP
• What part of the healthcare service do you work in (primary care, secondary care, 
community pharmacy etc)
• What would you say is your specialty area.
• Do you ever come across chronic pain
• If so why don't you prescribe in CHRONIC PAIN
• What do you feel will enable you prescribe in chronic pain
• Work history and experience in prescribing
Factors affecting NP in Practice
• Are you able to access CPD relevant to your specialty?
• How has continuing professional development affected your prescribing?
• What are your views on the preparation of the Clinical Management Plan in
supplementary prescribing with respect to fulfilling your role as a prescriber?
• Do you feel that networking with other NPs will affect your prescribing?
• If it Is or was applicable to you, Increased/reduced clinical supervision will affect your 
prescribing capability?
• How do you feel about interdisciplinary collaboration in practice (doctors, 
pharmacists, nurses)
• What kind of infrastructural support is presently in place to support your prescribing 
(software, pads, remuneration, official recognition, CPD etc)?
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• What kind o f infrastructural support do you think will improve your prescribing?
• What are your views about how qualifying as a prescriber should influence the 
remuneration o f a nurse (cheap prescribet)
• What will improve your status as a NP?
Patients
• What do you feel about the concordance model In prescribing for your patients?
• Do you use any tools to aid your consultation, if so what are they?
• How adequate is the current prescribing setup in your establishment (time, space, 
tools, infrastructural support etc)
• i f  they are not, what do you suggest could improve them
Treatment and Medication
• What are your opinions about patients' access to appropriate medicines In your 
specialty?
• What do you feel about the use of non drug measures
• Do you discuss side effects and their management with your patient, i f  so, how?
• Does the price o f medication affect your decision to prescribe specific products? If 
so, how?
Conclusion
If you could influence how NP was earned out, what messages would you like to provide 
policymakers regarding how NP could be made safer, more effective and easier for patients. 
Prompts
i  Are there any factors that have not been mentioned already that would prevent, 
suppress or hinder your provision o f these services?
Thank you.
Please be assured that everything we've discussed will be treated confidentially and 
that nothing will be reported in such a way that will make the people that said them 
identifiable.
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297
Field Notes interview Nine.
The interview was held in one of the rooms at the University of Leeds. The room was quiet, and the 
seating arrangement was made in such a way that there was no potential distraction from either the 
window or the door. The Prescriber arrived on time and In a bid to make her comfortable, offered a 
cup of tea. She accepted the offer, and this increased the ambience of the interview. The seating 
arrangement had been done earlier in such a way that will give me the view of the clock. This 
seemed unnecessary, as the prescriber told me to take as much time as I needed.
We had a brief interruption during the interview by a security personnel, but it did not seem to 
affect the countenance of the either myself or the prescriber. The fact that I was a pharmacist 
seemed to encourage the prescriber to be more open when she was answering her questions. I 
noticed this because she confirmed that I was a pharmacist, before she confided in me certain 
observations about pharmacists, as well as other phenomena that she thought I would understand 
better, or perhaps see from the point of view of a pharmacist.
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Appendix 15: A bstract from  School of Healthcare conference
Obi Adlgwe
Barriers and facilitators to analgesic prescribing by nurses and pharmacists In 
primary care
Background
Up to one in five adults in the UK may suffer from chronic pain which may negatively affect 
their quality of life. The management of chronic non malignant pain is inadequate In order 
to improve various shortcomings In healthcare services such as availability of choice, access 
lo care, and efficiency of services provided by healthcare professionals, recent policy 
changes In the UK have led to enhanced prescribing rights for nurses, pharmacists and 
others
Aim
The study aims to explore how prescribing by nurses and pharmacists for chronic non 
malignant pain is perceived by nonmedics! prescribers and patients with chronic non 
malignant pain, and what factors influence the use of non medical prescribing rights in the 
treatment and management of chronic non-malignant pain
Research Questions
What are the views and experiences of non medical prescribers (nurses and pharmacists) 
In the treatment and management of chronic non malignant pain?
How Is prescribing by nurses and pharmacists in the treatment and management of 
chronic non malignant pain perceived by patients with chronic non malignant pain?
In the treatment and management of chronic non malignant pain, what barriers and 
facilitators are perceived to influence the implementation of non-medical prescribing?
Method
At part of the multi methods approach being employed for this study, the first phase 
involves the exploration of the views and experiences of patients and non medical 
prescribers. These participants are being sampled purpdsively Initially, then theoretically. 
Oata will be collected using m-depth interviews
The data collected during this first phase is being analysed using the constant comparative 
method of qualitative analysis following (he principles of grounded theory.
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Appendix 16: A bstract from British and Canadian Pain Society conferencc
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|Vcsciil)CUlll tlio Yorkshire and Himilici rcgon'of Die UK tnterviuws wereaudiotixanSM and lunscriftSI 
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Appendix 18: Non-m edical prescribers’ survey
NON MEDICAL PRESCRIBING IN CHRONIC NON 
MALIGNANT PAIN
This survey is the second phase of a study being carried out in the School of Healthcare in 
the University of Leeds. The purpose is to further examine the views and experiences of 
Non Medical Prescribers (NMPs) which were revealed in the interview phase of the study.
We also aim to determine barriers and facilitators to the use of Non Medical Prescribing in 
the treatment of Chronic Non Malignant Pain (subsequently referred to as chronic pain). 
The questionnaire will take approximately 10 minutes to complete. Your responses will be 
treated in the strictest confidence. All data will be anonymised.
Thank you fortaking the time to participate in this study
* 1. What is your.PRIMARY profession?
OiNurse
pjMidwife
QPhanriacfet 
0  Other; v
2. How many years' ago did you qualify as a Nurse, Midwife or Pharmacist?
Djless'than. Shears 
C)’5 to ipiysear#&
O lfi to j^yea rs . ’ . 
p :16to}2pyears;-.rj 
SPiMoreanan 20 years
|  WHaljis^o^'primary specialty (or area of pra'ctice)v’<iB B B i f c  ^  -
....... ^309
4. How long ago did you qualify as a PR ESC R IBER ?
jss than 1  year 
year- 2 years 
5 months -4years 
ibre than 4 years
h h h h h h b h
5, Whatas you  r ia g e?  
elow 25
5-54, r  1 5  ■ 3
6. What iSjyour gender?
*7. Have you prescribed since qualifying as a Non Medical Prescriber?
:^ 5proVer.
I) Yes iff
* 8ipfese-gly^ ab rief suggestion as to what measures you feel would enable you use 
OT^^BSnqwiiaiification ________ ;_______________________
• 9. The following factors have been a barrier to my ability to commence prescribing 
since I qualified as a prescriber (please mark as many as are applicable to you)
n There is no role within my organisation that involves prescribing 
H i will not be paid for the extra responsibility attached to prescribing 
f j If I prescribe, there will no 'second check’ to assess my prescriptions 
,10 The budget from which my prescribing will be paid for has not yet been identified 
Other factors that I have seen as a barrier are (Please specify)____________________
*10. Do you PRESCRIBE for patients with Chronic Pain 
DNo . *
111.1 do not prescribe in chronic pain because....
(pleasemark as many as are applicable to you)
mido not feel confident prescribing in chronic pain 
W] I feej that only chronic pain specialists should prescribe in chronic pain 
E  lfeel that my knowledge about chronic pain is inadequate 
C  H «s not included in the list of diseases that I have included in my 'prescribing passpoi 
DI feel that my experience with patients that have chronic pain is inadequate 
Oleelthatmy experience with drugs used for chronic pain is inadequate 
lE lfti hot have any certificated training In chronic pain 
O |o  not feel that I am competent to prescribe in chronic pain 
IpiBd not feel comfortable prescribing controlled drugs 
Clatfi afraid I would be struck off if I made a mistake 
O flo ' fibt come across any patients with chronic pain
Others reasons why l do not prescribe are (Please s p e c i f y ) ___________________
_____________________  311
*12. How often do you refer patients with chronic pain?
j  More than five times a week 
Between once and five times a week 
g Less than once a week but more than once a month 
i At least once a month 
lessthan once a month
1 | neyer refer patients with chronic pain
13. Who do you refer patients with chronic pain to?
n General Practitioners (GPs)
Other Non l^edical.Prescribers 
APainClfnic 
j Hospital Consultants 
Other(Please specify) m .  ^ zdM M W : -I — ^  _  
‘14. How often do.you prescribe for patients with chronic pain?
More than five times a week 
Between tince and five times a week 
> Less than once a week but more than once a month 
U least once a month 
Less than once a month
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15, B e l o w  are some factors that affect how prescribers gain COMPETENCE to 
prescribe for patients with chronic pain.
A BO U T  my PRESCRIBING IN CHRONIC PAIN:
Strongly
Agree Agree Neutral Disagree Strongly
1 lean access 
| networks of 
others who 
i prescribe for 
! chronic pain
a o o <5
I re}# on more 
knowledgeable 
in
team/practice
O o ° E vO
1 l ean access 
chronic pain 
specific 
courses
o
__ _ J
a , o  - a
I would rather 
ref^ r, patients 
than undertake 
morejstudy/
Prescribing
controlled
drugs is 
frightening for
o O Q O’ H
me
ijeam ffom.N- 
others?* 
■«(^ eTienc^ .;>;B H
networks of
O O O: O |R
HraulaeaBI J T
1 always use a 
guideline when 
prescribing in 
chronic pain
!; o ! o< 0 i !§j
!ti| important 
io.beitrained’
on using'
B D H \  o ° M i M e m
drugs before 
prescribing
Other factors that help me gain competence are
16. The following are some of the resources that I have used in my prescribing for 
patients with chronic pain.
(pleasemark as many as are applicable to you)
r t do not feel that I need guidance to prescribe for chronic pain 
iQ Tlie British.National Formulary 
Fotmulary/Guideline produced by my establishment 
[i National institute for Health and Clinical Excellence’s guideline 
Other resources I use that not indicated here are (please specify)
17. My continuing professional development in CHRONIC PAIN has been through . 
(please mark as many as are applicable to you)
^attending meetings of the pain group of my professional body 
] accessing online pain group of my professional body 
~ accessingwebsites that specialise on pain 
] attending in house sessions in my. organisation 
] attending pertinent day courses organised elsewhere 
Jreadingrelevantjournals
attending meetings of non medical prescribers who specialise in pain 
j accessing online groups of non medical prescribers who specialise in pain
ecify)
IS. In order to develop your PRESCR IBIN G  SK ILLS, it may be necessary to access 
continuing professional developm ent SPEC IFIC  TO PRESCRIBIN G
ABOUT MY CONTINUING PRO FESSIO NAL DEVELOPMENT NEEDS IN 
PRESCRIBING:
L 314
I am presently 
allowed a 
proportion of 
my normal 
working time 
for continuing 
professional 
development
(should be 
allowed 3 
proportion of 
my normal 
working time 
for continuing 
professional 
development
I am satisfied 
with my access 
lo continuing 
professional 
development 
specific to 
prescribing
1 prefer to fitlfil 
my continuing 
professional 
development 
needsbyself 
dfrected' : 
framing in my 
own tim e:',
I do not think 
that it is 
necessary to 
cany out any 
continuing 
professional 
development in 
prescribing
Strongly
Agree Agree Neutral Disagree
Strongly
Disagree
O | 0 0 0
o . o
o 0 o O
IPS!
■gif' Q '' Q ■ O '
O D O 0
o
Other important issues regarding my continuing professional development in 
are
L
19,A-safe environment’ has been described as an environment that encourages the 
development of non medical prescriber’s skills. How important are following in 
determining how safe an environment is for your prescribing?
FOR ME, A SAFE ENVIRONMENT IS ONE WHERE:
. Veiy 
important Important Neutral Unimportant V«Unimj
1 lam sure that
\ mutual respect 
I exists among 
• colleagues
D O 0 Q fe
llcan relyort 
knowledgeable 
Gojlfagiies to O a , O ‘ 0 . Be
support.me in 
prescribing
I lean work in a
I ‘no blame’ Q D> ;a o 1
| culture
Iwilindtbe.
told off If 1* . fcf
mak^r. - o . - r 'Q X . w
jr^gijijrig.
wror-1 * r
| I will be more
| respected than 
I my colleagues 
| who are not
o D O 1 ;
| prescribers
Other factors that I think constitute a ‘safe environment’ are
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20. After deciding that you are competent to prescribe for a particular patient, how 
important are the following in aiding your decision regarding whether you should 
actually go ahead and prescribe
|WILL PRESCRIBE FOR A PATIENT ONLY IF:
very
Important Important
VeryNeutral Unimportant Unimpor
I lhave
j  access to 
software to 
produce a 
u prescription 
1 forthe 
U patient
0 0
QH 
- 
0
l.amgiven
the
authority to 
f^ iiesjt j 
further, 
diagrios^ c 
CT^B
o . : o 3 t P
1 lam 
,1 authorized 
I to prescribe 
tj controlled 
a drugs for 
v that patient
- G-. 0
oo
■ 
"
lhave fulk. 
access to* 
illife c 
pariefife 
medical. 
records
=<V-C! ' o o L _ o- °
fl lhave fully 
D accepted 
1 the legal 
4| liabilities for 
I my
( prescribing
]" c
0 o 
1 #
Other factors that will aid my decision to prescribe are (please specify) ---
ui
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a.The following are factors that I feel WILL FACILITATE my prescribing for patients 
withchronic pain
(please mark as many as are applicable to you)
jil have no interest In prescribing for patients with chronic pain 
[access to continuing professional development specific to chronic pain 
access to networks of other non medical prescribers who prescribe in chronic pain 
remuneration for my prescribing in chronic pain 
access to software that enables me to prescribe electronically 
j training on how to prescribe for patients with chronic pain 
j more respect from other team members
1 training on how to prescribe controlled drugs
2 better excess to patients' medical records
iworkihjj ih aTi ^ hvironment where I trust my colleagues 
Other factors that will facilitate my prescribing for patients with chronic pain are
I—
22. Please add any (other) comments that,you have on Non Medical Prescribing in 
chronic ga|p
f 23. How many minutes did it take yoii to complete this questionnaire?
318
Appendix 19: D raft o f  non-m edical p resc ribers ' survey
CHRONIC PRESCRIBING IN CHRONIC NON MALIGNANT PAIN
This survey is the second phase of a study being carried out in the School of Healthcare in University 
of Leeds. The purpose of this survey is to carry out a quantitative examination of the views and 
experiences of Non Medical Prescribers in the treatment of Chronic Non Malignant Pain (CP) that 
were revealed in the first phase of the study. The study also aims to determine barriers and 
facilitators influencing the implementation of Non Medical Prescribing in the treatment of CP,
The first section is focused on getting demographic data of the study participants while the second 
section will ask for your views and experiences. The questionnaire will take approximately 10 
minutes to complete and for each question, only one choice can be selected. Your participation in 
the study will help us better understand what barriers and facilitators nurses and pharmacists face 
when prescribing for people with chronic pain, and will be treated anonymously and confidentially.
Thank you for taking the time to participate in this study 
SECTION ONE : ABOUT YOU
1. What is your primary profession?
c Nursec Midwifen Pharmacistc Other
2. How long ago did you qualify as a Nurse, Midwife or Pharmacist?
n less than 5 years
^ 5  to 10 years
^  11 to 15 years
^  16 to 20 years 
r
■ More than 20 years
319
I J, How long ago did you qualify as a PRESCRIBER?
I ^ less than 1 year 
■rj
u  1 year -2 years 
r
M 25 months -4 years 
r«  more than 4 years
4 Have you prescribed since qualifying as a non medical prescriber?
| 5.What isyour age? 
below 25 
P  25-34 
f j  35-44
§  45-54 
r
*** 55 or over_____________
| 6. What is your gender?
r
“  Female 
“  Male
7. Please indicate which of the following best describes your prescribing with respect to CP 
r
I prescribe for patients with CP
I do not prescribe for patients with CP as it is in no way related to my primary area(s) of prescribing 
I ought to prescribe for CP but I do not feel I am competent to do so
p
I would like to prescribe for CP and feel competent to do so, but do not because of some barriers to my prescribing
! G Q f t e y . . . . . . . . . . - ------------- — -------------- ------------
320
SECTION TWO : ABOUT YOUR PRESCRIBING
9. How often do you prescribe for patients with C P?
P more than five times a week
E  between once and five times a week
P  less than once a week but more than once a month
E  at least once a month
^  less than once a month
A safe environment’ has been described as an environment that encourages the growth and development of the non 
medical prescrlber's skills. How do you rate the following in determining whether an environment is safe for you to 
develop as a prescriber:
Neither
FOR ME TO DEVELOP A S A PRESC R IBER , 1 NEED TO: Veryimportant Important
Important 
nor un­
important
Not
Important
Very
Unimportant
Be able to challenge and be challenged by team members e E c e E
be in a team with a structured hierarchy E ; E E E E
work in a 'no blame' service | E E E E
have a mentor to turn to when necessary e E E E E
Others (please specify)
In relation to your prescribing, do you have a proportion of your normal paid working time set aside by your 
employer to enable you to go for continuing professional development (CPD) specific to prescribing?
I would rather attend CPD during paid working hours than doing self directed learning in my own time
sS y Ao"*  iBr DiS89ree S " *a9ree disagree
c  e »  c  i  i
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Please rate your level of agreement on each of the following statements regarding which factors motivated you to 
qualify to become a Non Medical Prescriber
IBECAMEAPRESCIBERTO: Stronglyagree Agree
Neither 
agree nor 
disagree
Disagree StronglyDisagree
provide better care for patients e e e c e
&e better paid than my colleagues that are not prescribers c c c I i
give me a higher status than my colleagues that are not prescribers e e 0 e c
improve my career progression e c e 1 p
oihers (please specify)
As GPs and Hospital Doctors are paid more as prescribers, if I had a choice I would rather 'cop out' of prescribing 
and refer patients to them
Agree agree nor Disagree Strongly 
a9re* disagree Dtaa9ree
c  e  c  c  c
Non Medical Prescribers must only prescribe within their own level of competence, in your practice, how would you 
rate the following in your determination of your competence:
1 MEASURE MY COMPETENCE BY: Veryimportant Important
Neither 
Important 
nor un­
important
Not
Important
Very 
Unimportant 1
Ifie knowledge that 1 have about the drugs in that area(s) c E E E E
the number of conferences 1 have attended E E E E E
Seamount of experience 1 have with patients C E E E E
having documented evidence of experience in my prescribing area(s) E E E E E
others (please specify)
After deciding that I am competent to prescribe for a particular patient, the following helps my decision making as to 
whether I should actually go ahead and prescribe:
Very Important Neither Not Very
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my access to software to produce a prescription for the patient 
having the authority to request further diagnostic tests 
consideration of legal liabilities for prescnbing 
the access that I have to the patient s medical records
others (please specify)_________________________
Important Important Important Unimportant
c e
nor un­
important
e c c
E c c e E
C e e c E
c e c c E
WE APPRECIATE THE TIME THAT YOU HAVE TAKEN TO COMPLETE THIS QUESTIONNAIRE AND 
THANK YOU ONCE AGAIN FOR YOUR CONTRIBUTION.
Appendix 20: Letter to non-medical prescribing leads 
Dear Colleague
We plan to conduct an online survey of how Non Medical Prescribing is carried out in chronic pain, 
the aim will be to explore barriers and facilitators Non Medical Prescribers encounter when dealing 
with this condition.
323
The study Is part of a PhD being carried out by me, at the University of Leeds. I am a qualified 
pharmacist, with a Master's in Global Health and Public Policy and am now researching Non Medical 
Prescribing.
Currently, ethics approval has been given to approach prescribers through you (Non Medical 
Prescribing Leads). We believe that at this stage your input is invaluable.
We hope to have your support to
forward an online questionnaire to the Non Medical Prescribers on your mailing list
let us know the total number of prescribers on your list, to enable us calculate a sampling frame.
forward a reminder after two weeks
We look forward to your support, and hope that together we can make a significant contribution. 
If you wish to contact any of my supervisors, their e-mails are shown below
Thanks you for your assistance
Obi Peter Adigwe, BPharm, MSc
Principal Investigator, School of Healthcare, Baines Wing, 
University of Leeds, hcopa(8>leeds.ac.uk
Appendix 21: Q uestionnaire  flow chart
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Questionnaire Flow Chart
■XII non-medical 
prescribers
Inexperienced prescribers got lo got to items 8 and 9 then skip to 22
Item 10
Determine experience in 
chronic pain prescribing
Inexperienced prescrihers got to items I land 12 then skip to 18
Experienced prescribers skip to item 13 then go on
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Appendix 22: Patients* in lo r m at ion sheet
PA T IEN T INFORMATION SHEET
PRESC RIB IN G  FOR CHRONIC PA IN  BY  NURSES AND PHARMACISTS
I would like to invite you to take part in a research study. Before you decide whether to take part 
you need to understand why the research is being done and what it will involve. Please read the 
following information carefully and talk to others about the study if you wish.
What is the purpose of this study?
The study aims to explore what you think of prescribing by nurses and pharmacists for chronic pain. 
Who is carrying out the study?
The study is being carried out by Obi Adigwe, a PhD Student In the School of Healthcare at the 
University of Leeds. The study is supervised by a team of three experienced researchers led by 
Professor Jose Closs.
Why have I been chosen?
You have been asked to participate because of your chronic pain.
Do I have to take part?
The decision to take part is entirely voluntary. You do not have to take part if you do not want to. 
What will happen if I choose to take part?
If you do decide to take part, I will contact you to discuss the study and invite you to take part in an 
informal interview during which I would talk to you about your views and experiences of nurse and 
pharmacist prescribing with respect to your pain. The interview will last approximately one hour, 
and will be arranged at a time and place of your convenience. With your permission the interview 
will be tape recorded so that it can be transcribed.
What are the advantages and disadvantages of taking part?
Participating in the study will help us understand more about how nurses and pharmacists prescribe 
for people with chronic pain. The results of the research may lead to an improvement in the way 
nurses and pharmacists manage pain for patients like you.
The interview will involve you giving up approximately one hour of your time. I have undergone 
appropriate training specifically for this study and I appreciate that issues regarding your pain may 
be sensitive.
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Can I withdraw from the study at anytime?
You are free to withdraw from the study during or at the end of the interview and you do not have 
to give a reason. If you decide to withdraw from the study, any information that you have already 
given will not be used, and will be destroyed.
Will the information I give be kept confidential?
The information you tell me in the interview will be treated in the strictest confidence. Only my 
supervisors and I will have access to your personal data such as your name and contact details. All 
data will be stored in a secure and locked location in accordance with data protection requirements 
and all information collected about you during the study will be stored securely in a locked office 
and on a password protected computer.
The interview will be stored securely and separately from your personal details. Only my supervisors 
and I will have access to the interview transcripts. These will be made anonymous and any 
identifying features will be removed. The tapes will be destroyed after they have been transcribed 
and the transcripts will be stored securely for 5 years.
Outputs including direct quotes from the interviews may be used to develop the questionnaire, but 
these will be anonymised and will not be traceable to specific individuals.
Will my General Practitioner/Family Doctor (GP) be involved?
If you agree, we will let your GP know that you are taking part in this study.
What will happen to the results of the study?
The study is for my PhD and the results will form a part of this. The results may also be reported in 
scientific and academic journals and during conference proceedings. No individual will be able to be 
identified from details in any reports, papers or presentations that come out of the study.
Who has reviewed this study?
This study has been reviewed and approved by the appropriate regulatory bodies that have been set 
up by the government to protect the interests of patients and research participants. These include 
National Research Ethics Service (NRES) and National Health Service (NHS) Research Ethics 
Committees.
If you agree to take part, would like more information or have any questions or concerns about 
the study please contact me:
Obi Adigwe (PhD Student)
Room 3.35
School of Healthcare, Baines Wing 
University of Leeds, LEEDS LS2 9UT
Tel: 0113 3437366
Email: hcopa(S)leeds.ac.uk
Thank you for taking the time to read this information sheet.
Patient Information Sheet Version 2.0 22/01/2010 Ref: 10/111307/2
Faculty of Medicine and Health,
School of Healthcare 
Participant Consent Form
PRESCRIBING FOR CHRONIC PAIN BY NURSES AND PHARMACISTS
Appendix 23: P a tien ts ' consent form
THIS FORM IS TO BE COMPLETED BY THE PARTICIPANT
S/No Statement Please initial 
below
1 1 have read, understood and kept a copy of the information sheet.
2 1 have had the opportunity to ask questions and discuss the study and 1 have received 
satisfactory answers to my questions and sufficient information about the study.
3 1 understand that 1 am free to withdraw from the study at anytime and do not have to give a 
reason for withdrawing.
4 1 understand my personal details and other information 1 provide will be kept confidential, 
stored securely and only accessed by authorised persons.
S 1 understand that information 1 give may be included in published reports, but 1 will not be 
identified, or have such information traced back to me.
6 1 understand that relevant sections of my medical notes and data collected during the study 
may be looked at by individuals from the University of Leeds, from the regulatory authorities 
or from the NHS Trust, where it is relevant to my taking part in this research. 1 give permission 
for these individuals to have access to my records.
1 1 agree to have my interview audio recorded.
8 1 agree to my GP being informed about my participation in this study.
1 agree to take part in this study
Participant Signature..................... ........... Date..........................
Name of Participant
Researcher Signature................................ Date...........................
Name of Researcher
Thank you for agreeing to take part in this study.
Participant Consent Form Version 2.0 22/01/2010 Ref: 10/111307/2
Appendix 24: Topic guide for chronic pain patients 
Introduction:
Introduction of the interviewer, the study and its objectives
Briefly mention their place in the study (The study will explore how patients with chronic pain perceive 
pain relief and prescribing from nurses and pharmacists, their experiences of available services and 
their views about how services might be improved in future.)
Assure anonymity and confidentiality in the course of the study 
Ask for permission to use the tape recorder
Background information
Could we just start by asking you to say a bit about yourself and your pain?
Prompts
• How long since diagnosis
• Whether you have underlying o r complicating illnesses
• What you need to do on a daily basis to manage your pain
• How well you would say your pain is managed now
Prescriber Related Factors
Can you give me an idea of your experiences of using the services of NP's for the treatment of your 
chronic pain?
Prompts
• What went well in your experience o f the management of your pain
• What went less well
• Views about the continuity o f care received (i.e. whether the sen/ices seem integrated or 
fragmented from the patient's perspective)
• Whether you have had any problems accessing services in the past and how this has been 
affected by NP (why/ examples)
• Level o f consultation desired (in which circumstances); importance of being consulted/not 
being consulted
• Degree to which you felt involved/ consulted about your treatment while seeing the prescriber
• Your feelings about the manner in which the NP carried out your consultation and prescribing 
(perhaps in relation to previous experiences, for instance another NP, a GP or another 
Doctor).
• Your feelings about the time taken by the NP to consult/prescribe (perhaps in relation to 
previous experiences, for instance another NP, a GP or another Doctor)
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• Adequacy of the circumstances surrounding the consultation/prescribing process (time, space, 
privacy)
• Your knowledge of the kind o f skills the NP possessed that has really helped in the treatment 
o f your CP
•  Your feelings about the adequacy of skill o f the NP (perhaps in relation to previous 
experiences, for Instance another NP, a GP or another Doctor)
• Whether you feel that the NP prescribing for them provided clear and full infomiation about 
your medication, and how this compared to your past experiences
• Whether you were given sufficient Information about how to manage your CP when you 
returned home
Perception of Medication
Can you give me an idea of what you feel about the medications that you have taken or currently take 
for your CP, and its effects on your life/health/wellbeing?
Prompts
• Whether you felt that the medication given to you worked (what other benefits did you derive if 
any?)
• Whether any form of non drug measures were provided by your NP
• Your feelings and experiences of side effects and how this affects or has affected your 
medicine taking behaviour
• What other measures o f pain relief have been used, and your perception of these measures' 
effectiveness, compared to medication
• Your feeling and experiences regarding medications with potential for addiction (name, 
duration o f administration, fears etc)
Conclusion
If you could influence how you received your pain relief, what messages would you like to provide 
policymakers regarding how NP could be made more effective in the treatment and management of
ep
Prompts
• Key elements of the treatment and management of CP from your perspective
• Any changes required in the current system to better meet the needs of people with CP 
Thank you.
Please be assured that everything we have discussed will be treated confidentially and that 
nothing will be reported in such a way that will make the people that said them identifiable.
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Sh o r t C o m m u n ic a t io n
PRESCRIBING BY PHARMACISTS 
IN TH£UNIT|D KINGSOM:
WHAT CAN WE BEARN?
Adigwe* 0;P, Strickland-Hodge, B., Briggs; M: and Closs, SJ i J
School of Healthcare, University of Leads, Leeds LS2 9UT, UK.
Introduction ,
In recent yean, advance miHe: • j P  ■
(UK) hav e led  t o j h a n g g  in  leg is la tio n . 
th a t n o w  au th o riz e  p harm acis ts  w h O j • 
have been addition ally, tra ined  to  j .  
prescribe..The»'mnft^ artic i^gBncflw 
to  d esc rib fcp h a m ad so p re sm b in ^ m ^ B B  
UK then  outline tK e'fdciliS tors a n d ' 
b irr ic n  reported  by, B ritish p h a r tn s o s i  
p re s c r ib e r s ^ ith  t h e  in te n rio n 'o f ' 
gleaning insights in to ' w h a t possib le 
im plications e n s f  fpr.pharTnacisis an d  
[yjlicyinaken'irD tl ie  N igerian  hca lth c a re
Policy Goals behind Pharmacists 
Prescribing inthe
In the UK, the Department of Health 
(DH) is the arm of government M
responsible for ajl1 K&kn’Ssues. Its stated , 
objectives for this new policy direction * 
on prescribinginclude;irnproveinent of 
patientnre wiUjQut cojiiprdrnising 
safety, provision of quicker and easier 
access for patients to medication; increase 
in choice available to the patient in 
accessing medicines; more efficient use of 
the skills of health professionals; and to 
help improve flexibility, in team working 
across the Notional'Health Service ' > 
(NHS) (DHj 2010)./Presently the. two 
models used by pharmacists to, prescribe 
are supplementary and independent 
prescribing.
Supplementary Prescribing 
This form of prescribing which was 
initiated in 2003 was the Cm that legally 
allowed pharmacists to prescribe. In  
supplementary prescribing, phannacists >. 
can prescribe any medicine, w ith a few ■* 
exceptions, including controlled drugs 
within the framework of a clinical 
management plan(GMFOi'following 
consultation and agreement with a 
medical praoirioner (or dentist) (D H ,
j2C03)r Inthis form;of, prescribing, thought 
* there a.aiprescriKIngparmerihip^fetk^
'the plu rm'aci^ themedicalpnrationcr 
(or dent&)|cxerG^'sbihe IirvfcKof 
.controlover^hafandKtwlEeSL '
jinusi beronsulted'andagree t? fe  treated)
I'miihis.wayr, ’ .
Independent Prescribing .
A further development m*20p6'  led to,the 
i introduction of independMtprescribing.. 
•Tlus W Kanoti^rab'dM ^^abicito •
. pharmacists in addition tosi^usnentaiY' 
prescribing. As independen t prescribes;: 
pharmacists are able to prcscribe'any iC"
: medicine for: any^ medical’condition” ' 
'within their- competence:ex«pg>i ■ i  
: controlled tlnigs and afcrc other - 
inceptions (DH, 2006).1 Under ithe hew 
legislation, pharmacists who are _■ 
independent prescribera are responsible 
and accountable for. the assessment of 
patients with undiagnosed or diagnosed 
conditions.' In addition to prescribing, 
they can also make clinical management 
decisions for these patients.-This means 
that independent pharmacist prescribers 
are.able to prescribe and diagnose 
-without the involvement of a medical 
practitioner (or dentist) or a CM P, as 
long as they practice within their 
competence.
Literature Review 
A  systematic search using relevant 
keywords was canied out on the 
following databases: Embase (1996 to 
2010); M ED LIN E (1996 to 2010)| and 
•EsydNFO (2002 to 2010); The libraries 
oflhe University of Leeds and reference 
Has of obtained papets were hand 
searched, and U K  government ’ 
publications and websites were consulted.
T h e  a im  o f  th e  lite rature rev iew  w as t o
offer greater insights into the barriers and
facilitators to non medical prescribing in 
preparation for the fieldwork currently 
rcingatrned out; A  range of relevant 
themes were revealed, butthis ankle is 
focused on a concise and descriptive 
i^ ^ l^ f^ g fa g ljw o B  and barriers to 
pharmacist prescribing,_;i
Faalitators to PHamudst Prescribing 
Following the inception of pharmacist 
prescribing,' a growing body of evidence 
suggeststhat thenew-palicy djrmtpri can 
lead io an improvement in patients' 
access to healthcare (Smalley, 2006). 
^Pharmacists have also benefitted from 
being involved with prescribing. Being 
able to prescribe enabled pharmacists to 
milte biner use of the skills that they 
acquired as a resuh of their training and 
| experience (Warchal :et al.,2006), 
suggesting more efficient use of health 
1 care resources and provision of greater 
benefits for patients. In  addition to this, 
pharmacists reported that as a result of 
prescribing, they had more job 
satisfaction, and greater self confidence 
(George er all, 2006), Other advantages 
reported by pharmacist prescribers 
indude a perception that their role 
became more important in 
interdisciplinary teams and they were 
better recognised for the expertise that 
they possessed (Warchal et oL, 2006). 
Furthermore, having the legal right to 
prescribe meant that phannacists were 
now more involved in setting up new 
services (Hobson fic Sewell, 2006).
Barriers to Pharmacist Prescribing 
Aswith any new policy, it is expected 
that difficulties should have been 
encountered when prescribing by 
pharmacists was being implemented in 
the UK . Two dosely related barriers 
that were repotted in the literature were 
organisational and infrastructural. In 
some organisations, hurdles identified to ►
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the development of pharmacist 
prescribing were Sack of 'official 
recognition (of their prescribing status) 
within their specificTrusts as well as lack 
of funding for professional roles that 
involved prescribing (George et a], 2007). 
With respect to ihfrannjctural support, 
pharmacist p rescribers reported'that in 
some cases, there was little or no support 
to enable pharmacists to generate 
electronic prescriptions (Warchal et aL, 
2006) and gain access to patients' 
medication records (While et aL, 2004; 
George et al., 2007).' Another barrier that 
was revealed in the review was related to 
the Clinical Management Plan. Preparing 
and administering the Clinical 
Management Plan is a legal requirement 
associated with supplementary 
prescribing, however, using the Clinical 
Management Plan has sometimes been 
described as being restrictive (George et 
al., 2006), and impractical (Warthal er al., 
2006).
Implications for Pharmacists in 
Nigeria
Even though the latest W HO country 
report suggests a general improvement in 
the health care sector (W HO Country 
Office Nigeria, 2007), the average life 
expectancy of a typical Nigerian is still 
less than fifty years, and as a country, it 
continues to perform below regional 
averages in many other health indices 
(WHO, 2006). The main victim remains 
the Nigerian patient whose access to 
genuine medicines is severely limited.
The British model presents an 
opportunity that may improve the speed, 
safety and quality of the average 
Nigerian's access to medicines.
Though the Nigerian healthcare system 
differs markedly from the NHS in the 
United Kingdom, there are'many 
similarities in the manner that 
pharmacists in both countries perform 
professional duties. .Traditionally, 
pharmacists have been involved in the 
management of.prescriptions (Davies et 
a l, 1994), in overseeing patients' 
medication and in monitoring-therapy 
(Galindo et aL, 2003). Nigerian 
pharmacists are engaged in these activities 
as well. In the United Kingdom, before 
the law authorised pharmacists to 
prescribe, pharmacists have been known 
to author prescriptions which were 
signed off by doctors (Bellingham 2004),
anecdotal evidence suggests that 
pharmacists in Nigeria may be doing the 
same, in a bid to improve desperately 
needed access to medicines. It could be 
argued that granting legal rights to 
prescribe to Nigerian pharmacists is a 
logical extension of roles that they 
already perform or that k formalises a 
process that may already be in existence
For both the pharmacist and the policy 
maker in the Nigerian health care sector, 
there is scope to -reflect upon the evidence 
from the UK regarding how the 
pharmacist prescribing policy was 
implemented, and what British 
pharmacists identified as the barriers and 
facilitators to their practice. If  Nigeria 
chooses to amend present legislation to 
allow pharmacists to prescribe, the 
opportunity exists to draw on the 
positive experiences and avoid the 
hurdles that were associated with the 
British reform
Conclusion
The training and experience associated 
with medicines that pharmacists have 
would suggest a good candidacy for 
becoming a prescriber. However, being a 
good candidate does not automatically 
translate into gaining the right to 
prescribe. There arc other faciors that are 
also at play, such as determining 
standards for pre-qualification, setting up 
training programmes to enable the 
acquisition of other relevant skills and 
instituting clinical governance structures.
W ith over 15,000 registered pharmacists 
(PCN, 2011) in Nigeria, granting 
prescribing rights is an option to be 
seriously contemplated if unproved 
healthcare access for millions of 
Nigerians is to be achieved in safe and 
efficient manner. The willingness shown 
by Nigerian pharmacists to engage in 
professional practices that may improve 
patient outcomes (Oparah and Efrekaya, 
2005) is a step in the right direoion.
More work is however needed if this 
article is to do more than stimulate 
interest and generate debate. The reform 
which led to prescribing by British 
pharmacists should be carefully 
considered by policy makers and 
healthcare practitioners. International 
evidence on prescribing by pharmacists 
w ill need to be rigorously evaluated
(WHO, 2004), and a cautious approach 
adopted in determining suitability 
(Chinnock et aL( 2005) of this model to 
the Nigerian context.
REFEREN CES
Bellingham C; 2004 How supplementary 
prescribing helps in both acute and 
chronic hospital care. Pharmaceutical 
Journal, 272,640-641
Chinnock P, Siegfried N , Clarke M. 2005 
Is Evidence-Based Medicine Relevant to 
the Developing World? PLoS Med 2(5)
-BSviesJ, Horne R, Bennett J. and Stott 
R . 1994 Doctors, pharmacists and the 
prescribing process. B rJ Hasp Med, 
11*167-170,
Department of Health (DH) 2003 
Supplementary Prescribing [Online] 
Available at:
http://webarchive.nationalarchiYes.gov.u 
k/+/www.dh.gov.uk/en/Consultations 
/Responsestoconsukaoons/DH_4017050 
I (accessed 20th September 2010)
I Department of Health (DH) 2005 
Supplementary Prescribing by Nunes. 
Pharmacists, Chiropodists/Podiatrists, 
Physiotherapists and Radiographers 
within the NHS in England: -uide for 
implementation [Online] A- *c 
http://www.dh.gov.uk/en/ i'ublkationsa 
ndstatistics/Pubiicauons/PublicatiotuPol 
icyAndGi iidanrr/DH_4110032 (accessed 
I 10th September 201(9 
I Department of Health (DH) 2006 
Improving Patient's Access to Medicines:
A  Guide to Implementing Nurse and 
Pharmacist Independent Prescribing 
within the NHS in England [Online] 
Available at: http://www.dh.gov.uk/en/ 
Publicationsandstatistics/Publications/Pu 
blicationsPol icy AndGuidance/DH_4133 
' 743 (accessed 20th September 2010)
Department of Health (DoH) 2010 The 
non medical prescribing programme 
[Online] Available at: 
http://www.dh.gov.iik/en/Healtbcare/ 
Medicinespharmatyandindustry/Prescrip 
tions/TheNon-MedicalPrescribing 
Programme/Background/in dex.htm 
(accessed 19th September 2010)
I Galindo C, Olive M, Lacasa C, Martinez 
J, Roure C, Llado M, Romero L and Vila 
A, 2003 Pharmaceutical care: pharmacy 
involvement in prescribing in an acutc- 
care hospital. Pharm World Sci, 25-36^ 4 ►
V o lu m e  44, No 1,2011 
THE N ig e r i a n  J o u r n a l  o f  P h a rm a c y 65!
George J.McGaig D , Bond CM  et al. 
2QQ6 Supplementary prescribing; early 
experiences of pharmacists in Great 
Britain. Annals o f Pharmacotherapy, 40, 
1843-1850.
GeorgeJ.MccaigD, Bond C, 
Cunningham Is, D eck H I, Stewart D . 
2007 Benefits and challenges of 
prescribing training and implementation: 
perceptions and early experiences of 
RPSGB prescribers. International Journal 
of Pharmacy Practice;15:23-30.
Hobson R J, Sewell G J 2006. 
Supplementary prescribing by 
pharmacists in England. American 
Journal of Heahh-System Pharmacy, 63, 
244-253)..
Oparah A.C, Eferakeya A Ji. 2005 
Atdtudes of Nigerian pharmacists 
towards pharmaceutical care.
Pharmacy World and Science. 273:208- 
214
Pharmacists Council of Nigeria 2011 List 
of Registered Pharmacists as A t 4th June, 
2011 [Online] Available from: 
http://www.pciing.org/ fullreg.htm 
(accessed 15th June, 2011)
Smalley L  2006 Patient's experience of 
pharmacist-led supplementary 
prescribing in primary care. 
Pharmaceutical J  burnaIj276;567-9:
W a n M  S., D . Brown, E t A l. 2006 
Attitudes of successful candidates of 
supplementary prescribing courses to 
•their training and their extended roles. 
Pharmaceutical Journal 276(7393): 348- 
1352.
While A JvM udaly M, Nathan A  .2004. 
Views of community pharmacists 
regarding supplementary prescribing. 
International Journal of Pharmacy 
Practice; 12J143.
World Health Organization 1994 World
Health Assembly. Resolution 
WHA47.12: Role O f The Pharmacist In 
Support O f The W HO  Revised Drug 
Strategy. WHA47/1994/REC/1
World Health Organization. 2004. The 
Mexico statement on health research, 
[Online]Available from: 
hup://www.who.int/rpc/summit/agend 
a/Mexico_Starement- English.pdf 
(accessed 10th September 2010)
World Health Organization 2006 
Country Health profile of Nigeria 
[Online] Available from: 
http://www .afro.wha.ini/en/nige ria/co 
untry-health-profile.html (accessed 20th 
September 2010)
W H O  Country Office Nigeria; 2007 
Annual report; technical cooperation for 
sustainable development [Online] 
Available from:
http://www.who.int/couniries/nga/en/ 
(accessed 22nd September 2010)
